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Abstract 
The synthesis of compounds containing α-arylated quaternary stereogenic centres is 
a significant synthetic challenge.  This thesis describes the development of an 
organocatalytic methodology for the direct construction of this motif through the 
Michael addition of carbon-centered pro-nucleophiles to highly reactive and 
unstable ortho-benzoquinones.  
 
Proof-of-principle for the base catalysed Michael addition to ortho-quinones was 
established with stable 1,2-naphthoquinone (Chapter 2), however typical ortho-
benzoquinones were found to be too unstable to use in this process.  Accordingly an 
oxidative coupling strategy was developed for in-situ generation of the o-
benzoquinone electrophile (Chapter 3.1). The base catalysed Michael addition 
followed by aromatisation allows for the direct construction of arylated quaternary 
stereocentres.  An asymmetric variant was also developed by replacing the base 
catalyst with a cinchona alkaloid derived organocatalyst, up to 82% ee was 
achieved (Chapter 3.2).  
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The methodology was then applied to the racemic total synthesis of the 
amaryllidaceae alkaloids powelline and buphanidrine (Chapter 4).  The oxidative 
coupling methodology allowed rapid construction of the sterically congested 
arylated quaternary stereocentre in the key step of the syntheses, which were then 
completed in 13 and 14 steps respectively in 6% overall yield. Employing quinidine 
derived organocatalyst QD-265 in the oxidative coupling step gave arylated product 
208 in 57% yield (3 steps) and 70% ee (Chapter 5).  However, the enantioselective 
total synthesis was thwarted by racemisation during the Dieckmann-type cyclisation 
for the formation of enol ether 212 and an alternative synthetic strategy will be 
required to synthesise the enantiopure alkaloid. 
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Abbreviations 
ºC degrees Celsius 
Å ångström 
Ac acetyl 
Anh anhydrous 
aq aqueous 
Ar aromatic group 
BEMP 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
BINOL 1,1'-bi-2,2'-naphthol 
Bn benzyl 
Boc tert-butoxycarbonyl 
br. broad 
Bu butyl 
c concentration 
calcd. calculated 
cat. catalyst 
Cbz benzyloxycarbonyl 
CI (+/-) chemical ionisation (positive/negative) 
cm centimetre 
COD 1,5-cyclooctadiene 
conv. conversion 
COSY correlation spectroscopy 
Cy cyclohexyl 
d day/doublet (NMR) 
DABCO 1,4-diazabicyclo[2.2.2]octane 
dba dibenzylideneacetone 
DEAD diethyl azodicarboxylate 
DEPT distortionless enhancement by polarization transfer 
DIBAL diisobutylaluminium hydride 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
dr diastereomeric ratio 
dtpf 1,1 -bis(di-tert-butylphosphino)ferrocene 
ee enantiomeric excess 
EI (+/-) electron ionisation (positive/negative) 
epi epimer 
equiv equivalents 
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ES (+/-) electrospray (positive/negative) 
ESI electrospray ionisation 
Et ethyl 
EWG electron withdrawing group 
g gram 
h hour 
HMBC heteronuclear multiple bond correlation 
HMDS hexamethyldisilazane 
HMQC heteronuclear multiple-quantum coherence 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectroscopy 
HSQC heteronuclear Single Quantum Coherence 
Hz hertz 
i iso 
IR infra-red 
L/K/N-Selectride® lithium/potassium/sodium tri-sec-butylborohydride 
LHMDS lithium hexamethyldisilazane 
m multiplet 
m meta 
M molar 
m/z mass-to-charge ratio 
max maximum 
Me methyl 
mg milligram 
MHz megahertz 
min minute 
mL millilitre 
mmol millimole 
mol mole 
MP melting point 
MS mass spectroscopy 
Ms mesyl (methanesulfonyl) 
n normal, straight chain 
NMR nuclear magnetic resonance 
NOE/NOESY nuclear Overhauser effect 
Nu nucleophile 
o ortho 
p para 
Pg Protecting group 
Ph phenyl 
PIFA phenyliodonium bis(trifluoracetate) 
 10
PMP 1,2,2,6,6-pentamethylpiperidine 
ppm parts per million 
Pr propyl 
ps polymer-supported 
q quartet 
Q quinine 
QD quinidine 
Red-Al® sodium bis(2-methoxyethoxy)aluminium hydride 
rt room temperature 
s singlet 
sec secondary 
SNAr nucleophilic aromatic substitution 
Super-hydride® lithium triethylborohydride 
T temperature 
t time or triplet (NMR) 
t/tert tertiary 
TBDMS tert-butyldimethylsilyl 
TBME tert-butyl methyl ether 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TIPS tri-isopropyl 
TLC thin layer chromatography 
TMG 1,1,3,3-tetramethylguanidine 
TMS trimethylsilyl 
Tr trityl 
Ts tosyl (p-toluenesulfonyl) 
vs versus 
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Stereochemistry 
Stereochemistry is drawn in accord with the conventions proposed by Maehr.‡ 
Normal bond thickness is used for racemic compounds or enantioenriched 
compounds where stereochemistry is unknown.  Enantioenriched compounds are 
identifiable by a (+) or (-) compound number prefix indicating the sign of the 
optical rotation. Solid and broken wedges are used to indicate absolute 
configuration when known (or inferred from other results) in enantioenriched or 
enantiopure compounds.  Solid and broken lines are used to indicate the relative 
stereochemistry (when known) of diastereopure or diastereoenriched racemates (or 
diastereopure/diastereoenriched, enantioenriched compounds with known relative 
but unknown absolute stereochemistry). 
MeO O
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O
OMe
O
MeO O
O
BocN
OMe
O
racemic or enantioenriched
 compound with 
unknown stereochemistry
MeO
O
O
O
OH
OH
enantiopure or enantioenriched
compound where stereochemistry
is known (or assumed)
racemic diastereopure or 
diastereoenriched compound with 
known relative stereochemistry  
 
                                                 
‡ Maehr, H. J. Chem. Educ. 1985, 62, 114–120   
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1 Introduction 
1.1 Significance of α-arylated quaternary stereocentres 
A significant number of pharmaceutically important compounds and biologically 
active natural products contain substituted catechol (1,2-dihydroxylated benzene) 
derivatives covalently bonded to all-carbon quaternary stereocentres. Typical 
examples include: the calcium channel antagonists verapamil (1);1 the 
phosphodiesterase IV inhibitor cilomilast (2);2 the paraherquamide family of anti-
parasitic alkaloids (3);3 several members of the amaryllidaceae alkaloid family, 
including haemanthidine (4), and tazettine (5) that exhibit analgesic and anti-cancer 
properties;4 and the galanthamine type amaryllidaceae alkaloids that exhibit 
significant and diverse biological activities.5 Galanthamine (6) has been shown to 
be effective in the symptomatic treatment of senile dementia of the Alzheimer’s 
type,6 and further analogues of galanthamine with increased blood-brain barrier 
permeability have recently been reported as treatments for human brain diseases 
associated with a cholinergic deficit including Alzheimer’s disease, Parkinson’s 
disease, vascular dementia, schizophrenia and epilepsy.7,8   
 
O
MeO
CN
COOH
cilomilast 2
MeO
MeO
CN
N
MeO
OMe
verapamil 1
OHO O
N
galanthamine 6
O
N
O
O
MeO
H
OH
tazettine 5
N
N
O
O
NH
O
MeO
R2
H
R1
paraherquamide A: R1 = OH, R2 = Me 3a
paraherquamide B: R1 = R2 = H 3b
N
O
O
MeO
H
OH
OH
haemanthidine 4  
Scheme 1.1: A selection of pharmaceuticals and biologically active natural products 
containing catechol derivatives bonded to all carbon quaternary stereocentres. 
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1.2 Methods for synthesising α-arylated quaternary carbon centres 
The construction of α-arylated all-carbon quaternary stereogenic centres is still a 
significant synthetic challenge.  Several approaches have been investigated and are 
detailed below. 
1.2.1 Friedel-Crafts Alkylation 
The synthesis of simple tri-alkyl substituted quaternary arylated carbon centres 
through Friedel-Crafts chemistry (e.g. introduction of a tert-butyl substituent) is a 
well established transformation.  More recently enantioselective Friedel-Crafts 
reactions have been developed;9 however this chemistry is yet to find significant 
application in the synthesis of all-carbon arylated quaternary stereocentres.  
Examples of the diastereoselective synthesis of this motif have been reported, these 
include the intramolecular Friedel-Crafts-type cyclisation of tertiary benzylic 
cations generated through protonation of styrene precursors such as 7, reported by 
Bach to give α-arylated quaternary centres with high levels of facial selectivity 
(Scheme 1.2).10 
F3CSO3H (1 equiv)
25 ºC, CH2Cl2
95% yield
98:2 dr.
7 8
 
Scheme 1.2: Intramolecular Friedel-Crafts alkylation for the 
synthesis of α-arylated quaternary stereocentres 
During studies towards the total synthesis of the hauoamines, Trauner developed an 
intramolecular Friedel-Crafts alkylation to generate α-arylated quaternary centres 
with simultaneous formation of enol triflates.11  Triflic anhydride activates enones 
such as 9 to generate a stabilised cation that is trapped by the pendant electron-rich 
arene (Scheme 1.3). 
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N
O
O OMe
OMe
MeO
MeO
Tf2O (1.5 equiv)
CH2Cl2
63%
N
N
H
OTf
O OMe
OMe
OMe
MeO
9 10  
Scheme 1.3: Triflic anhydride promoted Friedel-Crafts alkylation 
1.2.2 Stoichiometric Organometallic Reagents 
The reaction of enolate nucleophiles with electrophiles including alkyl halides, 
carbonyls and α,β-unsaturated carbonyl compounds is one of the most widespread 
methods for the construction of carbon – carbon bonds.  However the reaction of 
enolate nucleophiles with aromatic species for the construction of carbon – aryl 
bonds is far less common.   
Pinhey has demonstrated the ability of aryllead tricarboxylates to react with β-
ketoesters, cyanoacetates and malononitriles to give arylated quaternary carbon 
centres in modest to good yields.12  For example cyanoacetate 11 was reacted with 
p-methoxyphenyllead triacetate 12 to give arylated adduct 13 in 72% yield (Scheme 
1.4).  The involvement of free radicals in the reaction mechanism has been excluded 
and a ligand coupling mechanism proposed.13  Diastereoselective examples have 
also been reported (Scheme 1.5).14 
 
CNEtO2C
Pb(OAc)3
OMe
DMAP, CHCl3+
OMe
CNEtO2C
11
12 13, 72%  
Scheme 1.4: Arylation of cyano acetate 11 with aryllead triacetate 12. 
O
OTBDMS
CO2Me p-MeOC6H4Pb(OAc)3
pyridine, CHCl3
O
OTBDMS
OMe
CO2Me
97% yield, 20:1 dr.
14 15
 
Scheme 1.5: Diastereoselective arylation with aryllead triacetate. 
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Whilst these aryllead reagents allow the construction of sterically congested 
quaternary centres and are readily prepared, given the toxicity of lead compounds 
the stoichiometric use of these reagents is not desirable.   
Organobismuth reagents have also been reported for the α-arylation of ketones, 
diketones and β-keto-esters (Scheme 1.6).  Whilst these reagents do not have the 
toxicity liabilities associated with the aryllead reagents, in these cases only one of 
three aryl groups is transferred from the bismuth reagent.15 
O
OEt
O Ph3BiOCOCF3 (2 equiv)
C6H6, 60 ºC, 24 h
2-tert-Butyl-1,1,3,3-tetramethylguanidine
O
OEt
O
Ph
16 17, 90%  
Scheme 1.6: α-Arylation of β-keto-ester with organobismuth reagent. 
1.2.3 Asymmetric conjugate additions 
 A few isolated examples of quaternary carbon – aryl bond formation through the 
copper catalysed conjugate addition of Grignard or aryl zinc reagents to α,β-
unsaturated ketones have been reported.  For example the chiral imidazolidinium 
salt (ImH+) assisted copper catalysed addition of phenylmagnesium bromide to 3-
methyl-2-cyclohexen-1-one 18 gave arylated adduct 19 in modest yield and 
enantioselectivity  (Scheme 1.7).16   Alternatively, the use of copper triflate in 
combination with a silver/N-heterocyclic carbene complex has been reported to 
catalyse the addition of diphenyl zinc to methyl-3-oxocyclohex-1-ene-1-carboxylate 
21 to give arylated adduct 22 in good yield and with high levels of stereocontrol 
(Scheme 1.8).17 
 
O PhMgBr
3% Cu(OTf)2, 4% ImH*
-30 ºC, 30 min
O
Ph
ImH* =
N+N
HOH
61% yield
 66% ee
18 19 20
 
Scheme 1.7: Chiral imidazolidinium salt (ImH*) assisted Cu catalysed 
conjugate addition of PhMgBr to generate an α-aryl quaternary carbon 
centre in modest yield and enantioselectivity.  
 16
O
CO2Me Ph2Zn
2.5 mol % Cu(OTf)2.C6H6
-30 ºC, 21 h
O
Ph
CO2Me
82% yield
 93% ee
2.5 mol % N-heterocyclic carbene-Ag complex
21 22
 
Scheme 1.8:  N-heterocyclic carbene silver complex assisted copper 
catalysed conjugate addition of an aryl-zinc reagent to generate an α-aryl 
quaternary stereocentre in high yield and enantioselectivity.  
Whilst excellent enantioselectivities can be achieved (up to 93% ee) the aromatic 
group is limited and this approach has more generally been applied to the 
construction of tertiary arylated carbon centres.18  
 
1.2.4 Transition metal catalysed arylation of carbon acids 
The α-arylation of enolates has become more attractive since the introduction of the 
transition metal catalysed processes, which now represent the most general 
approach to arylated quaternary stereocentres.19 
The first direct arylation of a ketone enolate was reported by Hartwig in 1997 
(Scheme 1.9), employing 10 mol% Pd(dba)2 catalyst.  Only one example of the 
formation of a quaternary centre was presented and it is not stereogenic.20 
Br
+ Ph
O
Pd(dba)2 (10 mol %)
dtpf (15 mol %)
KN(SiMe3)2 (1.2 equiv)
THF, reflux, 5 h
Ph
O
23 24 25, 55%  
Scheme 1.9: First example of transition metal catalysed arylation of 
ketone enolate for the synthesis of α-arylated quaternary centres. 
Following from this, the first asymmetric example of a palladium catalysed 
arylation of a ketone enolate was reported by Buchwald in 1998.  A typical example 
is illustrated in Scheme 1.10, the absolute stereochemistry was not reported.  
Isolated yields ranged from 40 – 74% and enantioselectivities ranged from 61 – 
88%.21 
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O Br
2 eq.
10 - 20 mol % Pd(0)/BINAP
NaOt-Bu, toluene, 100 ºC
O
73% yield
 88% ee
26
27
28
 
Scheme 1.10: Pd catalysed asymmetric arylation of a ketone enolate. 
 
When α’-blocked α-methylcyclopentanones (e.g. 29) were employed as substrates 
excellent enantioselectivities were observed in the products (Scheme 1.11) 
 
O
Ph
20 mol % Pd(OAc)2/BINAP
75% yield
 98% ee
Br
O
Ph
29
27
30
NaOt-Bu
 
Scheme 1.11: Pd catalysed asymmetric arylation of α’-blocked 
ketone enolates.  The absolute stereochemistry was not reported. 
 
Subsequently an improved catalyst system has been reported employing Pd2(dba)3  
and the bulky (R)-2-(diisopropylphosphino)-2’-(1-naphthylmethoxy)-1,1’-
binaphthyl ligand to give greater reactivity (reactions could be performed at room 
temperature with 2 mol% catalyst) giving high yields and enantioselectivities of up 
to 94%.22 This system, in addition to allowing broad functional group tolerance, 
was highly selective for the less substituted position of ketones with 2 enolizable 
positions. The scope of these reactions was more recently expanded with the 
palladium or nickel catalysed coupling of aryl triflates reported by Hartwig.23 
Buchwald24 and Hartwig25 both reported the α-arylation of esters in 2001, 
containing isolated examples of the formation of quaternary centres.  Expansion of 
this work allowed the coupling of a broad range of aryl halides to α,α-disubstituted 
esters in consistently high yield (for example, Scheme 1.12).26  
CO2Me
Br
+
CO2Me
Pd(dba)2 (0.1 mol %)
P(t-Bu)3 (0.1 mol %)
LiNCy2 (1.3 equiv)
toluene, rt
(1.1 equiv)31
32 33, 87%
 
Scheme 1.12: α-Arylation of α,α-disubstituted ester 
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The strongly basic conditions required to generate the enolate coupling partners, 
particularly in the cases of esters and amides, can result in low reaction yields for 
substrates with functionalities that are sensitive to basic or strongly nucleophilic 
reaction conditions.  Coupling of the more hindered enolizable position is also not 
possible with the above chemistry.   To allow more neutral conditions to be 
employed, Hartwig has reported the use of zinc enolates and silyl ketene or silyl 
ketimine acetals in the presence of zinc fluoride (for example, Scheme 1.13) for the 
arylation of esters and amides.27 Whilst this method requires pre-formed enolate 
equivalents and the use of stoichiometric metal reagents, it does allow the scope of 
the arylation to be increased, with many examples synthesised here that failed with 
the palladium catalysed alkali metal enolate chemistry. 
Br
NMe2
O
NMe2
O
NN
Br
Zn (1.5 equiv)
THF, rt, 30 min
{[P(t-Bu)3]PdBr}2 (2.5 mol %)
THF/toluene (2:8)
70 ºC, 12 h
1)
2)
34
35, 94%
 
OTMS
OMe
Br
O
Ph
+
O
Ph CO2Me
Pd(dba)2 (1 mol %)
P(t-Bu)3 (2 mol %)
  ZnF2 (0.5 equiv) 
DMF, 80 ºC, 12 h36 37 38, 99%  
Scheme 1.13:  Arylation of pre-formed ester and amide enolate 
equivalents under more neutral conditions 
The palladium catalysed intramolecular α-arylation of amides has also been 
reported for the synthesis of oxindoles.28  Particular attention was paid to α-methyl, 
α-aryl systems not accessible via the intramolecular Heck reactions described in 
chapter 1.2.5.  In both racemic and asymmetric (assisted with chiral carbene 
ligands) cases, yields are typically excellent; however enantioselectivities are 
variable, ranging from 33 – 76%.  A typical example is illustrated in Scheme 1.14. 
 19
N+N
BF4-
Br
N
O
Ph
N
O
Ph
99% yield
Br
N
O
Ph
N
O
Ph
carbene ligand
5 mol % Pd(dba)2
5 mol % carbene ligand
25 ºC, 24 h
74% yield
 57% ee
5 mol % Pd(OAc)2
5 mol % PCy3
1.5 equiv NaOt-Bu,
 50 ºC, 14 h
39 40
41
42
 
Scheme 1.14: Racemic and asymmetric syntheses of α-methyl-α-
aryl oxindoles via intramolecular Pd catalysed coupling. 
The α-arylation of ketones, esters and amides can therefore be accomplished with 
the appropriate transition metal catalyst and base.  Extension of these 
methodologies to the α-arylation of aldehydes is hindered by the aldol condensation 
of the aldehydes under the basic reaction conditions.  In 2002 Miura developed a 
protocol for the α-arylation of aldehydes however isolated yields were modest and 
2 equivalents of aldehyde were needed.29  An improved procedure was reported in 
2007, with increased substrate scope and significantly improved isolated yields of 
α-arylated aldehydes (for example, Scheme 1.15).30 
+
MeO2C Br MeO2C CHO
Ph
CHOPh
Pd(OAc)2 (2 mol %) PCy2
OMeMeO
ligand
ligand (3 mol %)
Cs2CO3, Dioxane
44 45 46, 75%
47
 
Scheme 1.15:  α-Arylation of aldehydes 
An enantioselective nickel-BINAP catalysed α-arylation of α-substituted γ-
butyrolactones has also been reported by Buchwald in which the products are 
obtained in consistently high enantiomeric excess (90 – 99% ee); a representative 
example is shown in Scheme 1.16.31  Bicyclic lactones were also arylated under 
microwave irradiation catalysed by Pd(dba)2.32  
O
O
+
1.2 equiv
1 equiv
Cl
OMe 5 mol % Ni(COD)2
8.5 mol % (S)-BINAP
2.3 equiv NaHMDS
 15 mol % ZnBr2
O
O
OMe
86% yield
 96% ee
48 49 50
 
Scheme 1.16: Ni catalysed α-arylation of γ-butyrolactones. 
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α,α-Disubstituted nitriles have also been arylated under palladium catalysis.33  A 
range of arylated products were obtained in good yield (for example, Scheme 1.17). 
+
Br CN
Ph
Pd(OAc)2/BINAP (1 mol %)
P(t-Bu)3 (1 mol %)
CHCl3, 100 ºC
NaN(SiMe3)2 (1.3 equiv)
Ph
CN
Ph
51 52 53, 94%  
Scheme 1.17: Pd catalysed α-arylation of nitrile 52. 
Copper catalysis has also been reported for the arylation of 2-methylacetoacetates, 
assisted by chiral L-proline ligands.  The isolated yields are again consistently good 
and the enantiomeric excesses are typically >80%.  A representative example is 
illustrated in Scheme 1.18.34  
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Scheme 1.18: Cu catalysed arylation of 2-methylacetoacetate 55. 
Transition metal catalysis therefore allows for the α-arylation of a broad range of 
carbonyl compounds, generating arylated quaternary stereocentres, often with high 
levels of stereocontrol and in excellent yield whilst employing low catalyst 
loadings.19  
1.2.5 Asymmetric intramolecular Heck coupling 
The first asymmetric Heck couplings were reported concurrently by Overman35 and 
Shibasaki36 in 1989 for the formation of cis-decalin derivatives and 2-dienyl-1,3-
cyclohexandiones respectively.  Subsequently intramolecular Heck reactions have 
been reported in which an arylated quaternary stereogenic carbon centre is created.  
This work has been pioneered by Overman, who reported the Pd-BINAP catalysed 
synthesis of oxindole derivatives in enantiomeric excesses up to 95% ee (Scheme 
1.19).37  The stereoselectivity is reversed depending on whether cationic Heck 
conditions (employing silver salts as additives) or neutral Heck conditions 
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(employing 1,2,2,6,6-pentamethylpiperidine (PMP) as the acid scavenging additive) 
are utilised.  
O
O
O
N
I
5 mol % Pd2(dba)3
10 mol % R-(+)-BINAP
1.2 equiv Ag3PO4
MeCONMe2, 80 ºC
81% yield  
 71% ee
O
O
N
O
O
O
N
O10 mol % Pd2(dba)3
20 mol % R-(+)-BINAP
5 equiv PMP
MeCONMe2, 80 ºC
77% yield
 66% ee
57
58
59
 
Scheme 1.19: Intramolecular asymmetric Heck coupling for the 
synthesis of oxindole derivatives. 
Wide variation to the alkene substituents in the substrate has been reported, and 
both E and Z isomers can give excellent enantioselectivities.38  The methodology 
has been applied to the synthesis of the Calabar alkaloids physostigmine and 
physovenine39 and has recently been expanded to include the creation of quaternary 
stereogenic centres bearing 2 aryl substituents (Scheme 1.20).40  
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N
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O
Ph
OMe
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O
Ph OMe
Pd(OAc)2, (R)-BINAP
PMP, THF, 80 ºC 86% yield
 84% ee
60
61
 
Scheme 1.20: Intramolecular Heck coupling to produce a quaternary 
carbon centre bearing 2 aryl substituents.  
 
The intramolecular Heck reaction has also been applied by Shibasaki to carbocyclic 
systems for the synthesis of the analgesic (-)-eptazocine.  In this case the Z 
geometry of the alkene (62) was found to be essential for high enantioselectivity 
(Scheme 1.21).41  
 
OTfMeO
Me
OTBDPS
Pd(0) - (R)-BINAP complex
 (10 mol %)
K2CO3, THF, 60 ºC
90% yield 
  90% ee
MeO
Me
OTBDPS
62
63
 
Scheme 1.21: Intramolecular Heck coupling for the creation of a 
carbocyclic system containing an α-arylated quaternary stereocentre. 
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1.2.6 Organocatalysis 
Over the past decades the field or organocatalysis has grown significantly and 
continues to be an intensely researched field.42  The advantages of organocatalysis 
over transition metal catalysis have been well documented and include the reduced 
toxicity and environmental impact of the catalysts and the ability of the reactions to 
tolerate air and moisture. The field is broad, encompassing: covalent catalysis such 
as proline43 (64) and MacMillan’s imidazolidinone catalyst44 (65); non-covalent 
Brønsted acid catalysis such as BINOL phosphoric acids45 (66a, b); non-covalent 
hydrogen bonding catalysts such as Jacobsen’s Schiff base derived ureas/thioures46 
(67), Takamoto’s bifunctional urea/thiourea catalysts47 (68) and cinchona alkaloid 
derived bifunctional organocatalysts developed by Chen, Connon, Dixon, Deng and 
others (69, 70, QD-71)48 (see chapter 2.3.1); and phase transfer catalysts49 (for 
example 72) (Figure 1.1).   
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70, X = O
NO
N
O
Cl
72
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Figure 1.1: Selection of organocatalysts 
Whilst the synthesis of α-arylated quaternary stereocentres is dominated by 
transition metal catalysis, an organocatalytic approach is described below. 
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1.2.6.1 Nucleophilic Aromatic Substitution 
In 2002 the SNAr reaction of β-ketoesters and p-nitro-o-cyano chlorobenzenes was 
reported for the synthesis of racemic isoquinolones.50  Subsequently Jørgensen has 
reported the enantioselective SNAr reaction of 1,3-dicarbonyl compounds with 
para-fluoronitrobenzenes, catalysed by cinchona alkaloid derived phase transfer 
catalyst 72, the most successful result is illustrated in Scheme 1.22.51   
NO
N
O
Cl
72
H
F
NO2
NO2
Br
O O
OEt
+ cat. 72 (15 mol %)
KOH
toluene/CH2Cl2 (4:1)
 -40 ºC
O
CO2Et
NO2
NO2Br
76% Yield, 94% ee
73
74
75
 
Scheme 1.22: Organocatalytic construction of products containing α-aryl quaternary carbon 
centre via an SNAr reaction of β-ketoester 73 and para-fluoro nitrobenzene 74 catalysed by 
cinchona alkaloid derived phase transfer catalyst 72. 
The arylated products are generally obtained in good yield with, in some cases, 
excellent enantioselectivities, however due to the nature of the SNAr reaction 
substitution patterns around the aromatic ring are restricted. This approach therefore 
only allows access to electron poor aromatic systems, and in all examples a para-
nitro group is present.  At the start of our research this was the only example of an 
organocatayltic arylation methodology for the creation of all-carbon quaternary 
stereocentres. 
1.3 Aims of this thesis 
We believed an effective strategy for the direct synthesis of catechols bearing all 
carbon quaternary stereocentres could be based on the Michael addition of a 
suitably acidic carbon-centred pro-nucleophile (77) to an ortho-benzoquinone (76) 
reagent in the presence of a basic catalyst, Scheme 1.23.  Michael addition to the 
highly reactive o-quinone followed by aromatisation generates the substituted 
catechol product 79, containing the desired arylated quaternary stereogenic centre. 
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Scheme 1.23: Concept: Michael addition to o-benzoquinone electrophiles 
for the creation of products containing α-arylated quaternary stereocentres. 
Due to their instability, ortho-Benzoquinones are rarely used as reagents in organic 
synthesis; however we believed that harnessing their reactivity could allow rapid 
access to this challenging motif. The aims of this research were to probe the 
reactivity of a range of ortho-benzoquinones towards carbon-centred pro-
nucleophiles and to investigate the use of organocatalysts to give asymmetric 
induction in the reaction products. In addition we hoped to apply the methodology 
in the total synthesis of one of the many natural products bearing the target motif. 
2 Methodology Development 
2.1 Introduction to quinone chemistry 
2.1.1 Para-quinones 
para-Quinones are stable, often commercially available reagents that are known to 
act as dienophiles53 and Michael acceptors.54,55  The quinine (see chapter 2.3.1) 
catalysed Michael addition of β-keto esters (e.g. 80) to commercially available 
para-quinones was reported during the course of this work to give products 
containing arylated quaternary stereogenic centres, with high yields and 
enantioselectivities (Scheme 2.1).56 
O
OO
CO2tBu +
O
CO2tBu
O
O
76% yield
 94% ee
quinine (136)
 (10 mol %)
CH2Cl2, -20 ºC
80
81 82
 
Scheme 2.1: Organocatalytic Michael addition of β-ketoester 80 to para-
quinone 81 to generate 82 containing an α-aryl quaternary stereocentre in 
high enantiomeric excesses.  The absolute stereochemistry was not reported. 
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The α-arylation of aldehydes and vinylogous addition of dicyanoalkylidenes to p-
quinones for the formation of arylated tertiary centres was also reported by 
Jørgensen.57, 58  
2.1.2 Synthesis of ortho-quinones 
In contrast to para-quinones, ortho-benzoquinones are notoriously difficult to 
handle due to rapid decomposition through dimerisations, polymerisations and 
isomerisations. Since ortho-quinones are known to act as carbodienes, heterodienes 
and dienophiles in Diels-Alder reactions a suggested mechanism for the 
dimerisation of ortho-quinone 83 is the Diels-Alder reaction to give dimer 84.59  
O
O
O
OO
O
2 x
83 84  
Scheme 2.2: Dimerisation of o-benzoquinone reported 
to be responsible for the instability of this reagent. 
 As a result of this instability many ortho-benzoquinones cannot be isolated or 
stored.  An increased number of substituents around the quinone ring increases 
stability, for example, 3,5-di-tert-butyl-o-benzoquinone 88 is stable and 
commercially available (Figure 2.1).  In particular substituents in the 4-position 
appear to confer stability, for example 4-tert-butyl-o-benzoquinone 89 can be 
isolated in quantitative yields through conventional methods whereas we have 
found 3-tert-butyl-o-benzoquinone to be unstable (see chapter 3.1, Figure 3.1).60  
O
O
O
O
O
O
O
O
O
O
Cl
Cl
Cl
Cl Br
Br
Br
Br
8988878685  
Figure 2.1: Selection of stable o-benzoquinones. 
Isolable ortho-quinones are generally synthesised through oxidation of the parent 
catechol.  Many oxidising agents have been reported for this, including manganese 
dioxide,61 silver oxide,62 hypervalent iodine reagents63 and diphenylselenide.64 
There are conflicting reports in the literature on the isolation of unsubstituted ortho-
benzoquinone 83 through various oxidation techniques, however experimental 
details and spectral data are rarely given.  In 1952 silver oxide was reported to 
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oxidise catechol 90 to ortho-benzoquinone in a 15% yield and it is claimed that the 
red crystals can be kept unchanged for several days in the dark at -70 ºC.62  
Subsequently in 1998 ortho-benzoquinone was reported to be isolated in a 97% 
yield after refluxing catechol in acetone with manganese dioxide.61 In neither case 
is spectral data given to confirm the synthesis. Recently it has been reported that 
treatment of catechol with silver oxide in acetone affords ortho-benzoquinone, 
which is claimed to be stable for 3-4 hours at room temperature, a yield was not 
given but a proton NMR spectrum supports the structure (Scheme 2.3).65  We were 
unable to isolate o-benzoquinone following any of the reported procedures and 
found this reagent to be highly unstable. 
 
OH
OH
O
O
Ag2O
acetone
catechol ortho-benzoquinone
90 83
 
Scheme 2.3: Oxidation of catechol with silver oxide to give ortho-
benzoquinone, a yield was not reported. 
2.1.3 Reactions of ortho-quinones 
Owing to the electron deficient nature of the olefinic carbons and the energy gained 
from aromatisation, ortho-benzoquinones are powerful electrophiles; reactive 
towards a range of carbon and heteroatom nucleophiles at every carbon atom in the 
ring.53  They can also act as carbodienes, heterodienes and dienophiles in Diels-
Alder reactions (Figure 2.2). 
 
O
O
1,4 addition
1,6 addition
1,2-addition
O
O
carbodiene
heterodiene
dienophile
Electrophilic sites Diels-Alder sites  
Figure 2.2: Reactive positions of ortho-benzoquinones . 
 
Despite this reactivity, reports of their use in synthesis as Michael acceptors are rare 
due to their rapid decomposition under attempted reaction conditions.  Attempted 
additions to sparsely substituted ortho-benzoquinones generally suffer from low 
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yields and a lack of regiocontrol.  The few reported examples of the addition of 
carbon-based nucleophiles are discussed below. 
2.1.3.1 Nucleophilic additions of carbon-centred nucleophiles to o-quinones 
The Lewis acid catalysed addition of allyl stannanes to 1,2-naphthoquinone 85, 4-
methyl-o-benzoquinone 92, 4-tert-butyl-o-benzoquinone 89 and 3,5-dimethyl-o-
benzoquinone 93 gave the allylated products 94 – 97 in excellent yields (Scheme 
2.4).66,67  In the case of sterically hindered 3,5-di-tert-butyl-o-benzoquinone 88 the 
1,2-addition products 98a and 98b were isolated in a 93% combined yield (Scheme 
2.5). Some of the allylated hydroquinone products were found to be air sensitive 
and were therefore protected as the di-acetate. 
O
O
Bu3Sn
1) BF3.Et2O, CH2Cl2, -78 ºC
2) H3O+
O
O
O
O
O
O
+
OAc
OH
78%
93%
93%
85%
OAc
OH
OAc
OAc
OH
OH
85
92
89
93
94
95
96
97
91
Bu3Sn+
91
Bu3Sn+
91
Bu3Sn+
91
3) Ac2O, pyridine
3) Ac2O, pyridine
1) BF3.Et2O, CH2Cl2, -78 ºC
1) BF3.Et2O, CH2Cl2, -78 ºC
1) BF3.Et2O, CH2Cl2, -78 ºC
2) H3O+
2) H3O+
2) H3O+
 
Scheme 2.4: The addition of allyl stannane 91 to a range of ortho-
quinones to give 1,4-addition products 94 – 97. 
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Bu3Sn
1) BF3.Et2O, CH2Cl2, -78 ºC
2) H3O+
+ O
OH
OH
O
+
88 98a 98b
91
93% combined yield  
Scheme 2.5: The addition of allyl stannanes 91 to sterically hindered 3,5-
di-tert-butyl-o-benzoquinone 88, to give the 1,2-addition products 98a 
and 98b. 
 
In 1986 the addition of pre-formed sodium enolates of malonic and cyanoacetic 
esters to 1,2-naphthoquinones to give 4-substituted 1,2-napthalenediols such as 100 
in high yields was reported, a typical example is illustrated in Scheme 2.6.68  The 
reaction was not reported with the use of catalytic base. 
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CO2EtEtO2C
BrBr
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BrBr
EtO2C CO2Et
NaOEt 97%
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Scheme 2.6: The addition of the pre-formed sodium enolate of diethyl 
malonate to 4-unsubstituted 1,2-napthoquinone 99. 
 
In 1988 the addition of silyl enol ethers to ortho-benzoquinones, promoted by 
catalytic trityl perchlorate, was reported.  1,4-Addition was found in the case of 
unsubstituted ortho-benzoquinone and 4-methyl-o-benzoquinone 92, whereas 1,6-
addition was found in the case of 4-tert-butylbenzoquinone 89 which resulted in 
further cyclisation to the benzofuran derivative 104 (Scheme 2.7).69 
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Scheme 2.7: The addition of silyl enol ethers 101 and 103 to 4-methyl-o-
benzoquinone (92) and 4-tert-butyl-o-benzoquinone (89) giving 1,4 and 1,6 
additions respectively. 
 
More recently the FeCl3 mediated vinylogous Michael addition to 1,2-
naphthoquinone 85 has been reported (Scheme 2.8).  Due to the redox ability of the 
quinone starting materials and hydroquinone addition products, the oxidation state 
of the products obtained from Michael additions to quinones often depends on the 
reaction conditions and the particular substrates involved.  In this case an excess of 
1,2-naphthoquinone is used and the product 106 is obtained in the quinone 
oxidation state with oxidation of the cyclohexenone ring to the phenol moiety also 
occurring.  Subsequent reduction with sodium hydrosulfite (Na2S2O4) gives the bi-
aryl product 107.70 
O
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O
OH
EtO2C
FeCl3.6H2O Na2S2O4
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EtO2C
OH
OH
85 105
106 107 43%  
Scheme 2.8: The vinylogous Michael addition to 1,2-naphthoquinone. 
These examples clearly demonstrate the ability of ortho-benzoquinones to act as 
Michael acceptors. At the start of this research no examples existed of a base 
catalysed Michael addition to o-quinones.  The lack of exploitation of this reactivity 
reflects the difficulty in handling ortho-benzoquinone reagents. 
An isolated example of the organocatalytic addition of a carbon-centred pro-
nucleophile to an isolable ortho-naphthoquinone (Scheme 2.9) was reported during 
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the course of this work alongside the para-quinone examples discussed in section 
2.1.1.56  In this case the quinone and β-ketoester are reacted in a 1:1 ratio and the 
1,4-addition product (108) is obtained at the quinone oxidation level following 
column chromatography.  It is proposed that the hydroquinone adduct is oxidised 
catalytically by the quinone starting material which is continually re-oxidised by 
atmospheric oxygen.   
O
O O
CO2tBu
+
O
CO2tBu
O O
Quinine 136
 (10 mol %)
-40 ºC
85 80
108 58%
CH2Cl2
 
Scheme 2.9: The organocatalytic Michael addition of β-ketoester 80 to 1,2-
naphthoquinone (85) to give 108 containing an α-arylated quaternary 
stereocentre. 
 
Within our group the organocatalytic addition of β-ketoesters to heavily substituted 
ortho-benzoquinones has been investigated. An aryloxylation reaction results to 
give tricyclic products such as 110, illustrated in Scheme 2.10.71   
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O
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cat 70 (10 mol %)
TBME, -20 ºC, 7 h
91% yield, 86% ee
N
HN
N
HN O
CF3F3C
cat 70  
Scheme 2.10: Aryloxylation reaction of β-ketoester 109 to sterically 
hindered 3,5-di-tert-butyl-o-benzoquinone 88 to give tricyclic product 
110. 
In order to act as electrophiles at carbon, and to avoid the aryloxylation reaction, the 
quinone substrate must not be too heavily substituted and is therefore likely to be 
unstable.  A general method for the Michael addition to ortho-benzoquinones must 
accommodate this instability. 
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2.1.3.2 Nucleophilic additions to o-quinones generated in-situ 
The addition of sulphur nucleophile 112 to ortho-benzoquinone and 4-methyl-o-
benzoquinone generated in situ from the parent catechols 90 and 111 respectively 
through oxidation with hydrogen peroxide has been reported, however the products 
113 and 114 are isolated in a disappointing 9 and 23% yield respectively (Scheme 
2.11).72   
OH
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NN+
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N N+
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113, R = H, 9% Yield
114, R = Me, 23% Yield
H2O2, H2O
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90, R = H
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112
 
Scheme 2.11:  Addition of triazolium thiolate 28 to in situ generated 
ortho-benzoquinones to give the 1,4-addition products 29a and 29b. 
Electrochemical methods for additions of carbon-based nucleophiles to unstable o-
quinones have also been reported in which electrochemical oxidation of catechols in 
the presence of β-dicarbonyl pro-nucleophiles (e.g. 116) in a buffered solution gives 
the addition products in high yields (Scheme 2.12).73  In the case of 3-substituted 
catechols (e.g. 115), the addition products were obtained as mixtures or 
regioisomers (the ratio was not reported). 
OH
OH
+
O O electrolysis, 0.32 V
phosphate buffer, pH 6.5
85% (sum of regioisomers)
OH
OH
OH
OH
O
O
O
O
+
115 116
117 118
85% combined yield  
Scheme 2.12: Electrochemical oxidation of catechol 115 in the presence of β-
diketone 116 to give a regioisomeric mixture of addition products 117 and 118. 
2.2 Proof of Principle studies: Organocatalytic Michael addition to 
isolable ortho-quinones 
To establish the feasibility of the base catalysed Michael addition to ortho-quinone 
reagents initial proof of principle studies were conducted with 1,2-naphthoquinone 
85.  1,2-Naphthoquinone is one of the few stable, commercially available, ortho-
quinone reagents and is therefore not a representative ortho-benzoquinone; but was 
chosen since no examples of base-catalysed Michael additions to ortho-quinones 
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had been reported when this work was begun. Methyl cyclopentanone-2-
carboxylate 109 was chosen as a representative pro-nucleophile (Scheme 2.13).§ 
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Scheme 2.13: The addition of β-ketoester 109 to 1,2-naphthoquinone 85 to give 
hydroquinone adduct 119 that can be oxidised to quinone 120 or protected to the di-
acylated product 121a. 
Preliminary experiments were conducted with 2-tert-butylimino-2-diethylamino-
1,3-dimethyl-perhydro-1,3,2-diazaphosphorine (BEMP) as the catalytic base, in 
CH2Cl2 at room temperature.  When 1,2-naphthoquinone (added portion-wise) was 
reacted with 1 equivalent of pro-nucleophile 109 in the presence of BEMP (10 
mol%) and the resulting mixture subjected to column chromatography on silica gel, 
the product was identified as the oxidised addition product 120, and could only be 
isolated in disappointing yields of 40-50%.  The presence of a singlet in the 
aromatic region of the crude proton NMR spectrum and the appearance of a new 
methyl ester signal provided clear indication of a reaction. Whilst 1,4-addition was 
expected on the basis of reactivity and previous literature examples, the 
regioselectivity of addition was confirmed by COSY, HSQC and HMBC NMR 
analysis.  This product could be quantitatively reduced back to the desired 
naphthalenediol addition product 119 using Na2S2O4. 70  Crude proton NMR of the 
reaction mixtures in CDCl3 identified a mixture of naphthalenediol 119 and 
naphthoquinone 120 addition products that was found to shift towards the quinone 
with time.  Crude NMR in d6-DMSO however showed good conversion to only the 
                                                 
§ The reaction of 1,2-naphthoquinone and methyl cyclopentanone-2-carboxylate was initially 
conducted by Dr Kevin Greenaway.  Quinone adduct 120 was isolated in poor yield and was not 
fully characterised. 
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naphthalenediol adduct 119.  It was therefore concluded that the reaction proceeds 
to the naphthalenediol addition product 119, which is oxidised by air in chloroform 
solution and during chromatography on silica gel.  Several by-products were 
observed in the crude 1H NMR spectrum which we believed may have been a result 
of decomposition of 1,2-naphthoquinone.  In an effort to decrease the probability of 
1,2-naphthoquinone reacting with itself the reaction solvent was changed from 
CH2Cl2 to tert-butylmethylether (TBME) in which 1,2-naphthoquinone is sparingly 
soluble.  Pleasingly the reaction in TBME gave significantly cleaner conversion to 
the desired naphthalenediol product, with few by-products visible in the crude 1H 
NMR spectrum.  The crude reaction mixtures could be deliberately oxidised using 
aqueous sodium periodate, however the naphthoquinone product was found to be 
unsuitable for column chromatography; decomposition on silica gel was observed 
and the isolated yields did not reflect conversion.  A method for protecting the 
naphthalenediol adduct was therefore investigated.  Accordingly, the reaction was 
repeated and the crude reaction mixture treated with acetic anhydride in pyridine at 
room temperature overnight.66  Complete conversion to the di-acetylated product 
121a was observed which could be purified by column chromatography on silica 
gel with no noticeable decomposition.  With the ability to isolate the protected 
product, a screen of bases and temperatures was conducted to optimise the yield of 
product 121a (Table 2.1). 
The optimised reaction conditions are illustrated by entry 8.  Two equivalents of 
nucleophile were required however increasing the number of equivalents further 
than this had little effect on the reaction yield (entries 7, 8 and 9).  The reaction 
proceeded well at room temperature, although starting the reaction at -20 ºC for 1 h 
then warming to room temperature resulted in slightly improved yields (entry 8 vs. 
6). Holding the reaction at -20 ºC for 5 h gave a lower yield of arylated product 
(entry 10 vs. 8).  The reaction also proceeded with triethylamine, 1,1,3,3-
tetramethylguanidine (TMG) and 1,4-diazabicyclo-[2.2.2]octane  (DABCO) (entries 
1, 2 and 3) although the BEMP catalysed process was the highest yielding.  The 
desired product was not identifiable by crude 1H NMR when no base was added 
(entry 11).  The optimal loading of base was found to be 10%; lowering the amount 
of base resulted in a reduction in yield (entries 4 and 5 vs. 6).  With the optimal 
reaction conditions the protected arylated adduct 121a could be isolated in a 
pleasing 83% yield over 2 steps. 
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OMe
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85
109
119 121a  
entry Base, mol % Equiv Pro-nucleophile Temp, ºC Time h 
Yield 
%a 
1 NEt3, 10 2 -20 – rt 1 66 
2 DABCO, 10 2 -20 – rt 1 57 
3 TMG, 10 2 -20 – rt 1 56 
4 BEMP, 1 2 rt 24 46 
5 BEMP, 5 2 rt 3 59 
6 BEMP, 10 2 rt 1 77 
7 BEMP, 10 1 -20 – rt 1 42 
8 BEMP, 10 2 -20 – rt 1 83 
9 BEMP, 10 3 -20 – rt 1 84 
10 BEMP, 10 2 -20 5 73 
11 no base 2 RT 24 0b 
Table 2.1: Optimisation of the reaction of 1,2-naphthoquinone 85 with methyl cyclopentanone-2-
carboxylate 109.   aisolated yield following column chromatography on silica gel; bconversion by 
NMR 
 
The scope of this reaction with respect to the pro-nucleophile was then investigated.  
A series of pro-nucleophiles 122 – 134 and 73 (Chart 2.1) were chosen and reacted 
with 1,2-naphthoquinone 85.  Lactones, indanones, oxindoles, α-cyano ketones and 
α-cyano acetates all performed well to give adducts 121b - 121h in consistently 
high yields (Chart 2.2). 
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Chart 2.1: Pro-nucleophiles screened in the reaction with 1,2-naphthoquinone. 
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Chart 2.2: Naphthalene-1,2-diol adducts 121b – 121h synthesised from the base 
catalysed Michael addition of a range of pro-nucleophiles to 1,2-naphthoquinone. 
Whilst 1,2-naphthoquinone can be isolated and stored and is stable in solution, it is 
still believed to decompose under the reaction conditions.  Therefore, to obtain the 
desired arylation product in high yield the rate of Michael addition to the quinone 
must be fast with respect to the rate of decomposition.  Pro-nucleophiles 128 - 134 
were found to give unsatisfactory conversion to the hydroquinone product.  In these 
cases crude proton NMR spectra showed un-reacted pro-nucleophile and a complex 
mixture of quinone decomposition products.  It is interesting to note the contrast in 
reactivity between the 5-membered cyclic β-ketoester 109 and its 6- and 7-
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membered analogues.  Particularly in the case of methyl- or ethyl-cyclohexanone-2-
carboxylate (131, 132) the desired product could not be identified in the crude 
NMR spectra even when stoichiometric base was employed with 4 equivalents of 
nucleophile.  We believe the low reactivity of the cyclohexanone derived pro-
nucleophiles in comparison to methyl cyclopentanone-2-carboxylate 109 could be 
attributed to a possible increase in stability of the 6-membered cyclic enolate. 
 
2.3 Enantioselective Michael addition to stable ortho-quinones 
With a racemic method for the base catalysed Michael addition to stable ortho-
quinones developed an enantioselective approach was desired.  The fact that 
triethylamine and DABCO were able to catalyse the reaction led us to investigate 
the use of cinchona derived bifunctional organocatalysts to give asymmetric 
induction in the arylated products.   
2.3.1 Cinchona Alkaloids 
The parent cinchona alkaloids quinidine (135), quinine (136), cinchonine (137) and 
cinchonidine (138) are small, yet complex, natural products, isolated from the bark 
of cinchona officinallis.  Their use in medicine and in organic synthesis has been 
well documented.74  The stereogenic centres at C8 and C9 are inverted in quinidine 
and quinine (and cinchonine and cinchonidine) and so the pairs of alkaloids are 
referred to as pseudo enantiomers, and when employed as catalysts normally give 
rise to opposite enantiomers of products with very similar levels of 
enantioselectivity.   
N
HO
N
OMe
quinidine 135
N
OH
N
OMe
pseudo
enantiomers
quinine 136
N
HO
N
cinchonine 137
N
OH
N
pseudo
enantiomers
cinchonidine 138
C8
C9
 
Figure 2.3: Structures of the parent cinchona alkaloids 
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Whilst the parent alkaloids are catalysts in their own right, significant effort has 
gone into developing modified cinchona alkaloid catalysts that offer improved 
levels of stereoselectivity.  Those which have found particular use in conjugate 
additions will be discussed in more detail here. 
 
2.3.2 C9-Epi-amino cinchonine/cinchonidine derived catalysts 
Bifunctional organocatalysts 69 derived from 9-amino(9-deoxy) epi-cinchonine were 
developed by Chen75 and Dixon76 and, for example, have been shown to induce 
high levels of stereocontrol in the addition of dimethyl malonates and 5-aryl-1,3-
dioxolan-4-ones to nitroolefins (Scheme 2.14). 
N
HN
N
HN S
CF3F3CO
OO
Ph
CF3
CF3
NO2
Br
0.5 equiv
cat 69 (5 mol %)
toluene, 0 ºC
58% yield
>98% de, 89% ee
O
OO
CF3
CF3
O2N Ph
Br
cat 69
MeO
O
OMe
O
NO2O
MeO
CH2Cl2, -20 - 0 ºC
cat 69 (5 mol %)
NO2O
MeO
O
MeO
O
OMe
96% yield, 94% ee
139 140
141
142
143
 
Scheme 2.14: Application of cat 69 in conjugate addition reaction to nitro olefins. 
The postulated mode of action of the catalyst involves activation of the pro-
nucleophile by the bridge-head nitrogen to give a hydrogen bonded ammonium 
enolate, and concurrent activation of the electrophile through co-planar bidentate 
hydrogen bonding interactions with the thiourea moiety of the catalyst.  The 
predicted transition state is stabilised by the complete hydrogen bonding network 
with the catalyst and positions the nucleophile and electrophile so that there is a 
favourable staggered arrangement around the newly formed C-C bond.77 
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Figure 2.4: Postulated transition state and mode of action of bifunctional 
organocatalyst of type 69 in the reaction of malonates with nitro olefins, the 
catalyst vinyl group has been omitted for clarity. 
Subsequently the urea analogue 70 was found within the Dixon group to offer equal 
levels of stereocontrol with significantly improved reaction rates, and was 
employed, for example, in the Michael addition step in the elegant synthesis of 
nakadomarin A (Scheme 2.15).78, 79 
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+
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O
O2N
MeO2C
cat 70 (15 mol %)
Toluene, 30 ºC, 8 d
57%, 91:9 dr
N
HN
N
HN O
CF3F3C
cat 70
144
145
146
 
Scheme 2.15: Application of urea catalyst 70 in the Michael addition 
step in the synthesis of nakadomarin A. 
2.3.3 Quinidine/Quinine Derived organocatalysts 
Deng and co-workers have developed a series of quinidine/quinine-derived 
organocatalysts (Chart 2.3) that have been employed in highly enantioselective 
conjugate additions with a range of pro-nucleophiles and electrophiles including, 
for example, methyl vinyl ketone (Scheme 2.16) and nitro olefins (Scheme 
2.17).80,81 
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Chart 2.3: Examples of quinidine (QD) and quinine (Q) derived 
organocatalysts developed by Deng. 
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CH2Cl2, rt 150
O
COtBu
80
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O
COtBu
O
96% yield
 96% ee
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N
OH
cat. Q-148
 
Scheme 2.16: Example of the use of Deng catalysts Q-148 in the conjugate 
addition of β-keto ester 80 to methyl vinyl ketone.  The absolute stereochemistry 
was determined by comparison of optical rotation data with literature values. 
Deng has proposed that in these systems the bridge head nitrogen of the 
quinuclidine ring of the catalyst activates the pro-nucleophile to give a hydrogen 
bonded ammonium enolate (as in the case of catalysts 69 and 70) with the hydroxyl 
on the quinoline acting as a monodentate hydrogen bond donor able to activate the 
electrophile and deliver it selectively to one face of the pro-nucleophile (Scheme 
2.17).82  A second hydrogen bond from the quinoline hydroxyl is believed to aid 
positioning of the pro-nucleophile, bonding to the ring oxygen in the case of lactone 
154 or the ester in the case of  ethyl 2-oxocyclohexanecarboxylate 132.  The 
relative stereochemistry of the product 153 and the absolute stereochemistry of 
product (-)-155 were proven by single crystal X-ray diffraction and support the 
transition state model proposed.  Replacing catalyst Q-71 with QD-148 in the 
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synthesis of (-)-155 gave the opposite enantiomer (+)-155 with increased yield and 
almost identical levels of enantiomeric excess (92% yield, 97:3 dr, 98% ee). 
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Scheme 2.17: Postulated mode of action of Deng catalysts in the synthesis of adducts 153 and 155. 
Of the low energy conformers of quinidine-derived catalysts of type QD-148, the 
postulated mode of action requires the catalyst to bind the reactants in its ‘gauche-
open’ conformer (Figure 2.5).  Due to the constraints of the additional ring, 
cupreidine catalyst 15183 is held in such a conformation and when employed in the 
synthesis of (+)-155 gave identical levels of enantiocontrol compared to catalyst 
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QD-148 (Scheme 2.17).  This further supports Deng’s postulated mode of action for 
catalysts Q/QD-71 and Q/QD-148. 
N
O
R
H
N
HO
H
O
H
N
HO
HN
catalyst QD-71, R = Bn
catalyst QD-148, R = PHN catalyst 151  
Figure 2.5: Cat. QD-71/QD-148 in the ‘gauche-open’ conformation and cupreidine catalyst 151. 
 
2.3.4 Catalyst Screen 
A range of known organocatalysts (Chart 2.4) were examined in the reaction of 1,2-
naphthoquinone with tert-butyl 1-oxindane-2-carboxylate pro-nucleophile 80. The 
reactions were performed in an identical fashion to the racemic examples, replacing 
BEMP with the required organocatalyst.  The enantioselectivities were determined 
by chiral HPLC analysis in comparison to a racemic sample prepared with BEMP 
catalysis (Table 2.2).  The absolute stereochemistry was not proven and is drawn by 
analogy to the work of Deng whereby for quinidine derived catalysts the 
electrophile is delivered to the bottom face of the pro-nucleophile as drawn in Table 
2.2.80-82 
N
O
N
OH
N
O
N
OH
cat. QD-71cat. QD-147 cat. QD-148
N
HO
N
OH
N
HN
N
HN O
CF3F3C
cat. 70  
Chart 2.4: Catalysts screened in the reaction of tert-butyl 1-oxindane-2-
carboxylate 80 and 1,2-naphthoquinone 85. 
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O
O
catalyst (10 mol %)
TBME, -20 ºC - rt
O
O
O
(2 equiv)
OAc
OAc
O
O
O
85
80
(+)-156
1)
2) Ac2O, pyridine  
Entry Catalyst Yield ee 
1 BEMP 75% 0% 
2 70 78% 11% 
3 QD-147 32% 26% 
4 QD-71 53% 40% 
5 QD-148 55% 70% 
Table 2.2: Screen of organocatalysts in the reaction of tert-butyl 1-
oxindane-2-carboxylate 80 with 1,2-naphthoquinone 85. 
Catalyst 70 can be seen to give a slightly increased yield compared to the BEMP 
catalysed process (entry 2 vs. 1), however a disappointing enantiomeric excess of 
11% was obtained.  The Deng-catalysts QD-71, QD-147 and QD-148 gave more 
successful results, with the phenanthryl derived catalyst QD-148 giving 70% ee 
(entry 5), albeit in lower yield.   
Having developed a method for the organocatalysed Michael addition of a range of 
pro-nucleophiles to 1,2-naphthoquinone, expansion of the scope of the reaction with 
regard to the quinone electrophile was investigated. 
3 Oxidative coupling strategy – Michael addition to in 
situ generated ortho-benzoquinones 
3.1 Racemic method 
In order to expand the arylation methodology developed for 1,2-naphthoquinone to 
a range of ortho-benzoquinones, the synthesis of a range of 3-substituted ortho-
benzoquinones was attempted through oxidation of the parent 3-substituted 
catechols.  3-Substituted ortho-benzoquinones were chosen in the belief that the 3-
substituent would aid the regioselectivity of the Michael addition and increase the 
stability of the quinone relative to the unsubstituted reagent. A range of 3-
substituted catechols were prepared through a one-pot formylation and Dakin 
oxidation of the appropriate 2-substituted phenol (Scheme 3.1).84   
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160, R = t-Bu, 32%  
161, R = Et, 36%   
162, R = Ph, 57%
157, R = t-Bu
158, R = Et
159, R = Ph
OH
R
OH
R1) (CH2O)n, MgCl2
NEt3, THF
2) H2O2, NaOH
OH
R OH
O
 
Scheme 3.1: One-pot ortho-formylation/Dakin oxidation for the synthesis of 3-
substituted catechols 160 – 162 from 2-substituted phenols 157 – 159. 
For larger scale preparation of catechols, the dihydroxylation of substituted 
benzenes using a bacterial dioxygenase enzyme followed by oxidation with either 
palladium on carbon or a cis-dioldehydrogenase enzyme has also been reported.85  
Accordingly 3-tert-butylcatechol 160 was synthesised from 2-tert-butylphenol 157 
and subject to aqueous sodium periodate oxidation (Scheme 3.2).  Separation of the 
organic phase and evaporation of the solvent gave a highly coloured residue (often 
indicative of a quinone), however 1H NMR of the residue showed a complex 
mixture.  
 
complex 
 mixture
NaIO4
OH
OH
160
 
Scheme 3.2: Attempted oxidation of 3-tert-butylcatechol 
(160) to the ortho-benzoquinone with NaIO4. 
Similarly, treatment of catechol, 3-phenyl-, 3-ethyl-, and 3-methoxycatechol with 
aqueous sodium periodate also lead to complex mixtures after attempted isolation.  
Attempts to obtain a cold solution of quinone reagent and react this directly with a 
solution of pro-nucleophile and base showed no conversion to the desired arylated 
products.  It was rapidly concluded that these reagents were too unstable to be 
isolated and stored.  To demonstrate the instability of the 3-substituted ortho-
benzoquinones, 3-methoxycatechol 163 and 3-tert-butylcatechol 160 were oxidised 
with polymer-supported periodate (ps-IO4-)60 in deuterated chloroform, filtered and 
the decomposition followed by 1H NMR. The amount of o-benzoquinone with 
respect to an internal standard (methyl-3,4,5-trimethoxybenzoate) was recorded at 
various time intervals.  The decomposition rate is illustrated in Figure 3.1.  The half 
life of 3-methoxy and 3-tert-butyl ortho-benzoquinone was calculated from the plot 
to be approximately 8 hours and 1 hour respectively.  The decomposition of o-
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quinone, 3-ethyl- and 3-phenyl-o-quinone was found to be too rapid to measure in 
this way. 
OH
OHR ps-IO4-
O
OR
163, R = OMe
decomposition
CDCl3
160,  R = tBu
164, R = OMe
165, R = tBu  
 
Figure 3.1: Plot showing the decomposition rate of 3-methoxy- 164 and 3-tert-butyl-o-
quinone 165 in CDCl3 (calculated with respect to an internal standard – methyl-3,4,5-
trimethoxybenzoate) in comparison with stable 1,2-naphthoquinone. 
 
Accordingly a method for in-situ generation of the reactive o-quinone intermediate 
from the catechol precursor was envisaged based on an ‘oxidative coupling’ 
strategy (Scheme 3.3).  The catechol is oxidised in the presence of the pro-
nucleophile and base catalyst to the highly electrophilic and unstable o-
benzoquinone species 76; Michael addition followed by aromatisation regenerates 
the substituted catechol product 79, containing the desired arylated quaternary 
stereogenic centre. 
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Scheme 3.3: Concept: an oxidative coupling strategy for the 
synthesis of α-arylated all-carbon quaternary stereocentres. 
Since this strategy does not rely on the ability to isolate (and store) the reactive o-
benzoquinone reagent, and the 3-substituted catechols are either commercially 
available or readily prepared, it has the potential to provide a powerful and general 
route to compounds containing arylated quaternary stereogenic centres either where 
the aromatic ring contains the 1,2-dihydroxyl functionality, or where this has been 
further functionalised.  
 
This strategy relies on the compatibility of the pro-nucleophile and base catalyst 
with the oxidising conditions.  Periodate is known to be an effective and selective 
oxidising agent for catechols; however the aqueous conditions prevent low 
temperatures being employed which are desirable for decreasing the rate of 
decomposition of the o-quinone reagents.  Therefore polymer-supported periodate 
(ps-IO4-), reported to be very effective for the oxidation of catechols to stable 
quinones, was chosen for initial studies and prepared from the anion exchange resin 
Amberlite® IRA-900.60  This reagent allows the oxidation to be performed in purely 
organic solvents and at temperatures below 0 ºC, and was therefore believed to be 
ideal for the oxidative coupling strategy.  The loading of periodate on the resin was 
determined by oxidising an excess of 3,5-di-tert-butylcatechol to the stable 3,5-di-
tert-butyl-o-benzoquinone in deuterated chloroform and determining the ratio of 
catechol (167):quinone (88) (Scheme 3.4). 
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167
ps-IO4- 
(approx. 0.5 equiv)
CDCl3
O
O
88
(+ recovered 167)  
Scheme 3.4: Oxidation of an excess of 3,5-di-tert-butylcatechol 
to determine ps-IO4- oxidant loading. 
3.1.1 Proof-of-principle for oxidative coupling methodology 
Initial experiments were conducted with 3-tert-butylcatechol 160 and 1 equivalent 
of ethyl phenylcyanoacetate 125 as a representative pro-nucleophile (Scheme 3.5) 
with 1 equivalent of ps-IO4- in dichloromethane at -20 ºC.  Polymer-supported 
BEMP was used in place a liquid BEMP since this would be removed from the 
reaction mixture during the filtration to remove the oxidant. 
OH
OH
169a 
1 equiv ps-IO4-, 68%
2 equiv ps-IO4-, 85%
NC
Ph
OEt
O
ps-IO4- (1 or 2 equiv)
O
O
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O
OEt
Na2S2O4 (aq)
OH
OH
NC
Ph
O
OEt
ps-BEMP (10 mol %)
CH2Cl2, -20 ºC
160
125
168
CH2Cl2
 
Scheme 3.5: Proof-of-principle studies for the oxidative coupling of 3-tert-
butylcatechol 160 and ethyl phenylcyanoacetate 125. 
The reaction mixture was subjected to aqueous Na2S2O4 reductive work-up to 
ensure all products were at the catechol oxidation level.  Under these conditions the 
desired arylated product could be isolated in 68% yield following column 
chromatography.  The catechol product was not found to be oxidatively unstable in 
air and therefore protection as the di-acetate was not required.  It was noted that not 
all of the starting catechol was consumed in this reaction, this was attributed to 
competing oxidation of the product by the periodate resin.  The reaction was 
therefore repeated with 2 equivalents of oxidant to achieve complete consumption 
of the starting catechol and give the arylated product in a pleasing 85% yield.  In 
this case the direct product of the reaction is at the quinone oxidation level and the 
reductive work-up is required to obtain the catechol product (the distinctive bright 
red quinone colour fades rapidly during the reductive work-up). In contrast to the 
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1,2-naphthoquinone examples, 2 equivalents of pro-nucleophile were not required 
to give satisfactory yields in this case.   
 
Michael addition to the 5-position of the quinone (1,4-addition) was anticipated due 
to the 3-substituent hindering attack at the 4-position.  The 1H NMR spectrum of the 
arylated product 169a shows 2 doublets for the aromatic protons with a coupling 
constant of 2.0 Hz indicating a meta relationship and confirming the anticipated 
regiochemistry of the Michael addition. 
 
3.1.2 Scope of in-situ methodology 
The scope of the reaction with respect to the catechol substrate and pro-nucleophile 
was then investigated.  In addition to 3-tert-butylcatechol 160, 3-methoxy- 163, 3-
phenyl- 162 and 3-ethylcatechol 161 were found to be successful substrates with a 
range of pro-nucleophiles to give arylated products 169b – 169p (Chart 3.1).  In all 
cases the addition was found to be highly regioselective; none of the other possible 
addition products could be detected in the crude 1H NMR spectra.  In the case of 3-
phenylcatechol, 2 equivalents of pro-nucleophile were required to give satisfactory 
isolated yields.  For example, the yield of 169f decreased from 72% to 60% when 
one equivalent of pro-nucleophile was employed. The yield of the reaction of 3-tert-
butylcatechol with methyl cyclopentanone-2-carboxylate to give adduct 169b was 
also improved through the use of 2 equivalents of pro-nucleophile.  In most cases, 
however, using an excess of pro-nucleophile resulted in no appreciable increase in 
reaction yield.  In all cases where an excess of the catechol substrate was used the 
1H NMR spectra of the crude reaction mixtures showed many by-products. The 
reaction times varied from 30 min to 6 h.  Unfortunately 3-bromocatechol was a 
poor substrate in this reaction.   
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Chart 3.1: α-Arylated addition products 169b – 169p synthesised via an 
oxidative coupling of the appropriately substituted catechol and carbon based 
pro-nucleophile. * 2 equiv of pro-nucleophile were required, ** 2 equiv pro-
nucleophile, 1 equiv oxidant. 
This represents the first general organocatalytic method for the addition of a 
carbon-based pro-nucleophile to ortho-benzoquinones generated in situ.  The 
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method is practically simple and the addition is rapid, high yielding, and highly 
regioselective giving access to a broad range of arylated products.  Alkyl, aryl, tert-
butyl and methoxy substituted catechols are tolerated and the scope of the pro-
nucleophile is large.  In addition to the lactones, indanones, oxindoles, α-cyano 
ketones and α-cyano acetates already encountered (chapter 2.2), β-diketones, β-
diketoamides and 7-membered cyclic pro-nucleophiles were also successful 
substrates. Furthermore the coupling substrates do not require extensive synthesis as 
they are either commercially available or are readily prepared in one-step from 
commercial materials (see chapters 7.2.1 and 7.3.1). 
Catechols with different substitution patterns were also investigated.  When 4-
methylcatechol was reacted with 1 equivalent of methyl cyclopentanone-2-
carboxylate no arylated products could be identified in the crude NMR, increasing 
the number of equivalents of pro-nucleophile to 2 gave 169p in a 10% yield (Chart 
3.1).  No other addition products (regioisomers) could be isolated from the reaction 
mixture or identified in the crude 1H NMR spectra, therefore, in this case 1,4-
addition is still preferable, but occurs with significantly decreased efficiency.  When 
the reaction was repeated with 4-tert-butylcatehol no desired arylated product could 
be identified in the crude 1H NMR.  The steric effect of a substituent at the 4-
position clearly has a considerable impact on the Michael addition at the adjacent 
position.   
Catechol 90 was also investigated in the oxidative coupling reaction, generating 
unsubstituted o-benzoquinone following oxidation.  Methyl cyclopentanone-2-
carboxylate 109 was again chosen as the pro-nucleophile, and gave the 1,4-addition 
product 169q in a modest 17% yield when reacted with catechol, 10 mol % ps-
BEMP and 2 equivalents of oxidant (Table 3.1, entry 1).  Alternative conditions 
were screened to increase the isolated yield (Table 3.1); up to 21% was achieved 
with portion-wise addition of 1 equivalent of oxidant.  Despite the poor yield, no 
other addition products could be isolated from the reaction mixture. 
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OH
OH
O
OMe
O OH
OH
O
OMe
O
1)
ps-IO4- (1 or 2 equiv) 
ps-BEMP (10 mol %)
CH2Cl2, -20 ºC
2) Na2S2O4 (aq)
109
90
169q  
Entry Equiv Nu Equiv ps-IO4 Equiv Base T / ºC % Yield 
1 1 2 0.1 -20 17 
2 2 1 0.1 -20 18 
3 2 2 0.1 -20 18 
4 2 1 (slow addition) 0.1 -20 21 
Table 3.1: Oxidative coupling conditions screened for the reaction of catechol 90 with 
methyl cyclopentanone-2-carboxylate 109. 
The 3-substituent on the catechol/o-quinone is therefore required to obtain the 
arylated products in high yield.  A substituent at the 3 position appears to be 
important for increasing the stability of the o-benzoquinone compared to the 
unsubstituted reagent without hindering the preferred 1,4-addition, and so is also 
important for aiding the regioselectivity.  
3.2  Asymmetric Michael addition to in situ generated ortho-
benzoquinones 
In an analogous fashion to the work with 1,2-naphthoquinone an enantioselective 
oxidative coupling was investigated by replacing ps-BEMP with cinchona alkaloid 
derived organocatalysts.  A range of known catalysts (Chart 3.2) were tested in the 
reaction of 3-methoxycatechol 163 with tert-butyl 1-oxoindane-2-carboxylate 
80.86,87  Gratifyingly the organocatalysts screened were compatible with the 
oxidising reaction conditions and were all able to catalyse the reaction.  The results 
of the initial catalyst screen are illustrated in Table 3.2 entries 1 – 7. 
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N
Cat QD-148Cat QD-71
N
Cat 70
O
N
OH
R
HN
N
OHN
CF3F3C
Cat QD-170
N
O
N
HN S
HN CF3
CF3
Cat QD-171  
Chart 3.2: Known organocatalysts screened in the reaction of 3-
methoxycatechol 163 with tert-butyl 1-oxoindane-2-carboxylate 80. 
OH
OH
O
CO2tBu MeO OH
OH
(1 equiv)
ps-IO4- (2 equiv)
CH2Cl2, -20 ºC
O
CO2tBu
catalyst
MeO
163
80
(-)-169r
1)
2) Na2S2O4 (aq)  
Entry Catalyst Loading/mol% Time/h % yield % ee 
1 70 10 2 62 40 
2 QD-71 1 3 78 58 
3 QD-71 10 2.5 86 61 
4 QD-71 100 2.5 78 58 
5 QD-148 10 2 81 74 
6 QD-170 10 2.5 76 67 
7 QD-171 10 3 50 58 
8 QD-172 10 3 78 70 
9 QD-173 10 3 75 50 
10 QD-174 10 2 84 81 
11 QD-174 1 3 71 43 
Table 3.2: Results of the catalyst screen on the reaction of 3-methoxycatechol 163 with 
tert-butyl-1-oxoindane-2-carboxylate 80.  Enantiomeric excesses were determined by 
HPLC analysis in comparison to a racemic sample prepared with ps-BEMP catalysis. 
The tertiary amine bifunctional catalysts all efficiently catalysed the reaction with 
no appreciable loss in rate compared with ps-BEMP catalysis.  In the case of 
catalyst QD-71, the enantiomeric excess appears to be independent of catalyst 
loading (entries 2-4) and at 10 mol% gave the arylated product in a moderate 58% 
 52
ee. From a comparison of the results of the reaction with catalyst QD-71 and 
catalyst QD-148/ QD-170 (entry 3 vs. 5-6) it appears that a bulky substituent at the 
C9 hydroxyl increases the asymmetric induction and that the proximity of the 
substituent to the C9 hydroxyl is also important.  From these two results alone it is 
unclear whether it is the overall size of this group or the local bulk around the C9 
hydroxyl that is important for asymmetric induction.  Comparing the result with 
catalyst QD-171 and QD-71 (entry 7 vs. 3) it appears that the nature of the 
hydrogen bond donor substituent on the quinoline ring has little effect on 
enantiocontrol.  A series of novel catalysts were synthesised from quinidine 
(Scheme 3.6) and screened in the oxidative coupling reaction to begin to investigate 
the effect of changing the O-substituent on the enantioselectivity (Table 3.2, entries 
8 – 11). 
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Scheme 3.6: Synthesis of novel bifunctional organocatalysts QD-172, QD-173 
and QD-174 tested for their ability to catalyse the reaction of 3-methoxycatechol 
163 with tert-butyl 1-oxoindane-2-carboxylate 80. 
A comparison of the result of known catalyst QD-71 with novel catalyst QD-172  
(Table 3.2, entries 3 vs. 8) suggests that local bulk around the C9 hydroxyl is 
important for organising the quinoline ring to enhance the asymmetric induction, 
however changing the phenyl group to trimethylphenyl (catalyst QD-173) results in 
a drop in enantiomeric excess (entries 8 vs. 9).  The most successful catalyst 
identified was catalyst QD-174 with the large adamantyl group attached via an ester 
linkage to the C9 hydroxyl.  This catalyst allowed arylated adduct (-)-169r to be 
isolated in 84% yield and 81% ee (entry 10).  Unlike catalyst QD-71, decreasing the 
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catalyst loading to 1 mol % resulted in a significant decrease in enantiomeric excess 
with catalyst QD-174 (entries 10 vs. 11).  Encouragingly, similarly high levels of 
enantiocontrol were achieved with 3-tert-butylcatechol to give adduct (+)-169s in 
74% yield and 82% ee (Scheme 3.7).  The absolute stereochemistry of the major 
enantiomer of (-)-169r and (+)-169s has been inferred from the results of Deng and 
co-workers (see chapter 2.3.3) but has not been proven.88  
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Scheme 3.7:  Addition of tert-butyl 1-oxoindane-2-carboxylate 80 to 
3-tert-butylcatechol 160 with catalyst QD-174 to give arylated product 
(+)-169s in good enantiomeric excess. 
 
To investigate the effect of changing the pro-nucleophile on the enantiomeric 
excess a small screen of pro-nucleophiles was conducted.  Pro-nucleophiles tert-
butyl 2-oxocyclopentanecarboxylate and 2,2,2-trifluoro-1-(trifluoromethyl)ethyl 2-
oxocyclopentanecarboxylate (see chapter 7.3.1), reported to give high enantiomeric 
excesses with cinchona alkaloid derived catalysts, were chosen and screened, along 
with methyl 2-oxocyclopentanecarboxylate 109, in the oxidative coupling reaction 
with 3-methoxy 163 and 3-tert-butyl- 160 catechols giving arylated adducts 169t – 
169w (Chart 3.3, Table 3.3).89  
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Chart 3.3: Enantioselective coupling examples 
Entry Product Catalyst (mol %) T /ºC solvent % Yield % ee 
1 (+)-169t QD-148 -20 CH2Cl2 62 65 
2 (+)-169t QD-148 -45 CH2Cl2 66 40 
3 (+)-169t QD-148 -20 toluene 31 58 
4 (+)-169t QD-174 -20 CH2Cl2 72 61 
5 (+)-169t QD-70 -20 CH2Cl2 84 26 
6 169u QD-174 -20 CH2Cl2 79 0 
7 (+)-169v QD-174 -20 CH2Cl2 62 16 
8 (-)-169w QD-174 -20 CH2Cl2 85 8 
Table 3.3: Screen of alternative pro-nucleophiles in the enantioselective oxidative 
coupling giving arylated adducts 169t – 169w. 
The arylated products 169r – 169w were obtained with widely varying degrees of 
enantiocontrol (Table 3.3).  The pro-nucleophile therefore has a significant effect on 
enantioselectivity.  This could be expected if, (in accordance with the postulated 
mode of action for quinidine-derived organocatalysts) the deprotonated nucleophile 
is held through a hydrogen bonding network to the bridge-head nitrogen of the 
quinuclidine ring and the quinoline hydroxyl (see chapter 2.3.3). The quinone 
electrophile appears to have less influence on enantioselectivity, with 16% 
difference in ee between 169u and (+)-169v (entries 6 and 7) and only 1% 
difference between adducts (-)-169r and (+)-169s.  In the postulated mode of 
enantiomeric induction, the electrophile is delivered to one face of the pro-
nucleophile through a second hydrogen bond to the quinoline hydroxyl, with the 
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catalyst acting in a bifunctional manner.  From these results it is clear that the 
interaction of the pro-nucleophile and catalyst is key for achieving high levels of 
stereocontrol.  It is unclear, however, to what extent the quinone interacts with the 
catalyst.  Changing the solvent and reaction temperature (entries 1 – 3) did not 
significantly change the enantiomeric excess of the product.  In order to achieve 
high levels of enantiocontrol it is clear that the catalyst and pro-nucleophile must be 
matched. It was therefore decided to exemplify the methodology in total synthesis 
and optimise the catalyst for the pro-nucleophile required for the chosen target. 
 
4 Total Synthesis of (±)-powelline & (±)-buphanidrine 
4.1 Amaryllidaceae alkaloids 
Over 500 structurally diverse alkaloids have been isolated from the plants of the 
amaryllidaceae family.90  The alkaloids exhibit a wide range of biological activities 
including antibacterial, antimalarial, antiviral, antiparasitic and immunostimulatory 
properties and several members of the family are cytotoxic.  The alkaloid 
galanthamine is a competitive, reversible, inhibitor of acetylcholine esterase and is 
used to treat Alzheimer’s disease.91  Several of the alkaloids have been the subject 
many synthetic investigations, but many still have no reported syntheses.  The 
alkaloids can be grouped into 15 structural classes according to their core skeleton, 
of these 7 contain arylated quaternary stereocentres (Figure 4.1). 
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Figure 4.1: Amaryllidaceae alkaloid structural classes containing arylated 
quaternary stereocentres 
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We decided to target the crinine-type amaryllidaceae alkaloids buphanamine 183, 
buphanidrine 184, powelline 185, undulatine 186 and crinamidine 187 (Figure 4.2) 
since these contain an aromatic methoxy substituent which would aid the key 
oxidative coupling step of the planned syntheses.  Characterised by the 5,10β-
ethanophenanthridine skeleton they differ in their substitution of ring E.  Initial 
efforts concentrated on buphanamine, buphanidrine and powelline, all of which 
contain 6 fused rings and 3 stereocentres, one of which is quaternary.  They have 
been isolated from several amaryllidaceae species and have been shown to bind to 
the selective serotonin re-uptake inhibitor site on the serotonin transporter in 
radioligand ([3H]-citalopram) binding assays.92,93  Buphanamine and buphanidrine 
have been isolated from the bulbs and leaves of Boophane disticha which are used 
in South African herbal medicine for numerous purposes including the treatment of 
headaches and hysteria.94 
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Figure 4.2: Crinine-type amaryllidaceae alkaloids containing a methylene acetal 
capped ortho-methoxycatechol moiety. 
Crinine 194 (Scheme 4.1), the simplest member of this structural class, has been 
synthesised several times.95,96 Two of the main strategies involve either formation 
of 3α-arylhydroxyindoles as key intermediates and formation of the C ring typically 
through a Pictet-Spengler cyclisation, or in a biomimetic approach, through 
simultaneous synthesis of the C and D rings in an oxidative phenol coupling and 
Michael addition sequence (191 → 192).98 The later approach has recently been 
applied to the racemic total synthesis of powelline 185 (reported during the course 
of this work).  The synthesis follows an established route to crinine 194 and is 
shown in Scheme 4.1.97  Currently no syntheses of buphanidrine, buphanamine, 
undulatine or crinamidine have been reported. 
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Scheme 4.1: Total synthesis of (±)-crinine 19495c and (±)-powelline 18597 
The construction of the sterically congested arylated quaternary stereocentre is 
pivotal to the synthesis of this class of alkaloid.  Accordingly we considered our 
oxidative coupling methodology to be ideally suited to the synthesis of these 
alkaloids. 
4.2 Retrosynthetic analysis 
Many reported syntheses of crinine-type amaryllidaceae alkaloids construct the B 
ring in the final stages through a Pictet-Spengler cyclisation.  Whilst this strategy 
has not been applied to amaryllidaceae alkaloids with a substituent ortho to the 
catechol moiety, regioselective cyclisation could be expected due to the reduced 
electron donating nature of the methylene acetal group relative to the methoxy 
substituent.99  We planned to adopt a similar strategy (Scheme 4.2) so that the key 
disconnection is then that of the quaternary carbon of the 5,6-bicyclic ring system 
and the aromatic ring.  Two retrosynthetic strategies were envisaged, however since 
5,6-bicyclic nucleophiles such as 197 (strategy A) are untested in the oxidative 
coupling reaction and 6-membered ring nucleophiles are known not to perform 
well; a more tested approach to the key step would be to employ a 5-membered ring 
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nucleophile such as lactam 198 and build in the 6-membered ring in subsequent 
steps (strategy B). 
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Scheme 4.2: Retrosynthetic analysis of buphanamine/buphanidrine/powelline 
revealing alternative oxidative coupling substrates 
4.3 Initial approach to buphanamine 
Initially Buphanamine was targeted; the retrosynthetic analysis is shown in Scheme 
4.3.  Oxidative coupling of pro-nucleophile 205 with 3-methoxycatechol 163 in the 
key quaternary carbon-to-aryl bond forming step followed by methylene acetal 
protection should provide adduct 203.  Reduction of the lactam followed by 
acylation could allow introduction of the allyl group through reaction with allyl 
silane in the presence of a Lewis acid to give 201.  This sets up a ring closing 
metathesis to give the 5,6-bicyclic system 200.  Removal of the Boc protecting 
group, 1,2-reduction of the α,β-unsaturated ketone and Pictet - Spengler cyclisation 
could provide rapid access to buphanamine 183. 
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Scheme 4.3 Retrosynthetic analysis of buphanamine 183 via a ring-closing-metathesis 
The synthesis of pro-nucleophile 205 was initially attempted by adding LHMDS to 
a 1:1 mixture of N-boc-2-pyrrolidinone 206 and crotonoyl chloride.  This gave the 
desired product but in a meagre 4% yield.  Optimisation of the reaction conditions 
gave up to 41% yield when the lactam was added dropwise to 2.1 equivalents of 
base, followed by dropwise addition of freshly distilled electrophile (Scheme 4.4). 
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Scheme 4.4:  Synthesis of pro-nucleophile 205. 
Pro-nucleophile 205 (1 equiv) was reacted with 3-methoxycatechol according to the 
standard oxidative coupling conditions (Scheme 4.5) and gave the desired arylated 
product 204 in 53% yield following column chromatography on a 2 mmol scale.  
Increasing the quantity of pro-nucleophile to 2 equivalents increased the yield 
following chromatography to 56%, but was not practical due to the low yields for 
the synthesis of the pro-nucleophile. 
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Scheme 4.5: Oxidative coupling of pro-nucleophile 205 with 3-methoxycatechol 163. 
The next step in the planned synthesis was to introduce the methylene acetal 
capping group.  A series of reported conditions were tried and in all cases none of 
the desired product could be isolated (Table 4.1, entries 1-3).100  Acid and base 
catalysed reactions with formaldehyde and triethylorthoformate were also 
investigated, but also gave no conversion to the desired product. 
N
OH
OHMeO
O
O
O O
N
MeO
O
O
O O
O
O
base
CH2X2
204 203
 
Entry CH2X2 Base Solvent 
T / 
ºC time heating 
% 
conv. 
% 
yield 
1 CH2Br2 1.5 equiv 
Cs2CO3 
1.5 equiv DMF 90 18 h thermal 0 - 
2 CH2ClBr 10 equiv 
K2CO3 
10 equiv DMF 110 18 h thermal 0 - 
3 CH2Br2 1.2 equiv 
K2CO3 
10 equiv DMF 90 1h MW 0 - 
4 CH2ClBr 10 equiv 
KF 
17 equiv DMF 110 18 h thermal - 33 
5 CH2ClBr 5 equiv 
KF 
10 equiv DMF 120 15 min MW 48 - 
6 CH2ClBr 
KF 
10 eq CH2ClBr 70 15 min MW 0 - 
7 CH2ClBr 5 equiv 
KF 
10 equiv DMF 120 5 min MW 30 - 
8 CH2ClBr 5 equiv 
KF 
17 equiv DMF 120 
5x5 
min MW 80 10 
9 CH2ClBr 20 equiv 
KF 
34 equiv DMF 80 1 h MW - 50* 
Table 4.1:  Optimisation of methylene acetal protection. * 75% based on recovered starting material. 
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Changing the base from caesium/potassium carbonate to potassium fluoride and 
heating with CH2ClBr at 110 ºC in DMF for 15 h gave a 33% yield of the desired 
methylene acetal protected catechol 203 (entry 4).  The efficiency of this reaction 
was increased using microwave heating.  Heating to 120 ºC for 15 min gave 48% 
conversion by NMR (measured against remaining starting material) (entry 5).  
Conversion by NMR of 80% was achieved by heating to 120 ºC for 5 min 5 times, 
adding additional CH2ClBr and base each time (entry 8), however the isolated yield 
was a poor 10%.  Since the conversion by NMR was measured against remaining 
starting material, this implies that the starting material, product, or both are 
decomposing under the reaction conditions.  Improved isolated yields (50%) were 
achieved by lowering the temperature to 80 ºC and heating for 1 h (entry 9).   
 
The oxidative coupling and methylene acetal protection were combined into a 
telescoped procedure, using the crude product from the oxidative coupling directly 
in the acetal protection reaction.  Yields up to 44% were achieved on a 1 mmol 
scale over the 3 steps (Scheme 4.6) 
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Scheme 4.6: One pot oxidative coupling – methylene acetal protection 
Further optimisation (Table 4.2) showed that the reaction time for the acetal 
protection could be reduced to 30 min without decreasing the reaction yield (entry 4 
vs 2) and that increasing the concentration or using hydrated KF decreased the yield 
of 203 (entry 3 vs 2). 
Entry CH2ClBr 
equiv 
KF equiv Concentration 
/M 
T/ºC t/min % yield 
1 20 34 (KF.2H2O) 0.125 80 60 34 
2 20 34 0.125 80 60 44 
3 10 17 0.333 80 60 18 
4 20 34 0.125 80 30 44 
Table 4.2: Optimisation of the telescoped oxidative coupling and methylene acetal 
protection (Scheme 4.6) for the synthesis of 203. 
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The next step involved selective reduction of the N-Boc lactam carbonyl over the 
α,β-unsaturated ketone to give N-Boc aminol 202 (Scheme 4.7).  To ensure the α,β-
unsaturated ketone was not reduced it was protected as its enolate through treatment 
of lactam 203 with 1.1 equivalents of LHMDS before adding the DIBAL 
reductant.101 
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Scheme 4.7: Selective reduction of N-Boc lactam 203 to 202. 
Whilst the reduction appeared to proceed smoothly with no starting material present 
in the crude 1H NMR and the correct mass ion for the reduced product present as 
the only major peak in the mass spectrum of the reaction mixture, varying 
diastereomeric mixtures of conjugated and non-conjugated enones (presumably 
resulting from competing γ− and α−reprotonation) were observed in the complex 
crude 1H NMR spectra obtained following work-up.  These inconsistent results, 
combined with the poor yields obtained in the pro-nucleophile synthesis, hampered 
this approach to the target alkaloid.  An alternative approach via a more readily 
prepared pro-nucleophile was sought. 
4.4 Alternative approach to powelline, buphanidrine, undulatine, 
crinamidine and buphanamine 
Since the high reactivity of the crotonoyl side chain of pro-nucleophile 205 was 
believed to be causing difficulties throughout the original synthesis, an alternative 
strategy utilising a less reactive pro-nucleophile was desired.  As such the α,β-
unsaturated ketone was replaced with a methyl ester in a new synthetic plan 
(Scheme 4.8).  Instead of a ring closing metathesis to form the key 5,6-bicyclic 
intermediate, a Dieckmann-type cyclisation of keto-ester intermediate 210 was 
envisaged to give diketone 211.  Formation of the methyl enol ether 212 could then 
give access to the 5 alkaloids buphanamine, buphanidrine, undulatine, powelline 
and crinamidine from this common intermediate. Thus in addition to the anticipated 
 63
advantages of removing the crotonoyl side chain this route also provides a more 
general strategy to this family of alkaloids. 
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Scheme 4.8: Alternative retrosynthetic analysis avoiding highly reactive 
crotonoyl pro-nucleophile 205. 
Pleasingly, synthesis of the methyl ester pro-nucleophile 207 proceeded smoothly in 
up to 96% yield on a 5 g scale, following the same procedure used previously for 
the synthesis of 205 (Scheme 4.9), but replacing crotonoyl chloride with methyl 
chloroformate.  The increased yield in the pro-nucleophile synthesis compared to 
crotonoyl pro-nucleophile 205 facilitated the synthesis of multi-gram quantities of 
synthetic intermediates.   
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Scheme 4.9: Synthesis of pro-nucleophile 207. 
The oxidative coupling (Scheme 4.10) of 207 with 3-methoxycatechol 163 gave 
reasonable conversion to the desired arylated product under the established 
conditions.  The crude product was used directly in the reaction with CH2ClBr to 
form the methylene acetal protecting group.  This was unsuccessful with KF as base 
giving 208 in a poor 10% yield.  Changing the base to Cs2CO3 and irradiating at 85 
ºC in a microwave for 1 hour gave 208 in 38% yield (Table 4.3, entry 1).102  A 
temperature, solvent, and concentration screen showed that increasing or decreasing 
the reaction temperature from -20 ºC had a detrimental effect on the yield of 208 
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(entry 1 vs. 2, 3).  Increasing the number of equivalents of pro-nucleophile also 
decreased the isolated yield (entry 4), although this was mainly due to difficulties in 
separating the arylated product from the excess of pro-nucleophile during column 
chromatography and did not reflect a decrease in conversion.  Increasing the 
dilution of the reaction mixture also had a detrimental effect on reaction yield (entry 
5).  The reaction in acetonitrile was equivalent to CH2Cl2 however the isolated yield 
was increased to 52% on a 10 mmol scale by running the oxidative coupling 
reaction in acetone (entries 6 and 7).  The methylene acetal capping reaction was 
initially conducted under microwave irradiation; however conventional heating in a 
sealed vessel was later shown to give the same result. 
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Scheme 4.10: One pot oxidative coupling and methylene acetal 
protection of 207 and 3-methoxycatechol 163.  
Entry Equiv Pro-Nu Solvent 
Equiv 
base 
Concentration 
/M T/ºC % yield
a 
1 1 CH2Cl2 0.1 0.1 -20 38 
2 1 CH2Cl2 0.1 0.1 0 18 
3 1 CH2Cl2 0.1 0.1 -30 28 
4 2 CH2Cl2 0.2 0.1 -20 20 
5 1 CH2Cl2 0.1 0.05 -20 20 
6 1 MeCN 0.1 0.1 -20 37 
7 1 acetone 0.1 0.1 -20 52b 
Table 4.3: Optimisation of oxidative coupling of 163 and 207 (Scheme 4.10). a isolated yield of 
208 after methylene acetal protection with CH2ClBr and Cs2CO3, b methylene acetal protection 
conducted with conventional heating in a sealed vessel or under microwave irradiation gave 
identical product yields. 
Subsequent reduction of the ketonic N-Boc lactam carbonyl (the most reactive 
carbonyl) with 1 equivalent of Super-hydride® was highly chemoselective and gave 
quantitative conversion to N-Boc aminol 209 as a 1:1 diastereomeric mixture.  
Isolated yields of 93% following simple filtration through a plug of silica gel were 
achieved (Scheme 4.11).   
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Scheme 4.11: N-Boc lactam reduction to give 209. 
Although signals indicative of the open form aldehyde 213 were not observed in the 
1H NMR in d6 DMSO of this N-Boc aminol, the two forms were expected to exist in 
dynamic equilibrium (Scheme 4.12).  As such 209 was treated with Horner-
Wadsworth-Emmons reagent dimethyl 2-oxopropylphosphonate and potassium tert-
butoxide and heated to reflux.  The only products obtained from the reaction 
mixture were identified as formamide 214 and de-formylated product 215 (Scheme 
4.13). 
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Scheme 4.12:  Anticipated equilibrium of aminol 209 and open form aldehyde 213. 
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Scheme 4.13: Attempted Horner-Wadsworth-Emmons reaction of aminol 209.  
The desired product was not isolated. 
Treatment of N-Boc aminol 209 with strong base resulted in apparent complete 
conversion to the formamide 214 and subsequent conversion to de-formylated 
product 215 after extended heating.  This process destroys the quaternary centre 
created in the key step.  Introduction of the ketonic side chain of 210 was therefore 
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deemed to be impossible using Wittig or Horner-Wadsworth-Emmons chemistry 
and an N-acyliminium ion approach was investigated instead. 
 
Acylation of N-Boc aminol 209 with acetic anhydride in pyridine gave quantitative 
conversion to 216, which was used crude in the Lewis acid mediated reaction with 
(isopropenyloxy)trimethylsilane (Scheme 4.14).103  
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Scheme 4.14: Acylation of N-Boc aminol 209 and Lewis-acid mediated displacement 
with (isopropenyloxy)trimethylsilane to give 210. 
 
Pleasingly treatment of 216 with BF3.Et2O in CH2Cl2 with an excess of 
(isopropenyloxy)trimethylsilane gave the desired product in 91% yield (over 2 
steps), although in a moderate 3:1 dr (Table 4.4, entry 1).  A series of solvents and 
Lewis/Brønsted acids were screened in order to increase the dr (Table 4.4).  The 
highest dr was achieved in acetone (entry 6), which also gave smooth conversion 
and an isolated yield of 76%.  Both the minor and major diastereomers show an 
NOE interaction between proton HA and the protons of the aromatic ring (Figure 
4.3), so the relative stereochemistry of the major diastereomer could not be 
determined by 1H NMR analysis at this stage. 
 
Entry Lewis/Brønsted Acid Solvent dr (isolated yield) 
1 BF3.Et2O CH2Cl2 3:1 (91%) 
2 BF3.Et2O THF 4:1 
3 BF3.Et2O TBME 5:2 
4 BF3.Et2O Et2O 5:2 
5 BF3.Et2O MeCN No conversion 
6 BF3.Et2O Acetone 7:1 (76%) 
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7 BF3.Et2O EtOAc 4:1 
8 TMSOTf CH2Cl2 3:2 
9 SnCl4 CH2Cl2 2:1 
10 CSA CH2Cl2 No conversion 
11 BF3.THF CH2Cl2 No conversion 
Table 4.4: Screen of solvents and Lewis/Brønsted acids for the reaction of 
acylated aminol 216 and (isopropenyloxy)trimethylsilane to give  210. 
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Figure 4.3: NOE interactions (average values) observed for the major and minor 
diastereomer of 210.  The relative stereochemistry could not be determined from 
these results. 
Treatment of keto-ester 210 with potassium tert-butoxide (2 equivalents) in THF 
gave smooth conversion to the cyclic diketone 211 (Scheme 4.15), identifiable by 
mass-spectrometry.  No conversion was observed with the alternative bases, NaH or 
KH in THF or with NaOMe/KOMe in methanol or NaOEt in ethanol.  Adding keto-
ester 210 to a warm (40 ºC) solution of KOtBu in THF gave smooth conversion to 
the cyclic product, complete in 10 min.  1H NMR of the crude reaction mixture was 
broad with no sharpening of the peaks upon heating to 90 ºC. This is possibly due to 
the presence of rotamers and meant that an accurate measure of conversion (or dr) 
could not be determined at this stage.  Since the diketone was extremely polar the 
crude reaction mixture was reacted directly under various conditions to form the 
methyl enol ether 212 which was easier to handle and purify.  Treatment of the 
crude mixture with 10 mol% CSA in methanol resulted in slow conversion to the 
methyl enol ether and a low isolated yield of 28%.  This was increased to 46% with 
20 mol% HCl in methanol.  Quenching the cyclisation reaction with dimethylsulfate 
gave the desired enol ether in 29% yield and Mitsunobu conditions (1 equiv each of 
PPh3 and DEAD, 5 equiv of methanol in THF) gave 42% (all yields over 2 steps).104  
Alternatively, treating the crude diketone with 5 mol % TiCl4 in methanol gave 
good conversion to the desired methyl enol ether 212 and pleasing isolated yields of 
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64 % over 2 steps (Scheme 4.15).105  The methyl enol ether formation was highly 
regioselective; no minor regioisomer was identifiable in the crude 1H NMR of the 
reaction mixture.  The structure of methyl enol ether 212 was assigned through 
analysis of the 13C, HSQC and HMBC NMR spectra.  Cross peaks between the 
protons of the pyrollidine ring and the carbonyl carbon in the HMBC spectra 
confirmed that the desired regioisomer had been formed. 
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Scheme 4.15:  Dieckmann-type cyclisation of keto ester 210 and 
subsequent formation of enol ether 212. 
Only one diastereomer of the methyl enol ether was isolated from the reaction and a 
minor diastereomer could not be identified in the NMR of the crude reaction 
mixture.  Furthermore the isolated yield of methyl enol ether was consistent 
irrespective of the diastereomeric ratio of keto-ester 210 cyclisation substrate.  This 
implies the Dieckmann step is reversible and gives only the thermodynamic product 
under these conditions.  Subsequent scaled-up batches of keto-ester 210 were 
therefore prepared in CH2Cl2 to give optimised yield and not dr. 
To access the allylic alcohol system present in the target alkaloids, reductive 
manipulation of the enol ether moiety was required.  The DIBAL reduction of enol 
ether systems to their corresponding enones is well documented in the literature,106 
however there are few examples where the ketone is adjacent to a sterically 
congested quaternary centre. Treatment of methyl enol ether 212 with DIBAL in 
toluene gave, following hydrolysis in aqueous HCl/diethyl ether, disappointing 
yields of the desired enone 217 and significant quantities of saturated ketone by-
product 217b resulting from competing 1,4-reduction, elimination of methanol and 
a second 1,4-reduction (Table 4.5, entry 6).  Whilst 1,2-reduction would be 
expected with DIBAL, the adjacent quaternary centre is believed to hinder 1,2 
reduction so that the 1,4-reduction process becomes competitive.  Altering the 
temperature and rate of addition of DIBAL gave no significant improvement in 
result (entries 6 – 9).  Treatment of enol ether 212 under Luche reduction 
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conditions, or with LiAlH4 or Red-Al® gave no conversion to the desired enone 
(entries 1 – 4).  Changing the reducing agent to Super-hydride® resulted in saturated 
alcohol products 217c in a 1:1 diastereomeric ratio (separable by column 
chromatography) (entry 5).  The isolated yield of enone 217 and the ratio of 
217:217b:217c was improved by changing the solvent for the DIBAL reduction to 
CH2Cl2.  With the optimal conditions (entry 12), enone 217 could be isolated in 
58% yield over the 2 steps (reduction and hydrolysis).  Increasing the reaction 
temperature from -20 to 0 ºC improved the ratio of 217:217b but decreased the 
isolated yield of 217; decreasing the reaction temperature had a detrimental effect 
on both the product ratio and yield (entries 11, 12 and 13).  Changing the 
equivalents of DIBAL had little effect on the product ratio or isolated yield (entry 
10 vs. 11). 
MeO O
O
NO
O O
MeO O
O
NO
O
O
OMe
MeO O
O
NO
O
O
MeO O
O
NO
O
OH
1) DIBAL
2) HCl (aq), Et2O
+ +
212 217 217b 217c  
Entry Reductant (equiv) Solvent 
T 
/ºC 
Ratio 
217:217b:217c 
% Yield 
217 
1 NaBH3/CeCl3 (1) MeOH 0 - 0a 
2 LiAlH4 (1) THF 0 0:1:0 - 
3 LiAlH4 (1) toluene 0 0:1:0 - 
4 Red-Al® (2) toluene 0 - 0b 
5 Super-hydride® (2.2) THF -78 0:0:1 217c 52% (1:1 ratio of diastereomers) 
6 DIBAL (2) toluene -78 1:1:0 217 33%, 217b 33% 
7 DIBAL (2) toluene -85 1:1:0 - 
8 DIBAL (2) toluene -20 1.2:1:0 - 
9 DIBAL (2, dropwise) toluene -78 1.3:1:0 - 
10 DIBAL (2) CH2Cl2 0 7:1:0c 217 28%, 217b 4% 
11 DIBAL (4) CH2Cl2 0 7.5:1:0 217 32%, 217b 4% 
12 DIBAL (2.5) CH2Cl2 -20 5.3:1:0 217 58%, 217b 11% 
13 DIBAL (2) CH2Cl2 -78 2:1:0 217 44%, 217b 21% 
Table 4.5: Screen of reducing agents and conditions for reduction of methyl enol ether 212. aStarting 
material was recovered, bdecomposition of starting material, 217 could not be detected in crude 
NMR, c 6% unreacted starting material also recovered. 
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In an attempt to increase the ratio of 217:217b:217c in favour of the desired enone, 
ethyl-enol ether 218 was synthesised in 38% yield from 210 following the 
established procedure for the preparation of 212 but replacing methanol with 
ethanol (Scheme 4.16).  It was hoped that the small increase in bulk of the ether 
substituent would decrease the propensity for 1,4-reduction.  Treatment of 218 with 
DIBAL in toluene gave enone 217 and ketone 217b in 36% and 18% yield 
respectively.  The isolated yield is comparable to the analogous reduction of 212, 
and the ratio is improved, however the low yield for the synthesis of the ethyl enol 
ether (38% vs. 64%) rendered this approach unattractive. 
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MeO O
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O
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1) KOt-Bu, THF
2) TiCl4, EtOH
210
1) DIBAL
2) HCl (aq), Et2O
218 217
36% 18%38%  
Scheme 4.16: synthesis of enone 217 via ethyl enol ether 218. 
The enone product 217 was found to be highly crystalline; therefore the relative 
stereochemistry at the ring-junction was proven to be cis (as desired) by single-
crystal X-ray crystallography (Figure 4.4).  
 
Figure 4.4: X-ray crystal structure of enone 217, confirming 
relative stereochemistry of ring junction. 
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Reduction of enone 217 was initially attempted under standard Luche conditions 
(NaBH4, CeCl3.7H2O) and gave the desired allylic alcohol as the minor component 
of a 5.5:1 diastereomeric mixture (overall yield 95%) (Scheme 4.17).  The 
diastereomers were separable by silica gel chromatography although complete 
separation was difficult and the minor diastereomer was typically isolated 
containing varying degrees of major diastereomer.  NOE studies on pure samples of 
both diastereomers confirmed the relative stereochemistry of the major and minor 
components (Figure 4.5).   
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O OH
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O OH
NaBH4, CeCl3.7H2O +
217
MeOH
219 219b
95% combined yield
1:5.5 dr (219:219b)  
Scheme 4.17: Luche reduction of enone 217 
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Figure 4.5: NOE studies (average values) on both 
diastereomers of allylic alcohol 219/219b. 
Mesylation and inversion of the undesired allylic alcohol has been reported on 
similar systems to be an effective, but lengthy, strategy to obtain the desired allylic 
alcohol.107 
Accordingly 219b (dr >99:1 219b:219) was treated with methanesulfonic anhydride 
followed by CsOAc and hydrolysis of the resulting ester with K2CO3 in methanol 
(Scheme 4.18).  The desired diastereomer was obtained in 75% yield as the major 
component of a 3.1:1 diastereomeric mixture.   
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Scheme 4.18: Inversion of 219b to 219. 
Whilst this approach allowed the desired diastereomer to be obtained as the major 
product, it is lengthy and the loss of stereochemical integrity meant that isolating 
the desired diastereomer in good yield would be difficult, with a theoretical 
maximum yield of 46% attainable assuming complete separation of diastereomers 
after the initial reduction and the inversion.  Consequently a screen of reducing 
reagents/conditions was undertaken to try and alter the diastereomeric ratio (Table 
4.6).   Since the aim of the screen was to optimise dr, which was determined from 
the crude 1H NMR, in most cases isolated yields were not determined. 
MeO O
O
NO
O O
MeO O
O
NO
O OH
MeO O
O
NO
O OH
+
reducing agent
(see table 4.6)
217 219 219b
 
Entry Reductant  T /ºC Solvent dr a (219:219b) Yieldb 
1 Superhydride® -20 THF 1:2 - 
2 N-Selectride® -20 THF 2:1 - 
3 N-Selectride® -20 CH2Cl2 1:1 - 
4 N-Selectride® -20 toluene 1:1.3 - 
5 N-Selectride® -78 THF 2:1 77% 
6 N-Selectride® rt THF 2:1 - 
7 K-Selectride® -20 THF 1.7:1 - 
8 L-Selectride® -20 THF 3.5:1 - 
9 L-Selectride® -78 THF 3.5:1 78% 
Table 4.6: Screen of reducing conditions for synthesis of allylic alcohol 219. aCalculated from crude 
NMR at 90 ºC, boverall yield of both diastereomers 
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Whilst Superhydride® was found to give the undesired diastereomer 219b as the 
major product (entry 1), pleasingly N-, K- and L-Selectride® reversed the 
stereoselectivity and gave the desired allylic alcohol 219 as the major diastereomer.  
With N-Selectride® up to 2:1 dr and 77% overall yield was obtained in THF (entries 
2, 5 and 6).  Changing the temperature had no effect on the diastereomeric ratio 
however the crude spectra were noticeably cleaner at lower temperature; changing 
the reaction solvent had a detrimental effect on the stereoselectivity.  L-Selectride® 
was found to be the optimal reagent, allowing the desired allylic alcohol to be 
synthesised as the major component of a 3.5:1 diastereomeric mixture, in an overall 
yield of 78%. 
The difference in stereoselectivity between NaBH4 and the Selectride® reducing 
agents could be expected based on the differing sizes of these reducing agents.  For 
the reduction of rigid cyclohexanone systems with small reducing agents (such as 
NaBH4) torsional effects dominate and so axial attack is expected (giving an 
equatorial hydroxyl group) to avoid the development of eclipsing interactions in the 
transition state.  In contrast larger reducing agents (such as L-Selectride®) are more 
influenced by steric effects which are greater for axial attack and therefore these 
reagents prefer equatorial attack to give an axial hydroxyl.  Whilst the reduction of 
217 is significantly more complicated than simple cyclohexanone systems, this 
rationale can explain the experimental outcome of the reduction reactions if enone 
217 reacts through the pseudo-chair conformations shown in Figure 4.6. 
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BocN
Ar
H
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     attack
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Figure 4.6: Stereochemical outcome of reduction of enone 217. 
For the synthesis of (±)-powelline, allylic alcohol 219 was treated with neat TFA to 
remove the Boc protecting group (Scheme 4.19).  The crude secondary amine 
(identifiable by mass spectrometry) was free-based and used directly without 
purification in the Pictet-Spengler cyclisation.108  Accordingly the crude amine was 
treated with aqueous formaldehyde in methanol for 15 min before adding 6 M HCl.  
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For crinine systems the analogous Pictet-Spengler cyclisation required heating to 40 
ºC, however with the additional electron donating methoxy group on the aromatic 
ring heating was not required on this system, with the reaction complete in 10 min 
after the addition of acid at room temperature.  Pleasingly the two possible 
regioisomers in the Pictet-Spengler reaction were formed with ~7:1 selectivity for 
the desired product (Scheme 4.19) to give (±)-powelline 185 in 49% yield over 2 
steps.  Whilst (±)-powelline could be isolated free from the minor regioisomer, it 
was not possible to isolate the minor regioisomer from (±)-powelline and a further 
35% of a 2.5:1 mixture of 185:185b was isolated.  The minor regioisomer 185b was 
characterised from this mixture. 
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Scheme 4.19:  Synthesis of (±)-powelline 185 from 219. 
The spectral data for (±)-powelline (Figure 4.7) were consistent with the published 
data,109 and in addition the structure of synthetic powelline was confirmed with 2D 
and NOE NMR experiments (Figure 4.8). An NOE interaction between the 
NCH2Ar protons and the protons of the methoxy group confirmed the 
regioselectivity of the Pictet-Spengler cyclisation.  Furthermore NOE experiments 
on the minor regioisomers 185b showed an interaction between the protons of the 
aromatic methoxy group and the proton of the aromatic ring that was absent in the 
major component.   
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Figure 4.7: 1H NMR spectrum of (±)-powelline 185. 
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Figure 4.8: NOE studies (average values) on synthetic 
(±)-powelline 185 and regioisomer 185b. 
The synthesis of C3-epi-powelline (C3-epi-185) was also accomplished from allylic 
alcohol 219b, following the same deprotection Pictet-Spengler sequence (Scheme 
4.20).  The major product was identified by 2D NMR and NOESY analysis as C3-
epi-powelline.  Sufficient quantities of the minor component of the crude reaction 
mixture could not be obtained for full characterisation, however identical mass-
spectra and proton and NOESY spectra suggest this minor component is, as 
expected, the other regioisomer C3-epi-185b.  The products obtained from this 
reaction sequence could not be identified in the crude reaction mixture in the 
synthesis of powelline, indicating that epimerisation of the allylic alcohol does not 
occur during the deprotection or Pictet-Spengler reactions. 
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Scheme 4.20: Synthesis of C3-epi-powelline (C3-epi-185) from 219b. 
For the synthesis of (±)-buphanidrine 184 allylic alcohol 219 was O-methylated 
under standard conditions (NaH, MeI) to give methyl ether 221 in excellent yield 
(Scheme 4.21).  Following the same deprotection/Pictet-Spengler sequence 
provided (±)-buphanidrine, again as the major component of a separable ~10:1 
regioisomeric mixture in 51% yield (over 2 steps). Again the minor regioisomer 
184b could not be completely separated from (±)-buphanidrine and a further 32% 
of a 2.8:1 184:184b mixture was isolated.  The minor regioisomer was characterised 
from this mixture. 
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Scheme 4.21: Synthesis of (±)-Buphanidrine 184 from 219. 
 The spectral data (Figure 4.9) were in excellent agreement with the published 
data,110 and again NOE studies also confirmed the reported structure (Figure 4.10).  
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Figure 4.9: 1H NMR spectrum of (±)-buphanidrine 184. 
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Figure 4.10: NOE studies (average values) of synthetic (±)-buphanidrine 184 
Thus the total syntheses of (±)-powelline 185 and (±)-buphanidrine 184 were 
accomplished in 13 and 14 linear steps respectively and in 6% overall yield in both 
cases (Scheme 4.22).  This route represents a novel approach to the crinine skeleton 
with the quaternary carbon to aryl bond constructed directly through an oxidative 
coupling to allow rapid construction of the target alkaloids.  No attempt was made 
to synthesise the remaining target alkaloids at this time as an enantioselective 
approach to powelline and buphanidrine was investigated.  The synthesis of (±)-
undulatine and (±)-crinamidine would require diastereoselective epoxidation of the 
allylic alcohol, and the synthesis of buphanamine would require an alternative 
reduction sequence or rearrangement of the allylic alcohol. 
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Scheme 4.22: Total synthesis of (±)-powelline 185 and (±)-buphanidrine 184. 
 
5 Enantioselective total synthesis studies 
5.1 Initial organocatalyst screen 
With proof of concept for an organocatalysed enantioselective oxidative coupling 
established with 3-methoxycatechol and 3-tert-butylcatechol during methodology 
development (chapter 3.2), it was believed that an enantioselective synthesis of the 
target alkaloids could be achieved by employing similar organocatalysts in the key 
oxidative coupling step.  However since the enantioselectivity was found to vary 
widely with the pro-nucleophile employed it was anticipated that a significant 
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degree of optimisation would be required to obtain high levels of stereocontrol with 
pro-nucleophile 207. 
An initial screen of organocatalysts (Chart 5.1) was undertaken under the standard 
oxidative coupling procedure (Table 5.1) and the enantioselectivity determined by 
chiral HPLC analysis compared to a racemic sample.  The methylene acetal 
protected product was initially used for HPLC analysis since the catechol product 
was found to ‘streak’ on silica.  To increase the ease of catalyst screening the 
methylene acetal protecting group was later replaced with diacetate protection, 
following the established protocol described in chapter 2.2.  The enantioselectivity 
obtained with catalyst QD-71 was identical from either method (entries 5 and 5b). 
OH
OHMeO
N
O
OMe
OO
O
N
OR
ORMeO
O
OMe
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+
1) catalyst (10 mol %)
    ps-IO4- (2 equiv)
    CH2Cl2
2) Na2S2O4 (aq)
3) CH2ClBr, Cs2CO3
or Ac2O, pyridine
(+)/(-)-208, R = -CH2- 
(+)/(-)-223, R= Ac
163
207
 
Entry Catalyst Scale/mmol Product % ee % Yield 
1 135 0.1 (-)-223 15 41 
2  QD-147 0.2 (+)-223 11 38 
3  137 0.1 (-)-223 1 31 
4  70 0.1 (+)-208 34 15 
5  QD-71 0.1 (+)-208 50 35 
5b   QD-71 0.5 (+)-223 50 30 
6  QD-148 0.1 (+)-208 49 20 
7  QD-172 0.1 (+)-208 42 28 
8  QD-173 0.1 (+)-208 31 13 
9  QD-174 0.1 (+)-208 11 28 
10 QD-170 0.1 (+)-208 55 25 
11 QD-225 0.1 (+)-223 6 35 
12  151 0.1 (+)-223 15 31 
13 68 0.1 (-)-208 35 18 
14 QD-171 0.1 (±)-208 0 25 
15  227 0.1 (+)-223 5 43 
16  228 0.1 (+)-223 12 43 
17  229 0.1 (-)-223 1 25 
18  230 0.1 (+)-223 3 30 
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19  231 0.1 (-)-223 32 20 
20  232 0.1 (-)-223 4 18 
21  233 0.1 (+)-223 4 33 
Table 5.1: Initial organocatalyst screen in the reaction of 3-
methoxycatechol 163 and 207. 
N
O
N
OH
N
HN
N
HN O
CF3F3C
N
O
N
OH
N
O
N
OH
N
O
N
OH
N
O
N
OH
N
O
N
HN
N
N
OH
O O
HN
O
CF3
CF3
O
N
NH
NHO
CF3F3C
cat. QD-71
cat. QD-148
cat. QD-172
cat. QD-225
cat. QD-173
cat. QD-170
cat. 70
cat. 151
cat. 68
N
O
N
OH
N
O
N
OH
cat. QD-174
cat. QD-171
N
HO
N
OMe
cat. 135
N
HO
N
cat. 137
N
HO
N
OH
cat. QD-147
 
 81
N
NH2
NH2
OH
NH2
NH2
NH2
NH2
N
H
N
H
S
N
O
N
N
H
N
H
S
N
O
HO N
N
H
N
H
SH
N
O
cat. 227 cat. 228 cat. 229 cat. 230
cat. 231 cat. 232 cat. 233
 
Chart 5.1: Organocatalysts screened in the oxidative coupling of 207 with 3-methoxycatechol 163. 
Whilst all enantioselectivities were modest, the quinidine-derived benzyl series 
(entries 5 and 10) gave the highest levels of stereocontrol.  Linking the aryl group 
directly to the C9-hydroxyl resulted in a loss in enantioselectivity (entry 5 vs. 7) and 
adding a carbonyl into the linker reduced the enantiomeric excess dramatically 
(entry 5 vs. 11).  The effect of changing the pro-nucleophile on the 
enantioselectivity is clear from entry 9, catalyst QD-174 gave the arylated product 
in only 11% ee, considerably decreased from the enantiomeric excess achieved with 
tert-butyl 1-oxoindane-2-carboxylate pro-nucleophile 80.  Takamoto’s catalyst47 
(entry 13), Hiemstra’s catalyst87 (entry 14), Jacobsen’s catalysts46 (entries 19 – 21) 
and a range of commercially available primary chiral amines all gave the arylated 
product in disappointing enantiomeric excesses.   
5.2 Phase transfer catalysis 
Although phase transfer catalysis has been reported to be incompatible with 
quinone reagents, phase transfer catalyst 72 has been shown to induce high levels of 
enantiocontrol in the SNAr reaction of fluoro-nitrobenzenes and pro-nucleophile 
236.51  
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Scheme 5.1:  Phase transfer catalysed SNAr reaction of N-Boc lactam pro-nucleophile 236. 
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Phase transfer catalyst 72 was screened in the oxidative coupling reaction with a 
range of stoichiometric bases (Table 5.2).  Whilst the phase transfer catalyst was 
able to catalyse the reaction, both yields and enantioselectivities were disappointing 
(entries 1 – 4).  When K3PO4 was employed as the stoichiometric base no 
conversion to the desired product was obtained.  Control experiments without phase 
transfer catalyst 72 did result in conversion to the arylated product 223 (entries 5 – 
7), so for high levels of enantiocontrol the rate of the phase transfer catalysed 
reaction must be greater than the background reaction rate.  Decreasing the amount 
of inorganic base to match the molar percentage of the catalyst (entry 8)  increased 
the enantiomeric excess of the product, as did employing stoichiometric phase 
transfer reagent, however the values obtained were still significantly lower than 
with the non-phase transfer cinchona alkaloid derived catalysts. 
OH
OHMeO
N
O
OMe
OO
O
N
OAc
OAcMeO
O
OMe
O
O
O
+
1) cat. 72, base
    ps-IO4- (2 equiv)
    CHCl3/toluene (9:1)
2) Na2S2O4 (aq)
3) Ac2O, pyridine
(-)-223
207
163
NO
N
O
Cl
72
H
 
Entry Cat. (mol %) Base (equiv) % Yield % ee 
1 72 (20 mol %) KOH (1.5) 9 3 
2 72 (20 mol %) CsOH.H2O (1.5) 13  16 
3 72 (20 mol %) K3PO4 (1.5) -a - 
4 72 (20 mol %) K2CO3 (1.5) 17 1 
5 - KOH (1.5) complete conversion in 7 h. - 
6 - K3PO4 (1.5) trace product in 3 days - 
7 - K2CO3 (1.5) 50% conversion in 3 days - 
8 72 (20 mol%) KOH (0.2) 22 12 
9 72 (1 equiv) KOH (1.0) 11 22 
Table 5.2: Screen of bases and conditions in the phase transfer catalysed 
oxidative coupling. a no conversion to arylated product after 3 days. 
The low levels of enantiocontrol in the phase transfer catalysed oxidative coupling 
could be attributed to competition from the background reaction or to poor 
interactions between the phase transfer catalyst and pro-nucleophile 207.  Since the 
analogous ethyl ester pro-nucleophile 236 is known to work well with catalyst 72, 
this pro-nucleophile was synthesised from tert-butyl 2-oxopyrrolidine-1-
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carboxylate 206 and ethylchloroformate (following the procedure for the synthesis 
of pro-nucleophile 207), and screened in the oxidative coupling reaction (Scheme 
5.2).  The yield and enantiomeric excess of the arylated product were still low, and 
as a result phase transfer catalysis was not investigated further. 
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Scheme 5.2: Phase transfer catalysed oxidative coupling with pro-nucleophile 236. 
 
5.3 Pro-nucleophile screen 
Since the benzyl-derived quinidine catalysts gave the best results so far, catalyst 
QD-71 (readily prepared on scale) was used for further screening.  A range of pro-
nucleophiles that could be suitable replacements for 207 with esters and carbamate 
protecting groups were synthesised following the established procedure for the 
synthesis of pro-nucleophile 207 (Scheme 5.3).  Benzyl and tosyl protected pro-
nucleophiles 248 and 247 were prepared in an analogous fashion from 
commercially available 1-benzyl-2-pyrrolidinone 245 and 1-(p-toluenesulfonyl)-2-
pyrrolidinone 244 respectively. Pro-nucleophile 249 was synthesised through 
deprotection of 207 with 4 M HCl in dioxane.   
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Scheme 5.3: Synthesis of alternative pro-nucleophiles. 
The range of pro-nucleophiles was screened in the oxidative coupling with catalyst 
QD-71 and the enantiomeric excess determined by chiral HPLC analysis (Table 
5.3).  In many cases protection of the catechol was not required for HPLC analysis, 
otherwise the catechol was protected as the diacetate or methylene acetal as before.  
  
N
O
N
OH
cat. QD-71
OH
OHMeO
+
R2 N
O
OMe
O
OR1
OR1MeO
R2 N
O O
OR3
163
1) catalyst QD-71 (10 mol%)   
     ps-IO4-, CH2Cl2
2) Na2S2O4 (aq)
3) Ac2O, pyridine
or CH2ClBr, Cs2CO3
250 - 257
 
Entry Pro-nucleophile R
1 R2 R3 Product % ee % Yield 
1 238 H COOtBu OPh (+)-250 40 29 
2 242 H COOMe OPh (+)-251 9 34 
3 239 -CH2- COOtBu OtBu 252 0 25 
4 246 Ac CBz OMe (+)-253 30 30 
5 247 Ac Ts OMe (+)-254 1 24 
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6 240 Ac COOtBu CH3 (+)-255 6 20 
7 248 - Bn OMe 256 - 0a 
8 249 - H OMe 257 - 0a 
Table 5.3: Screen of alternative pro-nucleophiles with cat QD-71.  a After 24 h reaction 
time no arylated product was detectable by crude NMR. 
Changing the bulk of the protecting group, or adding π-stacking ability to the ester 
group (entries 1 and 3) had no positive effect on the enantiomeric excess of the 
arylated product.  When the carbamate protecting group and ester are of equal steric 
bulk racemic product was obtained, implying there is either no preference for the 
orientation in which this pro-nucleophile is held by the catalyst or that there is no 
(or very little) interaction between the catalyst and this pro-nucleophile. Cbz and 
tosyl protected pro-nucleophiles 246, 247 (entries 4 and 5) also gave disappointing 
enantioselectivities.  According to the postulated mode of action of quinidine-
derived catalysts such as QD-71, the deprotonated nucleophile is held by the 
bridgehead nitrogen with an additional hydrogen bond from the quinoline hydroxyl 
to the ester of the pro-nucleophile (see Scheme 2.17, chapter 2.3.3).  In the case of 
pro-nucleophiles such as 207 this additional hydrogen bond could be formed with 
the ester or carbamate protecting group (Figure 5.1).  These two arrangements lead 
to opposite enantiomers of the arylated product (assuming attack from one face by 
the quinone electrophile) and therefore, whilst these two arrangements may have 
transition states of significantly different energies, could be a cause for the lower 
enantioselectivities observed with pro-nucleophiles 207, 238, 239, 242, 246, 247 
compared to tert-butyl 1-oxoindane-2-carboxylate pro-nucleophile 80 .   
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Figure 5.1:  Alternative catalyst (of type 71) – pro-nucleophile (of type 207) 
interactions leading to opposite enantiomers of product (assuming attack from 
one face by the electrophilic quinone). 
Pro-nucleophiles 240, 248 - 249 (Scheme 5.3) were synthesised to alter this 
hydrogen bonding pattern since the additional hydrogen bond can only be formed to 
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either the ester or the protecting group in these cases.  Pro-nucleophiles 248 and 249 
did not react successfully under the oxidative coupling procedures and no arylated 
product could be detected by crude 1H NMR (following reductive work-up) after 24 
h reaction time.  This is presumably due to the decreased acidity of these pro-
nucleophiles.  Pro-nucleophile 240 (not a direct replacement for 207) gave a poor 
6% ee.  Of the pro-nucleophiles tested the originally chosen Boc-protected methyl 
ester lactam 207 gave the highest level of enantioselectivity and was therefore used 
in further studies. 
5.4 Conditions screen 
A screen of solvents (Table 5.4, entries 1 – 15), temperature (entries 20 – 22) and 
concentration (entries 18 – 19) was undertaken with the optimal pro-nucleophile, 
207, and catalyst QD-71.  The conditions were screened for their effect on 
enantioselectivity, and accordingly yields (where recorded) are unoptimised.  In 
cases where yields are not reported the enantioselectivity was determined from a 
sample obtained from analytical TLC of the reaction mixture. 
OH
OHMeO
+
BocN
O
OMe
O
OR1
OR1MeO
BocN
O O
OMe
(+)-208, R1 = -CH2-   
(+)-223, R1 =  Ac
1) cat QD-71
     PS-IO4- (2 equiv)
2) Na2S2O4 (aq)
3) Ac2O, pyridine
or, CH2ClBr, Cs2CO3
163
207  
Entry Solvent mol % cat QD-71 
T/ºC Conc.
/M Product % ee 
% 
Yield 
1 CH2Cl2 10 -20 0.1 (+)-208 50 35 
2  CHCl3 10 -20 0.1 (+)-208 50 25 
3  TBME 10 -20 0.1 (+)-208 20 33 
4  toluene 10 -20 0.1 (+)-208 4 8 
5  MeCN 10 -20 0.1 (+)-208 37 38 
6  acetone 10 -20 0.1 (+)-208 36 38 
7  1,2-DCE 10 -20 0.1 (+)-223 38 - 
8  chlorobenzene 10 -20 0.1 (+)-223 19 - 
9  1,1,2,2-tetrachloroethane 10 -20 0.1 (+)-223 37 - 
10  Et2O 10 -20 0.1 (+)-223 24 - 
11 EtOAc 10 -20 0.1 (+)-223 40 - 
12 DMF 10 -20 0.1 (+)-223 5 - 
13  CH2ClBr 10 -20 0.1 (+)-223 50 - 
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14 CH2Br2 10 -20 0.1 (+)-223 46 - 
15 1,4-dioxane 10 -20 0.1 (+)-223 29 - 
16  THF 10 -20 0.1 (+)-223 30 - 
17  CH2Cl2 50 -20 0.1 (+)-223 52 - 
18  CH2Cl2 2 -20 0.1 (+)-223 51 - 
19  CH2Cl2 10 -20 0.02 (+)-223 56 - 
20  CH2Cl2 30 -20 0.01 (+)-223 62 38 
21  CH2Cl2 10 0 0.1 (+)-223 20 49 
22 CH2Cl2 10 -60 0.1 (+)-223 26 2 
23 CH2Cl2 10 -20 – -60 0.1 (+)-223 37 5 
Table 5.4: Conditions screen for the synthesis of (+)208/(+)-223 with  cat. QD-71. 
From the initial screen of solvents it was clear that chlorinated solvents offer 
significantly higher enantiomeric excess compared to non chlorinated solvents 
(entries 1 and 2 vs. 3 – 5, 10 – 12).  However, testing further halogenated solvents 
(entries 7 – 9, 13, 14) did not result in improved enantioselectivities.   A 
relationship between solvent polarity and enantiomeric excess is difficult to 
establish as both polar and non-polar solvents resulted in decreased enantiomeric 
excesses compared with dichloromethane.  Increasing or decreasing the reaction 
temperature (entries 21 – 22) decreased the enantiomeric excess, implying that -20 
ºC is near optimal.  A very small increase in enantiomeric excess was observed on 
increasing the catalyst loading (entry 17), however decreasing the catalyst loading 
did not result in a corresponding decrease in enantiomeric excess (entry 18). 
Increasing the dilution of the reaction mixture had a positive effect, increasing the 
enantiomeric excess from 50 to 56% with a 5-fold dilution (entries 1 vs. 19).  This 
was further increased to 62% by increasing the catalyst loading to 30 mol% at a 
concentration of 0.01 M (entry 20). 
5.5  Screen of novel cinchona alkaloid derived organocatalysts 
With optimal reaction conditions established, a range of benzyl substituted catalysts 
were synthesised (Scheme 5.4) in attempt to increase the enantioselectivities.111  A 
range of benzyl bromides/chlorides were selected and benzylation of the C9-
hydroxy of quinidine appeared to proceed smoothly in all cases, however attempted 
demethylation of the crude benzylated intermediates with BBr3 was unsuccessful. In 
most cases cleavage of the benzyl groups occurred faster than the demethylation 
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(QD-258, QD-259, QD-262, QD-263).  In some cases (QD-260, QD-261) a very 
small amount of product was obtained following mass-guided HPLC purification. 
N
HO
N
OMe Br/Cl
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N
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N
O
N
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R R
Ph N
N NO2 Cl
Benzyl substituent:
Yield of catalyst
(over 2 steps) QD-258, 0% QD-259, 0% QD-260, 19% QD-261, 9% QD-262, 0%
QD-263, 0%
BBr3
135
 
Scheme 5.4: Original synthetic approach to benzyl-substituted quinidine-
derived catalysts QD-258 – QD-263. 
Additional examples were synthesised following the above procedure with thiolate 
demethylation to give trifluoromethyl derivatives QD-265 and QD-267 (Scheme 
5.5). For the halogenated example QD-269, the thiolate demethylation was also 
unsuccessful.  A range of reported demethylation conditions including treatment 
with L-Selectride® in refluxing THF112 were tested with intermediate 268 however 
none of the desired catalyst could be isolated in any case.  This was true for all 
halogenated benzyl substituents tested, including bromo-, chloro- and 
fluorobenzenes. 
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Scheme 5.5: Alternative demethylation for the synthesis of trifluoromethylated 
quinidine derived catalysts QD-265 and QD-267 and further attempted synthesis 
of brominated quinidine derived catalyst QD-269. 
In a further attempt to synthesise halogenated benzyl catalysts an alternative 
protecting group for the phenolic hydroxyl group was investigated.  Accordingly, 
quinidine 135 was demethylated and protected as the triisopropylsilyl ether 
270.111(a) Benzylation with o-bromobenzylbromide and treatment of the crude 
reaction mixture with TBAF did not give the desired benzylated catalyst, but 
resulted in a mixture of QD-271 and doubly benzylated QD-272 (Scheme 5.6). 
Br
NaH, DMF N
O
N
OBr
Br
N
HO
N
OTIPS
1)
2) TBAF
N
HO
N
O
Br
+
QD-271, 30% QD-272, 15%
270
Br
 
Scheme 5.6: Synthesis of bromobenzyl quinidine-derived catalysts QD-271, QD-272. 
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The benzyl substituted catalysts were screened in the oxidative coupling step under 
standard conditions (Table 5.5).  The bromobenzene substituted catalyst QD-271 
afforded the arylated product in a moderate enantiomeric excess, with the opposite 
sense of stereocontrol compared to the C9-benzylated analogues (entry 5).  The 
doubly benzylated catalyst QD-272 resulted in a poor enantiomeric excess (entry 
6).  
OH
OHMeO
+
BocN
O
OMe
O
OR
ORMeO
BocN
O O
OMe
207
163
1) catalyst (10 mol %)   
     ps-IO4-, CH2Cl2, -20 ºC
2) Na2S2O4 (aq)
3) Ac2O, pyridine
or CH2ClBr, Cs2CO3
223, R = Ac
208, R = -CH2-  
Entry Catalyst (loading) Product Conc./M % ee % yield 
1 QD-260 (10 mol %) (+)-223 0.1 43 41 
2 QD-261 (10 mol %) (+)-223 0.1 50 25 
3 QD-267 (10 mol %) (+)-223 0.1 43 38 
4 QD-265 (10 mol %) (+)-223 0.1 64 56 
5 QD-271 (10 mol %) (-)-223 0.1 44 32 
6 QD-272 (10 mol %) (+)-223 0.1 5 24 
7 QD-265 (20 mol %) (+)-223 0.0125 73 54 
8 QD-265 (30 mol %) (+)-223 0.025 72 55 
9 QD-265 (20 mol %) (+)-208 0.025 70 57 
10 Q-265 (20 mol %) (-)-208 0.025 70 55 
Table 5.5: Screen of novel benzyl-substituted organocatalysts 
Pleasingly catalyst QD-265 afforded the arylated product in 64% ee, a significant 
improvement on the unsubstituted benzyl catalyst QD-71 (entry 4).  This catalyst 
was then tested at increased dilution with increased catalyst loading.  Running the 
reaction at 0.025 M with 20 mol % catalyst gave the arylated product in 57% yield 
and 70% ee (entry 9).  Further increases in dilution (entry 7) or catalyst loading 
(entry 8) did not improve the enantiomeric excess of the product sufficiently to 
justify the increased consumption of solvent/catalyst.  It was hoped that this would 
be sufficient for obtaining enantiomerically pure alkaloid following recrystallisation 
at the enone stage (known to be highly crystalline as a racemate). 
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Scheme 5.7: Synthesis of (+)-237 with optimal catalyst QD-265 
Ethyl ester pro-nucleophile 236 was also screened with the optimal catalyst QD-
265, however the enantiomeric excess of the arylated product was significantly 
decreased compared to methyl ester analogue (Scheme 5.7). 
Since the absolute stereochemistry of the major enantiomer is unknown, and 
difficult to predict, the pseudo enantiomer of catalyst QD-265 was prepared from 
quinine 136 (Scheme 5.8).  When catalyst Q-265 was employed in the oxidative 
coupling, the opposite enantiomer of the arylated product (-)-208 was obtained in 
70% ee (Table 5.5, entry 10). 
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Scheme 5.8: Synthesis of quinine-derived catalyst Q-265, pseudoenantiomer of catalyst QD-265. 
5.6 Enantioselective total synthesis 
In order to synthesise enantiomerically pure alkaloid, the catalyst synthesis was 
repeated on a 10 mmol scale to give 3.8 g of catalyst.  The oxidative coupling was 
then repeated on a 10 mmol scale to provide 2.2 g of arylated product (+)-208 in 
70% ee with the methylene acetal protecting group in place (Scheme 5.9).  
Reduction of the arylated product with Super-hydride® gave aminol (+)-209 as a 1:1 
mixture of diastereomers with no loss of stereochemical integrity.  Acylation and 
BF3.OEt2 mediated reaction with (isopropenyloxy)trimethylsilane gave keto ester (-
)-210 in 92 % yield (over 2 steps) as a 3:1 mixture of diastereomers in 69% ee 
(relative stereochemistry of the major diastereomer is unknown). 
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Scheme 5.9: Attempted enantioselective total synthesis, halted due to 
reduction in enantiomeric excess of (-)-212. 
The Dieckmann-type cyclisation was then repeated in identical fashion to the 
racemic synthesis; reacting the crude reaction mixture with TiCl4 in MeOH to give 
the methyl enol ether (-)-212 in 54% yield but with a significantly compromised 
enantiomeric excess. The enol ether was obtained in 24% ee.  This points to a fast 
racemisation process probably through retro-Michael, Michael addition (Scheme 
5.10); although it is interesting that the product is not completely racemised in this 
process.  This rapid epimerisation process could also explain the formation of a 
single diastereomer from the Dieckmann-type cyclisation. 
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Scheme 5.10: Possible racemisation mechanism during Dieckmann-type cyclisation 
To investigate the partial racemisation during the Dieckmann-type cyclisation, the 
reaction was repeated, removing an aliquot after 1, 5, 10 and 20 min and quenching 
each with 1 M HCl immediately.  After methyl enol ether formation of each aliquot, 
HPLC analysis of the product (-)-212 showed the enantiomeric excess to be 26% 
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±1% in each case (sufficient product could not be obtained after 1 min for analysis).  
Since the enantiomeric excess of the product does not change with time, this 
implies that the epimerisation process occurs before cyclisation.  To investigate the 
rate of epimerisation of the starting material (-)-210, the reaction was repeated and 
quenched after 1 min then purified to recover the starting material.  HPLC analysis 
showed a 1.7:1 dr and enantiomeric excess of 26% for the major diastereomer and 
21% for the minor.  This supports rapid epimerisation of the starting material.  
Reducing the temperature of the Dieckmann-type cyclisation did not prevent 
racemisation.  Changing the reaction solvent to toluene gave no product and did not 
prevent racemisation of the starting material (although this was slower than in 
THF). 
This rapid racemisation of the keto-ester 210 under the Dieckmann-type cyclisation 
reaction conditions prevented the enantioselective total synthesis of powelline and 
buphanidrine being complete via this route.  To obtain optically pure alkaloid, 
alternative conditions for the cyclisation step, or alterations to the route would be 
required in future studies. 
6 Summary 
In summary, a novel oxidative coupling methodology for the synthesis of arylated 
quaternary stereocentres has been developed and applied to the synthesis of 2 
amaryllidaceae alkaloids.113-115  Proof-of-principle studies with stable 1,2-
naphthoquinone established the ability of ortho-quinones to act as Michael 
acceptors towards carbon-centred pro-nucleophiles with organocatalytic base.  In 
situ formation of reactive and unstable ortho-benzoquinones through oxidation of 
the parent catechols allows extension of the methodology to a wide range of 
quinone electrophiles.  The scope of the method is also broad with respect to the 
pro-nucleophile, it is high yielding and provides remarkably simple access to a 
challenging motif.  Replacement of ps-BEMP with cinchona alkaloid derived 
organocatalyst allowed formation of the arylated adducts in up to 81% ee.  Catechol 
derivatives covalently bonded to all-carbon quaternary stereocentres are prevalent 
in nature, and the oxidative coupling methodology was successfully applied to the 
synthesis of 2 amaryllidaceae alkaloids (±)-powelline and (±)-buphanidrine.  In 
studies towards an enantioselective synthesis of the target alkaloids, screening 
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known and novel organocatalysts in the oxidative coupling step afforded the 
arylated product in 70% ee.  Unfortunately during the Dieckmann-type cyclisation 
rapid epimerisation of the quaternary carbon centre reduced the enantiomeric excess 
to 24%.  Alternative conditions or an alternative route will be required to access 
optically pure alkaloid utilising the oxidative coupling methodology. 
 
7 Experimental 
7.1 General Experimental 
7.1.1 General Techniques  
Reactions were conducted under an air atmosphere with no effort to exclude 
moisture unless otherwise stated.  For all reactions conducted under anhydrous 
conditions glassware was dried in an oven at 100 
o
C and cooled under a nitrogen 
atmosphere.  
7.1.2 Solvents  
Bulk solutions were evaporated under reduced pressure using a Büchi rotary 
evaporator. Solvents were obtained from commercial suppliers and used as 
supplied.  Anhydrous solvents were either purchased from commercial suppliers or 
purified according to standard procedures. Petroleum ether refers to distilled light 
petroleum of fraction 40–65 °C.  
7.1.3 Chromatography  
Flash column chromatography was carried out using Merck Kieselgel 60 silica gel 
(200–400 mesh) and commercial solvents. Thin layer chromatography (TLC) was 
performed on aluminium plates pre-coated with Merck Kieselgel 60 F254 and 
visualised by ultra-violet radiation or by staining with aqueous basic potassium 
permanganate as appropriate. Enantiomeric excesses were determined using high 
performance liquid chromatography (HPLC) performed on a Hewlett-Packard 
Series 1050 series system and an Agilent Technologies 1200 series machine 
(column and solvent conditions are given with the compound).  
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7.1.4 Spectroscopy 
All 1H and 13C NMR spectra were recorded using a Bruker AVII 500 MHz, Bruker 
DPX 400, DPX 500, Bruker DRX 500 MHz, and Varian 300 MHz spectrometers. 
Chemical shifts (δ) are given in ppm downfield of tetramethylsilane relative to the 
residual protiosolvent, and coupling constants (J) are given in Hertz (Hz).  The 1H 
NMR spectra are reported as follows: δ/ppm [number of protons, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, quin = quintet, m = multiplet), coupling 
constants J/Hz (where appropriate) and assignment]. DEPT135, two-dimensional 
(COSY, HSQC, HMQC, HMBC) and NOE/NOESY NMR spectroscopy were used 
where appropriate to assist the assignment of signals in the 1H and 13C NMR 
spectra.  Low resolution mass spectrometry was recorded on a Micromass Trio 
2000 quadrupole (EI/CI), a Micromass Platform II spectrometer, and a Micromass 
LCT premier (electrospray). High resolution mass spectra (accurate mass) were 
recorded on a Thermo Finnigan Mat95XP mass spectrometer and a Bruker 
MicroTof spectrometer. Infrared spectra were recorded on a Perkin Elmer Spectrum 
RX1 FTIR and a Bruker Tensor FT-IR spectrometer (solid state or thin film 
deposited onto a sodium chloride plate), only selected maximum absorbances are 
reported.  Melting points were recorded using a Gallenkamp and a Leica Galen II 
melting point apparatus and are uncorrected. Optical rotations were recorded using 
an Optical Activity AA-1000 polarimeter and a Perkin-Elmer 241 polarimeter; 
[α]DT values are reported in 10-1degcm2g-1; concentration (c) is given in g/100 ml at 
589 nm, T is given in ºC. (+) and (-) compound number prefixes indicate the sign of 
the optical rotation.  
7.1.5 X-ray Crystallographic Data  
X-ray crystallographic data were collected at low temperature [Cosier, J.; Glazer, A. 
M. J. Appl. Cryst. 1986, 19, 105-107. ] using an Enraf-Nonius KCCD 
diffractometer [Otwinowski, Z.; Minor, W. Processing of X-ray Diffraction Data 
Collected in Oscillation Mode Methods Enzymol; Carter, C. W., Sweet, R. M., Eds.; 
Academic Press, 1997; p 276]. The crystal structure of 217 was solved using SIR92 
[Altomare et al. J. Appl. Cryst. 1994, 27, 435] and refined using the CRYSTALS 
software suite [Betteridge et al. J. Appl. Cryst. 2003, 36, 1487], as per the appended 
CIF file. 
 96
7.2 Chapter 2 Experimental 
7.2.1 Reagents 
1,2-naphthoquinone was purchased from Fluka and used without further 
purification.  All other commercially available reagents were used as received 
unless otherwise stated.  Pro-nucleophiles 109, 125, 73, 128 – 132 and 134 are 
commercially available and were used as received, the following pro-nucleophiles 
were prepared according to literature procedures: tetrahydro-2-oxo-3-
furancarboxyllic acid methyl ester (122),116 2-(Methoxycarbonyl)indan-1-one 
(127),117 2-oxo-3-indolinecarboxylic acid methyl ester (126),118 tert-butyl 1-
oxoindane-2-carboxylate (80),119 2-oxocyclohexanecarbonitrile (123) and 2-
oxocyclopentanecarbonitrile (124).120  Catalysts 70, QD-147, QD-71, and QD-148 
were prepared according to literature procedures.75-77,111 
7.2.2 Synthesis and characterisation of methyl 1-(3,4-dioxo-3,4-
dihydronaphthalen-1-yl)-2-oxocyclopentanecarboxylate, 120 
O
O
O O
OMe
O
OMe
O
O
O
2 equiv.
BEMP (10 mol %)
CH2Cl285
120
109
 
To a stirred solution of methyl 2-oxocyclopentanecarboxylate 109 (284 mg, 4.00 
mmol) and 2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-
diazaphosphorine (BEMP) (59 μL, 0.20 mmol) in dichloromethane (20 mL) at 
room temperature was added, portion wise over 10 min, 1,2-naphthoquinone 85 
(316 mg, 2.00 mmol).  The resulting brown suspension was stirred at this 
temperature for 1 h then the solvent was removed by rotary evaporation.  The 
residue was purified by column chromatography on silica gel, eluting with 
petroleum ether containing 40 – 50% diethyl ether to give 120 (250 mg, 42%) as a 
dark red solid.  1H NMR (500 MHz, CDCl3) δH 8.20 (1H, dd, J = 7.5, 1.5 Hz, ArH), 
7.63 (1H, dt, J = 7.5, 1.5 Hz, ArH), 7.54 (1H, t, J = 7.5 Hz, ArH), 7.25 (1H, d, J = 
7.5 Hz, ArH), 6.23 (1H, s, ArH), 3.73 (3H, s, OCH3), 3.14 (1H, ddd, J = 13.5, 9.0, 
7.0, C(O)CH2CH2CH2), 2.59 – 2.55 (2H, m, C(O)CH2CH2CH2), 2.50 – 2.45 (1H, 
m, C(O)CH2CH2CH2), 2.24 – 2.19 (1H, m, C(O)CH2CH2CH2), 1.99 – 1.93 (1H, m, 
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C(O)CH2CH2CH2); 13C NMR (75 MHz, CDCl3) δC  210.7 (C(O)), 180.4 
(C(O)OCH3), 178.6 (quinone C(O)), 169.9 (quinone C(O)), 152.2 (4º ArC), 135.2 
(ArCH), 133.5 (4º ArC), 132.0 (4º ArC), 130.9 (ArCH), 130.7 (ArCH), 127.0 
(ArCH), 126.8 (ArCH), 65.5 (4º C), 53.7 (C(O)OCH3), 38.7 (C(O)CH2CH2CH2), 
35.1 (C(O)CH2CH2CH2), 19.5 (C(O)CH2CH2CH2); IR υmax/cm-1 1753, 1724, 1667, 
1605, 1587, 1450, 1261, 1238;  MP 155 – 159 ºC; MS (ES+) m/z (relative intensity 
%) 321 (M + Na+, 100%), 619 (2M + Na+);  HRMS (ES+): calcd. for C17H14O5Na 
(M + Na+) 321.0733, found 321.0739. 
 
7.2.3 Synthesis and characterisation of methyl 1-(3,4-dihydroxy-1-
naphthyl)-2-oxocyclopentanecarboxylate, 119 
O
OMe
O
OH
OH
O
OMe
O
O
O
 Na2S2O4(aq)
121 119  
To a solution of 121 (20 mg, 0.07 mmol) in CH2Cl2 (2 mL) was added a saturated 
aqueous solution of Na2S2O4 (2 mL) and the resulting biphasic mixture stirred 
vigorously at room temperature for 3 hours by which time the orange quinone 
solution had turned pale yellow.  The organic phase was separated and the aqueous 
extracted with CH2Cl2 (2 x 1 mL).  The combined organic portions were dried over 
Na2SO4, filtered and evaporated to give 119 (20 mg, 99%) as a pale yellow oil. 1H 
NMR (500 MHz, d6-DMSO) δH 9.29 (1H, s, OH), 8.99 (1H, s, OH), 8.09 (1H, d, J 
= 8.0 Hz, ArH), 7.43 (1H, d, J = 8.5 Hz, ArH), 7.38 (1H, t, J = 7.5 Hz, ArH), 7.27 
(1H, ddd, J = 8.5, 7.0, 1.0 Hz, ArH), 6.85 (1H, s, ArH), 3.56 (3H, s, OCH3), 2.96 
(1H, ddd, J = 13.0, 10.0, 7.0 Hz, C(O)CH2CH2CH2), 2.57 – 2.53 (2H, m, 
C(O)CH2CH2CH2) 2.48 – 2.43 (1H, m, C(O)CH2CH2CH2), 2.03 – 1.96 (1H, m, 
C(O)CH2CH2CH2), 1.67 – 1.58 (1H, m, C(O)CH2CH2CH2); 13C NMR (75 MHz, 
d6-DMSO) δC  213.9 (C(O)), 171.7 (C(O)OCH3), 138.3 (4º ArC), 137.2 (4º ArC), 
127.0 (4º ArC), 125.4 (4º ArC), 125.0 (4º ArC), 124.3 (ArCH), 123.8 (ArCH), 
123.0 (ArCH), 121.9 (ArCH), 118.2 (ArCH), 65.2 (4º C), 52.6 (C(O)OCH3), 38.1 
(C(O)CH2CH2CH2), 35.8 (C(O)CH2CH2CH2), 19.1 (C(O)CH2CH2CH2); IR 
υmax/cm-1 3419, 2953, 1748, 1716, 1637, 1609, 1437, 1361, 1238, 762; MS (ES-) 
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m/z (relative intensity %) 299 (M – H+, 100%), 599 (2M – H+);  HRMS (ES+): 
calcd. for C17H15O5 (M – H+) 299.0925, found 299.0930. 
7.2.4 General Procedure A: Michael addition to 1,2-Naphthoquinone 
O
O
BEMP, 10 mol %
TBME
2) Ac2O, pyridine
OAc
OAc
Nu85
1) pro-nucleophile (2 equiv)
121a - h  
To a stirred solution of pro-nucleophile (2 equivalents) and 2-tert-butylimino-2-
diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine (BEMP) (10 mol%) in 
tert-butyl methyl ether (5 mL/mmol) at -20 ºC was added, portion wise over 10 min, 
1,2-naphthoquinone 85 (1 equivalent).  The resulting brown suspension was stirred 
at this temperature for 1 h then allowed to warm to room temperature and stirred for 
a further 1 h.  The solvent was removed by rotary evaporation and the residue 
dissolved in pyridine (3 mL/mmol) and acetic anhydride (3.3 equivalents) was 
added.  The mixture was stirred at room temperature overnight then diluted with 
Et2O (6 mL/mmol) and washed with sat. aq. CuSO4 (4 x 6 mL/mmol).  The aqueous 
washings were re-extracted with CH2Cl2 (2 x 3 mL/mmol) and the combined 
organic portions washed with water (3 mL/mmol), brine (3 mL/mmol), dried over 
sodium sulfate, filtered and concentrated by rotary evaporation.  The crude residue 
was purified by column chromatography on silica gel to give the arylated products 
121a – h. 
 
The optimal reaction conditions were identified following general procedure A, 
employing the bases and reaction temperatures detailed in Table 2.1, Chapter 2.2. 
7.2.4.1 Synthesis and characterization of methyl 1-(3,4-diacetoxy-1-
naphthyl)-2-oxocyclopentanecarboxylate, 121a 
OAc
OAc
O
OMe
O
121a  
According to general procedure A, 1,2-naphthoquinone 85 (300 mg, 1.71 mmol) 
was reacted with methyl 2-oxocyclopentanecarboxylate 109 (501 mg, 3.42 mmol).  
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Purification by column chromatography on silica gel, eluting with petroleum ether 
containing 30% ethyl acetate, gave compound 121a (546 mg, 83%) as an off-white 
solid; 1H NMR (500 MHz, CDCl3) δH 7.89 (1H, d, J = 8.0 Hz, Ar-H), 7.70 (1H, d, 
J = 8.0 Hz, Ar-H), 7.55 – 7.48 (2H, m, Ar-H), 7.02 (1H, s, Ar-H), 3.65 (3H, s, 
C(O)OCH3), 3.23 (1H, ddd, J = 13.0, 9.5, 7.0 Hz, C(O)CH2CH2CH2), 2.61 – 2.52 
(3H, m, C(O)CH2CH2CH2 and C(O)CH2CH2CH2), 2.46 (3H, s, OC(O)CH3), 2.31 
(3H, s, OC(O)CH3), 2.16 – 2.09 (1H, m, C(O)CH2CH2CH2), 1.89 - 1.79 (1H, m, 
C(O)CH2CH2CH2); 13C NMR (125 MHz, CDCl3) δC 213.6 (C(O)), 171.6 
(C(O)OCH3), 168.2 (OC(O)CH3), 167.9 (OC(O)CH3), 137.9 (4º ArC), 136.7 (4º 
ArC), 133.7 (4º ArC), 129.9 (4º ArC), 128.9 (4º ArC), 126.7 (ArCH), 126.5 
(ArCH), 124.5 (ArCH), 122.4 (ArCH), 121.3 (ArCH), 65.6, (4º C) 53.3 
(C(O)OCH3), 38.9 (C(O)CH2CH2CH2), 36.4 (C(O)CH2CH2CH2), 20.7 
(OC(O)CH3), 20.5 (OC(O)CH3), 19.5 (C(O)CH2CH2CH2); IR υmax/cm-1 1765, 
1754, 1716, 1371, 1240, 1212, 1199, 770; MP 151-153 ºC (decomposed); MS 
(CI+) m/z (relative intensity %) 402 (M + NH4+, 100%); HRMS (ES+): calcd. for 
C21H24O7N1 (M + NH4+) 402.1547, found 402.1548. 
7.2.4.2 Synthesis and characterization of methyl 3-(3,4-diacetoxy-1-
naphthyl)-2-oxotetrahydrofuran-3-carboxylate, 121b 
O
OAc
OAc
O
OMe
O
121b  
According to general procedure A, 1,2-naphthoquinone 85 (300 mg, 1.71 mmol) 
was reacted with methyl 2-oxotetrahydrofuran-3-carboxylate 122 (493 mg, 3.42 
mmol) to give compound 121b (488 mg, 74%) as cream solid after column 
chromatography on silica gel, eluting with petroleum ether containing 30% ethyl 
acetate; 1H NMR (500 MHz, CDCl3) δH 7.93 (1H, dd, J = 8.0, 1.5 Hz,  Ar-H), 
7.61-7.51 (3H, m, 3 of Ar-H), 7.31 (1H, s, Ar-H), 4.54 (1H, dt, J = 9.0, 3.0 Hz, 
OCH2CH2), 4.19 (1H, dt, J = 9.0, 6.5 Hz, OCH2CH2), 3.73 – 3.66 (4H, m, 
OCH2CH2 and C(O)OCH3), 2.67 (1H, ddd, J = 13.0, 6.5, 3.0 Hz, OCH2CH2), 2.47 
(3H, s, OC(O)CH3), 2.33 (3H, s, OC(O)CH3); 13C NMR (125 MHz, CDCl3) δC 
173.3 (C(O)OCH2), 170.1 (C(O)OCH3), 168.1 (OC(O)CH3), 167.9 (OC(O)CH3), 
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138.1 (4º ArC), 137.5 (4º ArC), 131.1 (4º ArC), 129.3 (4º ArC), 129.0 (4º ArC), 
127.1 (ArCH), 126.9 (ArCH), 123.5 (ArCH), 122.8 (ArCH), 122.0 (ArCH), 66.4 
(OCH2), 60.1 (4º C), 54.0 (C(O)OCH3), 35.1 (OCH2CH2), 20.7 (OC(O)CH3), 20.5 
(OC(O)CH3); IR υmax/cm-1 1768, 1763, 1758, 1737, 1609, 1369, 1204, 1168, 1156, 
772; MP 141-143 ºC; MS (CI+) m/z (relative intensity %)  404 (M + NH4+, 100%); 
HRMS (ES+) calcd. for C20H22O8N (M + NH4+) 404.1340, found 404.1331  
7.2.4.3 Synthesis and characterization of 4-(1-cyano-2-
oxocyclohexyl)naphthalene-1,2-diyl diacetate, 121c 
121c
OAc
O CN
OAc
 
According to general procedure A, 1,2-naphthoquinone 85 (90 mg, 0.57 mmol) was 
reacted with 2-oxocyclohexanecarbonitrile 123 (140 mg, 1.14 mmol) to give 
compound 121c (167 mg, 80%) as a colourless solid after column chromatography 
on silica gel, eluting with petroleum ether containing 30% ethyl acetate; 1H NMR 
(500 MHz, CDCl3) δH 7.96 – 7.93 (1H, m, ArH), 7.85 – 7.82 (1H, m, ArH), 7.59 – 
7.54 (2H, m, ArH), 7.49 (1H, s, ArH), 2.94 (1H, ddd, J = 13.0, 10.0, 5.0 Hz, CH2),  
2.84 – 2.73 (2H, m, CH2), 2.53 – 2.48 (4H, m, CH2 and OC(O)CH3), 2.36 (3H, s, 
OC(O)CH3), 2.29 – 2.18 (3H, m, CH2), 2.04 – 1.96 (1H, m, CH2);  13C NMR (125 
MHz, CDCl3) δC 202.6 (C(O)), 168.2 (OC(O)CH3), 167.7 (OC(O)CH3), 138.2 (4º 
ArC), 137.9 (4º ArC), 129.7 (4º ArC), 128.7 (4º ArC), 128.4 (4º ArC), 127.1 
(ArCH), 127.0 (ArCH), 124.9 (ArCH), 122.4 (ArCH), 121.8 (ArCH), 119.1 (CN), 
54.8 (4º C), 39.1 (CH2), 38.5 (CH2), 28.7 (CH2), 21.9 (CH2), 20.8 (OC(O)CH3), 
20.5 (OC(O)CH3); IR υmax/cm-1 1769, 1764, 1754, 1749, 1608, 1369, 1195, 1164, 
1095, 1015, 765; MP 142-144 ºC; MS (ES+) m/z (relative intensity %) 383 (M + 
NH4+, 15%), 388 (M + Na+, 100%); HRMS (ES+) calcd. for C21H19O5NNa (M + 
Na+) 388.1155, found 388.1155. 
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7.2.4.4 Synthesis and characterization of 4-(1-cyano-2-
oxocyclopentyl)naphthalene-1,2-diyl diacetate, 121d 
121d
OAc
OAc
O CN
 
According to general procedure A, 1,2-naphthoquinone 85 (158 mg, 1.0 mmol) was 
reacted with 2-oxocyclopentanecarbonitrile 124 (218 mg, 2.0 mmol) to give 
compound 121d (283 mg, 81%) as a pale cream solid after column chromatography 
on silica gel, eluting with petroleum ether containing 50 – 70% diethyl ether; 1H 
NMR (500 MHz, CDCl3) δH  8.21 (1H, d, J = 7.5 Hz, ArH), 7.94 (1H, d, J = 7.5 
Hz, ArH), 7.65 – 6.57 (2H, m, ArH), 7.25 (1H, s, ArH), 2.90 – 2.80 (2H, m, 
C(O)CH2CH2CH2), 2.66 (2H, t, J = 8.0 Hz, C(O)CH2CH2CH2), 2.45 (3H, s, 
OC(O)CH3), 2.32 (3H, s, OC(O)CH3), 2.26 – 2.18 (1H, m, C(O)CH2CH2CH2), 2.08 
– 1.99 (1H, m, C(O)CH2CH2CH2); 13C NMR (125 MHz, CDCl3) δC 207.7 (C(O)), 
168.1 (OC(O)CH3), 167.7 (OC(O)CH3), 137.9 (4º ArC), 137.8 (4º ArC), 129.0 (4º 
ArC), 128.7 (4º ArC), 127.9 (4º ArC), 127.2 (ArCH), 127.0 (ArCH), 124.7 
(ArCH), 122.5 (ArCH), 122.0 (ArCH), 118.5 (CN), 52.7 (4º C), 37.4 (CH2), 36.7 
(CH2), 20.6 (OC(O)CH3), 20.3 (OC(O)CH3), 19.3 (CH2); IR υmax/cm-1 1769, 1766, 
1758, 1608, 1369, 1200, 1164, 1015, 768; MP 70-71 ºC (decomposed); MS (ES+) 
m/z (relative intensity %) 406 (M + Na+ + MeOH, 100%), 374 (M + Na+, 85%); 
HRMS (ES+): calcd. for C20H18O5N (M+H+) 352.1179, found 352.1178. 
7.2.4.5 Synthesis and characterization of ethyl cyano(3,4-diacetoxy-1-
naphthyl)phenylacetate, 121e 
121e
OAc
OAc
Ph
CN OEt
O
 
According to general procedure A, 1,2-naphthoquinone 85 (300 mg, 1.71 mmol) 
was reacted with ethyl phenylcyanoacetate 125 (647 mg, 3.42 mmol) to give 
compound 121e (565 mg, 77%) as a yellow solid after column chromatography on 
silica gel, eluting with petroleum ether containing 30% ethyl acetate; 1H NMR (500 
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MHz, CDCl3) δH 7.98 (1H, d, J = 8.0 Hz, ArH), 7.94 (1H, d, J = 8.0 Hz, ArH), 
7.64 – 7.63 (2H, m, ArH), 7.59 – 7.53 (2H, m, ArH), 7.51 – 7.47 (3H, m, ArH), 
6.91 (1H, s, ArH), 4.43 – 4.31 (2H, m, OCH2CH3), 2.46 (3H, s, OC(O)CH3), 2.26 
(3H, s, OC(O)CH3), 1.29 (3H, t, J = 7.0 Hz, OCH2CH3); 13C NMR (125 MHz, 
CDCl3) δc 167.8 (C(O)O), 167.6 (C(O)O), 167.0 (C(O)O), 138.2 (4º ArC), 137.9 
(4º ArC), 133.3 (4º ArC), 130.8 (4º ArC), 129.4 (ArCH), 129.4 (ArCH), 129.3 (4º 
ArC), 128.6 (4º ArC), 128.2 (ArCH), 127.1 (ArCH), 127.1 (ArCH), 124.4 (ArCH), 
124.1 (ArCH), 122.4 (ArCH), 118.0 (CN), 64.0 (OCH2), 57.6 (4º C), 20.6 
(OC(O)CH3), 20.4 (OC(O)CH3), 13.7 (OCH2CH3); IR υmax/cm-1 1787, 1761, 1750, 
1608, 1373, 1216, 1192, 1175, 1166, 1156, 895, 744, 734; MP 126-128 ºC;  MS 
(CI+) m/z (relative intensity %) 449 (M + NH4+, 100%); HRMS (ES+) calcd. for 
C25H25O6N2 (M + NH4+) 449.1707, found 449.1698. 
7.2.4.6 Synthesis and characterization of methyl 2-(3,4-diacetoxy-1-
naphthyl)-1-oxoindane-2-carboxylate, 121f 
121f
OAc
OAc
O
OMe
O
 
According to general procedure A, 1,2-naphthoquinone 85 (300 mg, 1.71 mmol) 
was reacted with methyl 1-oxoindane-2-carboxylate 127 (650 mg, 3.42 mmol) to 
give compound 121f (639 mg, 86%) as a yellow solid after column chromatography 
on silica gel, eluting with petroleum ether containing 30% ethyl acetate; 1H NMR 
(500 MHz, CDCl3) δH 7.92 – 7.89 (2H, m, ArH), 7.76 – 7.74 (1H, m, ArH), 7.65 
(1H, t, J = 7.5, ArH), 7.58 – 7.53 (2H, m, ArH), 7.45 – 7.42 (2H, m, ArH), 7.27 
(1H, s. ArH), 4.69 (1H, d, J = 17.0 Hz, CH2), 3.67 (3H, s, C(O)OCH3), 3.49 (1H, d, 
J = 17.0 Hz, CH2), 2.44 (3H, s, OC(O)CH3), 2.28 (3H, s, OC(O)CH3); 13C NMR 
(125 MHz, CDCl3) δC 200.4 (C(O)), 171.2 (C(O)OCH3), 168.1 (OC(O)CH3), 168.0 
(OC(O)CH3), 153.1 (4º ArC), 138.1 (4º ArC), 136.8 (4º ArC), 136.3 (ArCH), 135.2 
(4º ArC), 134.4 (4º ArC), 130.6 (4º ArC), 128.8 (4º ArC), 128.1 (ArCH), 126.8 
(ArCH), 126.7 (ArCH), 126.5 (ArCH), 125.3 (ArCH), 124.1 (ArCH), 122.6 
(ArCH), 121.4 (ArCH), 65.3 (4º C), 53.7 (C(O)OCH3), 41.6 (CH2), 20.7 
 103
(OC(O)CH3), 20.5 (OC(O)CH3); IR υmax/cm-1 1765, 1760, 1748, 1733, 1610, 1426, 
1368, 1199, 1170, 763; MP 187-189 ºC; MS (CI+) m/z (relative intensity %)  450 
(M + NH4+, 100%); HRMS (ES+) calcd. for C25H24O7N (M + NH4+) 450.1547, 
found 450.1537. 
 
7.2.4.7 Synthesis and characterization of methyl 3-(3,4-diacetoxy-1-
naphthyl)-2-oxoindoline-3-carboxylate, 121g 
121g
HN
OAc
OAc
O
OMe
O
 
According to general procedure A, 1,2-naphthoquinone 85 (47 mg, 0.30 mmol) was 
reacted with methyl 2-oxoindoline-3-carboxylate 126 (114 mg, 0.60 mmol) to give 
compound 121g (112 mg, 86%) as an off-white solid after column chromatography 
on silica gel eluting with diethyl ether; 1H NMR (500 MHz, d6-DMSO) δH 11.0 
(1H, s, NH), 8.17 – 8.15 (1H, m, ArH), 8.01 – 7.98 (1H, m, ArH), 7.68 – 7.64 (2H, 
m, ArH), 7.43 (1H, dt, J = 7.5, 1.0 Hz, ArH), 7.29 (1H, d, J = 7.5 Hz, ArH), 7.17 
(1H, t, J = 7.5 Hz, ArH), 7.04 (1H, d, J = 7.5 Hz, ArH), 6.85 (1H, s, ArH), 3.69 
(3H, s, C(O)OCH3), 2.48 (3H, s, OC(O)CH3), 2.25 (3H, s, OC(O)CH3);  13C NMR 
(75 MHz, d6-DMSO) δC 172.4 (C(O)), 169.8 (C(O)), 168.3 (C(O)), 168.2 (C(O)), 
142.5 (ArC), 137.8 (ArC), 137.1 (ArC), 131.9 (ArC), 130.4 (ArC), 130.0 (ArC), 
128.2 (ArC), 127.1 (ArC), 126.9 (ArC), 126.7 (ArC), 126.1 (ArC), 125.6 (ArC), 
122.7 (ArC), 121.8 (ArC), 121.7 (ArC), 110.5 (ArC), 63.5 (4º C), 53.5 
(C(O)OCH3), 20.3 (OC(O)CH3), 20.2 (OC(O)CH3); IR υmax/cm-1 3361, 1769, 1755, 
1738, 1729, 1474, 1370, 1212, 1193, 1165, 767, 750; MP 242 – 246 ºC 
(decomposed); MS (CI+) m/z (relative intensity %) 451 (M + NH4+, 100%); HRMS 
(ES+) calcd. for C24H23O7N2 (M + NH4+) 451.1500, found 451.1495. 
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7.2.4.8 Synthesis and characterization of ethyl 1-(3,4-diacetoxy-1-naphthyl)-
2-oxocyclopentanecarboxylate, 121h 
121h
OAc
OAc
O
O
OEt
 
According to general procedure A, 1,2-naphthoquinone 85 (270 mg, 1.71 mmol) 
was reacted with ethyl 2-oxocyclopentanecarboxylate 73 (534 mg, 3.42 mmol) to 
give compound 121h (444 mg, 65%) as an pale brown solid after column 
chromatography on silica gel eluting with petroleum ether containing 30% ethyl 
acetate; 1H NMR (500 MHz, CDCl3) δH 7.89 (1H, dd, J = 8.0, 1.0 Hz, ArH), 7.73 
(1H, d, J = 8.5 Hz, ArH), 7.54 – 7.46 (2H, m, ArH), 7.03 (1H, s, ArH), 4.15 (2H, q, 
J = 7.0 Hz, OCH2CH3), 3.21 (1H, ddd, J = 13.0, 9.5, 7.0 Hz, C(O)CH2CH2CH2), 
2.60 – 2.52 (3H, m, C(O)CH2CH2CH2 and C(O)CH2CH2CH2), 2.45 (3H, s, 
OC(O)CH3), 2.31 (3H, s, OC(O)CH3), 2.15 – 2.09 (1H, m, C(O)CH2CH2CH2), 1.89 
– 1.80 (1H, m, C(O)CH2CH2CH2), 1.07 (3H, t, J = 7.0 Hz, OCH2CH3); 13C NMR 
(75 MHz, CDCl3) δC  213.6 (C(O)), 171.0 (C(O)OCH3), 168.2 (OC(O)CH3), 167.9 
(OC(O)CH3), 137.8 (4º ArC), 136.6 (4º ArC), 133.9 (4º ArC), 129.9 (4º ArC), 
128.8 (4º ArC), 126.7 (ArCH), 126.3 (ArCH), 124.8 (ArCH), 122.3 (ArCH), 121.3 
(ArCH), 65.6 (4º C), 62.2 (OCH2CH3), 38.9 (C(O)CH2CH2CH2), 36.4 
(C(O)CH2CH2CH2), 20.8 (O(CO)CH3), 20.5 (OC(O)CH3), 19.5 
(C(O)CH2CH2CH2), 13.8 (OCH2CH3); IR υmax/cm-1 1774, 1736, 1718, 1609, 1514, 
1462, 1370, 1206, 1162, 769;  MP 156 – 157 ºC; MS (CI+) m/z (relative intensity 
%) 416 (M + NH4+, 100%);  HRMS (ES+): calcd. for C22H26O7N1 (M + NH4+) 
416.1704, found 416.1708. 
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7.2.5 Enantioselective Michael addition to 1,2-naphthoquinone. 
7.2.5.1 Synthesis and characterisation of tert-butyl (2R)-2-(3,4-diacetoxy-1-
naphthyl)-1-oxoindane-2-carboxylate, (+)-156 
(+)-156
OAc
OAc
O
O
O
 
According to general procedure A replacing BEMP with catalyst QD-148 (10 mol 
%), 1,2-naphthoquinone 85 (16 mg, 0.10 mmol) was reacted with tert-butyl 1-
oxindane-2-carboxylate 80 (46 mg, 0.20 mmol) to give compound (+)-156 (26 mg, 
55%) as an off-white solid after column chromatography on silica gel eluting with 
petroleum ether containing 30 – 40% diethyl ether in 70% ee determined by  HPLC 
analysis [ChiralpaK AD, hexane/iso-propanol, 4:1, 1 mL.min-1, λ = 230 nm,  t 
(minor) = 7.26 min, t (major) = 11.19 min] by comparison to a racemic sample 
prepared according to general procedure A; [α]D22 = + 123.7 (c 0.8, CHCl3); 1H 
NMR (500 MHz, CDCl3) δH 7.92 – 7.89 (2H, m, ArH), 7.84 – 7.82 (1H, m, ArH), 
7.64 (1H, t, J = 7.0 Hz, ArH), 7.57 – 7.53 (2H, m, ArH), 7.44 – 7.42 (2H, m, ArH), 
7.24 (1H, s, ArH), 4.62 (1H, d, J = 17.0 Hz, CH2), 3.48 (1H, d, J = 17.0 Hz, CH2), 
2.44 (3H, s, OC(O)CH3), 2.28 (3H, s, OC(O)CH3), 1.28 (9H, s, C(CH3)3); 13C 
NMR (75 MHz, CDCl3) δC  200.9 (C(O)), 169.2 (C(O)OC(CH3)3), 168.1 
(OC(O)CH3), 168.0 (OC(O)CH3), 153.1 (4º ArC), 138.1 (4º ArC), 136.5 (4º ArC), 
136.0 (4º ArC), 136.0 (ArCH), 134.78 (4º ArC), 130.5 (4º ArC), 128.7 (4º ArC), 
127.9 (ArCH), 126.5 (ArCH), 126.4 (ArCH), 126.3 (ArCH), 125.1 (ArCH), 124.7 
(ArCH), 122.4 (ArCH), 121.2 (ArCH), 82.8 (C(CH3)3), 66.2 (4º C), 41.4 (CH2), 
27.4 (C(CH3)3), 20.7 (OC(O)CH3), 20.4 (OC(O)CH3); IR υmax/cm-1 1773, 1742, 
1704, 1606, 1467, 1368, 1205, 1149, 748;  MP 60 – 64 ºC (69 – 73 ºC for 
racemate); MS (ES+) m/z (relative intensity %) 576 (M + NEt3 + H+, 100%), 497 
(M + Na, 90%), 971 (2M + H+, 80%);  HRMS (ES+): calcd. for C28H30O7N1 (M + 
NH4+) 492.2017, found 492.2013. 
 
 106
Similarly replacing ps-BEMP with catalysts 70, QD-71 and QD-147 gave arylated 
adduct (+)-156 in the yields and enantioselectivities shown in Table 7.1 (below). 
Entry Catalyst Scale (mmol) % Yield t (minor) (min) t (major) /min % ee 
1 BEMP 0.3 75 7.39 11.61 0 
2 70 0.2 78 7.42 11.61 11 
3 QD-147 0.1 32 7.42 11.61 26 
4 QD-71 0.2 53 7.45 11.76 40 
Table 7.1: Screen of organocatalysts in the Michael addition of 80 to 1,2-naphthoquinone 85. 
7.3 Chapter 3 Experimental 
7.3.1 Reagents 
Catechol, 3-Methoxy-, and 3-bromocatechol are commercially available and were 
used as received.  Pro-nucleophiles (Chart 7.1) methyl 6-methoxy-1-oxoindane-2-
carboxylate 77j,121 tert-butyl 5-bromo-1-oxoindane-2-carboxylate 77k,122 2-oxo-N-
propylcyclopentanecarboxamide 77o,123 2-oxocycloheptanonecarbonitrile 77n,120 
tert-Butyl 2-oxocyclopentanecarboxylate 77t,89 2,2,2-trifluoro-1-
(trifluoromethyl)ethyl 2-oxocyclopentanecarboxylate 77u,81(b) were synthesised 
according to literature procedures.  Pro-nucleophile 2-acetylcyclopentanone (77l) is 
commercially available.   
77o
O
Br
OtBu
O O O
OMe
O O
77j 77k 77l
77n 77t 77u
O O
NH
O
CN O
OtBu
O O O
O CF3
CF3
 
Chart 7.1: Pro-nucleophiles synthesised according to literature procedures 
Amberlite® IRA-900 was purchased from Aldrich.  Polymer bound 2-tert-
Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (polymer 
supported-BEMP or ps-BEMP) was purchased from Fluka and contains 2.2 mmol/g 
of base. 
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7.3.2 General procedure B for the synthesis of 3-substituted catechols113 
OH
R
OH
R1) (CH2O)n, MgCl2
NEt3, THF
2) H2O2, NaOH
OH
R OH
O
160, R = t-Bu, 32%  
161, R = Et, 36%   
162, R = Ph, 57%
157, R = t-Bu
158, R = Et
159, R = Ph  
To a stirred mixture of 2-substituted phenol 157 – 159 (1 equiv), MgCl2 (2 equiv) 
and para-formaldehyde (3 equiv) in anhydrous THF (1.5 mL/mmol) under N2 was 
added triethylamine (2 equiv) dropwise.  The reaction mixture was heated to reflux 
for 3 h then allowed to cool to room temperature before adding NaOH (0.1 M, 60 
mL) dropwise.  Once all components had dissolved H2O2 (30%, 0.4 mL/mmol) was 
added dropwise and the reaction mixture stirred vigorously for 2 h before adding a 
further portion of H2O2 (30% 0.4 mL/mmol).  The reaction mixture was stirred at 
room temperature for 12 h then acidified with HCl(aq) (1 M, 2.5 mL/mmol) and 
extracted with CH2Cl2 (3 x 1 mL/mmol).  The organic extracts were combined, 
dried over sodium sulfate and evaporated.  The dark brown residue was purified by 
column chromatography to afford the corresponding 3-substituted catechol 160 – 
162. 
7.3.2.1 Synthesis of 3-tert-butylbenzene-1,2-diol (3-tert-butylcatechol), 160124 
According to general procedure B, 2-tert-butylphenol 157 (6.01 g, 40.0 mmol) was 
formylated and oxidised to give, following column chromatography on silica gel 
eluting with CH2Cl2, 3-tert-butylcatechol 160 as a brown oil (2.13 g, 32%); NMR 
(500 MHz, CD3OD) δH  6.70 (1H, d, J = 8.0 Hz, ArH), 6.65 (1H, d, J = 8.0 Hz, 
ArH), 6.55 (1H, t, J = 8.0 Hz, ArH), 1.38 (9H, s, C(CH3)3); MS (ES-) m/z (relative 
intensity %) 165 (M – H+, 100%). Data is consistent with literature values. 
7.3.2.2 Synthesis of 3-ethylbenzene-1,2-diol (3-ethylcatechol), 161126 
According to general procedure B, 2-ethylphenol 158 (4.88 g, 40.0 mmol) was 
formylated and oxidised to give 3-ethylcatechol 161 (1.99 g, 36% yield) as a yellow 
oil following column chromatography on silica gel, eluting with CH2Cl2; NMR 
(500 MHz, CDCl3) δH 6.67 – 6.63 (3H, m, ArH), 5.09 (2H, br. s, OH), 2.57 (2H, q, 
J = 7.5 Hz, CH2CH3), 1.16 (3H, t, J = 7.5 Hz, CH2CH3); MS (CI-) m/z (relative 
intensity %) 137 (M – H+, 100%). Data consistent with literature values. 
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7.3.2.3 Synthesis of biphenyl-2,3-diol (3-phenylcatechol), 162125 
According to general procedure B, 1,1’-biphenyl-2-ol 159 (3.40 g, 20.0 mmol) was 
formylated and oxidised to give 3-phenylcatechol 162 (2.11 g, 57% yield) as a 
yellow solid following column chromatography on silica gel, eluting with CH2Cl2; 
NMR (500 MHz, CDCl3) δH 7.60 (2H, d, J = 8.0 Hz, ArH), 7.39 (2H, t, J = 8.0 Hz, 
ArH), 7.31 – 7.28 (1H, m, ArH), 6.86 (1H, d, J = 7.5 Hz, ArH), 6.82 (1H, d, J = 
7.5 Hz, ArH), 6.78 (1H, t, J = 7.5 Hz, ArH); MS (ES-) m/z (relative intensity %) 
185 (M – H+, 100%).  Data is consistent with literature values. 
 
7.3.3 Attempted synthesis of 3-substituted ortho-benzoquinones 
Several oxidising agents have been reported for the synthesis of ortho-quinones 
from catechols.  Attempted syntheses of o-benzoquinone and 3-substituted-o-
benzoquinones following literature procedures led to complex mixtures in all cases.  
For example sodium periodate has been reported for the synthesis of stable o-
benzoquinones from catechols in quantitative yields.63 Applying the same 
procedure to 3-tert-butylcatechol resulted in a complex mixture: 
OH
OH
O
O
NaIO4
CH2Cl2, H2O
160 165  
NaIO4 (139 mg, 0.65 mmol) was added to a vigorously stirred solution of 3-tert-
butylcatechol 160 (100 mg, 0.65 mmol) in CH2Cl2 (3 mL) and water (1 mL).  The 
biphasic mixture was stirred at room temperature for 30 min, after which TLC 
analysis showed complete conversion.  The organic phase was separated and the 
aqueous extracted with CH2Cl2 (2 x 1 mL).  The combined organic extracts were 
dried over MgSO4, filtered and the solvent evaporated under a flow of N2.  NMR 
analysis of the resulting residue showed a complex mixture of products. 
7.3.4 Preparation of polymer-supported periodate resin (ps-IO4-) 
Polymer-supported periodate was prepared from Amberlite® IRA-900 according to 
the method of Hodge.60  The periodate loading was determined through oxidation of 
an excess of 3,5-di-tert-butylcatechol 167 (known to give a stable quinone) and 
calculation of the ratio of catechol:quinone products and was found to vary between 
batches but is typically 4 – 6 mmol/g.  For example: 
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OH
OH
167
ps-IO4- 
(approx. 0.5 equiv.)
CDCl3
O
O
88
+ recovered starting material
 
Amberlite® IRA-900 resin (40 g) was stirred in a solution of NaIO4- (32 g) in H2O 
(240 mL) at room temperature of 10 h.  The solution was decanted from the resin 
and the resin stirred in a fresh solution of NaIO4- (32 g) in H2O (240 mL) for a 
further 18 h.  The resin was filtered, ground with a pestle and mortar and dried 
under vacuum.   
3,5-di-tert-butylcatechol 167 (52 mg, 0.23 mmol) was dissolved in CDCl3 (0.5 mL) 
and ps-IO4- (29 mg) was added.  The reaction mixture was stirred vigorously at 
room temperature for 2 h then filtered, washing the resin with CDCl3 ( 2 x 0.2 mL).  
The NMR spectrum of the filtrate was recorded and showed 70% oxidation of 
starting material, corresponding to a periodate loading of 5.7 mmol/g. 
7.3.5 Procedure for determining the decomposition rate of 3-substituted 
quinones by 1H NMR 
OH
OHR ps-IO4-
O
OR
163, R = OMe
decomposition
CDCl3
160,  R = tBu
164, R = OMe
165, R = tBu  
To a stirred solution of 3-substituted catechol (160, 163) (0.2 mmol) in CDCl3 (2 
mL) at -20 ºC in a flask wrapped in tin foil was added polymer-supported periodate 
(ps-IO4) (0.4 mmol) and the resulting mixture stirred at this temperature for 20 min.  
The cold solution was rapidly filtered into an NMR tube and an internal standard 
(methyl-3,4,5-trimethoxy benzoate) (approx. 10 mg accurately weighed) was added 
and NMR spectra recorded immediately (assumed to be t = 0) and at various time 
intervals over 24 h.  The distinctive o-quinone doublet at ca. 6 - 6.5 ppm was 
integrated with respect to the internal standard and the data plotted using Microcal 
Origin software.  Smooth curves were fitted to the data points (except for stable 1,2-
naphthoquinone where a linear plot was appropriate) and approximate half-lives 
calculated as 8 hours for 3-methoxy-o-benzoquinone 164 and 1 hour for 3-tert-
butyl-o-benzoquinone 165. No decomposition of 1,2-naphthoquinone could be 
detected over the time period measured. 
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Figure 7.1: Plot of decomposition rates of 3-tert-butyl and 3-methoxy-o-benzoquinone (164, 165) 
7.3.6 General procedure C: Michael addition to in-situ generated o-
benzoquinones 
OH
OHR1
H
+
O
R2
H
EWG
R3
OH
OHR1
R2
O
R3
EWG
160 - 163
77 169a-q
1) ps-BEMP (10 mo l%)
    ps-IO4- (2 equiv), CH2Cl2
2) Na2S2O4 (aq)
 
To a stirred solution of substituted catechol 160 – 163 (1 equivalent), pro-
nucleophile (1 or 2 equivalents) and ps-BEMP (10 mol %) in dichloromethane (10 
mL/mmol) at -20 ºC, in a flask wrapped in aluminium foil, was added ps-IO4- (2 
equivalents).  The resulting suspension was stirred at this temperature until TLC 
analysis showed complete consumption of starting materials.  The reaction mixture 
was filtered to remove the polymer supported reagents, and the resin washed on the 
sinter with CH2Cl2 (10 mL/mmol).  The typically deep red filtrate was stirred 
vigorously with saturated aqueous Na2S2O4 (20 mL/mmol) for 10 min (the colour 
typically fades to pale yellow).  The organic layer was separated and the aqueous 
extracted with CH2Cl2 (2 x 5 mL/mmol).  The combined organic portions were 
dried over sodium sulfate, filtered and concentrated by rotary evaporation. The 
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residue was purified by column chromatography on silica gel to give arylated 
products 169a-q. 
7.3.6.1 Synthesis and characterization of ethyl (3-tert-butyl-4,5-
dihydroxyphenyl)(cyano)phenylacetate, 169a 
OH
OH
O
OEtCN
Ph
169a  
According to general procedure C, 3-tert-butylcatechol 160 (166 mg, 1.00 mmol) 
was reacted with ethyl phenylcyanoacetate 125 (189 mg, 1.00 mmol) to give, after 
30 min reaction time, compound 169a (302 mg, 85%) as a cream solid following 
column chromatography on silica gel eluting with petroleum ether containing 50-
70% diethyl ether. 1H NMR (500 MHz, CDCl3) δH 7.38 – 7.33 (5H, m, ArH), 6.86 
(1H, d, J = 2.5 Hz, ArH), 6.82 (1H, d, J = 2.5 Hz, ArH), 6.09 (1H, s, OH), 5.89 
(1H, s, OH), 4.33 (2H, dq, J = 7.0, 1.0 Hz, OCH2CH3), 1.36 (9H, s, C(CH3)3), 1.31 
(3H, t, J = 7.0, OCH2CH3); 13C NMR (125 MHz, CDCl3) δC 167.7 
(C(O)OCH2CH3), 144.1 (4º ArC), 143.2 (4º ArC), 136.5 (4º ArC), 136.0 (4º ArC), 
128.9 (ArCH), 128.8 (ArCH), 127.9 (ArCH), 124.9 (4º ArC), 118.9 (CN), 118.6 
(ArCH), 112.4 (ArCH), 63.8 (OCH2CH3), 58.6 (4º C), 34.9 (C(CH3)3), 29.2 
(C(CH3)3), 13.9 (OCH3CH3); IR υmax/cm-1 3366, 2964, 2257, 1744, 1594, 1433, 
1300, 1233, 851, 744; MP 167-169 ºC; MS (CI+) m/z (relative intensity %) 371 (M 
+ NH4+, 100%), HRMS (ES+): calcd. for C21H27O4N2 (M + NH4+) 371.1965, found 
371.1962.  
7.3.6.2 Synthesis and characterization of methyl 1-(3-tert-butyl-4,5-
dihydroxyphenyl)-2-oxocyclopentanecarboxylate, 169b 
OH
OH
O
OMe
O
169b  
According to general procedure C, 3-tert-butylcatechol 160 (83 mg, 0.50 mmol) 
was reacted with methyl 2-oxocyclopentanecarboxylate 109 (142 mg, 1.00 mmol) 
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to give, after 4 h reaction time, compound 169b (119 mg, 78%) as a cream solid 
after column chromatography on silica gel, eluting with petroleum ether containing 
50% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 6.85 (1H, d, J = 2.0, ArH), 6.77 
(1H, d, J = 2.0 Hz, ArH), 6.39 (1H, br. s, OH), 5.77 (1H, br. s, OH), 3.72 (3H, s, 
OCH3), 2.81 (1H, td, J = 13.0, 6.5 Hz, CH2), 2.56 (1H, td, J = 13.0, 6.5 Hz, CH2), 
2.51 – 2.35 (2H, m, CH2), 2.01 – 1.90 (2H, m, CH2), 1.32 (9H, s, C(CH3)3); 13C 
NMR (125 MHz, CDCl3) δC 214.0 (C(O)), 171.9 (C(O)OCH3), 143.3 (4º ArC), 
143.0 (4º ArC), 136.0 (4º ArC), 125.3 (4º ArC), 117.2 (ArCH), 112.6 (ArCH), 64.6 
(4º C), 53.1 (OCH3), 37.8 (C(O)CH2CH2CH2), 34.9 (C(CH3)3), 34.8 
(C(O)CH2CH2CH2), 29.4 (C(CH3)3), 19.3 (C(O)CH2CH2CH2); IR υmax/cm-1 3261, 
2952, 1744, 1715, 1424, 1384, 1253; MP 156-158 ºC; MS (CI+) m/z (relative 
intensity %) 324 (M + NH4+, 100%), 307 (M + H+, 20%), HRMS (ES+): calcd. for 
C17H26O5N (M + NH4+) 324.1805, found 324.1805. 
7.3.6.3 Synthesis and characterization of methyl 2-(3-tert-butyl-4,5-
dihydroxyphenyl)-1-oxoindane-2-carboxylate, 169c 
OH
OH
OMe
OO
169c  
According to general procedure C, 3-tert-butylcatechol 160 (166 mg, 1.00 mmol) 
was reacted with methyl 1-oxoindane-2-carboxylate 127 (190 mg, 1.00 mmol) to 
give, after 3 h reaction time, compound 169c (299 mg, 84%) as a pale orange solid 
after column chromatography on silica gel, eluting with petroleum ether containing 
50-70% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 7.80 (1H, d, J = 7.5 Hz, 
ArH), 7.65 (1H, dt, J = 7.5, 1.0 Hz, ArH), 7.50 (1H, d, J = 7.5 Hz, ArH), 7.40 (1H, 
t, J = 7.5 Hz, ArH), 7.03 (1H, d, J = 2.0 Hz, ArH), 6.95 (1H, br. s, OH), 6.77 (1H, 
d, J = 2.0 Hz, ArH), 5.82 (1H, br. s, OH), 4.20 (1H, d, J = 17.5 Hz, CH2), 3.71 
(3H, s, OCH3), 3.61 (1H, d, J = 17.5 Hz, CH2), 1.37 (9H, s, C(CH3)3); 13C NMR 
(125 MHz, CDCl3) δC 202.1 (C(O)), 171.5 (C(O)OCH3), 152.6 (4º ArC), 143.2 (4º 
ArC), 143.1 (4º ArC), 136.1 (4º ArC), 136.0 (ArCH), 134.8 (4º ArC), 128.1 (4º 
ArC), 128.0 (ArCH), 126.2 (ArCH), 125.2 (ArCH), 117.5 (ArCH), 112.1 (ArCH), 
65.1 (4º C), 53.4 (OCH3), 40.8 (CH2), 34.8 (C(CH3)3), 29.3 (C(CH3)3); IR υmax/cm-
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1 3404, 1700, 1600, 1425, 1250, 1213, 959; MP 75-77 ºC; MS (CI+) m/z (relative 
intensity %) 372 (M + NH4+, 100%), 355 (M + H+, 50%); HRMS (ES+): calcd. for 
C21H23O5 (M+H+) 355.1540, found 355.1543. 
7.3.6.4 Synthesis and characterisation of 1-(3-tert-butyl-4,5-
dihydroxyphenyl)-2-oxocyclohexanecarbonitrile, 169d 
OH
OH
O
CN
169d  
According to general procedure C, 3-tert-butylcatechol 160 (83 mg, 0.50 mmol) 
was reacted with 2-oxocyclohexanecarbonitrile 123 (123 mg, 1.00 mmol) to give, 
after 4 h reaction time, compound 169d (84 mg, 58%) as a peach coloured solid 
after column chromatography on silica gel, eluting with petroleum ether containing 
50-70% diethyl ether; 1H NMR (400 MHz, CDCl3) δH 7.03 (1H, br. s, OH), 6.80 
(1H, d, J = 2.5 Hz, ArH), 6.71 (1H, d, J = 2.5 Hz, ArH), 5.99 (1H, br. s, OH), 2.79 
– 2.74 (1H, m, CH2), 2.68 – 2.61 (1H, m, CH2), 2.54 – 2.47 (1H, m, CH2), 2.44 – 
2.37 (1H, m, CH2), 2.00 – 1.93 (4H, m, CH2), 1.39 (9H, s, C(CH3)3); 13C NMR 
(100 MHz, CDCl3) δC 203.6 (C(O)), 144.3 (4º ArC), 143.8 (4º ArC), 136.8 (4º 
ArC), 122.5 (4º ArC), 119.8 (CN), 116.9 (ArCH), 111.8 (ArCH), 55.7 (4º C), 38.6 
(CH2), 36.8 (CH2), 34.9 (C(CH3)3), 29.3 (C(CH3)3), 27.3 (CH2), 21.3 (CH2); MP 
89 – 91 ºC; IR υmax/cm-13435, 2955, 2870, 2250, 1719, 1644, 1430, 1362, 1304, 
1252; MS (ES+) m/z (relative intensity %) 310 (M + Na+, 100%), 342 (M + Na+ + 
MeOH, 50%); HRMS: calcd. for C17H21N1O3Na (M + Na+) 310.1414, found 
310.1414. 
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7.3.6.5 Synthesis and characterization of methyl 2-(5,6-dihydroxybiphenyl-3-
yl)-1-oxoindane-2-carboxylate, 169e 
OH
OH
OMe
OO
Ph
169e  
According to general procedure C, 3-phenylcatechol 162 (93 mg, 0.50 mmol) was 
reacted with methyl 1-oxoindane-2-carboxylate 127 (190 mg, 1.00 mmol) to give, 
after 5 h reaction time, compound 169e (145 mg, 77%) as a pale yellow solid after 
column chromatography on silica gel, eluting with petroleum ether containing 40-
60% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 7.82 (1H, d, J = 7.5 Hz, ArH), 
7.64 (1H, dt, J = 7.5, 1.0 Hz, ArH), 7.49 – 7.35 (7H, m, ArH), 7.06 (1H, d, J = 2.5 
Hz, ArH), 6.85 (1H, d, J = 2.5 Hz, ArH), 4.19 (1H, d, J = 17.5 Hz, CH2), 3.74 (3H, 
s, OCH3), 3.62 (1H, d, J = 17.5 Hz, CH2); 13C NMR (125 MHz, CDCl3) δC 200.8 
(C(O)), 171.2 (C(O)OCH3), 152.2 (4º ArC), 144.1 (4º ArC), 140.1 (4º ArC), 136.8 
(4º ArC), 135.8 (ArCH), 134.8 (4º ArC), 130.5 (4º ArC), 129.0 (ArCH), 128.9 
(ArCH), 128.2 (4º ArC), 128.0 (ArCH), 127.8 (ArCH), 126.2 (ArCH), 125.2 
(ArCH), 120.6 (ArCH), 113.9 (ArCH), 64.7 (4º C), 53.4 (OCH3), 40.7 (CH2); IR 
υmax/cm-1 3403, 2963, 1702, 1700, 1603, 1430, 1300, 1274, 1212, 1178, 799, 850, 
754; MP 164-166 ºC; MS (CI+) m/z (relative intensity %) 392 (M + NH4+, 100%), 
375 (M + H+, 20%); HRMS (ES+): calcd. for C23H22O5N (M + NH4+) 392.1492, 
found 392.1491. 
7.3.6.6 Synthesis and characterization of ethyl cyano(5,6-
dihydroxybiphenyl-3-yl)phenylacetate, 169f 
OH
OH
Ph
CO2Et
CN
Ph
169f  
According to general procedure C, 3-phenylcatechol 162 (61 mg, 0.33 mmol) was 
reacted with ethyl phenylcyanoacetate 125 (125 mg, 0.66 mmol) to give, after 4 h 
reaction time, compound 169f (89 mg, 72%) as a colourless solid after column 
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chromatography on silica gel, eluting with petroleum ether containing 40-60% 
diethyl ether; 1H NMR (500 MHz, CDCl3) δH 7.47 – 7.38 (10H, m, ArH), 6.92 – 
6.91 (2H, m, ArH), 4.35 (2H, q, J = 7.0 Hz, OCH2CH3), 1.25 (3H, t, J = 7.0 Hz, 
OCH2CH3); 13C NMR (75 MHz, CDCl3) δC 167.3 (C(O)OCH2CH3), 144.3 (4º 
ArC), 140.9 (4º ArC), 136.1 (4º ArC), 135.7 (4º ArC), 129.2 (ArCH), 128.9 
(ArCH), 128.9 (ArCH), 128.4 (4º ArC), 128.2 (ArCH), 128.0 (ArCH), 127.9 
(ArCH), 127.9 (4º ArC), 121.3 (ArCH), 118.8 (CN), 114.3 (ArCH), 63.7 
(OCH2CH3), 58.3 (4º C), 13.9 (OCH2CH3); IR υmax/cm-1 3438, 3370, 2360, 2338, 
1737, 1598, 1425, 1308, 1241, 1006, 852 ; MP 126-130 ºC; MS (CI+) m/z (relative 
intensity %) 391 (M + NH4+, 100%); HRMS (ES+): calcd. for C23H23O4N2 (M + 
NH4+) 391.1652, found 391.1652. 
7.3.6.7 Synthesis and characterization of methyl 2-(3-ethyl-4,5-
dihydroxyphenyl)-1-oxoindane-2-carboxylate, 169g 
OH
OH
OMe
OO
169g  
According to general procedure C, 3-ethylcatechol 161 (138 mg, 1.00 mmol) was 
reacted with methyl 1-oxoindane-2-carboxylate 127 (190 mg, 1.00 mmol) to give, 
after 6 h reaction time, compound 169g (234 mg, 72%) as an orange oil after 
column chromatography on silica gel, eluting with petroleum ether containing 50% 
diethyl ether; 1H NMR (500 MHz, CDCl3) δH 7.79 (1H, d, J = 7.5 Hz, ArH), 7.63 
(1H, dt, J = 7.5, 1.0 Hz, ArH), 7.47 (1H, d, J = 7.5 Hz, ArH), 7.36 (1H, t, J = 7.5 
Hz, ArH), 7.15 (1H, br. s, OH), 6.94 (1H, d, J = 2.5 Hz, ArH), 6.65 (1H, d, J = 2.5 
Hz, ArH), 5.72 (1H, br. s, OH), 4.16 (1H, d, J = 17.5 Hz, CH2), 3.70 (3H, s, 
OCH3), 3.59 (1H, d, J = 17.5 Hz, CH2), 2.60 (2H, q, J = 7.5 Hz, CH2CH3), 1.17 
(3H, t, J = 7.5 Hz, CH2CH3); 13C NMR (125 MHz, CDCl3) δC 201.7 (C(O)), 171.5 
(C(O)OCH3), 152.5 (4º ArC), 143.1 (4º ArC), 142.0 (4º ArC), 135.9 (ArCH), 134.7 
(4º ArC), 130.7 (4º ArC), 129.2 (4º ArC), 128.0 (ArCH), 126.2 (ArCH), 125.2 
(ArCH), 119.6 (ArCH), 112.1 (ArCH), 64.8 (4º C), 53.4 (C(O)OCH3), 40.7 (CH2), 
23.1 (CH2CH3), 14.0 (CH2CH3); IR υmax/cm-1  3415, 1700, 1696, 1603, 1430, 1300, 
1274, 1212, 1178, 799; MS (CI+) m/z (relative intensity %) 344 (M + NH4+, 
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100%), 327 (M + H+, 50%); HRMS (ES+): calcd. for C19H19O5 (M + H+) 327.1277, 
found 327.1230. 
7.3.6.8 Synthesis and characterization of methyl 1-(3,4-dihydroxy-5-
methoxyphenyl)-2-oxocyclopentanecarboxylate, 169h 
OH
OH
OMe
OO
MeO
169h  
According to general procedure C, 3-methoxycatechol 163 (140 mg, 1.00 mmol) 
was reacted with methyl 2-oxocyclopentanecarboxylate 109 (142 mg, 1.00 mmol) 
to give, after 30 min reaction time, compound 169h (199 mg, 71%) as a pale brown 
solid after column chromatography on silica gel, eluting with petroleum ether 
containing 30 – 50% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 6.61 (1H, d, J = 
2.0 Hz, ArH), 6.56 (1H, d, J = 2.0 Hz, ArH), 5.54 (2H, br. s, OH) 3.85 (3H, s, 
OCH3), 3.70 (3H, s, OCH3), 2.79 (1H, td, J = 13.5, 7.0 Hz, CH2), 2.53 – 2.42 (2H, 
m, CH2), 2.39 – 2.32 (1H, m, CH2), 2.01 – 1.86 (2H, m, CH2); 13C NMR (125 
MHz, CDCl3) δC 212.3 (C(O)), 171.4 (C(O)OCH3), 146.8 (4º ArC), 143.7 (4º ArC), 
132.1 (4º ArC), 127.2 (4º ArC), 107.9 (ArCH), 102.9 (ArCH), 64.3 (4º C), 56.2 
(OCH3), 53.0 (OCH3), 37.7 (C(O)CH2CH2CH2), 34.9 (C(O)CH2CH2CH2), 19.2 
(C(O)CH2CH2CH2); IR υmax/cm-1 3436, 2953, 1720, 1700, 1601, 1426, 1301, 1252; 
MP 114-116 ºC; MS (CI+) m/z (relative intensity %) 298 (M + NH4+, 100%), 281 
(M + H+, 25%); HRMS (ES+): calcd. for C14H20O6N (M + NH4+) 298.1285, found 
298.1283. 
7.3.6.9 Synthesis and characterization of methyl 2-(3,4-dihydroxy-5-
methoxyphenyl)-1-oxoindane-2-carboxylate, 169i 
OH
OH
OMe
OO
MeO
169i  
According to general procedure C, 3-methoxycatechol 163 (140 mg, 1.00 mmol) 
was reacted with methyl 1-oxoindane-2-carboxylate 127 (190 mg, 1.00 mmol) to 
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give, after 2 h reaction time, compound 169i (289 mg, 88%) as a viscous orange oil 
after column chromatography on silica gel, eluting with diethyl ether; 1H NMR 
(500 MHz, CDCl3) δH 7.82 (1H, d, J = 7.5 Hz, ArH), 7.64 (1H, t, J = 7.5 Hz, ArH), 
7.49 (1H, d, J = 7.5 Hz, ArH), 7.41 (1H, t, J = 7.5 Hz, ArH), 6.65 (1H, d, J = 2.0 
Hz, ArH), 6.59 (1H, d, J = 2.0 Hz, ArH), 5.35 (1H, s, OH), 5.25 (1H, s, OH), 4.18 
(1H, d, J = 17.5 Hz, CH2), 3.87 (3H, s, OCH3), 3.74 (3H, s, OCH3), 3.55 (1H, d, J 
= 17.5 Hz, CH2); 13C NMR (125 MHz, CDCl3) δC 200.2 (C(O)), 171.1 
(C(O)OCH3), 152.1 (4º ArC), 146.8 (4º ArC), 143.7 (4º ArC), 135.7 (ArCH), 134.9 
(4º ArC), 131.9 (4º ArC), 130.1 (4º ArC), 128.0 (ArCH), 126.2 (ArCH), 125.1 
(ArCH), 108.0 (ArCH), 102.7 (ArCH), 64.8 (4º C), 56.2 (OCH3), 53.3 (OCH3), 
40.8 (CH2); IR υmax/cm-1 3415, 2952, 1742, 1701, 1604, 1518, 1251, 1200, 1176, 
1091, 754; MS (CI+) m/z (relative intensity %) 346 (M + NH4+, 100%), 329 (M + 
H+, 60%); HRMS (ES+): calcd. for C18H17O6 (M + H+) 329.1020, found 329.1016 . 
7.3.6.10 Synthesis and characterization of methyl 2-(3,4-dihydroxy-5-
methoxyphenyl)-6-methoxy-1-oxoindane-2-carboxylate, 169j 
OH
OH
OMe
OO
MeO
MeO 169j  
According to general procedure C, 3-methoxycatechol 163 (54 mg, 0.39 mmol) was 
reacted with methyl 6-methoxy-1-oxoindane-2-carboxylate 77j (56 mg, 0.39 mmol) 
to give, after 2 h reaction time, compound 169j (117 mg, 84 %) as a cream solid 
after filtering through a small plug of silica gel, eluting with diethyl ether; 1H NMR 
(500 MHz, CDCl3) δH 7.37 (1H, d, J = 9.0 Hz, ArH), 7.24 – 7.22 (2H, m, ArH), 
6.62 (1H, d, J = 2.0 Hz, ArH), 6.58 (1H, d, J = 2.0 Hz, ArH), 5.39 (1H, s, OH), 
5.31 (1H, s, OH), 4.08 (1H, d, J = 17.0 Hz, CH2), 3.86 (3H, s, OCH3), 3.84 (3H, s, 
OCH3), 3.74 (3H, s, OCH3), 3.46 (1H, d, J = 17.0 Hz, CH2); 13C NMR (125 MHz, 
CDCl3) δC 200.2 (C(O)), 171.1 (C(O)OCH3), 159.8 (4º ArC), 146.8 (4º ArC), 145.0 
(4º ArC), 143.7 (4º ArC), 136.0 (4º ArC), 131.9 (4º ArC), 130.1 (4º ArC), 126.9 
(ArCH), 125.2 (ArCH), 108.0 (ArCH), 106.0 (ArCH), 102.7 (ArCH), 65.6 (4º C), 
56.9 (OCH3), 55.6 (OCH3), 53.3 (OCH3), 40.2 (CH2); IR υmax/cm-1 3444, 3221, 
1705, 1615, 1517, 1495, 1432, 1307, 1275, 1195, 1173, 1107, 815; MP 143-145 ºC; 
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MS (CI+) m/z (relative intensity %) 359 (M + H+, 100%); HRMS (EI+): calcd. for 
C19H18O7 (M+) 358.1047, found 358.1052. 
7.3.6.11 Synthesis and characterization of tert-butyl 5-bromo-2-(3,4-
dihydroxy-5-methoxyphenyl)-1-oxoindane-2-carboxylate, 169k 
OH
OH
O
MeO
Br
O
Ot-Bu
169k
 
According to general procedure C, 3-methoxycatechol 163 (14 mg, 0.10 mmol) was 
reacted with methyl 5-bromo-2,3-dihydro-1-oxo-1H-indene-2-carboxylate 77k (31 
mg, 0.10 mmol) to give, after 2 h reaction time, compound 169k (36 mg, 80 %) as a 
pale yellow oil after column chromatography on silica gel, eluting with petroleum 
ether containing 50-70% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 7.66 (1H, s, 
ArH), 7.65 (1H, d, J = 8.5 Hz, ArH), 7.54 (1H, d, J = 8.5 Hz, ArH), 6.68 (1H, d, J 
= 2.0 Hz, ArH), 6.57 (1H, d, J = 2.0 Hz, ArH), 5.37 (1H, s, OH), 5.28 (1H, s, OH), 
4.04 (1H, d, J = 17.5 Hz, CH2), 3.87 (3H, s, OCH3), 3.52 (1H, d, J = 17.5 Hz, 
CH2), 1.39 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC 199.3 (C(O)), 169.0 
(C(O)OC(CH3)3), 153.5 (4º ArC), 146.7 (4º ArC), 143.6 (4º ArC), 134.0 (4º ArC), 
131.9 (4º ArC), 131.5 (ArCH), 130.7 (4º ArC), 129.8 (4º ArC), 129.4 (ArCH), 
126.1 (ArCH), 108.0 (ArCH), 102.9 (ArCH), 82.7 (C(CH3)3), 65.5 (4º C), 56.2 
(OCH3), 40.0 (CH2), 27.7 (C(CH3)3); IR υmax/cm-1 3422, 2976, 2930, 1735, 1716, 
1596, 1521, 1459, 1368, 1314, 1255, 1151; MS (ES+) m/z (relative intensity %) 
471 (M + Na+, 100%), 473 (M + Na+, 100%); HRMS (EI+): calcd. for 
C21H25O6NBr (M+ NH4+) 466.0860, found 466.0863. 
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7.3.6.12 Synthesis and characterization of 2-acetyl-2-(3,4-dihydroxy-5-
methoxyphenyl)cyclopentanone, 169l 
OH
OH
O
MeO
O
169l  
According to general procedure C, 3-methoxycatechol 163 (140 mg, 1.00 mmol) 
was reacted with 2-acetylcyclopentanone 77l (126 mg, 1.00 mmol) to give, after 4 h 
reaction time, compound 169l (191 mg, 72%) as a viscous yellow oil after column 
chromatography on silica gel, eluting with petroleum ether containing 60-80% 
diethyl ether; 1H NMR (500 MHz, CDCl3) δH 6.54 (1H, d, J = 2.0 Hz, ArH), 6.43 
(1H, d, J = 2.0 Hz, ArH), 5.62 (2H, br. s, OH), 3.85 (3H, s, OCH3), 2.86 (1H, td, J 
= 13.5, 7.0 Hz, CH2), 2.38 (2H, dt, J = 7.0, 3.5 Hz, CH2), 2.21 (1H, m, CH2), 2.07 
(3H, s, C(O)CH3), 1.90-1.81 (2H, m, CH2); 13C NMR (75 MHz, CDCl3) δC 213.9 
(C(O)), 204.2 (C(O)), 147.2 (4º ArC), 144.1 (4º ArC), 132.1 (4º ArC), 129.5 (4º 
ArC), 107.6 (ArCH), 102.0 (ArCH), 71.9 (4º C), 56.3 (OCH3), 39.2 
(C(O)CH2CH2CH2), 34.2 (C(O)CH2CH2CH2), 26.6 (C(O)CH3), 19.0 
(C(O)CH2CH2CH2); IR υmax/cm-1 3426, 1729, 1698, 1613, 1517, 1204, 1091; MS 
(CI+) m/z (relative intensity %) 282 (M + NH4+, 100%), 265 (M + H+, 20%); 
HRMS (ES+): calcd. for C14H20O5N (M + NH4+) 282.1336, 282.1335. 
7.3.6.13 Synthesis and characterization of ethyl cyano(3,4-dihydroxy-5-
methoxyphenyl)phenylacetate, 169m 
OH
OH
O
MeO
OEtCN
Ph
169m  
According to general procedure C, 3-methoxycatechol 163 (140 mg, 1.00 mmol) 
was reacted with ethyl phenylcyanoacetate 125 (189 mg, 1.00 mmol) to give, after 
30 min reaction time, compound 169m (311 mg, 95%) as a brown oil after filtering 
through a small plug of silica gel, eluting with diethyl ether; 1H NMR (500 MHz, 
CDCl3) δH 7.40 – 7.38 (5H, m, ArH), 6.62 (1H, d, J = 2.0 Hz, ArH), 6.55 (1H, d, J 
= 2.0 Hz, ArH), 5.52 (1H, s, OH), 5.39 (1H, s, OH), 4.34 (2H, q, J = 7.0 Hz, 
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OCH2CH3), 3.82 (3H, s, OCH3), 1.32 (3H, t, J = 7.0 Hz, OCH2CH3); 13C NMR 
(125 MHz, CDCl3) δC 167.2 (C(O)OCH2CH3), 147.0 (4º ArC), 143.8 (4º ArC), 
135.7 (4º ArC), 132.8 (4º ArC), 128.9 (ArCH), 128.8 (ArCH), 127.9 (ArCH), 127.2 
(4º ArC), 118.8 (CN), 109.2 (ArCH), 103.2 (ArCH), 63.7 (C(O)OCH2CH3), 58.5 
(4º C), 56.2 (OCH3), 13.9 (C(O)OCH2CH3); IR υmax/cm-1 3431, 2895, 1747, 1615, 
1517, 1452, 1305, 1223, 1096; MS (CI+) m/z (relative intensity %) 345 (M + NH4+, 
100%); HRMS (ES+): calcd. for C18H21O5N2 (M + NH4+) 345.1445, found 
345.1436. 
7.3.6.14 Synthesis and characterization of 1-(3,4-dihydroxy-5-
methoxyphenyl)-2-oxocycloheptanecarbonitrile, 169n 
OH
OH
O
MeO
CN
169n  
According to general procedure C, 3-methoxycatechol 163 (70 mg, 0.50 mmol) was 
reacted with 2-oxocycloheptanecarbonitrile 77n (69 mg, 0.50 mmol) to give, after 4 
h reaction time, compound 169n (107 mg, 78%) as an off-white solid after filtering 
through a small plug of silica gel, eluting with diethyl ether; 1H NMR (500 MHz, 
d6-DMSO) δH 9.28 (1H, s, OH), 8.66 (1H, s, OH), 6.54 (2H, m, ArH), 3.78 (3H, s, 
OCH3), 2.87 – 2.81 (1H, m, CH2), 2.55 – 2.43 (2H, m, CH2), 2.32 – 2.28 (1H, m, 
CH2), 2.12 – 2.09 (1H, m, CH2), 1.99 – 1.95 (1H, m, CH2), 1.83 (1H, d, J = 14 Hz, 
CH2), 1.61 – 1.52 (1H, m, CH2)1.40 – 1.28 (2H, m, CH2); 13C NMR (75 MHz, d6-
DMSO) δC 204.6 (C(O)), 148.7 (4º ArC), 146.1 (4º ArC), 134.8 (4º ArC), 124.2 (4º 
ArC), 120.9 (CN), 107.5 (ArCH), 101.7 (ArCH), 59.5 (4º C), 56.1 (OCH3), 38.9 
(CH2), 33.0 (CH2), 28.7 (CH2), 26.6 (CH2), 25.0 (CH2); IR υmax/cm-1 3333, 2936, 
1720, 1700, 1612, 1519, 1302, 1107; MP 155 – 158 ºC; MS (CI+) m/z (relative 
intensity %) 293 (M + NH4+, 100%); HRMS (ES+): calcd. for C15H21O4N (M + 
NH4+) 293.1496, found 293.1496. 
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7.3.6.15 Synthesis and characterization of 1-(3,4-dihydroxy-5-
methoxyphenyl)-2-oxo-N-propylcyclopentanecarboxamide, 169o 
OH
OH
O
MeO
HN
O
169o  
According to general procedure C, 3-methoxycatechol 163 (28 mg, 0.20 mmol) was 
reacted with 2-oxo-N-propylcyclopentanecarboxamide 77o (34 mg, 0.20 mmol) to 
give, after 6 h reaction time, compound 169o (48 mg, 78%) as a colourless oil after 
column chromatography on silica gel, eluting with petroleum ether containing 50-
70% diethyl ether; 1H NMR (500 MHz, CDCl3) δH 6.61 (1H, d, J = 1.0 Hz ArH), 
6.58 (1H, s, NH), 6.48 (1H, d, J = 1.0 Hz, ArH), 6.03 (1H, s, OH), 5.53 (1H, s, 
OH), 3.86 (3H, s, OCH3), 3.17 (2H, q, J = 7.5 Hz, NCH2CH2CH3), 2.88 (1H, ddd, J 
= 13.5, 8.5, 6.5 Hz, CH2), 2.46 – 2.40 (3H, m, CH2), 1.95 (1H qd, J = 13.0, 6.5 Hz, 
CH2), 1.84 – 1.75 (1H, m, CH2), 1.46 (2H, sextet, J = 7.5 Hz, NCH2CH2CH3), 0.83 
(3H, t, J = 7.5 Hz, NCH2CH2CH3); 13C NMR (75 MHz, CDCl3) δC 217.9 (C(O)), 
169.6 (C(O)NCH2CH2CH3), 147.3 (4º ArC), 144.2 (4º ArC), 132.3 (4º ArC), 130.0 
(4º ArC), 107.4 (ArCH), 101.7 (ArCH), 64.5 (4º C), 56.2 (OCH3), 41.5 (CH2), 39.2 
(CH2), 35.8 (CH2), 22.5 (CH2), 18.8 (CH2), 11.2 (CH3); IR υmax/cm-1 3369, 2963, 
2935, 2877, 1726, 1652, 1520, 1460, 1206, 1094; MS (ES-) m/z (relative intensity 
%) 306 (M - H+, 100%); HRMS (EI+): calcd. for C16H21O5N (M+) 307.1414, found 
307.1429. 
7.3.6.16 Synthesis and characterisation of methyl 1-(4,5-dihydroxy-2-
methylphenyl)-2-oxocyclopentanecarboxylate, 169p 
OH
OH
Me
O
OMe
O
169p  
According to general procedure C coupling procedure, 4-methylcatechol 111 (124 
mg, 1.00 mmol) was reacted with methyl cyclopentanone-2-carboxylate 109 (284 
mg, 2.00 mmol) to give, after 5 h reaction time, compound 169p (27 mg, 10%) as a 
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yellow oil after column chromatography on silica gel, eluting with petroleum ether 
containing 50-70% diethyl ether; 1H NMR (400 MHz, CDCl3) δH 6.70 (1H, s, 
ArH), 6.46 (1H, s, ArH), 5.37 (1H, br. s, OH), 5.28 (1H, br. s, OH), 3.75 (3H, s, 
OCH3), 2.99 (1H, ddd, J = 13.0, 9.0, 7.0 Hz, CH2), 2.52 – 2.48 (2H, m, CH2), 2.30 
– 2.24 (1H, m, CH2), 2.09 – 2.01 (1H, m, CH2), 2.07 (3H, s, CH3) 1.89 – 1.77 (1H, 
m, CH2);13C NMR (100 MHz, CDCl3) δC 215.2 (C(O)), 171.8 (C(O)O), 142.9 (4º 
ArC), 140.9 (4º ArC), 129.2 (4º ArC), 128.8 (4º ArC), 119.1 (ArCH), 114.6 
(ArCH), 65.9 (4º C), 53.2 (OCH3), 39.0 (CH2), 35.7 (CH2), 19.5 (CH2), 19.3 
(CH3); IR υmax/cm-1 3417, 2955, 1748, 1720, 1518, 1436, 1280, 1233; MS (ES+) 
m/z (relative intensity %) 282 (M + NH4+, 100%), 287 (M + Na+, 80%), 319 (M + 
Na+ + MeOH, 20%); HRMS (ES+): calc. for C14H20O5N (M + NH4+) 282.1336, 
found 282.1327. 
7.3.6.17 Synthesis and characterisation of methyl 1-(3,4-dihydroxyphenyl)-2-
oxocyclopentanecarboxylate, 169q 
OH
OH
O
OMe
O
169q  
According to general procedure C, except that ps-IO4- oxidant was added portion-
wise over 75 min, catechol 90 (110 mg, 0.50 mmol) was reacted with methyl 
cyclopentanone-2-carboxylate 109 (142 mg, 1.00 mmol) to give, after 2 h reaction 
time, compound 169q (27 mg, 21%) as a yellow oil after column chromatography 
on silica gel, eluting with petroleum ether containing 50-70% diethyl ether; 1H 
NMR (500 MHz, CDCl3) δH 6.95 (1H, d, J = 2.0 Hz, ArH), 6.80 – 6.74 (2H, m, 
ArH), 3.71 (3H, s, OCH3), 2.79 (1H, td, J = 13.5, 7.0 Hz, CH2), 2.55 – 2.43 (2H, 
m, CH2), 2.40 – 2.34 (1H, m, CH2), 2.02 – 1.86 (2H, m, CH2); 13C NMR (75 MHz, 
CDCl
3
) δ
C 
212.9 (C(O)), 171.6 (C(O)O), 143.6 (4º ArC), 143.5 (4º ArC), 128.0 (4º 
ArC), 119.8 (ArCH), 115.3 (ArCH), 114.9 (ArCH), 64.3 (4º C), 53.1 (OCH3), 37.7 
(CH2), 34.8 (CH2), 19.2 (CH2); IR υmax/cm-1 3430, 1745, 1718, 1638, 1523, 1436, 
1261; MS (ES+) m/z (relative intensity %) 273 (M + Na+, 100%), 523 (dimer + 
Na+, 45%); HRMS (ES+): calc. for C13H14O5Na (M + Na+) 273.0733, found 
273.0731. 
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7.3.7 Enantioselective Examples 
7.3.7.1 Synthesis and characterisation of (-)-tert-butyl (2R)-2-(3,4-dihydroxy-
5-methoxyphenyl)-1-oxoindane-2-carboxylate, (-)-169r 
OH
OH
MeO
O
O
O
(-)-169r  
According to general procedure C, where ps-BEMP is replaced by catalyst QD-174 
(4.8 mg, 10 mol%), 3-methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with  
tert-butyl 1-oxindane-2-carboxylate 80 (23 mg, 0.10 mmol) to give, after 2 h 
reaction time, compound (-)-169r (31 mg, 84%) as an off-white solid after column 
chromatography on silica gel eluting with petroleum ether containing 50 – 70% 
diethyl ether, in 81% ee, determined by HPLC analysis [Chiralpak AD, hexane/iso-
propanol, 4:1, 1.0 mL.min-1, λ = 230 nm, t (minor) = 19.82 min, t (major) = 25.83 
min] by comparison to a racemic sample prepared in 68% yield on 0.5 mmol scale 
according to general procedure C;  [α]D24 = -1.61 (c 0.87, CHCl3); 1H NMR (500 
MHz, CDCl3) δH 7.80 (1H, d, J = 7.5 Hz, ArH), 7.61 (1H, t, J = 7.5 Hz, ArH), 7.48 
(1H, d, J = 7.5 Hz, ArH), 7.39 (1H, t, J = 7.5, ArH), 6.71 (1H, d, J = 2.0 Hz, ArH), 
6.61 (1H, d, J = 2.0, Hz, ArH), 5.45 (1H, s, OH), 5.41 (1H, s, OH), 4.05 (1H, d, J = 
17.0 Hz, CH2), 3.85 (3H, s, OCH3), 3.56 (1H, d, J = 17.0 Hz, CH2), 1.39 (9H, s, 
C(CH3)3); 13C NMR (75 MHz, CDCl3) δC 200.6 (C(O)), 169.6 (C(O)OC(CH3)3), 
152.0 (4º ArC), 146.7 (4º ArC), 143.6 (4º ArC), 135.3 (ArCH), 135.1 (4º ArC), 
131.9 (4º ArC), 130.1 (4º ArC), 127.7 (ArCH), 126.0 (ArCH), 124.9 (ArCH), 108.0 
(ArCH), 103.1 (ArCH), 82.4 (C(O)OC(CH3)3), 65.4 (4º C), 56.1 (OCH3), 40.4 
(CH2), 27.7 (C(O)OC(CH3)3); IR υmax/cm-1 3416, 2966, 1729, 1713, 1607, 1517, 
1463, 1370, 1254, 1153, 1096, 842; MP 66 – 68 ºC (144-147 ºC for racemate);  MS 
(CI+) m/z (relative intensity %) 332 (M - tBu + NH4+, 100%), 388 (M + NH4+, 
15%); HRMS (ES+): calcd. for C21H26O6N (M + NH4+) 388.1755, found 388.1763. 
Similarly replacing ps-BEMP with catalysts 70, QD-71, QD-148, QD-170 – QD-
174 gave arylated adduct (-)-169r in the yields and enantioselectivities shown in 
Table 7.2 (below). 
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Catalyst (mol %) Scale (mmol) % Yield 
t(minor) 
(min) 
t(major) 
(min) % ee 
70 (10 mol %) 0.1 62% 19.75 25.80 40% 
QD-71 (10 mol %) 0.1 86% 19.97 26.00 61% 
QD-71 (1 mol %) 0.1 78% 19.82 26.17 58% 
QD-71 (1 equiv) 0.1 78% 20.14 26.39 58% 
QD-148 (10 mol %) 0.1 81% 20.16 26.56 74% 
QD-170 (10 mol %) 0.1 76% 19.83 26.17 67% 
QD-171 (10 mol %) 0.1 50% 19.80 26.22 58% 
QD-172 (10 mol %) 0.1 78% 19.96 26.33 70% 
QD-173 (10 mol %) 0.1 75% 19.07 24.73 50% 
QD-174 (1 mol %) 0.1 71% 19.12 24.81 43% 
Table 7.2: Screen of organocatalysts for the synthesis of (-)-169r. 
7.3.7.2 Synthesis and characterisation of (+)-tert-butyl (2R)-2-(3-tert-butyl-
4,5-dihydroxyphenyl)-1-oxoindane-2-carboxylate, (+)-169s 
O
OH
OH
O
O
(+)-169s  
According to general procedure C, replacing ps-BEMP with catalyst QD-174, 3-
tert-butylcatechol 160 (16 mg, 0.10 mmol) was reacted with tert-butyl 1-oxindane-
2-carboxylate 80 (23 mg, 0.10 mmol) to give, after 2 h reaction time, (+)-169s (29 
mg, 74%) as a yellow solid after column chromatography on silica gel, eluting with 
petroleum ether containing 50-70% diethyl ether, in 82% ee, determined by HPLC 
analysis [Chiralpak AD, hexane/iso-propanol 95:5, 1.0 mL.min-1, λ = 230 nm, t 
(minor) = 37.62 min, t (major) = 40.96 min] by comparison to a racemic sample 
prepared in 50 % yield on a 0.2 mmol scale according to the general procedure C; 
[α]D24 = + 5.3 (c 3.0, CHCl3); 
1
H NMR (500 MHz, CDCl3) δH 7.78 (1H, d, J = 7.5 
Hz, ArH), 7.63 (1H, t, J = 7.5 Hz, ArH), 7.48 (1H, d, J = 7.5 Hz, ArH), 7.39 (1H, t, 
J = 7.5 Hz, ArH), 6.91 (1H, d, J = 2.0 Hz ArH), 6.83 (1H, d, J = 2.0 Hz, ArH), 
4.09 (1H, d, J = 17.0 Hz, CH2), 3.54 (1H, d, J = 17.0 Hz, CH2), 1.37 (18H, s, 
C(CH3)3); 13C NMR (100 MHz, CDCl3) δC 202.7 (CO), 170.0 (C(O)O), 152.7 (4º 
ArC), 143.2 (4º ArC), 143.0 (4º ArC), 135.7 (4º ArC), 135.6 (ArCH), 135.1 (4º 
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ArC), 128.6 (4º ArC) , 127.8 (ArCH), 126.1 (ArCH), 125.0 (ArCH), 117.6 
(ArCH), 112.1 (ArCH), 82.7 (C(O)OC(CH3)3), 66.1 (4º C), 40.8 (CH2), 34.8 
(C(CH3)3), 29.4 ((CH3)3), 27.7 ((CH3)3); MP: 124 – 126 ºC (142 – 144 ºC for 
racemate); IR υmax/cm-1 3388, 2953, 1708, 1693, 1601, 1426, 1368, 1250, 1150; 
MS (ES+) m/z (relative intensity %) 419 (M + Na+, 100%); HRMS (ES+): calcd. 
for C24H32O5N (M + NH4+) 414.2275, found 414.2276. 
7.3.7.3 Synthesis and characterisation of (+)-tert-butyl (1R)-1-(3,4-dihydroxy-
5-methoxyphenyl)-2-oxocyclopentanecarboxylate, (+)-169t 
OH
OH
MeO
O
O
O
(+)-169t  
According to general procedure C, replacing ps-BEMP with catalyst QD-148, 3-
methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with pro-nucleophile 77t (18 
mg, 0.10 mmol) to give, after 2 h reaction time, compound (+)-169t (21 mg, 62%) 
as a pale pink oil after column chromatography on silica gel, eluting with petroleum 
ether containing 50-70% diethyl ether, in 65% ee, determined by HPLC analysis 
[Chiralpak AD, hexane/iso-propanol 4:1, 1.0 mL.min-1, λ = 230 nm, t (minor) = 
18.67 min, t (major) = 21.97 min] by comparison to a racemic sample prepared, in 
69% yield on a 0.1 mmol scale, according to general procedure C; [α]D24 = + 20.0 (c 
0.9, CHCl3); 1H NMR (500 MHz, CDCl3) δH 6.62 (2H, s, ArH), 5.35 (1H, s, OH), 
5.25 (1H, s, OH), 3.87 (3H, s, OCH3), 2.76 (1H, td, J = 12.0, 6.5 Hz, CH2), 2.50 – 
2.41 (2H, m, CH2), 2.31 (1H, td,  J = 19.0, 8.5 Hz, CH2), 1.98 – 1.93 (2H, m, 2H of 
CH2), 1.42 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC 212.1 (CO), 169.8 
(C(O)O), 146.6 (4º ArC), 143.5 (4º ArC), 131.9 (4º ArC), 128.0 (4º ArC), 107.9 
(ArCH), 103.1 (ArCH), 82.2 (OC(CH3)3), 65.1 (4º C), 56.2 (OCH3), 37.6 (CH2), 
34.7 (CH2), 27.8 (C(CH3)3), 19.3 (CH2); IR υmax/cm-1 3436, 2979, 2938, 1747, 
1725, 1613, 1520, 1455, 1369, 1255, 1152; MS (ES+) m/z (relative intensity %) 
345 (M + Na+, 100%); HRMS (ES+): calcd. for C17H22O6Na (M + Na+) 345.1309, 
found 345.1303. 
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Similarly replacing ps-BEMP with catalyst QD-148, QD-174 or QD-71 in the 
following solvents gave (+)-169t in the following enantiomeric excesses: 
Catalyst Temp/ºC Solvent Scale/mmol Yield t(minor)/min t(major)/min %ee 
QD-148 -45 CH2Cl2 0.1 66 18.53 21.83 40 
QD-148 -20 toluene 0.1 31 18.79 22.13 58 
QD-174 -20 CH2Cl2 0.1 72 21.37 25.35** 61 
QD-71 -20 CH2Cl2 0.1 84 18.65 21.96 26 
 
7.3.7.4 Synthesis and characterization of 1,1,1,3,3,3-hexafluoropropan-2-yl )-
1-(3-tert-butyl-4,5-dihydroxyphenyl)-2-oxocyclopentanecarboxylate, 169u 
OH
OH
O
O
O
CF3
CF3
169u  
According to general procedure C, replacing ps-BEMP with QD-174, 3-tert-
butylcatechol 160 (17 mg, 0.10 mmol) was reacted with 1,1,1,3,3,3-
hexafluoropropan-2-yl 2-oxocyclopentanecarboxylate 77u (28 mg, 0.10 mmol) to 
give, after 3 h reaction time, compound 169u (35 mg, 79%) as an off-white solid 
after column chromatography on silica gel, eluting with petroleum ether containing 
50% diethyl ether; in 0% ee, determined by HPLC analysis [Chiralpak AD, 
hexane/iso-propanol 4:1, 1.0 mL.min-1, λ = 230 nm, t = 12.51 min, t = 14.66 min] 
by comparison to a racemic sample prepared, in 80% yield on a 0.1 mmol scale, 
according to general procedure C; 1H NMR (500 MHz, CDCl3) δH 6.85 (1H, d, J = 
2.1 Hz, ArH), 6.82 (1H, d, J = 2.1 Hz, ArH), 5.81 (1H, s, OH), 5.79 (1H, s, OH), 
5.71 (1H, h, J = 6.0 Hz CH(CF3)2), 2.81 – 2.75 (1H, m, CH2), 2.72 – 2.67 (1H, m, 
CH2), 2.53 – 2.40 (2H, m, CH2), 2.08 – 1.92 (2H, m, CH2), 1.38 (9H, s, C(CH3)3; 
13C NMR (75 MHz, CD3OD) δC 211.9 (C(O)), 169.7 (C(O)O), 146.2 (4º ArC), 
145.6 (4º ArC), 137.4 (4º ArC), 124.8 (4º ArC), 123.9 (m, CF3), 120.2 (m, CF3), 
118.1 (ArCH), 112.7 (ArCH), 68.1 (h, 2JC,F = 34.5 Hz, CH(CF3)2), 65.3 (4º C), 38.1 
(CH2), 35.8 (CH2), 35.5 (C(CH3)3), 29.9 (C(CH3)3), 20.1 (CH2); IR υmax/cm-1 3488, 
                                                 
** Measured on different instrument resulting in shift in retention times, matches racemic sample run 
on same intrument 
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2961, 2535, 1773, 1737; MP 117-118 ºC; MS (ES+) m/z (relative intensity %) 460 
(M + NH4+, 100%), 465 (M + Na+, 85%), HRMS (EI+): calcd. for C19H20O5F6 (M+) 
442.1209, found 442.1214. 
7.3.7.5 Synthesis and characterisation of (+)-1,1,1,3,3,3-hexafluoropropan-2-
yl (1R)-1-(3,4-dihydroxy-5-methoxyphenyl)-2-oxocyclopentanecarboxylate, 
(+)-169v 
OH
OH
MeO
O
O
O
CF3
CF3
(+)-169v  
According to the general procedure C, replacing ps-BEMP with cat QD-174, 3-
methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with 1,1,1,3,3,3-
hexafluoropropan-2-yl 2-oxocyclopentanecarboxylate 77u (28 mg, 0.10 mmol) to 
give, after 2 h reaction time, compound (+)-169v (26 mg, 62%) as an off-white 
solid after column chromatography on silica gel, eluting with petroleum ether 
containing 50% diethyl ether in 16% ee, determined by HPLC analysis [Chiralpak 
AD, hexane/iso-propanol 4:1, 1.0 mL.min-1, λ = 230 nm, t (minor) = 27.07 min, t 
(major) = 31.70 min] by comparison to a racemic sample prepared, in 54% yield on 
a 0.1 mmol scale, according to general procedure C; [α]D24 = + 12.0 (c 0.5, CHCl3); 
1H NMR (500 MHz, CDCl
3
) δ
H 
6.63 (1H, d, J = 1.5 Hz, ArH), 6.57 (1H, d, J = 1.5 
Hz, ArH), 5.72 (1H, h, J = 6.0 Hz, CH(CF
3
)
2
), 3.86 (3H, s, OCH
3
), 2.79 – 2.73 
(1H, m, CH
2
), 2.70 – 2.65 (1H, m, CH
2
), 2.52 – 2.38 (2H, m, CH
2
), 2.08 – 1.92 
(2H, m, CH
2
); 13C NMR (75 MHz, CDCl
3
) δ
C 
209.5 (CO), 168.1 (C(O)O), 147.0 
(4º ArC), 143.9 (4º ArC), 132.5 (4º ArC), 125.1 (4º ArC), 121.3 (m, CF3), 119.1 
(m, CF3), 107.8 (ArCH), 103.1 (ArCH), 67.1 (h, 2JC,F = 35 Hz, CH(CF3)2), 63.6 (4º 
C), 56.2 (OCH3), 37.2 (CH2), 34.1 (CH2), 19.2 (CH2); MP 104 – 105 ºC (108 – 110 
ºC for racemate); IR υ
max
/cm
-1 
3460, 2973, 2854, 2370, 1775, 1747, 1618, 1521, 
1466, 1386, 1359, 1291, 1235, 1202, 1110; MS (EI-) m/z (relative intensity %) 415 
(M - H+, 100%); HRMS (EI+): calcd. for C16H14O6F6 (M+) 416.0689, found 
416.0709. 
 128
7.3.7.6 Synthesis and characterisation of (-)-methyl (1R)-1-(3,4-dihydroxy-5-
methoxyphenyl)-2-oxocyclopentanecarboxylate, (-)-169w 
OH
OH
O
O
O
MeO
(-)-169w  
According to general procedure C, replacing ps-BEMP with cat. QD-174,  3-
methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with methyl 2-
oxocyclopentanecarboxylate 109 (14 mg, 0.10 mmol) to give, after 30 min reaction 
time, compound (-)-169w (24 mg, 85%) as a yellow oil after column 
chromatography on silica gel, eluting with petroleum ether containing 30 – 50% 
diethyl ether in 8% ee, determined by HPLC analysis [Chiralpak AD, hexane/iso-
propanol 4:1, 1.0 mL.min-1, λ = 230 nm, t (minor) = 36.90 min, t (major) = 43.63 
min] by comparison to a racemic sample prepared according to general procedure 
C; [α]D24 = -38.0 (c 1.0, CHCl3); other data matches racemic example (section 
7.3.6.8). 
7.3.8 Preparation of catalysts 
Catalyst 70 was prepared according to published procedures.75,76  Catalysts QD-71, 
QD-148, QD-170 were prepared according to the method of Deng and co-
workers.80-82,86  Catalyst QD-171 was prepared according to the method of Hiemstra 
and co-workers.87  The synthesis and characterization of the novel cinchona 
alkaloid derived organocatalysts QD-172 – QD-174 is described below. 
7.3.8.1 Synthesis and characterisation of (9S)-9-phenoxycinchonan-6'-ol, 
catalyst 172 
N
O
N
OH
N
HO
N
OMe
N
O
N
OMe
PhI, NaH, 
CuI, pyridine
DMSO
 QD-172
172b
NaSEt
135
 
To a solution of quinidine 135 (500 mg, 1.54 mmol) in anhydrous 
dimethylsulfoxide (10 mL) at room temperature was added sodium hydride (60% 
dispersion in mineral oil, (77 mg, 1.92 mmol)) in small portions to give an orange 
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solution.  Pyridine (0.30 mL, 3.70 mmol) and copper(I) iodide (37 mg, 1.54 mmol) 
were added (reaction mixture turned dark green) and reaction mixture was stirred at 
room temperature for 30 min. Iodobenzene (0.14 mL, 1.28 mmol) was added and 
the reaction mixture was heated to 113 ºC for 70 h then cooled to room temperature.  
Water (4 mL), CH2Cl2 (4 mL) and diethyl ether (4 mL) were added followed by 
ethylenediaminetetraacetate disodium salt decahydrate (78 mg) and concentrated 
ammonia solution (0.8 mL, 20% w/w).  The reaction mixture was stirred vigorously 
for 1 h then the aqueous layer was separated and re-extracted with CH2Cl2 (2 x 10 
mL).  The combined organic portions were extracted 3 times with aqueous 
ammonia solution (10 mL), then with HCl (1 M, 2 x 5 mL) and with water (3 x 5 
mL).  The organic layer was washed with NH4OH and dried over Na2SO4 and 
evaporated. The residue was dissolved in diethyl ether (20 mL) and treated with 
HCl (1 M in diethyl ether) until no further precipitate was generated.  The 
precipitates were collected and dissolved in CH2Cl2 (10 mL), basified with saturated 
aqueous NH4OH, washed with brine (5 mL) and dried over sodium sulfate.  The 
solvent was removed in vacuo to give intermediate 172b as a yellow solid which 
was used crude without purification or characterisation. 
The crude residue was dissolved in DMF (10 mL) and NaSEt (430 mg, 5.12 mmol) 
was added.  The reaction mixture was heated to 110 ºC for 12 h then cooled to room 
temperature and poured into a mixture of saturated aqueous NH4Cl solution (8 mL) 
and water (10 mL).  The resulting mixture was extracted with ethyl acetate (2 x 40 
mL).  The combined organic portions were washed with brine (2 x 10 mL), dried 
over sodium sulfate and evaporated.  The residue was purified by column 
chromatography on silica gel eluting with ethyl acetate containing 10% methanol 
and 1% triethylamine to give catalyst QD-172 (68 mg, 14% over 2 steps) as a pale 
yellow solid; [α]D24 = - 10.09 (c 0.77, CHCl3); 1H NMR (500 MHz, CD3OD) δH 
8.58 (1H, d, J = 4.5 Hz, ArH), 8.16 (1H, d, J = 2.0 Hz, ArH), 7.82 (1H, d, J = 9.0 
Hz, ArH), 7.30 (1H, d, J = 4.5 Hz, ArH), 7.22 (1H, dd, J = 9.0, 2.0 Hz, ArH), 6.74 
– 6.68 (3H, m, ArH), 6.43 (2H, d, J = 6.5 Hz, ArH), 6.29 (1H, ddd, J = 17.5, 10.0, 
7.5 Hz, CH=CH2), 6.15 (1H, s, OCH), 5.25 – 5.20 (2H, m, CH=CH2), 3.58 (1H, dd, 
J = 13.5, 7.5 Hz, aliphatic CH), 3.24 (1H, t, J = 9.5 Hz, aliphatic CH), 3.19 – 3.08 
(2H, m, aliphatic CH), 2.94 – 2.89 (1H, m, aliphatic CH), 2.60 – 2.56 (1H, m, 
aliphatic CH), 2.46 – 2.41 (1H, m, aliphatic CH), 1.93 (1H, s, aliphatic CH), 1.72 – 
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1.67 (1H, m, aliphatic CH), 1.56 (1H, dd, J = 20.5, 10.5 Hz, aliphatic CH), 1.30 – 
1.28 (1H, m, aliphatic CH); 13C NMR (75 MHz, CDCl3) δC 156.9 (4º ArC), 156.2 
(4º ArC), 146.6 (ArCH), 143.6 (4º ArC), 142.0 (4º ArC), 139.6 (CH=CH2), 131.8 
(ArCH), 129.3 (ArCH), 126.5 (4º ArC), 123.4 (ArCH), 121.2 (ArCH), 117.9 
(ArCH), 115.5 (CH=CH2), 114.9 (ArCH), 106.0 (ArCH), 58.5 (NCH), 49.6 
(NCH2), 49.1 (NCH2), 39.4 (CH), 31.4 (CH), 28.0 (CH2), 25.6 (CH), 19.6 (CH2); 
IR υmax/cm-1 3070, 2934, 2868, 1617, 1595, 1492, 1231, 752; MP 110 - 112 ºC MS 
(ES+) m/z (relative intensity %) 387 (M + H+, 100%); HRMS (ES+): calcd. for 
C25H27O2N2  (M + H
+
) 387.2067, found 387.2077 
7.3.8.2 Synthesis and characterisation of (9S)-9-(mesityloxy)cinchonan-6'-ol, 
catalyst 173 
N
O
N
OH
N
HO
N
OMe
N
O
N
OMe
ArI, NaH, 
CuI, pyridine
DMSO
 QD-173173b
BBr3
135
 
According to the above procedure for the preparation of catalyst 172, quinidine 135 
(0.14 mmol) was reacted with 2-iodo-1,3,5-trimethylbenzene (0.34 mmol) to give a 
crude residue containing intermediate 173b. 
The crude residue was dissolved in dry CH2Cl2 (7 mL), cooled to -78 ºC and a 
solution of BBr3 in CH2Cl2 (1.36 mL of a 1 M solution in CH2Cl2, 1.36 mmol) 
added dropwise.  The reaction mixture was allowed to warm slowly to room 
temperature and subsequently refluxed for 1 h. The reaction mixture was then 
cooled to 0 ºC and a solution of 40% NH4OH added slowly.  After 30 min of 
vigorous stirring water (10 mL) and CH2Cl2 (10 mL) were added.  The organic 
phase was separated and the aqueous extracted with CH2Cl2.  The combined 
organics were dried over sodium sulfate, filtered and concentrated.  The residue was 
purified by column chromatography on silica gel eluting with ethyl acetate 
containing 10% methanol and 1% triethylamine to give catalyst QD-173 as an 
orange viscous oil (45 mg, 31% over two steps); [α]D24 = - 7.31 (c 0.29, CHCl3); 1H 
NMR (500 MHz, CD3OD) δH 8.59 (1H, d, J = 4.5 Hz, ArH), 7.92 (1H, d, J = 9.0 
Hz, ArH), 7.87 (1H, s, ArH), 7.38 (1H, d, J = 4.5 Hz, ArH), 7.26 (1H, d, J = 9.0 
Hz, ArH), 6.64 (1H, br. s, OCH), 6.58 (2H, s, ArH), 6.02 (1H, ddd, J = 17.5, 8.0, 
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9.5 Hz, CH=CH2), 5.09 – 5.02 (2H, m, CH=CH2), 3.47 – 3.31 (1H, aliphatic CH), 
3.20-3.07 (1H, s, aliphatic CH),  3.05 (1H, t, J = 11.5 Hz, aliphatic CH), 2.94 – 
2.90 (1H, m, aliphatic CH), 2.84 – 2.80 (1H, m, aliphatic CH), 2.65 (1H, q, J = 7.0 
Hz, aliphatic CH), 2.53 – 2.39 (1H, m, aliphatic CH), 2.32 (6H, s, ArCH3), 2.06 
(3H, s, ArCH3), 1.90 (1H, s, aliphatic CH), 1.63 – 1.46 (3H, m, aliphatic CH); δC 
156.7 (4º ArC), 151.2 (4º ArC), 146.4 (ArCH), 144.0 (4º ArC), 143.1 (4º ArC), 
139.8 (CH=CH2), 132.2 (4º ArC), 131.7 (ArCH), 130.7 (ArCH), 128.8 (4º ArC), 
127.9 (4º ArC), 122.9 (ArCH), 119.7 (ArCH), 115.7 (CH=CH2), 105.8 (ArCH), 
60.5 (NCH), 50.0 (NCH2), 49.6 (NCH2), 39.7 (CH), 28.3 (CH), 27.3 (CH), 26.0 
(CH2), 21.3 (CH2), 20.5 (CH3), 19.2 (CH3); IR υmax/cm-1 3070, 2925, 2869, 1617, 
1509, 1479, 1403, 1209, 1151, 755; MS (ES+) m/z (relative intensity %) 429 (M + 
H+, 100%); HRMS (ES+): calcd. for C28H33O2N2 429.2537 (M + H+), found 
429.2531. 
7.3.8.3 Synthesis and characterisation of (9S)-6'-hydroxycinchonan-9-yl 
adamantane-1-carboxylate, catalyst 174 
N
O
N
OH
O
N
O
N
OMe
O
N
HO
N
OMe
Cl
O
NEt3, CH2Cl2 BBr3
135 174b QD-174  
To a stirred solution of quinidine 135 (648 mg, 2.00 mmol) in CH2Cl2 (12 mL) was 
added triethylamine (0.55 mL, 4.00 mmol), 1-adamantylcarbonyl chloride (437 mg, 
2.20 mmol) and 4-(dimethylamino)pyridine (24 mg, 0.20 mmol).  The reaction 
mixture was stirred at room temperature overnight then the solvent removed by 
rotary evaporation. 
The crude residue containing 174b was dissolved in anhydrous CH2Cl2 (20 mL) and 
cooled to -78 ºC under nitrogen.  BBr3 (6.6 mL of a 1 M solution in CH2Cl2, 6.60 
mmol) was added dropwise.  The reaction mixture was allowed to warm slowly to 
room temperature and stirred overnight.  The reaction mixture was cooled to 0 ºC 
and NH4OH (16 mL of a 40% aq. solution) was added slowly. The biphasic mixture 
was stirred vigorously for 30 min then diluted with water (10 mL) and CH2Cl2 (10 
mL).  The organic phase was separated and the aqueous extracted with CH2Cl2 (3 x 
10 mL).  The combined organic portions were dried over MgSO4, filtered and 
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concentrated.  The residue was purified by column chromatography on silica gel 
eluting with EtOAc containing 2 – 10% MeOH and 1% triethylamine to give 
catalyst QD-174 (426 mg, 47% over 2 steps) as an off-white solid following 
purification by column chromatography eluting with ethyl acetate containing 10% 
methanol and 1% triethylamine: [α]D24 = +27.03 (c 1.45, CHCl3); 1H NMR (500 
MHz, CD3OD) δH 8.60 (1H, d, J = 4.5 Hz, ArH), 7.93 (1H, d, J = 9.0 Hz, ArH) 
7.41 – 7.40 (2H, m, ArH), 7.37 (1H, d, J = 9.0 Hz, ArH), 6.46 (1H, d, J = 4.0 Hz, 
OCH), 6.12 (1H, ddd, J = 17.5, 10.5, 7.5 Hz, CH=CH2), 5.17 – 5.14 (2H, m, 
CH2=CH), 3.33 (1H, br. s, NCH), 3.14 – 3.09 (1H, m, NCH), 3.02 – 2.97 (1H, m, 
NCH), 2.89 – 2.86 (1H, m, NCH), 2.81 – 2.74 (1H, m, NCH), 2.39 (1H, dd, J = 
16.5, 8.0 Hz, aliphatic CH), 2.03 (4H, br. s, aliphatic CH), 1.97 (6H, br. s, aliphatic 
CH), 1.84 (1H, br. s, aliphatic CH), 1.77 (6H, q, J = 12.0 Hz, aliphatic CH), 1.61 
(2H, t, J = 6.5 Hz, aliphatic CH), 1.49 (1H, s, aliphatic CH); 13C NMR (75 MHz, 
CDCl3) δC 176.0 (C(O)O), 156.0 (4º ArC), 146.3 (ArCH), 143.7 (4º ArC), 143.4 (4º 
ArC), 139.3 (CH=CH2), 131.3 (ArCH), 127.0 (4º ArC), 122.4 (ArCH), 118.0 
(ArCH), 115.4 (CH=CH2), 105.2 (ArCH), 73.1 (4º C), 58.7 (NCH), 49.5 (NCH2), 
49.0 (NCH2), 40.8 (OCH), 39.3 (CH), 38.8 (CH2), 36.4 (CH2), 27.8 (CH), 27.4 
(CH), 25.6 (CH2), 22.6 (CH2); IR υmax/cm-1 2907, 2850, 1730, 1618, 1468, 1454, 
1226, 1182; MP 182 – 185 ºC MS (ES+) m/z (relative intensity %); 473 (M + H+, 
100%), 495 (M + Na+, 70%), 427 (M + Na+ + MeOH, 70%); HRMS (ES+): calcd. 
for C30H37O3N2 (M + H+) 473.2789, found 473.2799. 
7.4 Chapter 4 Experimental 
7.4.1.1 Synthesis and characterisation of tert-butyl 3-[(2E)-but-2-enoyl]-2-
oxopyrrolidine-1-carboxylate, 205 
N
O OO
O
N
O
O
O
O
Cl
LHMDS (2.1 equiv)
     THF, -78 ºC
1 equiv
206 205  
To a stirred solution of HMDS (13.2 mL, 57.0 mmol), in THF (20 mL) at -78 ºC, 
was added n-BuLi (35.4 mL, 62.0 mmol) and the reaction mixture warmed to 0 ºC 
for 10 min, then cooled back to -78 ºC.  tert-Butyl 2-oxopyrrolidine-1-carboxylate 
206 (5.00 g, 27.0 mmol) was added dropwise as a solution in THF (30 mL) (cooled 
to -78 º C) followed immediately by freshly distilled crotonoyl chloride (2.6 mL, 
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27.0 mmol) also as a solution in THF (20 ml) (cooled to -78 ºC).  The resulting 
bright yellow solution was stirred at -78 ºC for 5 min then quenched with 1 M HCl 
(~70 ml, to pH 1) and allowed to warm to room temperature.  The now almost 
colourless biphasic mixture was extracted with ethyl acetate (3 x 40 mL).  The 
combined organic portions were dried, filtered and concentrated and the residue 
purified by column chromatography on silica gel, eluting with petroleum ether 
containing 30-50% ethyl acetate to give 205 (2.40 g, 41%) as a colourless solid.   
1H NMR (500 MHz, CDCl3, 1.1:1 ratio of enol:keto forms) δH 11.73 (1H, d, J = 1.5 
Hz, OH enol), 7.04 (1H, qd, J = 15.5, 7.0 Hz, CH=CHCH3 keto), 6.67 (1H, qd, J = 
15.5, 7.0 Hz, CH=CHCH3 enol), 6.44 (1H, qd, J = 15.5, 1.5 Hz, CH=CHCH3 keto), 
5.87 (1H, td, J = 15.5, 1.5 Hz, CH=CHCH3 enol), 3.87 (1H, dd, J = 9.0, 5.5 Hz, 
CH keto), 3.84 – 3.68 (4H, m, CH2 keto and  CH2 enol), 2.68 (2H, t, J = 7.5 Hz, 
CH2 enol), 2.51 (1H, tdd, J = 13.5, 8.0, 5.0 Hz, CH2 keto), 2.06 (1H, dtd, J = 13.0, 
9.0, 7.0 Hz, CH2 keto), 1.94 (3H, dd, J = 7.0, 1.5 Hz, CH=CHCH3 keto), 1.90 (3H, 
dd, J = 7.0, 1.5 Hz, CH=CHCH3 enol), 1.53 (s, 9H, C(CH3)3 keto), 1.50 (s, 9H, 
C(CH3)3 enol); 13C NMR (125 MHz, CDCl3) δC 192.8 (CO), 173.1 (C=C-O enol), 
169.5 (C(O)N), 161.7 (C(O)N), 150.4 (OC(O)N), 150.0 (OC(O)N), 146.3 (C=C), 
136.8 (C=C), 130.2 (C=C), 123.1 (C=C), 99.9 (C=C-O), 83.2 (C(CH3)3), 82.8 
(C(CH3)3), 54.5 (CH), 45.1 (CH2), 44.1 (CH2), 28.0 (C(CH3)3), 27.9 (C(CH3)3), 
19.6 (CH2), 19.2 (CH2), 18.6 (CH3), 18.6 (CH3); IR υmax/cm-1 2979, 2934, 1781, 
1716, 1369, 1309, 1257, 1153;  MP 121 – 124 ºC; MS (ES-) m/z (relative intensity 
%) 252 (M - H+, 100%); HRMS (ES+): calcd. for C13H20O4N1 (M + H+) 254.1387, 
found 254.1387. 
7.4.1.2 Synthesis and characterisation of tert-butyl 3-[(2E)-but-2-enoyl]-3-
(3,4-dihydroxy-5-methoxyphenyl)-2-oxopyrrolidine-1-carboxylate, 204 
N
O OO
O
N
OH
OHMeO
O
O
O O
OH
OH
MeO ps-BEMP (10 mol %)
ps-IO4- (2 equiv)
CH2Cl2, -20ºC+
1)
2) Na2S2O4
205
204
163
 
To a stirred solution of 3-methoxycatechol 163 (280 mg, 2.00 mmol) and 205 (506 
mg, 2.00 mmol) in CH2Cl2 (20 mL) at -20 ºC in a flask wrapped in aluminium foil 
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was added ps-BEMP (91 mg, 0.20 mmol) followed by ps-IO4 (800 mg, 4.00 mmol).  
The reaction mixture was stirred at this temperature for 2 h then filtered and the 
resin on the filter washed with CH2Cl2 (30 mL).  The deep red filtrate was stirred 
with saturated aqueous Na2S2O4 (20 mL) for 5 min then the now pale yellow 
organic phase separated and the aqueous extracted with CH2Cl2 (2 x 10 mL).  The 
combined organic portions were dried over Na2SO4, filtered and concentrated.  The 
residue was purified by column chromatography on silica gel eluting with 
petroleum ether containing 70 to 90% ethyl acetate to give the arylated product 204 
(413 mg, 53%) as a colourless solid. 1H NMR (500 MHz, CDCl3) δH 6.97 (1H, qd, 
J = 15.5, 7.0 Hz, CH=CHCH3), 6.61 (1H, d, J = 2.0 Hz, ArH), 6.53 (1H, d, J = 2.0 
Hz, ArH), 6.46 (1H, qd, J = 15.5, 1.5 Hz, CH=CHCH3), 5.39 (1H, s, OH), 5.30 
(1H, s, OH), 3.87 (3H, s, OCH3), 3.64 (2H, dd, J = 8.0, 5.5 Hz, CH2), 3.03 (1H, td, 
J = 13.0, 5.5 Hz, CH2), 2.07 (1H, td, J = 13.0, 8.0 Hz, CH2), 1.79 (3H, dd, J = 7.0, 
1.5 Hz, CH=CHCH3), 1.53 (s, 9H, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC 
191.7 (CO), 171.6 (C(O)N), 150.0 (NC(O)O)), 147.3 (C=C), 144.9 (4º ArC), 144.2 
(4º ArC), 132.2 (4º ArC), 129.3 (4º ArC), 127.0 (C=C)), 108.0 (ArCH), 102.3 
(ArCH), 83.3 (C(CH3)3), 66.5 (4º C), 56.3 (OCH3), 43.4 (CH2), 29.3 (CH2), 28.0 
(C(CH3)3), 18.4 (CH3); IR υmax/cm-1 3411, 1710, 1686, 1624, 1519, 1370, 1316;  
MP 162 – 164 ºC.; MS (ES-) m/z (relative intensity %) 390 (M - H+, 100%); 
HRMS (ES-): calcd. for C20H24O7N1 (M - H+) 390.1562, found 390.1558. 
7.4.1.3 Synthesis and characterisation of tert-butyl 3-[(2E)-but-2-enoyl]-3-(7-
methoxy-1,3-benzodioxol-5-yl)-2-oxopyrrolidine-1-carboxylate, 203 
N
OH
OHMeO
O
O
O O
N
MeO
O
O
O O
O
O
204 203
CH2ClBr
KF
 
To a solution of 204 (39 mg, 0.10 mmol) in DMF (1 mL) in a microwave vial was 
added KF (197 mg, 3.40 mmol), and CH2ClBr (130 μL, 2.00 mmol) and the 
mixture irradiated at 80 ºC for 1 h.  The resulting purple/brown solution was 
evaporated to dryness and the residue purified by column chromatography on silica 
gel eluting with petroleum ether containing 70% diethyl ether to give the methylene 
acetal protected product 203 as a pale yellow solid (20 mg, 50%) along with 
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recovered starting material 204 (10 mg, 25%).    1H NMR (500 MHz, CDCl3) δH 
6.98 (1H, qd, J = 15.5, 7.0 Hz, CH=CHCH3), 6.58 (1H, d, J = 1.5 Hz, ArH), 6.53 
(1H, d, J = 1.5 Hz, ArH), 6.46 (1H, dd, J = 15.5, 1.5 Hz, CH=CHCH3), 5.96 (2H, s, 
OCH2O), 3.87 (3H, s, OCH3), 3.64 – 3.61 (2H, m, CH2), 3.03 (1H, ddd, J = 12.5, 
6.5, 4.5 Hz, CH2), 2.04 (1H, td, J = 12.5, 8.5 Hz, CH2), 1.80 (3H, dd, J = 7.0, 1.5 
Hz, CH=CHCH3), 1.52 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC 191.4 
(CO), 170.4 (C(O)N), 149.9 (OC(O)N), 149.3 (C=C), 145.2 (4º ArC), 143.8 (4º 
ArC), 134.9 (4º ArC), 132.1 (4º ArC), 126.9 (C=C), 107.0 (ArCH), 101.6 (ArCH), 
101.6 (OCH2O), 83.3 (C(CH3)3), 66.7 (4º C), 56.8 (OCH3), 43.3 (CH2), 29.4 (CH2), 
28.0 (C(CH3)3), 18.4 (CH3); IR υmax/cm-1 3417, 2981, 1775, 1711, 1687, 1622, 
1519, 1371, 1318, 1262, 1154, 1097;  MP 165 – 168 ºC.; MS (ES+) m/z (relative 
intensity %) 426 (M + Na+, 100%), 458 (M + Na+ + MeOH, 15%), 829 (dimer + 
Na+, 40%); HRMS (ES+): calcd. for C21H25O7NNa (M + Na+) 426.1527, found 
426.1523. 
 
A screen of alternative alkylating agents/bases was conducted following the above 
procedure under the conditions indicated in Table 7.3 (except for entries 1, 2 and 4 
where conventional heating in a round bottom flask equipped with reflux condenser 
was employed).  Conversions were measured with respect to remaining starting 
material, however this was found to be unreliable since conversion did not reflect 
isolated yield (entry 8), presumable due to decomposition of starting 
material/product under the reaction conditions.   
Entry CH2X2 Base Solvent 
T / 
ºC Time Heating 
% 
Conv. 
% 
Yield 
1 CH2Br2 1.5 equiv 
Cs2CO3 
1.5 equiv DMF 90 O/N thermal 0 - 
2 CH2ClBr 10 equiv 
K2CO3 
10 equiv DMF 110 O/N thermal 0 - 
3 CH2Br2 1.2 equiv 
K2CO3 
10 equiv DMF 90 1h MW 0 - 
4 CH2ClBr 10 equiv 
KF 
17 equiv DMF 110 O/N thermal - 33 
5 CH2ClBr 5 equiv 
KF 
10 equiv DMF 120 15 min MW 48 - 
6 CH2ClBr 
KF 
10 eq CH2ClBr 70 15 min MW 0 - 
7 CH2ClBr 5 equiv 
KF 
10 equiv DMF 120 5min MW 30 - 
8 CH2ClBr 5 equiv 
KF 
17 equiv DMF 120 5x5min MW 80 10 
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9 CH2ClBr 20 equiv 
KF 
34 equiv DMF 80 1h MW - 50* 
Table 7.3:  Optimisation of methylene acetal protection. * 75% based on recovered starting material. 
Alternatively tert-butyl 3-[(2E)-but-2-enoyl]-3-(7-methoxy-1,3-benzodioxol-5-yl)-
2-oxopyrrolidine-1-carboxylate 203 was prepared by an oxidative coupling – 
methylene acetal protection sequence following the above procedures for the 
syntheses of compounds 204 and 203 without purification of the catechol to give 
203 in 44% yield on a 1 mmol scale. 
N
O OO
O
OH
OH
MeO
N
MeO
O
O
O O
O
O
ps-BEMP
ps-IO4-
CH2Cl2
+
1)
2) Na2S2O4
3) CH2ClBr, KF, DMF
     μw 85 ºC, 1h
205
163
203
44% over 3 steps  
To a stirred solution of 3-methoxycatechol 163 (140 mg, 1.00 mmol) and pro-
nucleophile 205 (278 mg, 1.10 mmol) in CH2Cl2 (10 mL) at -20 ºC in a flask 
wrapped in aluminium foil was added ps-BEMP (46 mg, 0.10 mmol) followed by 
ps-IO4- (505 mg, 2.00 mmol).  The reaction mixture was stirred at this temperature 
for 2 h then filtered and the resin on the filter washed with CH2Cl2 (30 mL).  The 
deep red filtrate was stirred with saturated aqueous Na2S2O4 for 5 min then the (now 
pale yellow) organic phase separated and the aqueous extracted with CH2Cl2 (2 x 10 
mL).  The combined organic portions were dried over Na2SO4, filtered and 
concentrated.  The residue was dissolved in DMF (1 mL) in a microwave vial and 
KF (197 mg, 3.4 mmol) and CH2ClBr (130 μL, 2 mmol) were added.  The reaction 
mixture was irradiated at 80 ºC for 1 h.  The resulting purple/brown solution was 
evaporated to dryness and the residue purified by column chromatography on silica 
gel eluting with petroleum ether containing 70% diethyl ether to give the methylene 
acetal protected product 203 as a pale yellow solid (176 mg, 44%).  All data 
identical to product obtained from the 2 step procedure. 
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7.4.2 Attempted reduction of 203 
N
MeO
HO
O
O
O
O
O
N
MeO
O
O
O
O
O
O
LHMDS
THF, -78 ºC
DIBALH
203 202
 
To a stirred solution of 203 (135 mg, 0.33 mmol) in THF (4 mL) at -78 ºC was 
added, dropwise, LHMDS (0.50 mL of a 1 M solution in cyclohexane, 0.50 mmol).  
The reaction mixture was stirred at this temperature for 10 min before added 
DIBALH (0.66 mL of a 1 M solution, 0.66 mmol).  The reaction mixture was 
allowed to warm slowly to -20 ºC and stirred at this temperature for a further 14 h.  
The reaction mixture was quenched with sat. aq. NH4Cl (2 mL) then sat. aq 
potassium sodium tartrate (3 mL).  The reaction mixture was warmed to room 
temperature and extracted with ethyl acetate (3 x 5 mL) and the organic extracts 
dried over Na2SO4, filtered and concentrated.  Crude 1H NMR showed a mixture of 
several compounds, MS (ES+) m/z (relative intensity %) 428 (M + Na+, 100%); 
HRMS (ES+): calcd. for C21H27O7NNa (M + Na+) 428.1680, found 428.1677.  No 
further attempts were made to characterise the crude reactions products as an 
alternative synthetic strategy was sought. 
7.4.3 Alternative Approach to Buphanidrine and Powelline 
7.4.3.1 Synthesis and characterisation of 1-tert-butyl 3-methyl 2-
oxopyrrolidine-1,3-dicarboxylate, 207 
N
O
O
O
N
O
O
O O
OMe
O
Cl OMe
LHMDS
206 207
THF
 
To a stirred solution of LHMDS (57 mL of a 1 M solution in cyclohexane, 57.0 
mmol) in THF (20 mL) at -78 ºC was added 206 (5.00 g, 27.0 mmol) dropwise as a 
solution in THF (20 mL) followed by methylchloroformate (2.09 mL, 27.0 mmol) 
also dropwise as a solution in THF (20 mL).  The resulting bright yellow reaction 
mixture was stirred at this temperature for 10 min then quenched with 1 M HCl (to 
pH 1, approx 70 mL) and allowed to warm to RT.  The biphasic mixture was 
extracted with ethyl acetate (3 x 20 mL) and the combined organic portions dried 
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over Na2SO4, filtered and concentrated.  The residue was purified by column 
chromatography on silica gel, eluting with cyclohexane containing 20 – 60% ethyl 
acetate to give pro-nucleophile 207 (6.30 g, 96% yield). 1H NMR (500 MHz, 
CDCl3) δH 3.90 – 3.84 (1H, m, NCH2), 3.77 (3H, s, OCH3), 3.72 – 3.66 (1H, m, 
NCH2), 3.54 (1H, dd, J = 9.0, 7.5 Hz, CH), 2.43 – 2.34 (1H, m, NCH2CH2), 2.26 – 
2.17 (1H, m, NCH2CH2), 1.51 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC  
169.1 (C(O)N), 168.6 (C(O)O), 149.9 (NC(O)O), 83.4 (C(CH3)3), 52.8 (OCH3), 
50.1 (CH), 44.8 (NCH2), 27.9 (C(CH3)3), 21.4 (CH2); IR υmax/cm-1 2981, 1789, 
1737, 1370, 1297, 1258, 1153;  MP 65 – 67 ºC; MS (ES+) m/z (relative intensity 
%) 266 (M + Na+, 100%), 509 (dimer + Na+, 70%);  HRMS (ES+): calcd. for 
C11H17O5NNa (M + Na+) 266.0999, found 266.0991. 
7.4.3.2 Synthesis and characterisation of 1-tert-butyl 3-methyl 3-(7-methoxy-
1,3-benzodioxol-5-yl)-2-oxopyrrolidine-1,3-dicarboxylate, 208 
N
MeO O
O
O
OMeO
O
O
OH
OHMeO
NBoc
O
OMe
O+
1) ps-IO4- (2 equiv)
    ps-BEMP (10 mol %)
    CH2Cl2, -20 ºC
2) Na2S2O4
3) CH2ClBr, Cs2CO3
     DMF, 85 ºC
207 208
163
 
To a stirred solution of 3-methoxycatechol 163 (1.40 g, 10.0 mmol) and 207 (2.43 
g, 10.0 mmol) in acetone (100 mL) at -20 ºC was added ps-BEMP (450 mg, 1.00 
mmol) followed by ps-IO4 (2.50 g 20.0 mmol).  The reaction mixture was stirred at 
this temperature for 7 h then filtered and the resin on the filter washed with CH2Cl2 
(3 x 100 mL).  The filtrate was stirred with saturated aqueous Na2S2O4 (200 mL), 
the organic phase separated and the aqueous extracted with CH2Cl2 (2 x 50 mL).  
The combined organic portions were dried over Na2SO4, filtered and concentrated.  
The residue was dissolved in DMF and divided equally between 5 sealable vials.  
To each vial was added CH2ClBr (0.19 mL, 3.00 mmol) and Cs2CO3 (977 mg, 3.00 
mmol).  The vials were sealed and heated at 85 ºC for 1 h then cooled to room 
temperature.  The resulting purple-brown solution was concentrated and purified by 
column chromatography on silica gel, eluting with petroleum ether containing 30 – 
60% diethyl ether to give the arylated product 208 (2.03 g, 52% yield) as a cream 
solid.  1H NMR (500 MHz, CDCl3) δH 6.70 (1H, d, J = 1.5 Hz, ArH), 6.63 (1H, d, 
J = 1.5 Hz, ArH), 5.94 (2H, s, OCH2O), 3.88 (3H, s, ArOCH3), 3.75 – 3.70 (1H, m, 
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CH2N), 3.74 (3H, s, OCH3), 3.65 (1H, ddd, J = 11.0, 7.0, 5.5 Hz, CH2N), 2.91 (1H, 
ddd, J = 13.0, 7.0, 5.5, CH2CH2N), 2.38 (1H, ddd, J = 13.0, 7.0, 5.5 Hz, 
CH2CH2N), 1.52 (9H, s, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC 170.0 
(NC(O)), 169.3 (OC(O)), 149.9 (NC(O)O), 149.0 (4º ArC), 143.3 (4º ArC), 135.0 
(4º ArC), 130.1 (4º ArC), 107.3 (ArCH), 101.6 (OCH2O), 101.6 (ArCH), 83.5 
(C(CH3)3), 61.3 (4º C), 56.7 (ArOCH3), 53.4 (OCH3), 43.2 (NCH2), 30.4 
(NCH2CH2), 27.9 (C(CH3)3); IR υmax/cm-1 2980, 1784, 1726, 1643, 1368, 1311, 
1255, 1152, 1100; MP 86 – 89 ºC MS (ES+) m/z (relative intensity %) 416 (M + 
Na+, 100%), 448 (M + Na+ + MeOH, 20%);  HRMS (ES+): calcd. for 
C19H23O8NNa (M + Na+) 416.1316, found 416.1309. 
 
Alternatively following the same procedure with the conditions detailed in Table 
7.4 gave arylated product 208 in the yields shown. 
Scale 
/mmol 
Equiv 
Pro-Nu Solvent 
Equiv 
base 
Concentration 
/M T/ºC 
% 
Yielda 
1 1 CH2Cl2 0.1 0.1 -20 38 
0.5 1 CH2Cl2 0.1 0.1 0 18 
0.5 1 CH2Cl2 0.1 0.1 -30 28 
0.5 2 CH2Cl2 0.2 0.1 -20 20 
0.5 1 CH2Cl2 0.1 0.05 -20 20 
8 1 MeCN 0.1 0.1 -20 37 
Table 7.4: Optimisation of oxidative coupling. a isolated yield of 208 after 
methylene acetal protection. 
 
7.4.3.3 Synthesis and characterisation of 1-tert-butyl 3-methyl 2-hydroxy-3-
(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-1,3-dicarboxylate, 209  
N
MeO O
O
O
OMeO
O
O
N
MeO O
O
O
OMeO
O
HO
Super-hydride®
THF, -78 ºC
208 209
 
To a stirred solution of 208 (4.30 g, 10.9 mmol) in anhydrous THF (100 mL) at -78 
ºC was added, dropwise, Super-hydride® (13.1 mL of a 1 M solution in THF, 13.1 
mmol).  The reaction mixture was stirred at this temperature for 2 h then quenched 
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with sat. aq. NaHCO3 (150 mL) and allowed to warm to room temperature.  The 
biphasic mixture was extracted with EtOAc (3 x 50 mL), and the combined organic 
extracts dried over Na2SO4, filtered and concentrated.  The residue was purified by 
column chromatography on silica gel, eluting with diethyl ether containing 30% 
petroleum ether to give aminol 209 (4.00 g, 93%) as a colourless solid.  1H NMR 
(500 MHz, d6-DMSO, 90 ºC, 1:1 ratio of diastereomers) δH 6.53 (1H, d, J = 1.5 Hz, 
ArH diastereomer A), 6.52 (1H, d, J = 1.5 Hz, ArH diastereomer A), 6.43 (1H, d, J 
= 1.5 Hz, ArH of diastereomer B), 6.42 (1H, d, J = 1.5 Hz, ArH of diastereomer 
B),  5.97 (2H, d, J = 1.5 Hz, OCH2O), 5.95 (2H, s, OCH2O), 5.85 (1H, br. s, 
CHOH of diastereomer A), 5.71 (1H, br. s, CHOH of diastereomer B), 3.86 (3H, s, 
ArOCH3 of diastereomer A), 3.83 (3H, s, ArOCH3 of diastereomer B), 3.59 (3H, s, 
OCH3), 3.59 (3H, s, OCH3), 3.42 (1H, t, J = 11.0 Hz, NCH2 diastereomer A), 3.34 
(1H, t, J = 11.0 Hz, NCH2 diastereomer B), 3.18 (1H, ddd, J = 17.5, 11.0, 7.0 Hz, 
NCH2 diastereomer A), 2.91 (1H, ddd, J = 17.5, 11.0, 7.0 Hz, NCH2 diastereomer 
B), 2.78 (1H, m, NCH2CH2 diastereomer B), 2.68 (1H, dd, J = 11.0, 7.0 Hz, 
NCH2CH2 diastereomer A), 2.42 (1H, m, NCH2CH2 diastereomer A), 2.16 (1H, dd, 
J = 11.0, 7.0 Hz, NCH2CH2 diastereomer B), 1.45 (9H, s, C(CH3)3), 1.43 (9H, br. s, 
C(CH3)3); 13C NMR (125 MHz, d6-DMSO, 90 ºC, 1:1 mixture of diastereomers) δC  
172.0 (OC(O)), 170.8 (OC(O)), 153.1 (NC(O)O from HMBC, 2 peaks visible in 
RT spectrum at 153.2, 153.0), 152.7 (NC(O)O), 148.5 (4º ArC), 147.9 (4º ArC), 
142.6 (4º ArC), 142.3 (4º ArC), 133.8 (4º ArC), 133.8 (4º ArC), 133.0 (4º ArC), 
131.7 (4º ArC), 108.6 (ArCH diastereomer A), 106.3 (ArCH diastereomer B), 
101.8 (ArCH diastereomer A), 100.8 (OCH2O), 100.6 (OCH2O), 99.6 (ArCH 
diastereomer B), 82.9 (CHOH diastereomer B), 82.5 (CHOH diastereomer A), 78.7 
(C(CH3)3), 78.4 (C(CH3)3), 61.9 (4º C diastereomer A, from HMBC), 61.2 (4º C 
diastereomer B, from HMBC), 56.4 (ArOCH3), 56.3 (ArOCH3), 51.7 (OCH3), 51.2 
(OCH3), 42.5 (NCH2 diastereomer A), 42.1 (NCH2 diastereomer B), 30.0 
(NCH2CH2 diastereomer B, from HSQC), 27.7 (C(CH3)3), 27.6 (C(CH3)3), 27.2 
(NCH2CH2 diastereomer A, from HSQC);  IR υmax/cm-1 3428, 2978, 2897, 1732, 
1681, 1652, 1643, 1513, 1428, 1397, 1368, 1260, 1173, 1146, 1099, 1056; MP 71 – 
74 ºC;  MS (ES+) m/z (relative intensity %) 418 (M + Na+, 100%), 450 (M + Na+ + 
MeOH, 20%);  HRMS (ES+): calcd. for C19H25O8NNa (M + Na+) 418.1472, found 
418.1484. 
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7.4.3.4 Synthesis and characterisation of methyl 4-[(tert-
butoxycarbonyl)(formyl)amino]-2-(7-methoxy-1,3-benzodioxol-5-yl)butanoate, 
214 and methyl 4-[(tert-butoxycarbonyl)amino]-2-(7-methoxy-1,3-
benzodioxol-5-yl)butanoate, 215 
N
MeO O
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OMeO
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MeO
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O
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MeO O
O
O
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O
O
N
MeO O
O
O
OMeO
O
O
H
N
MeO O
O
O
OMeO
O
KOt-Bu, THF
  not
isolated
+
71% 5%
209
60
210 214 215
 
To a stirred solution dimethyl 2-oxopropylphosphonate (15 mg, 0.09 mmol) in THF 
(2 mL) was added KOtBu  (22 mg, 0.22 mmol) and the reaction mixture stirred at 
room temperature for 10 min before adding 209 (35 mg, 0.09 mmol) and heating to 
reflux for 24 h.  The reaction mixture was cooled to room temperature, diluted with 
sat. aq. NH4Cl (10 mL) and extracted with ethyl acetate (3 x 5 mL).  The desired 
product 210 was not isolated from the reaction mixture, instead formamide 214 (27 
mg, 71%) as a colourless solid and de-formylated product 215 (2 mg, 5%) as a 
colourless oil were obtained.  Formamide product 214: 1H NMR (500 MHz, 
CDCl3) 9.13 (1H, s, C(O)H), 6.49 (1H, d, J = 1.5 Hz, ArH), 6.46 (1H, d, J = 1.5 
Hz, ArH), 5.94 (2H, s, OCH2O), 3.90 (3H, s, OCH3), 3.66 (3H, s, OCH3), 3.62 – 
3.48 (2H, m, CH2N), 3.45 (1H, t, J = 7.5 Hz, CH), 2.28 – 2.19 (1H, m, CH2CH2N), 
2.02 – 1.95 (1H, m, CH2CH2N), 1.53 (9H, s, C(CH3)3); 13C NMR (75 MHz, 
CDCl3) δC 173.5 (C(O)O), 163.0 (NC(O)H), 152.2 (OC(O)N), 149.0 (4º ArC), 
143.6 (4º ArC), 134.6 (4º ArC), 132.5 (4º ArC), 107.5 (ArCH), 101.8 (OCH2O), 
101.5 (ArCH), 84.2 (C(CH3)3), 56.6 (OCH3), 52.2 (OCH3), 49.0 (CH), 38.8 (CH2), 
31.5 (CH2), 28.0 (C(CH3)3); MP 88 – 90 ºC; IR υmax/cm-1 2953, 1737, 1688, 1635, 
1510, 1452, 1434, 1370, 1341, 1195, 1151, 1094;  MS (ES+) m/z (relative intensity 
%) 418 (M + Na+, 100%), 450 (M + Na+ + MeOH 20%); HRMS (ES+): calcd. for 
C19H29O8N2 (M + NH4+) 413.1915, found 413.1918.   
De-formylated product 215: 1H NMR (500 MHz, CDCl3) 6.49 (1H, d, J = 1.5 Hz, 
ArH), 6.44 (1H, d, J = 1.5 Hz, ArH), 5.94 (2H, s, OCH2O), 3.89 (3H, s, OCH3), 
3.66 (3H, s, OCH3), 3.49 (1H, t, J = 7.5 Hz, CH), 3.08 (2H, dd, J = 13.0, 7.0 Hz, 
CH2N), 2.21 (1H, qd, J = 14.5, 7.0 Hz, CH2CH2N), 1.91 (1H, dt, J = 14.5, 7.0 Hz, 
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CH2CH2N), 1.43 (9H, s, C(CH3)3); 13C NMR (75 MHz, CDCl3) δC  174.0 (C(O)O), 
155.8 (OC(O)N), 149.0 (4º ArC), 143.5 (4º ArC), 134.5 (4º ArC), 132.7 (4º ArC), 
107.5 (ArCH), 101.8 (OCH2O), 101.5 (ArCH), 79.3 (C(CH3)3), 56.6 (OCH3), 52.2 
(OCH3), 48.9 (CH), 38.7 (CH2), 33.6 (CH2), 28.4 (C(CH3)3),  IR υmax/cm-1 2976, 
1732, 1711, 1634, 1510, 1452, 1433, 1366, 1167;  MS (ES+) m/z (relative intensity 
%) 390 (M + Na+, 100%), 757 (dimer + Na+, 30); HRMS (ES+): calcd. for 
C18H25O7NNa (M + Na+) 390.1523, found 390.1535.  
 
 
7.4.3.5 Synthesis and characterisation of 1-tert-butyl 3-methyl 3-(7-methoxy-
1,3-benzodioxol-5-yl)-2-(2-oxopropyl)pyrrolidine-1,3-dicarboxylate, 210 
N
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Aminol 209 (4.00 g, 10.1 mmol) was dissolved in pyridine (20 mL) and cooled to 0 
ºC before adding acetic anhydride (4 mL).  The reaction mixture was allowed to 
warm to room temperature and stirred for 20 h then diluted with ethyl acetate (100 
mL) and washed with saturated copper sulfate (until no darkening of the copper 
sulfate solution was noticeable).  The organic phase was dried over Na2SO4, filtered 
and concentrated.  The residue containing intermediate 216 (MS (ES+): 539 (M + 
HNEt3+, 100%), 460 (M + Na+, 50%), 897 (2M + Na+) was used directly in the next 
step without purification or characterisation. 
 
To a solution of crude 1-tert-butyl 3-methyl-2-acetoxy-3-(7-methoxy-1,3-
benzodioxol-5-yl)pyrrolidine-1,3-dicarboxylate, 216 (4.40 g, 10.1 mmol) and 
(isopropenyloxy)trimethylsilane (16.7 mL, 100 mmol) in anhydrous CH2Cl2 (50 
mL) at – 78 ºC was added, dropwise, BF3.Et2O (2.8 mL, 22.2 mmol).  The reaction 
mixture was stirred at – 78 ºC for 5 h then diluted with water, warmed to RT and 
extracted with CH2Cl2.  The organic extracts were dried over Na2SO4, filtered and 
concentrated and the residue purified by column chromatography on silica gel, 
eluting with petroleum ether containing 60 – 80% diethyl ether, to give keto-ester 
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210 (4.0 g, 91 %) as a colourless oil. 1H NMR (500 MHz, d6-DMSO, 90 ºC, 3:1 
ratio of diastereomers, relative stereochemistry of major diastereomer (A) 
unknown) δH 6.53 (2H, s, ArH diastereomer B), 6.50 (1H, d, J = 1.5 Hz, ArH 
diastereomer A), 6.47 (1H, d, J = 1.5 Hz, ArH diastereomer A), 5.97 (4H, s, 
OCH2O diastereomer A and B), 5.14 (1H, t, J = 6.0 Hz, CHCH2C(O)CH3 
diastereomer A), 4.87 (1H, t, J = 6.0 Hz, CHCH2C(O)CH3 diastereomer B), 3.85 
(3H, s, ArOCH3 diastereomer B), 3.84 (3H, s, ArOCH3 diastereomer A), 3.62 (3H, 
s, OCH3 diastereomer A), 3.55 (3H, s, OCH3 diastereomer B), 3.40 (1H, t, J = 10.0 
Hz, NCH2 diastereomer A), 3.31 (1H, t, J = 10.0 Hz, NCH2 diastereomer B), 3.17 
(1H, ddd, J = 18.0, 10.0, 7.0 Hz, NCH2 diastereomer A), 3.02 – 2.97 (1H, m, NCH2 
diastereomer B), 2.67 – 2.55 (4H, m, NCH2CH2 diastereomer A and B and 
CHCH2C(O)CH3 diastereomer B), 2.41 (1H, m, NCH2CH2 diastereomer A), 2.32 
(1H, dd, J = 13.5, 7.0 Hz, NCH2CH2 diastereomer B), 2.23 (2H, d, J = 6.0 Hz, 
CHCH2C(O)CH3 diastereomer A), 2.14 (3H, s, CHCH2C(O)CH3 diastereomer B), 
1.86 (3H, s, CHCH2C(O)CH3 diastereomer A), 1.40 (9H, s, C(CH3)3 diastereomer 
A), 1.38 (9H, s, C(CH3)3 diastereomer B); 13C NMR (125 MHz, d6-DMSO, 90 ºC, 
3:1 mixture of diastereomers) δC 207.3 (C(O)CH3 diastereomer B), 204.4 
(C(O)CH3 diastereomer A), 172.8 (C(O)OCH3 diastereomer A), 171.3 (C(O)OCH3 
diastereomer B), 152.7 (NC(O)OC(CH3)3 diastereomer A and B), 148.5 (4º ArC 
diastereomer B), 148.3 (4º ArC diastereomer A), 142.5 (4º ArC diastereomer A), 
142.2 (4º ArC diastereomer B), 134.2 (4º ArC diastereomer A), 133.9 (4º ArC 
diastereomer B), 133.9 (4º ArC diastereomer B), 130.5 (4º ArC diastereomer A), 
108.2 (ArCH diastereomer A), 106.6 (ArCH diastereomer B), 101.4 (ArCH 
diastereomer A), 100.9 (OCH2O diastereomer A), 100.8 (OCH2O diastereomer B), 
99.8 (ArCH diastereomer B), 78.7 (NC(O)OC(CH3)3 diastereomer A), 78.4 
(NC(O)OC(CH3)3 diastereomer B), 60.3 (4º C diastereomer A), 58.2 
(CHCH2C(O)CH3 diastereomer B), 58.1 (CHCH2C(O)CH3 diastereomer A), 56.2 
(ArOCH3 diastereomer A), 55.4 (ArOCH3 diastereomer B), 52.1 (C(O)OCH3 
diastereomer A), 51.4 (C(O)OCH3 diastereomer B), 46.1 (CHCH2C(O)CH3 
diastereomer B), 45.1 (CHCH2C(O)CH3 diastereomer A), 42.6 (NCH2 diastereomer 
A), 42.2 (NCH2 diastereomer B), 31.2 (CHCH2COCH3 diastereomer B), 29.3 
(NCH2CH2 diastereomer A), 29.1 (CHCH2COCH3 diastereomer A), 29.1 
(NCH2CH2 diastereomer B), 27.6 (NC(O)OC(CH3)3 diastereomer A), 27.5 
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(NC(O)OC(CH3)3 diastereomer B);  IR υmax/cm-1 2977, 1732, 1693, 1633, 1396; 
MS (ES+) m/z (relative intensity %) 458 (M + Na+, 100%), 893 (2M + Na+60%); 
HRMS (ES+): calcd. for C22H29O8NNa (M + Na+) 458.1785, found 458.1780. 
 
NOE interactions were found between proton HA and the aromatic protons in both 
diastereomers of 210 (Figure 7.2).  The relative stereochemistry of the major 
diastereomer could therefore not be determined by NMR analysis. 
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Figure 7.2: NOE interactions observed for the major and minor diastereomer of 210 
A solvent and Lewis/Brønsted acid screen was conducted following the above 
procedure with the conditions detailed in Table 7.5 (equivalents of reagents are 
unchanged).  The dr was calculated from the crude NMR (at 90 ºC). 
Entry Lewis/Brønsted Acid Solvent 210 dr 
1 BF3.OEt2 CH2Cl2 3:2 
2 BF3.OEt2 THF 4:1 
3 BF3.OEt2 TBME 5:2 
4 BF3.OEt2 Et2O 5:2 
5 BF3.OEt2 MeCN No conversion 
6 BF3.OEt2 Acetone 7:1 
7 BF3.OEt2 EtOAc 4:1 
8 TMSOTf CH2Cl2 3:2 
9 SnCl4 CH2Cl2 2:1 
10 CSA CH2Cl2 No conversion 
11 BF3.THF CH2Cl2 No conversion 
Table 7.5: Optimisation of synthesis of ketoester 210. 
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7.4.3.6 Synthesis and characterisation of tert-butyl rel-(3aS,7aR)-6-methoxy-
3a-(7-methoxy-1,3-benzodioxol-5-yl)-4-oxo-2,3,3a,4,7,7a-hexahydro-1H-
indole-1-carboxylate, 212 
N
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O
NO
O
O
OMe210 211
KOt-Bu, THF TiCl4, MeOH
212
 
A solution of keto-ester 210 (3.55 g, 8.16 mmol, 3:1 dr) in anh THF (20 mL) was 
added rapidly dropwise to a stirred solution of KOtBu (17.1 mL of a 1 M solution in 
THF, 17.1 mmol) in anh THF (130 mL) at 40 ºC.  The resulting bright orange 
solution was stirred at this temperature for 10 min then quenched with 1 M HCl (20 
mL, to pH ~1) and allowed to cool to room temperature.  The reaction mixture was 
diluted with ethyl acetate (50 mL), the organic phase separated and the aqueous 
phase extracted with ethyl acetate (2 x 50 mL).  The combined organic portions 
were dried and concentrated to give crude tert-butyl rel-(3aR,7aS)-3a-(7-methoxy-
1,3-benzodioxol-5-yl)4,6-dioxooctahydro-1 H-indole-1-carboxylate 211 (MS (ES-): 
402 (M - H+, 100%) as a yellow solid which was used directly without purification 
or characterisation. 
 
Diketone 211 (1.0 g of crude residue, 2.48 mmol) was dissolved in MeOH (10 mL) 
and TiCl4 (0.12 mL of a 1 M solution in CH2Cl2, 0.12 mmol) was added in one 
portion at RT.  The reaction mixture was stirred at RT for 30 min then quenched 
with sat. aq. NaHCO3 (10 mL).  The biphasic mixture was extracted with CH2Cl2 (2 
x 10 mL) then with chloroform:isopropyl alcohol (4:1, 10 mL).  The combined 
organic portions were dried over Na2SO4, filtered and concentrated.  The residue 
was purified by column chromatography on silica gel, eluting with petroleum ether 
containing 50 – 95 % diethyl ether to give methylenol ether 212 as a single 
diastereomer (665 mg, 64%) as a colourless solid.  1H NMR (500 MHz, d6-DMSO, 
90 ºC) δH 6.57 (1H, d, J = 1.5 Hz, ArH), 6.56 (1H, d, J = 1.5 Hz, ArH), 5.95 (2H, s, 
OCH2O), 5.53 (1H, s, CH=COCH3), 4.27 (1H, t, J = 4.5 Hz, CHCH2), 3.84 (3H, s, 
ArOCH3), 3.75 (3H, s, OCH3), 3.35 (1H, ddd, J = 10.5, 8.5, 2.5  Hz, NCH2), 3.16 
(1H, br. d, J = 18.5 Hz, CHCH2), 3.04 – 2.99 (1H, m, NCH2), 2.76 (1H, dd, J = 
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18.5, 4.5 Hz, CHCH2), 2.54 (1H, ddd, J = 10.5, 8.5, 2.5 NCH2CH2), 2.21 – 2.15 
(1H, m, NCH2CH2), 1.42 (9H, s, C(CH3)3); 13C NMR (125 MHz, d6-DMSO, 90 ºC) 
δC 196.5 (C=CHC(O)), 174.1 (CH=COCH3), 153.5 (NC(O)OC(CH3)3), 148.3 (4º 
ArC), 142.5 (4º ArC), 133.7 (4º ArC), 133.6 (4º ArC), 107.3 (ArCH), 101.0 
(ArCH), 100.6 (CH=COCH3), 100.6 (OCH2O), 78.6 (C(CH3)3), 60.5 (CHCH2), 
57.8 (4º C), 56.4 (ArOCH3), 55.5 (OCH3), 45.0 (NCH2), 33.5 (NCH2CH2), 28.9 
(CHCH2), 27.6 (C(CH3)3); IR υmax/cm-1 2976, 2894, 1691, 1650, 1617, 1392, 1201, 
1166, 1118;  MP 109 - 113 ºC; MS (ES+) m/z (relative intensity %) 476 (M + NH4+ 
+ MeCN, 100%); HRMS (ES+): calcd. for C22H27O7NNa (M + Na+) 440.1680, 
found 440.1668. 
 
 
In order to determine the effect of the dr of the starting keto-ester 210 on the yield 
of enol ether 212 2 experiments were conducted in parallel on a 0.5 mmol scale 
using keto-ester 210 with 3:1 dr (prepared according to the above procedure in 
CH2Cl2) and 7:1 (prepared according to the above procedure in acetone) to give 
enol ether 212 as a single diastereomer in 53% and 55% yields respectively.  
 
Alternatively enol ether 212 was prepared in 28% yield on a 0.87 mmol scale 
following the above procedure replacing TiCl4 with CSA (10 mol%), and in a 46% 
yield on a 0.12 mmol scale replacing TiCl4 with 0.5 M HCl in methanol (20 mol%).   
 
Alternatively, crude diketone 211 was prepared on a 0.1 mmol scale according to 
the above procedure and the reaction mixture treated, at room temperature, with 
dimethylsulfate (3 equivalents) for 1 h.  The reaction mixture was concentrated and 
purified by column chromatography on silica gel, eluting with petroleum ether 
containing 50 – 95 % diethyl ether, giving enol ether 212 (12 mg, 29%). 
 
Alternatively crude diketone 211 was prepared on a 0.23 mmol scale and the 
residue dissolved in THF (5 mL) and treated with methanol (47 μL, 1.15 mmol), 
triphenylphosphine (60 mg, 0.23 mmol) and DIAD (46 mg, 0.23 mmol).  The 
reaction mixture was stirred at room temperature overnight then concentrated and 
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purified by column chromatography on silica gel, eluting with petroleum ether 
containing 50 – 95 % diethyl ether, giving 212 (40 mg, 42%). 
7.4.3.7 Synthesis and characterisation of tert-butyl rel-(3aR,7aS)-6-ethoxy-
3a-(7-methoxy-1,3-benzodioxol-5-yl)-4-oxo-2,3,3a,4,7,7a-hexahydro-1H-
indole-1-carboxylate, 218 
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211 218
 
Alternatively, following the above procedure for the synthesis of methyl enol ether 
212, crude diketone 211 (200 mg of crude residue, 0.50 mmol) was dissolved in 
ethanol (2 mL) and treated with TiCl4 (25 μL of a 1 M solution in CH2Cl2), 0.025 
mmol) to give ethyl enol ether 218 (81 mg, 38% over 2 steps) following column 
chromatography on silica gel, eluting with petroleum ether containing 50 – 80% 
diethyl ether.  1H NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.57 (1H, br. s, ArH), 6.55 
(1H, br. s, ArH), 5.95 (2H, s, OCH2O), 5.50 (1H, s, CH=COEt), 4.26 (1H, t, J = 4.5 
Hz, CHCH2), 4.06 – 3.99 (2H, m, OCH2CH3), 3.84 (3H, s, ArOCH3), 3.55 – 3.51 
(1H, m, NCH2), 3.16 (1H, br. d, J = 18.5 Hz, CHCH2), 3.04 – 2.99 (1H, m, NCH2), 
2.74 (1H, dd, J = 18.5, 4.5 Hz, CHCH2), 2.56 – 2.53 (1H, m, NCH2CH2), 2.20 – 
2.14 (1H, m, NCH2CH2), 1.42 (9H, s, C(CH3)3), 1.30 (3H, t, J = 7.0 Hz, 
OCH2CH3); 13C NMR (125 MHz, d6-DMSO, 90 ºC) δC 196.5 (C=CHC(O)), 173.1 
(CH=COEt), 153.5 (NC(O)OC(CH3)3), 148.3 (4º ArC), 142.5 (4º ArC), 133.7 (4º 
ArC), 133.6 (4º ArC), 107.3 (ArCH), 101.4 (CH=COEt), 100.6 (ArCH), 100.6 
(OCH2O), 78.6 (C(CH3)3), 63.9 (OCH2CH3), 60.5 (CHCH2), 57.8 (4º C), 56.4 
(ArOCH3), 45.0 (NCH2), 33.5 (NCH2CH2), 29.0 (CHCH2), 27.6 (C(CH3)3), 13.3 
(OCH2CH3); IR υmax/cm-1 2979, 1691, 1649, 1613, 1392, 1199, 1165;  MP 129 - 
134 ºC; MS (ES+) m/z (relative intensity %) 863 (2M + H+, 100%), 490 (M + NH4+ 
+ MeCN, 80%), 432 (M + H+, 40%); HRMS (ES+): calcd. for C23H29O7NNa (M + 
Na+) 454.1836, found 454.1835.  
7.4.3.8 Synthesis and characterisation of tert-butyl rel-(3aR,7aS)-3a-(7-
methoxy-1,3-benzodioxol-5-yl)-6-oxo-2,3,3a,6,7,7a-hexahydro-1H-indole-1-
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carboxylate, 217 and tert-butyl rel-(3aR,7aS)-3a-(7-methoxy-1,3-benzodioxol-
5-yl)-4-oxooctahydro-1H-indole-1-carboxylate, 217b 
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To a stirred solution of 212 (300 mg, 0.72 mmol) in CH2Cl2 (25 mL) at -20 ºC was 
added diisobutylaluminium hydride (1.80 mL of a 1 M solution in hexane, 1.80 
mmol).  The reaction mixture was stirred at -20 ºC for 15 min then quenched with 
methanol (0.5 mL), diluted with saturated aqueous potassium sodium tartrate 
tetrahydrate (30 mL) and stirred vigorously for 30 min (until clean phase separation 
wash achieved).  The biphasic mixture was extracted with CH2Cl2 (3 x 10 mL) and 
the combined organic portions were dried over Na2SO4, filtered and concentrated.  
The residue was dissolved in diethyl ether (10 mL) and HCl(aq) (2 mL of a 2 M 
solution) was added and the mixture stirred vigorously for 1 h.  The organic phase 
was separated and the aqueous extracted with ethyl acetate (2 x 5 mL).  The 
combined organic portions were dried over Na2SO4, filtered and concentrated.  The 
residue was purified by column chromatography on silica gel, eluting with 
petroleum ether containing 50 – 70% diethyl ether to give enone 217 (161 mg, 
58%) as a colourless crystalline solid: 1H NMR (500 MHz,d6-DMSO, 90 ºC) δH 
6.84 (1H, d, J = 10.0 Hz, CH=CHC(O)), 6.74 (1H, d, J = 1.5 Hz, ArH), 6.68 (1H, 
d, J = 1.5 Hz, ArH), 6.09 (1H, d, J = 10 Hz, CH=CHC(O)), 5.98 (2H, s, OCH2O), 
4.17 (1H, t, J = 3.5 Hz, CHCH2CO), 3.88 (3H, s, OCH3), 3.62 (1H, ddd, J = 10.5, 
8.0, 2.5 Hz, NCH2), 3.13 (1H, td, J = 10.5, 6.5 Hz, NCH2), 2.99 (1H, dd, J = 16.5, 
3.5 Hz, CHCH2C(O)), 2.57 (1H, dd, J = 16.5, 3.5 Hz, CHCH2C(O)), 2.54 – 2.47 
(1H, m, NCH2CH2), 2.12 (1H, ddd, J = 12.5, 6.5, 2.5 Hz, NCH2CH2), 0.90 (9H, s, 
C(CH3)3); 13C NMR (125 MHz, d6-DMSO, 90 ºC) δC  195.9 (C(O)), 153.1 
(NC(O)O), 150.7 (CH=CHC(O)), 148.6 (4º ArC), 142.8 (4º ArC), 134.5 (4º ArC), 
133.9 (4º ArC), 128.2 (CH=CHC(O)), 107.3 (ArCH), 100.8 (OCH2O), 100.4 
(ArCH), 78.5 (C(CH3)3), 61.9 (CHCH2C(O)), 56.4 (OCH3), 50.5 (4º C), 45.2 
(NCH2), 37.2 (CHCH2C(O)), 35.4 (NCH2CH2), 27.6 (C(CH3)3); IR υmax/cm-1 2975, 
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2891, 1688, 1633, 1512, 1393;  MP 155 – 157 ºC; MS (ES+) m/z (relative intensity 
%) 446 (M + NH4++ MeCN, 100%), 410 (M + Na+, 60%), 797 (2M + Na+, 90%); 
HRMS (ES+): calcd. for C21H25O6NNa (M + Na+) 410.1574, found 410.1569. 
 
The by-product 217b (30 mg, 11%) was also isolated as a colourless solid: 1H 
NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.51 (1H, br. d. J = 1.5 Hz, ArH), 6.47 (1H, 
s, ArH), 5.96 (2H, s, OCH2O), 4.42 (1H, t, J = 5.5 Hz, CHCH2CH2CH2C(O)), 3.85 
(3H, s, OCH3), 3.36 (1H, ddd, J =10.5, 7.5, 5.5 Hz, NCH2), 3.16 (1H, td, J = 10.5, 
7.5, NCH2), 2.57 (1H, ddd, J = 13.0, 7.5, 5.5 Hz, NCH2CH2), 2.41 – 2.30 (2H, m, 
CHCH2CH2CH2C(O)), 2.14 – 2.06 (2H, m, CHCH2CH2CH2C(O)), 1.92 (1H, td, J 
= 7.5, 13.0, NCH2CH2), 1.88 – 1.83 (1H, m, CHCH2CH2CH2C(O)), 1.81 – 1.74 
(1H, m, CHCH2CH2CH2CO), 1.41 (9H, s, C(CH3)3); 13C NMR (125 MHz, d6-
DMSO, 90 ºC) δC 209.3 (C(O)), 153.2 (NC(O)O), 148.5 (4º ArC), 142.6 (4º ArC), 
133.7 (4º ArC), 133.6 (4º ArC), 107.2 (ArCH), 100.8 (OCH2O), 100.5 (ArCH), 
78.3 (C(CH3)3), 63.1 (CHCH2CH2CH2C(O)), 62.0 (4º C), 56.4 (OCH3), 44.3 
(NCH2), 37.7 (CHCH2CH2CH2C(O)), 33.0 (NCH2CH2), 27.7 (C(CH3)3), 25.6 
(CHCH2CH2CH2C(O)), 19.6 (CHCH2CH2CH2C(O)); IR υmax/cm-1 2973, 1694, 
1632, 1512, 1392, 1142;  MP 149 – 153 ºC; MS (ES+) m/z (relative intensity %) 
801 (2M + Na+, 100%), (2M + K+, 80%), 412 (M + Na+, 75%), 428 (M + K+, 50%); 
HRMS (ES+): calcd. for C21H27O6NNa (M + Na+) 412.1731, found 412.1730. 
 
Alternatively treating enol ether 212 with the reagents/conditions shown in Table 
7.6 (until no starting material was present by TLC analysis) gave enone 217 and by-
products 217b and 217c in the ratios and yields shown.  Product ratios were 
calculated from the crude NMR at 90 ºC; yields are isolated after column 
chromatography on silica gel under the above conditions. 
Entry Reductant (equiv) Solvent T /ºC 
Ratio 
217:217b:217c 
% Yield 
217 
1 NaBH3/CeCl3 (1) MeOH 0 - 0a 
2 LiAlH4 (1) THF 0 0:1:0 - 
3 LiAlH4 (1) Toluene 0 0:1:0 - 
4 Red-Al® (2) toluene 0 - 0b 
5 Super-hydride® (2.2) THF -78 0:0:1 52% (1:1 ratio of diastereomers) 
6 DIBAL (2) toluene -78 1:1:0 217 33%, 217b 33% 
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7 DIBAL (2) toluene -85 1:1:0 - 
8 DIBAL (2) toluene -20 1.2:1:0 - 
9 DIBAL (2, dropwise) toluene -78 1.3:1:0 - 
10 DIBAL (2) CH2Cl2 0 7:1:0c 217 28%, 217b 4% 
11 DIBAL (4) CH2Cl2 0 7.5:1:0 217 32%, 217b 4% 
12 DIBAL (2.5) CH2Cl2 -20 5.3:1:0 217 58%, 217b 11% 
13 DIBAL (2) CH2Cl2 -78 2:1:0 217 44%, 217b 21% 
Table 7.6: Screen of reducing agents/conditions for the reduction of 212. 
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Alternatively enone 217 was prepared from ethyl-enol ether 218 on a 0.1 mmol 
scale following the above procedure to give 217 (14 mg, 36%) and 217b (7 mg, 
18%). 
7.4.3.9 Synthesis and characterisation of tert-butyl-4-hydroxy-3a-(7-
methoxy-1,3-benzodioxol-5-yl)octahydro-1H-indole-1-carboxylate 217c 
(diastereomers A and B) 
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A solution of 212 (50 mg, 0.12 mmol) in anhydrous THF (3 mL) was prepared and 
cooled to -78 ºC.  Super-hydride® (0.26 mL of a 1 M solution, 0.26 mol) and the 
reaction mixture stirred for 1 h, warmed to -20 ºC and stirred for a further 1 h then 
quenched with 1 M HCl (5 mL).  The reaction mixture was extracted with EtOAc (3 
x 5 mL) and the combined organics dried over Na2SO4, filtered and concentrated.  
The residue was purified by column chromatography on silica gel to give 217c as a 
1:1 ratio of diastereomers A (12 mg, 26%) as a coloureless oil and B (12 mg, 26%) 
as a colourless oil (separated by column chromatography). 217c diastereomer A: 1H 
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NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.76 (1H, d, J = 1.5 Hz, ArH), 6.73 (1H, d, 
J = 1.5 Hz, ArH), 5.92 (2H, s, OCH2O), 4.06 (1H, dd, J = 6.0, 10.5 Hz, CHN), 
3.86 (3H, s, OCH3), 3.66 (1H, dd, J = 10.5, 5.0 Hz, CHOH), 3.29 – 3.24 (1H, m, 
NCH2), 3.09 – 3.04 (1H, m, NCH2), 2.25 – 2.22 (2H, m, NCH2CH2), 1.98 – 1.96 
(1H, m, CH2CHN), 1.74 – 1.71 (1H, m, CH2CHOH), 1.66 – 1.63 (1H, m, 
CH2CH2CH2), 1.45 – 1.34 (2H, m, CH2CHOH and CH2CH2CH2), 1.32 (9H, s, 
C(CH3)3), 1.24 – 1.19 (1H, m, CH2CHN) ; 13C NMR (125 MHz, d6-DMSO, 90 ºC) 
δC 152.7 (C(O)N), 147.9 (4º ArC), 142.0 (4º ArC), 140.0 (4º ArC), 132.7 (4º ArC), 
107.5 (ArCH), 100.8 (OCH2O), 100.2 (ArCH), 77.3 (C(CH3)3), 73.8 (CHOH), 69.0 
(CHN), 61.7 (4º C), 56.3 (OCH3), 42.1 (NCH2), 30.5 (NCH2CH2), 27.7 (CH2), 27.6 
(C(CH3)3), 25.3 (CH2), 19.8 (CH2CH2CH2); IR υmax/cm-1 3427, 2935, 1633, 1366; 
MS (ES-) m/z (relative intensity %) 390 (M – H+, 100%) HRMS (ES+): calcd. for 
C21H29O6NNa (M + Na+) 414.1887, found 414.1884. 
217c diastereomer B: 1H NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.57 – 6.56 (2H, 
m, ArH), 5.92 (2H, s, OCH2O), 4.24 (1H, dd, J = 9.5, 6.5 Hz, CHOH), 4.06 (1H, 
br. s, CHN), 3.84 (3H, s, OCH3), 3.22 – 3.18 (1H, m, NCH2), 2.84 – 2.78 (1H, m, 
NCH2), 2.30 (1H, td, J = 12.5, 9.5 Hz, NCH2CH2), 2.02 – 1.98 (1H, m, CH2CHN), 
1.91 (1H, dd, J = 12.5, 7.0 Hz, NCH2CH2), 1.79 – 1.63 (3H, m, CH2CH2CH2 and 
CH2CHOH), 1.44 – 1.38 (2H, m, CH2CHN and CH2CHOH), 1.41 (9H, s, 
C(CH3)3); 13C NMR (125 MHz, d6-DMSO, 90 ºC) δC 152.7 (C(O)N), 148.0 (4º 
ArC), 142.1 (4º ArC), 139.1 (4º ArC), 132.5 (4º ArC), 107.3 (ArCH), 100.5 
(OCH2O), 100.2 (ArCH), 77.5 (C(CH3)3), 69.0 (CHN), 56.1 (OCH3), 55.9 
(CHOH), 52.7 (4º C), 41.9 (NCH2), 32.3 (NCH2CH2), 28.7 (CH2), 27.7 (C(CH3)3), 
27.6 (CH2), 16.6 (CH2CH2CH2); IR υmax/cm-1 3441, 2973, 1686, 1408; MS (ES-) 
m/z (relative intensity %) 390 (M – H+, 100%) HRMS (ES+): calcd. for 
C21H29O6NNa (M + Na+) 414.1887, found 414.1884. 
 
NEOSY NMR confirmed the relative stereochemistry of the 2 diastereomers 
(Figure 7.3) 
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Figure 7.3: NOESY interactions observed to confirm relative 
stereochemistry of the 2 diastereomers of 217c. 
7.4.3.10 Synthesis and characterisation of tert-butyl rel-(3aS,6R,7aR)-6-
hydroxy-3a-(7-methoxy-1,3-benzodioxol-5-yl)-2,3,3a,6,7,7a-hexahydro-1H-
indole-1-carboxylate, 219 and tert-butyl rel-(3aS,6S,7aR)-6-hydroxy-3a-(7-
methoxy-1,3-benzodioxol-5-yl)-2,3,3a,6,7,7a-hexahydro-1H-indole-1-
carboxylate, 219b  
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To a stirred solution of enone 217 (365 mg, 0.94 mmol) in THF (15 mL) at -78 ºC 
was added L-Selectride® (1.13 mL of a 1 M solution in THF, 1.13 mmol).  The 
reaction mixture was stirred at -78 ºC for 3 h then quenched with sat. aq. NaHCO3 
and extracted with ethyl acetate.  The combined organic extracts were dried over 
Na2SO4, filtered and concentrated.  The residue was purified by column 
chromatography on silica gel, eluting with petroleum ether containing 60 – 70% 
diethyl ether to give 219 (198 mg, 54%, dr >97:3) as a colourless solid and mixed 
219 + 219b (88 mg, 24%, dr 1:1.1) as a colourless solid (combined yield 286 mg, 
78%, crude dr 3.5:1).  Major diastereomer 219: 1H NMR (500 MHz, d6-DMSO, 90 
ºC) δH 6.69 (1H, d, J = 1.5 Hz, ArH), 6.66 (1H, d, J = 1.5 Hz, ArH), 5.96 (2H, s, 
OCH2O), 5.91 (1H, dd, J = 10.0, 2.0 Hz, CH=CHCHOH), 5.53 (1H, d, J = 10.0 
Hz, CH=CHCHOH), 4.05 – 4.03 (1H, br. m, CHOH), 3.89 – 3.85 (1H, m, 
CHCH2CHOH), 3.87 (3H, s, OCH3), 3.54 (1H, ddd, J = 10.0, 8.0, 3.0 Hz, NCH2), 
3.11 (1H, td, J = 10.0, 6.5 Hz, NCH2), 2.37 – 2.31 (2H, m, CHCH2CHOH and 
NCH2CH2), 1.83 (1H, ddd, J = 12.0, 6.5, 3.0 Hz, NCH2CH2), 1.56 (1H, ddd, J = 
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11.5, 8.5, 3.0 Hz, CHCH2CHOH), 1.43 (9H, s, C(CH3)3); 13C NMR (125 MHz, d6-
DMSO,  90 ºC) δC 152.9 (NC(O)O), 148.3 (4º ArC), 142.4 (4º ArC), 138.1 (4º 
ArC), 133.2 (4º ArC), 132.3 (CH=CHCHOH), 131.0 (CH=CHCHOH), 107.3 
(ArCH), 100.6 (OCH2O), 100.6 (ArCH), 77.9 (C(CH3)3), 61.0 (CHOH), 60.7 
(CHCH2CHOH), 56.4 (OCH3), 49.6 (4º C), 44.8 (NCH2), 35.0 (NCH2CH2), 30.9 
(CHCH2CHOH), 27.7 (C(CH3)3); IR υmax/cm-1 3419, 2976, 1672, 1634, 1511, 
1406, 1131;  MP 63 – 66 ºC; MS (ES-) m/z (relative intensity %) 388 (M - H+, 
100%); HRMS (ES+): calcd. for C21H27O6NNa (M + Na+) 412.1731, found 
412.1731. 
Minor diastereomer 219b: 1H NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.56 (1H, d, J 
= 1.5 Hz, ArH), 6.53 (1H, d, J = 1.5 Hz, ArH), 5.94 (2H, d, J = 2.0 Hz, OCH2O), 
5.72 (1H, d, J = 10 Hz, CH=CHCHOH), 5.65 (1H, dd, J = 10.0, 2.0 Hz, 
CH=CHCHOH), 4.52 (1H, d, J = 3.5 Hz, OH), 4.23 (1H, br. s, CHOH), 4.04 (1H, 
dd, J = 10.5, 5.0 Hz, CHCH2CHOH), 3.84 (3H, s, OCH3), 3.38 (1H, td, J = 3.0, 
10.0 Hz, NCH2), 3.33 – 3.30 (1H, m, NCH2), 2.37 – 2.31 (1H, m, NCH2CH2), 2.20 
(1H, td, J = 5.0, 10.0 Hz, CHCH2CHOH), 2.10 (1H, td, J = 10.0, 13.0 Hz, 
NCH2CH2), 1.60 (1H, q, J = 10.5 Hz, CHCH2CHOH), 1.40 (9H, s, C(CH3)3); 13C 
NMR (125 MHz, d6-DMSO, 90 ºC) δC 152.8 (NC(O)O), 148.4 (4º ArC), 142.4 (4º 
ArC), 139.5 (4º ArC), 133.1 (4º ArC), 131.3 (C=C), 131.1 (C=C), 106.6, (ArCH) 
100.5 (OCH2O), 100.1 (ArCH), 77.8 (C(CH3)3), 63.6 (CHOH), 60.6 
(CHCH2CHOH), 56.3 (OCH3), 49.3 (4º C), 44.0 (NCH2), 35.2 (NCH2CH2), 35.0 
(CHCH2CHOH), 27.7 (C(CH3)3); IR υmax/cm-1 3419, 2360, 1669, 1634, 1450;  MP 
98 – 100 ºC; MS (ES+) m/z (relative intensity %) 448 (M + NH4+ + MeCN, 100%), 
412 (M + Na+, 50%), 390 (M + H+, 70%); HRMS (ES+): calcd. for C21H27O6NNa 
(M + Na+) 412.1731, found 412.1730. 
 
The relative stereochemistry of the allylic alcohol was confirmed by NOE analysis 
(Figure 7.4). 
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Figure 7.4: NOE interactions to confirm relative stereochemistry of 219/219b. 
Alternatively reacting enone 217 with the reagents shown in Table 7.7, following 
the above procedure at the temperature and in the solvents shown, allylic alcohols 
219 and 219b were synthesised in the diastereomeric ratio (determined from the 
crude NMR) and yields shown.  
Entry Reductant (equiv) T /ºC Solvent dr 
a 
(219:219b) Yield
b 
1 Super-hydride® -20 THF 1:2 - 
2 N-Selectride® -20 THF 2:1 - 
3 N-Selectride® -20 CH2Cl2 1:1 - 
4 N-Selectride® -20 toluene 1:1.3 - 
5 N-Selectride® -78 THF 2:1 77% 
6 N-Selectride® rt THF 2:1 - 
7 K-Selectride® -20 THF 1.7:1 - 
8 L-Selectride® -20 THF 3.5:1 - 
9 L-Selectride® -78 THF 3.5:1 78% 
Table 7.7: Screen of reducing conditions for synthesis of allylic alcohol. a calculated from crude 
NMR at 90 ºC, b overall yield of both diastereomers 
Alternatively, enone 217 (100 mg, 0.26 mmol) was treated with NaBH4 (23 mg, 
0.54 mmol) and CeCl3.7H2O (201 mg, 0.54 mol) in MeOH (7 mL) at 0 ºC for 1 h.  
The reaction mixture was diluted with sat. aq. NaHCO3 (10 mL) and extracted with 
CH2Cl2 (3 x 20 mL).  The combined organic portions were dried over Na2SO4, 
filtered and concentrated.  The residue was purified by column chromatography on 
silica gel, eluting with petroleum ether containing 70 -90% diethyl ether to give 
219:219b (96 mg, 95%, 1:5.5 dr). 
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To a stirred solution of 219b (24 mg, 0.06 mmol) in anh THF (1.5 mL) at 0 ºC was 
added NEt3 (43 μL, 0.31 mmol) and methanesulfonic anhydride (54 mg, 0.31 
mmol) as a solution in anh THF (1.5 mL).  The reaction mixture was stirred at this 
temperature for 2 h then evaporated and dissolved in anh DMF (2 mL) and CsOAc 
(172 mg, 0.9 mmol) was added.  The reaction mixture was stirred at room 
temperature overnight then filtered to remove the solids (washing with EtOAc) and 
the filtrate concentrated.  The residue was dissolved in MeOH (2.5 mL) and K2CO3 
(100 mg, 0.72 mmol) was added.  The reaction mixture was stirred at room 
temperature for 3 h then diluted with water (10 mL) and extracted with CH2Cl2 (3 x 
5 mL).  The combined organics were dried over Na2SO4, filtered and concentrated 
and the residue purified by column chromatography on silica gel eluting with 
petroleum ether containing 60 – 70% diethyl ether to give 219 and 219b (18 mg, 
75%, 3.1:1 dr), no attempt was made to separate the diastereomers in this case. 
7.4.3.11 Synthesis and characterisation of (±)-powelline, 185 
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Allylic alcohol 219 (21 mg, 0.05 mmol) was dissolved in TFA (1 mL) and stirred at 
RT for 5 min. The TFA was removed by rotary evaporation and the residue re-
dissolved in a second portion of TFA (1 mL).  The mixture was stirred at RT for a 
further 5 min then evaporated and the residue dissolved in CHCl3:isopropyl alcohol 
(4:1, 5 mL) and sat. aq. NaHCO3 (3 mL) was added.  The organic phase was 
separated and the aqueous extracted with CHCl3:isopropyl alcohol (4:1) (3 x 5 mL).  
The combined organic extracts were dried over Na2SO4, filtered and concentrated to 
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give crude rel-(3aR,6S,7aS)-3a-(7-methoxy-1,3-benzodioxol-5-yl)-2,3,3a,6,7,7a-
hexahydro-1H-indol-6-ol 220.  The residue was used directly in the next step 
without purification or characterisation, MS (ES+) m/z (relative intensity %) 290 
(M + H+, 100%). 
Crude 220 was dissolved in MeOH (0.5 mL) and aq. formaldehyde (2 mL, 37% wt.) 
was added.  The reaction mixture was stirred at RT for 15 min then 6 M HCl (5 mL) 
was added.  The reaction mixture was stirred at RT for 10 min then quenched by the 
addition of solid K2CO3 and extracted with CHCl3:isopropyl alcohol (4:1) (5 x 2 
mL).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated, the residue was purified by column chromatography on silica gel, 
eluting with CH2Cl2 containing 1 – 10 % MeOH to give (±)-powelline (±)-185 (7 
mg, 49%) as a colourless amorphous solid and a mixture of (±)-powelline (±)-185 
and regioisomer (±)-185b (5 mg, 35% 2.5:1 (185:1185b). (±)-powelline (±)-185: 1H 
NMR (500 MHz, CDCl3) δH 6.57 (1H, s, ArH), 6.55 (1H, d, J = 10.0 Hz, 
CH=CHCHOH), 5.95 (1H, dd, J = 10.0, 5.0 Hz, CH=CHCHOH), 5.87 (1H, d, J = 
1.5 Hz, OCH2O), 5.86 (1H, d, J = 1.5 Hz, OCH2O), 4.35 (1H, m, CHOH), 4.28 
(1H, d, J = 17.5 Hz, CH2N), 3.98 (3H, s, OCH3), 3.85 (1H, d, J = 17.5 Hz, CH2N), 
3.43 – 3.38 (2H, m, CHN and CH2CH2N), 2.93 – 2.88 (1H, m, CH2CH2N), 2.21 – 
2.16 (1H, m, CH2CH2N), 2.08 – 2.05 (1H, br. m, CHCH2CHOH), 1.95 – 1.89 (1H, 
m, CH2CH2N), 1.75 (1H, td, J = 13.5, 4.0 Hz CHCH2CHOH); 13C NMR (125 
MHz, CDCl3) δC 148.2 (4º ArC), 141.0 (4º ArC), 139.0 (4º ArC), 133.4 (4º ArC), 
132.2 (CH=CHCHOH), 127.4 (CH=CHCHOH), 116.9 (4º ArC), 100.6 (OCH2O), 
96.8 (ArCH), 64.0 (CHOH), 62.6 (CHCH2CHOH), 59.2 (ArOCH3), 58.6 (NCH2), 
53.7 (NCH2CH2), 44.2 (NCH2CH2), 43.9 (4º C), 32.4 (CHCH2CHOH); MP 95 – 
100 ºC; IR υmax/cm-1 3385, 3005, 1617, 1477, 1276, 1261, 1043, 940; MS (ES+) 
m/z (relative intensity %) 302 (M + H+, 100%); HRMS (ES+): calcd. for 
C17H20O4N (M + H+) 302.1387, found 302.1389. 
(±)-185b: 1H NMR (500 MHz, CDCl3) δH 6.60 (1H, d, J = 10 Hz, CH=CHCHOH), 
6.50 (1H, s, ArH), 5.97 (1H, dd, J = 10.0, 5.0 Hz, CH=CHCHOH), 5.94 (1H, d, J = 
1.0, OCH2O), 5.92 (1H, d, J = 1.0 Hz, OCH2O), 4.37 – 4.31 (2H, m, CHOH and 
CH2N), 3.90 (3H, s, OCH3), 3.84 (1H, d, J = 17.0 Hz, CH2N), 3.45 – 3.38 (2H, m, 
CHN and CH2CH2N), 2.98 – 2.91 (1H, m, CH2CH2N), 2.24 – 2.15 (2H, m, 
CH2CH2N, CHCH2CHOH), 1.99 – 1.93 (1H, m, CH2CH2N), 1.79 – 1.73 (1H, td, J 
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= 9.0, 5.0 Hz, CHCH2CHOH); 13C NMR (125 MHz, CDCl3) δC 146.2 (4º ArC), 
142.0 (4º ArC), 139.8 (4º ArC), 133.2 (4º ArC), 131.6 (CH=CHCHOH), 127.2 
(CH=CHCHOH), 107.7 (4º ArC), 101.9 (OCH2O), 101.6 (ArCH), 64.0 (CHOH), 
63.0 (CHCH2CHOH), 57.0 (ArOCH3), 56.9 (NCH2), 53.7 (NCH2CH2), 44.5 
(NCH2CH2), 44.0 (4º C), 32.6 (CHCH2CHOH); MS (ES+) m/z (relative intensity 
%) 302 (M + H+, 100%). 
 
The regioselectivity of the Pictet-Spengler reaction and the structures of 185 and 
185b were further confirmed by NOE analysis Figure 7.5. 
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Figure 7.5: NOE analysis of powelline 185 and regioisomer 185b. 
7.4.3.12 Synthesis and characterisation of (±)-C3-epi-powelline, C3-epi-185 
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Allylic alcohol 219b (15 mg, 0.05 mmol) was dissolved in TFA (1 mL) and stirred 
at RT for 5 min. The TFA was removed by rotary evaporation and the residue 
dissolved in a second portion of TFA (1 mL).  The mixture was stirred at RT for a 
further 5 min then evaporated and the residue dissolved in CHCl3:isopropyl alcohol 
(4:1, 5 mL) and sat. aq. NaHCO3 (3 mL) was added.  The organic phase was 
separated and the aqueous extracted with CHCl3:isopropyl alcohol (4:1) (3 x 5 mL).  
The combined organic extracts were dried over Na2SO4, filtered and concentrated to 
give crude C3-epi-220.  The residue was used directly in the next step without 
purification or characterisation, MS (ES+) m/z (relative intensity %) 290 (M + H+, 
100%). 
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Crude C3-epi-220 was dissolved in MeOH (0.5 mL) and aq. formaldehyde (2 mL, 
37% wt.) was added.  The reaction mixture was stirred at RT for 15 min then 6 M 
HCl (5 mL) was added.  The reaction mixture was stirred at RT for 10 min then 
quenched by the addition of solid K2CO3 and extracted with CHCl3:isopropyl 
alcohol (4:1) (5 x 2 mL).  The combined organic extracts were dried over Na2SO4, 
filtered and concentrated, the residue was purified by column chromatography on 
silica gel, eluting with CH2Cl2 containing 1 – 10 % MeOH to give (±)-C3-epi-
powelline C3-epi-185 (5 mg, 46%) as an off-white solid: 1H NMR (500 MHz, 
CDCl3) δH 6.53 (1H, s, ArH), 6.37 (1H, dd, J = 10.0, 2.0 Hz, CH=CHCHOH), 5.87 
(1H, d, J = 1.5 Hz, OCH2O), 5.86 (1H, d, J = 1.5 Hz, OCH2O), 5.78 (1H, d, J = 
10.0 Hz, CH=CHCHOH), 4.45 – 4.42 (1H, m, CHOH), 4.29 (1H, d, J = 17.5 Hz, 
CH2N), 3.98 (3H, s, OCH3), 3.84 (1H, d, J = 17.5 Hz, CH2N), 3.53 – 3.48 (1H, m, 
CH2CH2N), 3.25 (1H, dd, J = 13.0, 3.5 Hz, CHCH2CHOH), 2.94 (1H, ddd, J = 
13.5, 9.0, 6.0 Hz, CH2CH2N), 2.29 – 2.27 (1H, m, CHCH2CHOH), 2.20 (1H, ddd, J 
= 13.5, 9.0, 4.5 Hz, CH2CH2N), 2.13 – 2.08 (1H, m, CH2CH2N), 1.66 – 1.59 (1H, 
m, CHCH2CHOH); NOESY interaction found between NCH2 signal at 3.84 and 
OCH3 signal at 3.98;  13C NMR (125 MHz, CDCl3) δC 148.3 (4º ArC), 140.9 (4º 
ArC), 139.1 (4º ArC), 133.4 (4º ArC), 131.5 (CH=CHCHOH), 128.5 
(CH=CHCHOH), 116.0 (4º ArC), 100.7 (OCH2O), 96.7 (ArCH), 67.6 (CHOH), 
66.3 (CHCH2CHOH), 59.2 (ArOCH3), 58.2 (NCH2), 53.2 (NCH2CH2), 44.5 
(NCH2CH2), 44.4 (4º C), 34.5 (CHCH2CHOH); MP 95 – 100 ºC; IR υmax/cm-1 
3406, 3027, 1617, 1477, 1236, 1041; MS (ES+) m/z (relative intensity %) 302 (M + 
H+, 100%); HRMS (ES+): calcd. for C17H20O4N (M + H+) 302.1387, found 
302.1387. 
Insufficient quantities of the assumed minor regioisomer C3-epi-185b could be 
obtained for full characterisation. Selected data: 1H NMR (500 MHz, CDCl3) δH 
6.45 (1H, s, ArH), 6.43 (1H, dd, J = 10.0, 2.0 Hz, CH=CHCHOH), 5.94 (1H, d, J = 
1.5 Hz, OCH2O), 5.91 (1H, d, J = 1.5 Hz, OCH2O), 5.78 (1H, d, J = 10.0 Hz, 
CH=CHCHOH), 4.45 – 4.42 (1H, m, CHOH), 4.30 (1H, d, J = 17.5 Hz, CH2N), 
3.90 (3H, s, OCH3), 3.79 (1H, d, J = 17.5 Hz, CH2N), 3.53 – 3.48 (1H, m, 
CH2CH2N), 3.25 – 3.21 (1H, m, CHCH2CHOH), 2.96 – 2.90 (1H, m, CH2CH2N), 
2.27 – 2.23 (1H, m, CHCH2CHOH), 2.21 – 2.17 (1H, m, CH2CH2N), 2.13 – 2.06 
(1H, m, CH2CH2N), 1.66 – 1.59 (1H, m, CHCH2CHOH); NOESY interaction 
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found between OCH3 signal at 3.90 and the aromatic proton signal at 6.45; MS 
(ES+) m/z (relative intensity %) 302 (M + H+, 100%). 
7.4.3.13 Synthesis and characterisation of tert-butyl rel-(3aS,6R,7aR)-6-
methoxy-3a-(7-methoxy-1,3-benzodioxol-5-yl)-2,3,3a,6,7,7a-hexahydro-1H-
indole-1-carboxylate, 221 
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To a stirred solution of allylic alcohol 219 (36 mg, 0.095 mmol) in THF (2 mL) was 
added NaH (15 mg of 60% wt. in mineral oil, 0.37 mmol).  The reaction mixture 
was stirred at RT for 5 min then methyl iodide (25 μL, 0.37 mmol) was added.  The 
reaction mixture was stirred at room temperature for 6 h then quenched with 
saturated aqueous ammonium chloride (5 mL) and extracted with ethyl acetate (3 x 
3 mL).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated.  The residue was purified by column chromatography on silica gel, 
eluting with petroleum ether:diethyl ether (1:1) to give 221 (34 mg, 91%) as a 
colourless oil: 1H NMR (500 MHz, d6-DMSO, 90 ºC) δH 6.63 (1H, d, J = 1.5 Hz, 
ArH), 6.62 (1H, d, J = 1.5 Hz, ArH), 5.99 (1H, dd, J = 10.0, 3.0 Hz, 
CH=CHCHOCH3), 5.95 (2H, s, OCH2O), 5.68 (1H, d, J = 10.0 Hz, 
CH=CHCHOCH3), 3.94 (1H, dd, J = 7.0, 3.0 Hz, CHCH2CHOCH3), 3.85 (3H, s, 
OCH3), 3.77 – 3.74 (1H, m, CHOCH3), 3.50 (1H, ddd, J = 11.0, 7.5, 4.5 Hz, 
NCH2), 3.30 (3H, s, OCH3), 3.16 (1H, td, J = 11.0, 7.5 Hz, NCH2), 2.36 (1H, td, J 
= 12.5, 7.5 Hz, NCH2CH2), 2.32 – 2.28 (1H, m, CHCH2CHOH), 1.91 – 1.86 (1H, 
m, NCH2CH2), 1.71 (1H, ddd, J = 13.0, 7.0, 3.0 Hz, CHCH2CHOH), 1.42 (9H, s, 
C(CH3)3); 13C NMR (125 MHz, d6-DMSO, 90 ºC) δC 152.9 (NC(O)O), 148.4 (4º 
ArC), 142.5 (4º ArC), 137.9 (4º ArC), 133.2 (4º ArC + CH=CHCHOH), 127.6 
(CH=CHCHOH), 107.3 (ArCH), 100.6 (OCH2O), 100.4 (ArCH), 78.0 (C(CH3)3), 
70.8 (CHOH), 60.1 (CHCH2CHOCH3), 56.4 (ArOCH3), 54.7 (OCH3), 49.8 (4º C), 
44.7 (NCH2), 34.6 (NCH2CH2), 27.7 (C(CH3)3), 27.6 (CHCH2CHOH); IR υmax/cm-
1 2855, 1692, 1633, 1511, 1391, 1172, 1093; MS (ES+) m/z (relative intensity %) 
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462 (M + NH4++ MeCN, 100%); HRMS (ES+): calcd. for C22H29O6NNa (M + H+) 
426.1887, found 426.1883 
 
7.4.3.14 Synthesis and characterisation of (±)-buphanidrine, 184 
MeO O
O
NO
O
H
OMe
MeO O
O
HN
H
OMe
O
O
MeO
N
H
OMe
N
H
OMe
O
O OMe
TFA
+CH2O
6 M HCl
221 221b
184 184b  
Allylic ether 221 (20 mg, 0.05 mmol) was dissolved in TFA (1 mL) and stirred at 
RT for 5 min. The TFA was removed by rotary evaporation and the residue re-
dissolved in a second portion of TFA (1 mL).  The mixture was stirred at RT for a 
further 5 min then evaporated and the residue dissolved in CHCl3:isopropyl alcohol 
(4:1, 5 mL) and sat. aq. NaHCO3 (3 mL) was added.  The organic phase was 
separated and the aqueous extracted with CHCl3:isopropyl alcohol (4:1) (3 x 5 mL).  
The combined organic extracts were dried over Na2SO4, filtered and concentrated to 
give crude 221b.  The residue was used directly in the next step without purification 
or characterisation, MS (ES+) m/z (relative intensity %) 304 (M + H+, 100%). 
Crude 221b was dissolved in MeOH (1 mL) and aq. formaldehyde (2.5 mL, 37% 
wt.) was added.  The reaction mixture was stirred at RT for 15 min then 6 M HCl (5 
mL) was added.  The reaction mixture was stirred at RT for 10 min then quenched 
by the addition of solid K2CO3 and extracted with CHCl3:isopropyl alcohol (4:1) (5 
x 2 mL).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated, the residue was purified by column chromatography on silica gel, 
eluting with CH2Cl2 containing 1 – 10 % MeOH to give (±)-buphanidrine (±)-184 
(8 mg, 51%) as a colourless oil and a mixture of (±)-buphanidrine and regioisomer 
(±)-184b (5 mg, 32% 2.8:1 (184:184b)). (±)-Buphanidrine (±)-184: 1H NMR (500 
MHz, CDCl3) δH 6.58 (1H, d, J = 10 Hz, CH=CHCHOH), 6.56 (1H, s, ArH), 5.96 
(1H, ddd, J = 10.0, 5.0, 1.0, CH=CHCHOCH3), 5.86 (1H, d, J = 1.5 Hz, OCH2O), 
5.84 (1H, d, J = 1.5 Hz, OCH2O), 4.25 (1H, d, J = 17.5 Hz, NCH2), 3.96 (3H, s, 
ArOCH3), 3.81 (1H, d, J = 17.5 Hz, NCH2), 3.83 – 3.81 (1H, m, CHOCH3), 3.35 
(3H, s, OCH3), 3.39 – 3.34 (1H, m, NCH2CH2), 3.31 (1H, dd, J = 13.5, 4.0 Hz, 
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CHCH2CHOH), 2.88 (1H, ddd, J = 13.5, 9.0, 6.0 Hz, NCH2CH2), 2.15 (1H, ddd, J 
= 13.5, 9.0, 6.0 Hz, NCH2CH2), 2.10 (1H, br. d, J = 13.5 Hz, CHCH2CHOH), 1.91 
(1H, ddd, J = 12.0, 10.5, 6.0 Hz, NCH2CH2), 1.60 (1H, td, J = 13.5, 4.0 Hz, 
CHCH2CHOH); 13C NMR (125 MHz, CDCl3) δC 148.0 (4º ArC), 140.9 (4º ArC), 
139.4 (4º ArC), 133.4 (4º ArC), 133.0 (CH=CHCHOCH3), 125.3 
(CH=CHCHOCH3), 117.3 (4º ArC), 100.5 (OCH2O), 96.9 (ArCH), 72.6 
(CHOCH3), 62.7 (CHCH2CHOCH3), 59.1 (ArOCH3), 58.6 (NCH2), 56.4 (OCH3), 
53.7 (NCH2CH2), 44.3 (NCH2CH2), 44.1 (4º C), 28.7 (CHCH2CHOH); IR υmax/cm-
1 2925, 1615, 1478, 1314, 1281, 1083, 1045, 936; MS (ES+) m/z (relative intensity 
%) 316 (M + H+, 100%); HRMS (ES+): calcd. for C18H22O4N (M + H+) 316.1543, 
found 316.1542.  
(±)-184b: 1H NMR (500 MHz, CDCl3) δH 6.63 (1H, d, J = 10.0 Hz, 
CH=CHCHOH), 6.49 (1H, s, ArH), 5.97 (1H, dd, J = 11.5, 6.0, CH=CHCHOCH3), 
5.93 (1H, d, J = 1.0 Hz, OCH2O), 5.90 (1H, d, J = 1.0 Hz, OCH2O), 4.31 (1H, d, J 
= 17.0 Hz, CH2N), 3.89 (3H, s, OCH3), 3.84 – 3.78 (2H, m, CHOCH3 and CH2N), 
3.42 – 3.31 (2H, m, CHCH2CHOCH3 and CH2CH2N), 3.36 (3H, s, OCH3), 2.94 – 
2.87 (1H, m, CH2CH2N), 2.20 – 2.10 (2H, m, CHCH2CHOCH3 and CH2CH2N), 
1.97 – 1.89 (1H, m, CH2CH2N), 1.63 – 1.57 (1H, m, CHCH2CHOCH3); 13C NMR 
(125 MHz, CDCl3) δC 146.0 (4º ArC), 141.9 (4º ArC), 140.2 (4º ArC), 133.1 (4º 
ArC), 132.8 (CH=CHCHOCH3), 125.2 (CH=CHCHOCH3), 108.0 (4º ArC), 101.8 
(OCH2O), 101.5 (ArCH), 72.5 (CHOCH3), 63.2 (CHCH2CHOCH3), 57.1 (CH2N), 
56.9 (ArOCH3), 56.5 (OCH3), 53.7 (NCH2CH2), 44.5 (NCH2CH2), 44.2 (4º C), 
28.8 (CHCH2CHOCH3); MS (ES+) m/z (relative intensity %) 316 (M + H+, 100%). 
 
The regioselectivity of the Pictet-Spengler reaction and the structures of (±)-184 
and (±)-184b were further confirmed by NOE analysis (Figure 7.6). 
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MeO
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OMe
H
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O OMe
H
4%1% H
H
184b184  
Figure 7.6: NOE analysis to confirm structure of 184 and 184b. 
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7.5 Chapter 5 Experimental 
7.5.1 Reagents 
Catalysts 135, QD-147, 137, 227-229 and 231-233 are commercially available and 
were used as received from suppliers.  Catalysts 70, QD-71, QD-148, QD-170, 
QD-225, 152, 68, QD-171, 230, and 270 were prepared according to literature 
procedures.111  For the preparation of catalysts QD-172 - QD-174 see section 7.3.8.   
Phase transfer catalyst 72 was prepared according to literature procedures.51 
7.5.2 Synthesis of enantioenriched oxidative coupling adducts (+)/(-)-208 
and (+)/(-)-223 
Enantioenriched oxidative coupling adducts (+)-208 and (+)-223 were synthesised 
according to general procedure C, replacing ps-BEMP with the appropriate 
organocatalyst.  Since the unprotected catechol was found to be unsuitable for 
HPLC analysis (streaking on silica was observed), initially enantiomeric excesses 
were measured following methylene acetal protection (compound 208).  Since 
acetate protection is practically easier than methylene acetal protection, later 
screening was conducted following formation of the diacetate (223). 
7.5.2.1 Synthesis and characterisation of 1-tert-Butyl 3-methyl 3-(7-methoxy-
1,3-benzodioxol-5-yl)-2-oxopyrrolidine-1,3-dicarboxylate 1-tert-butyl 3-methyl 
3-(7-methoxy-1,3-benzodioxol-5-yl)-2-oxo-pyrrolidine-1,3-dicarboxylate, (+)-
208 
N
MeO O
O
O
OMeO
O
O
OH
OHMeO
NBoc
O
OMe
O+
1) ps-IO4- (2 equiv)
    cat QD-265 (10 mol %)
    CH2Cl2, -20 ºC
2) Na2S2O4
3) CH2ClBr, Cs2CO3
     DMF, 85 ºC
207 (+)-208
163
N
O
N
OH
CF3
QD-265
 
To a stirred solution of 3-methoxycatechol 163 (1.40 g, 10.0 mmol) and 207 (2.43 
g, 10.0 mmol) in CH2Cl2 (400 mL) at -20 ºC was added cat. QD-265 (936 mg, 2.00 
mmol) followed by ps-IO4- (3.22 g 20.0 mmol).  The reaction mixture was stirred at 
this temperature for 7 h then filtered and the resin on the filter washed with CH2Cl2 
(3 x 100 mL).  The filtrate was stirred with saturated aqueous Na2S2O4 (200 mL), 
the organic phase separated and the aqueous extracted with CH2Cl2 (2 x 50 mL).  
The combined organic portions were dried over Na2SO4, filtered and concentrated.  
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The residue was dissolved in DMF and divided equally between 5 sealable vials.  
To each vial was added CH2ClBr (0.19 mL, 3 mmol) and Cs2CO3 (977 mg, 3 
mmol).  The vials were sealed and heated at 85 ºC for 1 h then cooled to room 
temperature.  The resulting purple-brown solution was concentrated and purified by 
column chromatography on silica gel, eluting with petroleum ether containing 30 – 
60% diethyl ether to give the arylated product (+)-208 (2.24 g, 57% yield) as a pale 
yellow oil in 70% ee, determined by HPLC analysis [Chiralpak AD, hexane/iso-
propanol 85:15, 1.0 mL.min-1, λ = 215 nm, t (minor) = 11.95 min, t (major) = 18.30 
min] by comparison to a racemic sample prepared in according to the general 
oxidative coupling procedure. [α]D24 = + 38.1 (c 0.52, CHCl3).  Other data identical 
to racemic compound. 
7.5.2.2 Synthesis and characterisation of enantioenriched adduct 1-tert-
butyl 3-methyl 3-(3,4-diacetoxy-5-methoxy-phenyl)-2-oxo-pyrrolidine-1,3-
dicarboxylate, (+)-223 
N
MeO
O
OMeO
O
O
OH
OHMeO
NBoc
O
OMe
O+
1) ps-IO4- (2 equiv)
    cat QD-265 (10 mol %)
    CH2Cl2, -20 ºC
2) Na2S2O4
3) Ac2O, pyridine
207 208
163
OAc
OAc
N
O
N
OH
CF3
QD-265
 
According to the general oxidative coupling procedure, replacing ps-BEMP with 
catalyst QD-265, 3-methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with 207 
(24 mg, 0.10 mmol) and the crude reaction products dissolved in pyridine (0.5 mL) 
and Ac2O (0.25 mL) and stirred at room temperature overnight.  The reaction 
mixture was diluted with EtOAc (5 mL) and washed with saturated aqueous CuSO4 
(3 x 5 mL).  The organic phase was dried over Na2SO4, filtered and concentrated.  
The residue was purified by column chromatography on silica gel, eluting with 
70:30 diethyl ether:petroleum ether, to give the arylated product (+)-223 (26 mg, 
56%) as a colourless oil in 64% ee, determined by HPLC analysis [Chiralpak AD, 
hexane/iso-propanol 85:15, 1.0 mL.min-1, λ = 215 nm, t (major) = 11.382 min, t 
(minor) = 22.29 min] by comparison to a racemic sample prepared in 30% yield on 
a 0.5 mmol scale according to general procedure C. [α]D24 = + 34.4 (c 0.90, CHCl3);  
1H NMR (500 MHz, CDCl3) δH 7.17 (1H, d, J = 2.0 Hz, ArH), 6.87 (1H, d, J = 2.0 
Hz, ArH), 3.83 (3H, s, ArOCH3), 3.75 – 3.67 (2H, m, CH2N), 3.74 (3H, s, OCH3), 
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2.95 (1H, ddd, J = 12.5, 7.0 Hz, 5.0 Hz, CH2CH2N), 2.42 (1H, td, J = 13.0, 7.5 Hz, 
CH2CH2N), 2.28 (3H, s, OC(O)CH3), 2.26 (3H, s, OC(O)CH3), 1.52 (9H, s, 
C(CH3)3); 13C NMR (125 MHz, CDCl3) δC 169.4 (NC(O)), 168.9 (C(O)OCH3), 
168.0 (OC(O)CH3), 167.6 (OC(O)CH3), 152.2 (4º ArC),  149.8 (NC(O)O), 143.1 
(4º ArC), 134.1 (4º ArC), 131.8 (4º ArC), 113.8 (ArCH), 109.4 (ArCH), 83.6 
(C(CH3)3), 60.8 (4º C), 56.3 (ArOCH3), 53.6 (OCH3), 43.2 (NCH2), 30.0 
(NCH2CH2), 27.9 (C(CH3)3), 20.5 (OC(O)CH3), 20.3 (OC(O)CH3); IR υmax/cm-1 
2981, 1777, 1730, 1611, 1370, 1306, 1206, 1096; MS (ES+) m/z (relative intensity 
%) 524 (M + MeCN + NH4+, 100%), HRMS (ES+): calcd. for C22H27O10NNa (M + 
Na+) 488.1527, found 488.1536. 
 
7.5.3 Initial Organocatalyst Screen 
An initial screen of organocatalysts was conducted according to general procedure 
C (section 7.3.6), replacing ps-BEMP with the organocatalysts detailed in Table 
7.8.  For catalyst structures see Chart 5.1. 
OH
OHMeO
N
O
OMe
OO
O
N
OR
ORMeO
O
OMe
O
O
O
+
1) catalyst (10 mol %)
    ps-IO4- (2 equiv)
    CH2Cl2
2) Na2S2O4 (aq)
3) CH2ClBr, Cs2CO3
or Ac2O, pyridine
208, R = -CH2- 
223, R= Ac
163
207  
Entry Catalyst Scale /mmol Product t(minor)/min t(major)/min % ee 
% 
Yield 
1b 135 0.1 (-)-223 11.64 23.49 15 41 
2 b QD-147 0.2 (+)-223 24.52 12.08 11 38 
3 b 137 0.1 (-)-223 11.43 23.26 1 31 
4 a 70 0.1 (+)-208 7.81 9.65 34 15 
5 a QD-71 0.1 (+)-208 7.87 9.70 50 35 
5b b  QD-71 0.5 (+)-223 19.61 10.26 50 30 
6 a QD-148 0.1 (+)-208 7.82 9.62 49 20 
7 a QD-172 0.1 (+)-208 7.86 9.60 42 28 
8 a QD-173 0.1 (+)-208 7.88 9.64 31 13 
9 a QD-174 0.1 (+)-208 7.83 9.65 11 28 
10 a QD-170 0.1 (+)-208 7.87 9.61 55 25 
11 b QD-225 0.1 (+)-223 21.16 10.81 6 35 
12 b 151 0.1 (+)-223 20.35 10.68 15 31 
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13a 68 0.1 (-)-208 9.69 7.83 35 18 
14a QD-171 0.1 (±)-208 10.53 19.99 0 25 
15 b 227 0.1 (+)-223 23.73 11.62 5 43 
16 b 228 0.1 (+)-223 23.85 11.62 12 43 
17 b 229 0.1 (-)-223 11.75 23.93 1 25 
18 b 230 0.1 (+)-223 24.18 11.77 3 30 
19 b 231 0.1 (-)-223 11.84 24.37 32 20 
20 b 232 0.1 (-)-223 11.63 24.01 4 18 
21 b 233 0.1 (+)-223 23.93 11.62 4 33 
Table 7.8: Initial organocatalyst screen.  a HPLC conditions Chiralcel OD-H, heptane/ethanol 85:15, 
1.0 mL/min-1, λ = 215 nm. b HPLC conditions Chiralpak AD, hexane/iso-propanol 85:15, 1.0 
mL/min-1, λ = 215 nm. 
7.5.4 Phase transfer catalysis 
7.5.4.1 General procedure D for the phase transfer catalysed oxidative 
coupling 
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OHMeO
N
O
OMe
OO
O
N
OAc
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O
O
O
+
1) cat. 72, base
    ps-IO4- (2 equiv)
    CHCl3/toluene (9:1)
2) Na2S2O4 (aq)
3) Ac2O, pyridine
(-)-223
207
163 NO
N
O
Cl
72
H
 
To a stirred solution of 3-methoxycatechol 163 (14 mg, 0.10 mmol) and 207 (24 
mg, 0.10 mmol) in CHCl3/toluene (1 mL, 1:9) at -20 ºC was added base (typically 
1.5 equiv), catalyst 72 (typically 20 mol %) and ps-IO4- (35 mg, 0.20 mmol).  The 
reaction mixture was stirred at this temperature for 24 h, then filtered and the filtrate 
stirred with saturated Na2S2O4(aq) (5 mL).  The organic phase was separated and the 
aqueous extracted with CH2Cl2 (2 x 2 mL).  The combined organic phase was dried 
over Na2SO4, filtered and concentrated by rotary evaporation.  The residue was 
dissolved in pyridine (0.5 mL) and acetic anhydride (0.25 mL) was added.  The 
reaction mixture was stirred at room temperature overnight then diluted with EtOAc 
(5 mL) and washed with saturated CuSO4(aq) (4 x 5 mL).  The organic phase was 
dried over Na2SO4, filtered and concentrated.  The residue was purified by column 
chromatography on silica gel, eluting with 70:30 diethyl ether:petroleum ether to 
give (-)-223 in the yields and enantiomeric excess shown in Table 7.9.  
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Spectroscopic data was identical to that for 223, prepared according to general 
procedure C. 
Entry Cat.  (mol %) 
Base 
(equiv) t(minor)/min t(major)/min Yield % ee 
1 72  (20 mol %) 
KOH 
(1.5) 11.51 22.55 9 3 
2 72   (20 mol %) 
CsOH.
H2O 
(1.5) 
11.45 22.55 13  -16 
3 72  (20 mol %) 
K3PO4 
(1.5) - - -
a - 
4 72  (20 mol %) 
K2CO3 
(1.5) 11.22 21.98 17 1 
5 - KOH (1.5) - - 
complete 
conversion 
in 7 h. 
- 
6 - K3PO4 (1.5) - - 
trace 
product in 
3 days 
- 
7 - K2CO3 (1.5) - - 
50% 
conversion 
in 3 days 
- 
8 72  (20 mol%) 
KOH 
(0.2) 11.39 22.25 22 12 
9 72  (1 equiv) 
KOH 
(1.0) 11.25 22.02 11 22 
Table 7.9: Screen of bases and conditions in the phase transfer catalysed oxidative coupling. a no 
conversion to arylated product after 3 days. 
7.5.4.2 Synthesis and characterisation of (-)-1-tert-butyl 3-ethyl 3-(3,4-
diacetoxy-5-methoxyphenyl)-2-oxopyrrolidine-1,3-dicarboxylate 237 
OH
OHMeO
+
BocN
O
OEt
O
OAc
OAcMeO
BocN
O O
OEt
236
163
2) Na2S2O4 (aq)
3) Ac2O, pyridine
1) cat. 72 (20 mol %)
    KOH (20 mol %)
CHCl3/Toluene (1:9)
(-)-237
15% yield, 9% ee
NO
N
O
Cl
72
H
 
According to general phase transfer catalysed oxidative coupling procedure D, 3-
methoxycatechol 163 (14 mg, 0.10 mmol) was reacted with 236 (26 mg, 0.10 
mmol), KOH (20 mol %) and catalyst 72 (20 mol %) to give, following column 
chromatography on silica gel eluting with 30:70 petroleum ether:diethyl ether, (-)-
237 (5 mg, 13%) in 4% ee, determined by HPLC analysis [Chiralpak AD, 
hexane/iso-propanol 85:15, 1.0 mL.min-1, λ = 215 nm, t (minor) = 10.87 min, t 
(major) = 20.10 min] by comparison to a racemic sample prepared in 30% yield on 
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a 0.5 mmol scale according to general procedure C.  1H NMR (500 MHz, CDCl3) 
δH 7.18 (1H, d, J = 2.0 Hz, ArH), 6.88 (1H, d, J = 2.0 Hz, ArH), 4.24 – 4.19 (2H, 
m, OCH2CH3), 3.84 (3H, s, OCH3), 3.76 – 3.89 (2H, m, NCH2), 2.94 (1H, ddd, J = 
13.0, 7.0, 5.0 Hz, NCH2CH2), 2.43 (1H, td, J = 13.0, 7.5 Hz, NCH2CH2), 2.29 (3H, 
s, C(O)CH3), 2.26 (3H, s, C(O)CH3), 1.53 (9H, s, C(CH3)3), 1.23 (3H, t, J = 7.0 
Hz, OCH2CH3); 13C NMR (125 MHz, CDCl3) δC  168.9 (C(O)), 168.8 (C(O)), 
168.0 (C(O)), 167.6 (C(O)), 152.2 (4º ArC), 149.8 (NC(O)O), 143.0 (4º ArC), 
134.1 (4º ArC), 131.7 (4º ArC), 113.9 (ArCH), 109.5 (ArCH), 83.5 (C(CH3)3), 62.6 
(OCH2CH3), 60.8 (4º C), 56.3 (OCH3), 43.2 (NCH2), 29.8 (NCH2CH2), 27.9 
(C(CH3)3), 20.5 (C(O)CH3), 20.2 (C(O)CH3), 13.8 (OCH2CH3); IR υmax/cm-1 2980, 
2918, 1776, 1724, 1369, 1307, 1153; MS (ES+) m/z (relative intensity %) 981 (2M 
+ Na+, 100%), 502 (M + Na+, 50%);  HRMS (ES+): calcd. for C23H29O10NNa (M + 
Na+) 502.1684, found 502.1677. 
Alternatively (+)-237 was prepared in 30% yield following general procedure C 
replacing ps-BEMP with cat. 265; and in 49% ee determined by HPLC analysis 
[Chiralpak AD, hexane/iso-propanol 85:15, 1.0 mL.min-1, λ = 215 nm, t (major) = 
10.57 min, t (minor) = 19.54 min] by comparison to a racemic sample. [α]D25 = + 
11.4 (c 1.2, CHCl3); other data matches sample prepared from phase transfer 
catalysis. 
7.5.5 Synthesis of alternative pro-nucleophiles 
7.5.5.1 General procedure E, for the synthesis of alternative pro-
nucleophiles 
PgN
O
O
RCl
LHMDS (2.1 equiv.)
THF, -78 ºC
PgN
O O
R
206, 241,
243 - 245
238 - 240, 242,
246 - 248  
A solution of protected lactam (500 mg, 2.70 mmol) in anh THF (2 mL) was added 
to a solution of LHMDS (5.7 mL of a 1 M solution in THF, 5.70 mmol) in anh THF 
(2 mL) at -78 ºC.  The reaction mixture was stirred at this temperature for 5 min 
then the appropriate electrophile (1 equiv) was added as a solution in anh THF (2 
mL).  The reaction mixture was stirred for 15 min then quenched with 1 M HCl (10 
mL) and warmed to room temperature.  The mixture was extracted with EtOAc (3 x 
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10 mL) and the combined organic extracts dried over Na2SO4, filtered and 
concentrated.  The residue was purified by column chromatography on silica gel to 
afford the desired pro-nucleophile. 
7.5.5.2 Synthesis and characterisation of 1-tert-butyl 3-phenyl 2-
oxopyrrolidine-1,3-dicarboxylate 238 
BocN
O O
OPh
238  
According to general procedure E, tert-butyl-2-oxopyrrolidine-1-carboxylate 206 
(500 mg, 2.70 mmol) was reacted with phenyl chloroformate (0.34 mL, 2.70 mmol) 
to give 238 (450 mg, 55%) as a colourless solid. 1H NMR (500 MHz, CDCl3) δH 
7.31 (2H, t, J = 7.5 Hz, ArH), 7.17 (1H, t,  J = 7.5 Hz, ArH), 7.13 (2H, d, J = 7.5 
Hz, ArH), 3.87 (1H, ddd, J = 10.5, 9.0, 4.5 Hz, CH2N), 3.72 (1H, t, J = 9.0 Hz 
CH), 3.68 (1H, td., J = 10.5, 7.5 Hz, CH2N), 2.48 – 2.40 (1H, m, CH2CH2N), 2.31 
– 2.24 (1H, m, CH2CH2N), 1.47 (9H, s, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC 
168.2 (C(O)), 167.4 (C(O)), 150.3 (OC(O)N), 149.7 (4º ArC), 129.4 (ArCH), 126.1 
(ArCH), 121.3 (ArCH), 83.5 (C(CH3)3), 50.2 (CH), 44.7 (CH2), 27.9 (C(CH3)3), 
21.4 (CH2); MP: 72 – 74 ºC; IR υmax/cm-1 2980, 2934, 1788, 1756, 1721, 1492, 
1370, 1295, 1255, 1192, 1143, 1020, 936;  MS (ES+) m/z (relative intensity %)  
328 (M + Na+, 100%), 360 (M + Na+ + MeOH, 10%); HRMS (ES+): calcd. for 
C16H19O5N1Na (M + Na+) 328.1155, found 328.1151. 
7.5.5.3 Synthesis and characterisation of di-tert-butyl 2-oxopyrrolidine-1,3-
dicarboxylate 239 
BocN
O O
OtBu
239  
According to general procedure E, tert-butyl-2-oxopyrrolidine-1-carboxylate 206 
(500 mg, 2.70 mmol) was reacted with tert-butyl chloroformate (0.34 mL, 2.70 
mmol) to give 239 (370 mg, 48%) as a colourless solid. 1H NMR (500 MHz, 
CDCl3) δH 3.82 (1H, ddd, J = 10.5, 8.5, 5.5 Hz, NCH2), 3.64 (1H, td, J = 10.5, 7.5 
Hz, NCH2), 3.39 (1H, t, J = 8.0 Hz, CH), 2.28 (1H, td, J = 15.0, 8.0 Hz, 
NCH2CH2), 2.20 – 2.13 (1H, m, NCH2CH2), 1.49 (9H, s, C(CH3)3), 1.45 (9H, s, 
C(CH3)3); 13C NMR (125 MHz, CDCl3) δC  169.1 (C(O)), 167.8 (C(O)), 149.9 
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(C(O)), 83.1 (C(CH3)3), 82.3 (C(CH3)3), 51.1 (CH), 44.7 (NCH2), 27.9 (C(CH3)3), 
27.9 (C(CH3)3), 21.5 (NCH2CH2); IR υmax/cm-1 2981, 1789, 1757, 1723, 1369, 
1296, 1258, 1147;  MP 42 – 44 ºC; MS (ES+) m/z (relative intensity %) 308 (M + 
Na+, 100%);  HRMS (ES+): calcd. for C14H24O5N (M + H+) 286.1649, found 
286.1647. 
7.5.5.4 Synthesis and characterisation of tert-butyl 3-acetyl-2-
oxopyrrolidine-1-carboxylate 240 
BocN
O O
CH3
240  
According to general procedure E, tert-butyl-2-oxopyrrolidine-1-carboxylate 206 
(500 mg, 2.70 mmol) was reacted with acetyl chloride (0.34 mL, 2.70 mmol) to 
give 240 (427 mg, 70%) as a pale yellow solid. 1H NMR (500 MHz, CDCl3) δH 
3.77 – 3.71 (1H, m, NCH2), 3.70 – 3.63 (2H, m, CH and NCH2), 2.50 – 2.43 (1H, 
m, NCH2CH2), 2.40 (3H, s, CH3), 2.00 (1H, dtd, J = 15.0, 9.0, 6.0 Hz, NCH2CH2), 
1.49 (9H, s, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC  201.7 (C(O)), 169.1 
(NC(O)), 149.7 (NC(O)O), 83.3 (C(CH3)3), 57.2 (CH), 44.7 (NCH2), 29.7 (CH3), 
27.8 (C(CH3)3), 18.8 (NCH2CH2); IR υmax/cm-1 2981, 1780, 1718, 1641, 1369, 
1311, 1254, 1154;  MP 60 – 66 ºC; MS (ES-) m/z (relative intensity %) 226 (M – 
H+, 100%);  HRMS (ES+): calcd. for C11H17O4NNa (M + Na+) 250.1050, found 
250.1059. 
7.5.5.5 Synthesis and characterisation of 1-methyl 3-phenyl 2-
oxopyrrolidine-1,3-dicarboxylate 242 
N
O
OPh
O
242
MeO
O
 
According to general procedure E, methyl 2-oxopyrrolidine-1-carboxylate 241 (429 
mg, 3.00 mmol) was reacted with phenyl chloroformate (0.38 mL, 3.00 mmol) to 
give 242 (320 mg, 41%) as a colourless solid after column chromatography on 
silica gel, eluting with  cyclohexane containing 20 – 60% EtOAc. 1H NMR (400 
MHz, CDCl3) δH 7.39 – 7.34 (2H, m, ArH), 7.25 – 7.21 (1H, m, ArH), 7.14 – 7.10 
(2H, m, ArH), 3.97 (1H, ddd, J =11.0, 8.5, 5.0 Hz, CH2N), 3.86 (3H, s, OCH3), 
3.82 – 3.75 (2H, m, CH and CH2N), 2.52 (1H, dtd, J = 13.0, 8.5, 7.5 Hz, 
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CHCH2CH2N), 2.37 (1H, m, CHCH2CH2N); 13C NMR (100 MHz, CDCl3) δC 
168.2 (C(O)), 167.2 (C(O)), 151.7 (OC(O)N), 150.3 (4º ArC), 129.4 (ArCH), 126.2 
(ArCH), 121.2 (ArCH), 53.7 (OCH3), 49.9 (CH), 44.7 (NCH2), 21.5 (NCH2CH2); 
MP: 88 – 90 ºC; IR υmax/cm-1 1794, 1755, 1731, 1439, 1375, 1293, 1194, 1162, 
1142; MS (ES+) m/z (relative intensity %) 286 (M + Na+, 100%); HRMS (ES+): 
calcd. for C13H13O5NNa (M + Na+) 286.0686, found 286.0684. 
7.5.5.6 Synthesis and characterisation of 1-benzyl 3-methyl 2-
oxopyrrolidine-1,3-dicarboxylate 246 
CbzN
O
OMe
O
246  
According to general procedure E, benzyl 2-oxopyrrolidine-1-carboxylate 243 (440 
mg, 2.00 mmol) was reacted with methyl chloroformate (0.15 mL, 2.00 mmol) to 
give 246 (400 mg, 72%) as a colourless solid following column chromatography on 
silica gel, eluting with petroleum ether containing 70% diethyl ether. 1H NMR (500 
MHz, CDCl3) δH 7.42 – 7.41 (2H, m, ArH), 7.37 – 7.30 (3H, m, ArH), 5.29 (1H, d, 
J = 12.5 Hz, OCH2Ph), 5.26 (1H, d, J = 12.5 Hz, OCH2Ph), 3.93 (1H, ddd, J = 
10.5, 8.5, 5.5 Hz, CH2N), 3.78 – 3.73 (1H, m, CH2N), 3.77 (3H, s, OCH3), 3.56 
(1H, dd, J = 9.0, 7.5 Hz, CH), 2.44 – 2.37 (1H, m, CH2CH2N), 2.29 – 2.22 (1H, m, 
CH2CH2N); 13C NMR (75 MHz, CDCl3) δC  168.8 (C(O)), 168.5 (C(O)), 151.1 
(NC(O)O), 134.9 (4º ArC), 128.5 (ArCH), 128.4 (ArCH), 128.1 (ArCH), 68.3 
(OCH2Ph), 52.8 (OCH3), 49.8 (CH), 44.8 (CH2N), 21.5 (CH2CH2N); IR υmax/cm-1 
2956, 1792, 1730, 1638, 1375, 1289, 1164;  MP 39 – 41 ºC; MS (ES-) m/z (relative 
intensity %) 276 (M – H+, 100%);  HRMS (ES+): calcd. for C14H15O5NNa (M + 
Na+) 300.0842, found 300.0838. 
7.5.5.7 Synthesis and characterisation of methyl 1-[(4-
methylphenyl)sulfonyl]-2-oxopyrrolidine-3-carboxylate 247 
TsN
O
OMe
O
247  
According to general procedure E, 1-[(4-methylphenyl)sulfonyl]pyrrolidin-2-one 
244 (239 mg, 1.00 mmol) was reacted with methyl chloroformate (77 μL, 1.00 
mmol) to give 247 (173 mg, 59%) as a colourless solid following column 
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chromatography on silica gel, eluting with petroleum ether containing 50 – 70% 
diethyl ether. 1H NMR (500 MHz, CDCl3) δH 7.90 (2H, d, J = 8.0 Hz, ArH), 7.33 
(2H, d, J = 8.0 Hz, ArH), 3.99 (1H, ddd, J = 9.5, 8.5, 5.5 Hz, NCH2), 3.84 (1H, 
ddd, J = 9.5, 8.0, 7.0 Hz, NCH2), 3.67 (3H, s, OCH3), 3.45 (1H, dd, J = 9.0, 7.5 Hz, 
CH), 2.46 – 2.39 (1H, m, CH2CH2N), 2.43 (3H, s, CH3), 2.33 – 2.26 (1H, m, 
CH2CH2N); 13C NMR (125 MHz, CDCl3) δC  168.2 (C(O)), 168.1 (C(O)), 145.5 
(4º ArC), 134.5 (4º ArC), 129.7 (ArCH), 128.1 (ArCH), 52.8 (OCH3), 49.2 (CH), 
45.6 (NCH2), 22.2 (NCH2CH2), 21.6 (CH3); IR υmax/cm-1 2956, 1750, 130, 1596, 
1437, 1361, 1170, 1123;  MP 70 – 71 ºC; MS (ES+) m/z (relative intensity %) 320 
(M + Na+, 100%);  HRMS (ES+): calcd. for C13H15O5NSNa (M + Na+) 320.0563, 
found 320.0559. 
7.5.5.8 Synthesis and characterisation of methyl 1-benzyl-2-oxopyrrolidine-
3-carboxylate 248 
BnN
O
OMe
O
248  
According to general procedure E, 1-benzylpyrrolidin-2-one 245 (1.00 g, 5.70 
mmol) was reacted with methyl chloroformate (0.44 mL, 5.70 mmol) to give 248 
(900 mg, 73%) as a pale yellow oil following column chromatography on silica gel, 
eluting with cyclo-hexane containing 20 – 60% EtOAc.  1H NMR (500 MHz, 
CDCl3) δH 7.34 – 7.31 (2H, m, ArH), 7.28 (1H, d, J = 7.0 Hz, ArH), 7.24 (2H, d, J 
= 7.0 Hz, ArH), 4.47 (2H, s, NCH2Ph), 3.78 (3H, s, OCH3), 3.50 (1H, dd, J = 9.5, 
7.0 Hz, CH), 3.38 (1H, dt, J = 9.0, 5.0 Hz, NCH2), 3.25 – 3.20 (1H, m, NCH2), 
2.40 – 2.33 (1H, m, NCH2CH2), 2.27 – 2.19 (1H, m, NCH2CH2); 13C NMR (125 
MHz, CDCl3) δC  170.5 (C(O)), 169.5 (C(O)), 135.6 (4º ArC), 128.4 (ArCH), 127.7 
(ArCH), 127.4 (ArCH), 52.3 (OCH3), 48.1 (CH), 46.6 (NCH2), 44.8 (NCH2), 21.9 
(NCH2CH2); IR υmax/cm-1 2953, 1740, 1691, 1496, 1433, 1356, 1266, 1167, 1079, 
993, 702;  MS (ES+) m/z (relative intensity %) 256 (M + Na+, 100%);  HRMS 
(ES+): calcd. for C13H16O3N (M + H+) 234.1125, found 234.1126. 
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7.5.5.9 Synthesis and characterisation of methyl 2-oxopyrrolidine-3-
carboxylate 
BocN
O O
OMe
4 M HCl, dioxane
HN
O O
OMe
207 249  
To a stirred solution of 1-tert-butyl 3-methyl 2-oxopyrrolidine-1,3-dicarboxylate 
207 (243 mg, 1.00 mmol) in CH2Cl2 (5 mL) was added HCl (1 mL of a 4 M 
solution in dioxane).  The reaction mixture was stirred at room temperature for 18 h 
then loaded directly onto an isolute strong cation exchange (SCX) cartridge.  The 
cartridge was flushed with methanol (1 column volume) followed by 7 M methanol 
ammonia (1 column volume).  The ammonia eluent was concentrated by rotary 
evaporation to give 249 (100 mg, 70%) as a colourless solid.  1H NMR (500 MHz, 
CDCl3) δH 6.80 (1H, br. s, NH), 3.78 (3H, s, OCH3), 3.53 – 3.48 (1H, m, NCH2), 
3.42 – 3.35 (2H, m, CH and NCH2), 2.53 (1H, dddd, J = 13.5, 8.5, 7.5, 6.5 Hz, 
NCH2CH2), 2.40 – 2.31 (1H, m, NCH2CH2); 13C NMR (125 MHz, CDCl3) δC  
173.6 (C(O)), 170.4 (C(O)), 52.7 (OCH3), 47.4 (CH), 40.7 (NCH2), 24.9 
(NCH2CH2); IR υmax/cm-1 3434, 2959, 1720, 1676, 1438, 1353, 1282, 1222, 1172;  
MP 127 – 128 ºC; MS (ES+) m/z (relative intensity %) 166 (M + Na+, 100%);  
HRMS (ES+): calcd. for C6H9O3NNa (M + Na+) 166.0475, found 166.0473. 
7.5.6 Screen of alternative pro-nucleophiles 
7.5.6.1 Synthesis and characterisation of 1-tert-butyl 3-phenyl 3-(3,4-
dihydroxy-5-methoxyphenyl)-2-oxopyrrolidine-1,3-dicarboxylate, (+)-250 
N
OO
O
O
OPh
OH
OHMeO
N
MeO
O
O
OPh
O
OH
OH
+
1) ps-IO4- (2 equiv.)
    Cat QD-71 (10 mol %)
2) Na2S2O4
O
(+)-250
238
163
 
According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (28 mg, 0.20 mmol) was reacted with 238 (73 mg, 0.20 mol) 
to give after 12 hours reaction time (+)-250 (26 mg, 29%) as a peach coloured solid 
in 40% ee determined by HPLC analysis [Chiralpak AD, heptane/ethanol 55:45, 1.0 
mL.min-1, λ = 215 nm, t (minor) = 10.78 min, t (major) = 14.85 min] by comparison 
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to a racemic sample prepared according to the general oxidative coupling 
procedure. [α]D24 = + 34.2 (c 0.7, CHCl3);  1H NMR (500 MHz, CDCl3) δH 7.36 – 
7.32 (2H, m, ArH), 7.21 (1H, t, J = 7.5 Hz, ArH), 7.06 – 7.04 (2H, m, ArH), 6.84 
(1H, d, J = 2.0 Hz, ArH), 6.74 (1H, d, J = 2.0 Hz, ArH), 5.47 (2H, br. s, OH), 3.88 
– 3.82 (1H, m, CH2N), 3.87 (3H, s, OCH3), 3.69 (1H, td, J = 10.5, 7.0 Hz, CH2N), 
3.04 (1H, td, J = 13.0, 7.0 Hz, CH2CH2N), 2.57 (1H, ddd, J = 13.0, 7.0, 5.5 Hz, 
CH2CH2N), 1.54 (9H, s, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC 169.4 (C(O)), 
168.6 (C(O)), 150.6 (OC(O)N), 150.0 (4º ArC), 147.0 (4º ArC), 143.8 (4º ArC), 
132.5 (4º ArC), 129.4 (ArCH), 126.8 (4º ArC), 126.1 (ArCH), 121.2 (ArCH), 107.6 
(ArCH), 103.0 (ArCH), 83.7 (C(CH3)3), 61.3 (4º C), 56.3 (OCH3), 43.3 (CH2), 29.9 
(CH2), 28.0 (C(CH3)3); MP 137 – 139 ºC (140 – 141 ºC for racemate); IR υmax/cm-1 
3400, 2980, 2934, 1778, 1745, 1723, 1521, 1370, 1308, 1188, 1150; MS (ES+) m/z 
(relative intensity %) 466 (M + Na+, 100%); HRMS (ES+) calcd. for C23H25O8NNa 
(M + Na+) 466.1472, found 466.1473. 
7.5.6.2 Synthesis and characterisation of di-tert-butyl 3-(7-methoxy-1,3-
benzodioxol-5-yl)-2-oxopyrrolidine-1,3-dicarboxylate, 252 
N
OO
O
O
OtBu
OH
OHMeO
N
MeO
O
O
OtBu
O+
1) PS-IO4- (2 equiv.)
    CatQD- 71 (10 mol %)
2) Na2S2O4
3) CH2ClBr, Cs2CO3 O
252
239
163
O
O
 
According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (28 mg, 0.20 mmol) was reacted with 239 (57 mg, 0.20 
mmol) (6 h reaction time) and the crude residue treated with CH2ClBr/Cs2CO3 to 
give 252 (21 mg, 25 %) in 0% ee as a colourless oil.  1H NMR (500 MHz, CDCl3) 
δH 6.76 (1H, d, J = 1.5 Hz, ArH), 6.67 (1H, d, J = 1.5 Hz, ArH), 5.96 (2H, s, 
OCH2O), 3.90 (3H, s, OCH3), 3.73 – 3.64 (2H, m, NCH2), 2.82 (1H, ddd, J = 12.5, 
7.0, 5.0 Hz, NCH2CH2), 2.40 (1H, td, J = 12.5, 7.5 Hz, NCH2CH2), 1.53 (9H, s, 
C(CH3)3), 1.43 (9H, s, C(CH3)3); 13C NMR (125 MHz, CDCl3) δC  169.8 (C(O)), 
168.6 (C(O)), 150.2 (C(O)), 148.8 (4º ArC), 143.3 (4º ArC), 134.9 (4º ArC), 130.5 
(4º ArC), 107.5 (ArCH), 101.8 (ArCH), 101.6 (OCH2O), 83.3 (C(CH3)3), 83.1 
(C(CH3)3), 61.9 (4º C), 56.7 (OCH3), 43.2 (NCH2), 31.9 (NCH2CH2), 28.0 
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(C(CH3)3), 27.8 (C(CH3)3); IR υmax/cm-1 2923, 1719, 1636 (br.), 1511, 1459, 1368, 
1312, 1149; MS (ES+) m/z (relative intensity %) 458 (M + Na+, 100%);  HRMS 
(ES+): calcd. for C22H29O8NNa (M + Na+) 458.1785, found 458.1786. 
7.5.6.3 Synthesis and characterisation of tert-butyl 3-acetyl-3-(3,4-diacetoxy-
5-methoxyphenyl)-2-oxopyrrolidine-1-carboxylate, (+)-255 
N
OO
O
O
OH
OHMeO
N
MeO
O
O
O
OAc
OAc
+
1) ps-IO4- (2 equiv)
    CatQD- 71 (10 mol %)
2) Na2S2O4
3) Ac2O, pyridine
O
(+)-255
240
163
 
According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (42 mg, 0.30 mmol) was reacted with 240 (68 mg, 0.30 
mmol) (8 h reaction time) and the crude residue treated with Ac2O (0.75 mL) in 
pyridine (1.5 mL) (see preparation of 223) to give (+)-255 (27 mg, 20%) as a 
colourless oil in 6% ee determined by HPLC analysis [Chiralpak AD, hexane/iso-
propanol 85:15, 1.0 mL.min-1, λ = 215 nm, t (major) = 7.07 min, t (minor) = 14.65 
min] by comparison to a racemic sample. [α]D25 = +8.00 (c 0.4, CHCl3); 1H NMR 
(500 MHz, CDCl3) δH 6.97 (1H, d, J = 2.0 Hz, ArH), 6.81 (1H, d, J = 2.0 Hz, 
ArH), 3.82 (3H, s, OCH3), 3.65 – 3.62 (2H, m, NCH2), 3.05 – 3.01 (1H, m, 
NCH2CH2), 2.28 (3H, s, CH3), 2.26 (3H, s, CH3), 2.21 (3H, s, CH3), 2.14 – 2.07 
(1H, m, NCH2CH2), 1.53 (C(CH3)3); 13C NMR (125 MHz, CDCl3) δC  201.5 
(CC(O)CH3), 169.7 (C(O)), 167.9 (C(O)), 167.5 (C(O)), 152.8 (4º ArC), 149.6 
(NC(O)O), 143.6 (4º ArC), 135.9 (4º ArC), 131.7 (4º ArC), 113.8 (ArCH), 108.2 
(ArCH), 83.6 (C(CH3)3), 67.9 (4º C), 56.4 (OCH3), 43.2 (NCH2), 28.7 (NCH2CH2), 
27.9 (C(CH3)3), 26.6 (CH3), 20.5 (CH3), 20.2 (CH3); IR υmax/cm-1 2981, 1777 (br.), 
1718 (br.) 1610, 1370, 1309, 1208, 1104; MS (ES+) m/z (relative intensity %) 551 
(M + HNEt3+, 100%), 472 (M + Na+, 90%);  HRMS (ES+): calcd. for 
C22H27O9NNa (M + Na+) 472.1578, found 472.1581. 
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7.5.6.4 Synthesis and characterization of 1-Methyl-3-phenyl-3-(3,4-
dihydroxy-5-methoxyphenyl)-2-oxopyrrolidine-1,3-dicarboxylate, (+)-251 
N
OO
O
O
OPh
OH
OHMeO
N
MeO
O
O
OPh
O
OH
OH
+
1) ps-IO4- (2 equiv)
    Cat QD-71(10 mol %)
2) Na2S2O4
O
(+)-251
242
163
 
According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (28 mg, 0.20 mmol) was reacted with pro-nucleophile 242 (53 
mg, 0.20 mmol) to give, (+)-251 (27 mg, 34 %) in 9% ee, determined by HPLC 
analysis [Chiralpak AD, heptane/ethanol 70:30, 1.0 mL.min-1, λ = 215 nm, t (minor) 
= 6.74 min, t (major) = 12.37 min] by comparison to a racemic sample prepared 
according to the general oxidative coupling procedure (racemate MP 74 – 75 ºC); 
[α]D24 = + 12.3 (c 0.65, CHCl3); 1H NMR (400 MHz, CDCl3) δH 7.36 – 7.32 (2H, 
m, ArH), 7.23 – 7.19 (1H, m, ArH), 7.05 – 7.02 (2H, m, ArH), 6.84 (1H, d, J = 2 
Hz, ArH), 6.74 (1H, d, J = 2 Hz, ArH), 3.94 – 3.90 (1H, m, CH2N), 3.90 (3H, s, 
OCH3), 3.88 (3H, s, OCH3), 3.75 (1H, td, J = 10.5,  7.0 Hz, CH2N), 3.08 (1H, ddd, 
J = 13.0, 7.5, 7.0 Hz, CH2CH2N), 2.61 (1H, ddd, J = 13.0, 7.0, 5.5 Hz, CH2CH2N); 
13C NMR (100 MHz, CDCl3) δC 169.3 (C(O)), 168.3 (C(O)), 152.1 (OC(O)N), 
150.6 (4º ArC), 147.1 (4º ArC), 143.9 (4º ArC), 132.6 (4º ArC), 130.1 (4º ArC), 
129.4 (ArCH), 126.2 (ArCH), 121.1 (ArCH), 107.7 (ArCH), 102.9 (ArCH), 61.2 
(4º C), 56.3 (OCH3), 53.9 (OCH3), 43.3 (CH2), 30.1 (CH2); MP 74 - 75 ºC; IR 
υmax/cm-1 3417, 1783, 1738, 1615, 1439, 1372, 1305, 1223, 1188, 1091; MS (ES+) 
m/z (relative intensity %) 424 (M + Na+, 100%); HRMS (ES+): calcd. for 
C20H19O8NNa (M + Na+) 424.1003, found 424.1001. 
7.5.6.5 Synthesis and characterization of 1-benzyl 3-methyl 3-(3,4-diacetoxy-
5-methoxyphenyl)-2-oxopyrrolidine-1,3-dicarboxylate, (+)-253 
CbzN
O O
O
OH
OHMeO
CbzN
MeO
O
O
O
OAc
OAc
+
1) ps-IO4- (2 equiv)
    Cat QD-71 (10 mol %)
2) Na2S2O4
3) Ac2O, pyridine
(+)-253
246
163
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According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (28 mg, 0.20 mmol) was reacted with 246 (55 mg, 0.20 
mmol) and the crude reaction mixture treated with Ac2O (0.75 mL) in pyridine (1.5 
mL) (see preparation of 223) to give (+)-253 (30 mg, 30%) as a pale yellow oil, in 
30% ee, determined by HPLC analysis [Chiralpak AS, hexane/iso-propanol 70:30, 
1.0 mL.min-1, λ = 220 nm, t (minor) = 15.14 min, t (major) = 18.71 min] by 
comparison to a racemic sample prepared according to the general oxidative 
coupling procedure; [α]D25 = + 7.1 (c 2.0, CHCl3); 1H NMR (500 MHz, CDCl3) δH 
7.43 – 7.42 (2H, m, ArH), 7.38 – 7.32 (3H, m, ArH), 7.17 (1H, d, J = 2.0 Hz, ArH), 
6.87 (1H, d, J = 2.0 Hz, ArH), 5.32 – 5.27 (2H, m, OCH2Ph), 3.83 (3H, s, OCH3), 
3.81 – 3.77 (2H, m, CH2N), 3.75 (3H, s, OCH3), 3.01 – 2.96 (1H, m, CH2CH2N), 
2.45 (1H, td, J = 13.0, 7.5 Hz, CH2CH2N), 2.28 (3H, s, OC(O)CH3), 2.26 (3H, s, 
OC(O)CH3); 13C NMR (75 MHz, CDCl3) δC  169.1 (C(O)), 168.8 (C(O)), 168.0 
(C(O)), 167.5 (C(O)), 152.3 (4º ArC), 151.2 (NC(O)O), 143.1 (4º ArC), 134.9 (4º 
ArC), 133.9 (4º ArC), 131.9 (4º ArC), 128.6 (ArCH), 128.5 (ArCH), 128.2 
(ArCH), 113.8 (ArCH), 109.3 (ArCH), 68.4 (OCH2Ph), 60.6 (4º C), 56.4 (OCH3), 
53.7 (OCH3), 43.2 (CH2N), 30.2 (CH2CH2N), 20.5 (OC(O)CH3), 20.3 
(OC(O)CH3); IR υmax/cm-1 1781, 1774, 1731, 1371, 1296, 1207, 1098; MS (ES+) 
m/z (relative intensity %) 522 (M + Na, 100%);  HRMS (ES+): calcd. for 
C25H25O10NNa (M + Na+) 522.1371, found 522.1366. 
7.5.6.6 Synthesis and characterization of methyl 3-(3,4-diacetoxy-5-
methoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-2-oxopyrrolidine-3-carboxylate, 
(+)-254 
TsN
O O
O
OH
OHMeO
TsN
MeO
O
O
O
OAc
OAc
+
1) ps-IO4- (2 equiv)
    Cat QD-71 (10 mol %)
2) Na2S2O4
3) Ac2O, pyridine
(+)-254
247
163
 
According to general procedure C, replacing ps-BEMP with catalyst QD-71, 3-
methoxycatechol 163 (28 mg, 0.20 mmol) was reacted with 247 (59 mg, 0.20 
mmol) and the crude reaction mixture treated with Ac2O (0.75 mL) in pyridine (1.5 
mL) (see preparation of 223) to give (+)-254 (25 mg, 24%) as a pale yellow oil, in 
1% ee, determined by HPLC analysis [Chiralpak AD, hexane/iso-propanol 85:15, 
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1.0 mL.min-1, λ = 215 nm, t (major) = 22.39 min, t (minor) = 28.95 min] by 
comparison to a racemic sample prepared according to the general oxidative 
coupling procedure; [α]D25 = + 5.1 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δH 
7.89 (2H, d, J = 8.0 Hz, ArH), 7.33 (2H, d, J = 8.0 Hz, ArH), 6.95 (1H, d, J = 2.0 
Hz, ArH), 6.72 (1H, d, J = 2.0 Hz, ArH), 3.87 – 3.84 (2H, m, CH2N), 3.72 (3H, s, 
OCH3), 3.58 (3H, s, OCH3), 3.01 – 2.96 (1H, m, CH2CH2N), 2.50 – 2.43 (1H, m, 
CH2CH2N), 2.43 (3H, s, CH3), 2.27 (3H, s, OC(O)CH3), 2.25 (3H, s, OC(O)CH3); 
13C NMR (75 MHz, CDCl3) δC  168.6 (C(O)), 168.6 (C(O)), 167.9 (C(O)), 167.5 
(C(O)), 152.2 (4º ArC), 145.5 (4º ArC), 143.2 (4º ArC), 134.3 (4º ArC), 133.2 (4º 
ArC), 131.9 (4º ArC), 129.7 (ArCH), 128.2 (ArCH), 113.7 (ArCH), 109.0 (ArCH), 
60.1 (4º C), 56.2 (OCH3), 53.6 (OCH3), 44.0 (CH2N), 30.9 (CH2CH2N), 21.6 
(CH3), 20.5 (OC(O)CH3), 20.3 (OC(O)CH3); IR υmax/cm-1 1774, 1751, 1734, 1422, 
1207, 1173, 1093; MS (ES+) m/z (relative intensity %) 542 (M + Na+, 100%);  
HRMS (ES+): calcd. for C24H25O10NSNa (M + Na+) 542.1091, found 542.1091. 
7.5.7 Conditions Screen 
7.5.7.1 Solvent screen 
OH
OHMeO
+
BocN
O
OMe
O
OR1
OR1MeO
BocN
O O
OMe
208,  R1 = -CH2-   
223,  R1 =  Ac
1) cat QD-71
    ps-IO4- (2 equiv)
2) Na2S2O4 (aq)
3) Ac2O, pyridine
or, CH2ClBr, Cs2CO3
163
207  
According to general procedure C (section 7.3.6), replacing ps-BEMP with cat. 
QD-71 (10 mol %), 3-methoxycatechol 163 was reacted with 207 (1 equiv) in the 
solvents shown in Table 7.10 (0.1 M solutions), on a 0.1 mmol scale to give 208 or 
223 (following methylene acetal or acetate protection) in the yields and 
enantioselectivities shown.  In cases where the yield was not determined, 
enantiomeric excesses were determined from a sample of product obtained from 
preparative TLC of a sample of reaction mixture. 
Entry Solvent Product t(minor)/min t(major)/min % ee % Yield 
1 CH2Cl2 (+)-208 7.87 9.70 50 35 
2 CHCl3 (+)-208 7.96 9.77 50 25 
3 TBME (+)-208 7.96 9.78 20 33 
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4 toluene (+)-208 7.91 9.70 4 8 
5 MeCN (+)-208 7.90 9.69 37 38 
6 acetone (+)-208 7.90 9.66 36 38 
7 1,2-DCE (+)-223 27.01 12.52 38 - 
8 chlorobenzene (+)-223 27.08 12.67 19 - 
9 1,1,2,2-tetrachloroethane (+)-223 26.53 12.49 37 - 
10 Et2O (+)-223 26.75 12.51 24 - 
11 EtOAc (+)-223 26.76 12.46 40 - 
12 DMF (+)-223 26.45 12.47 5 - 
13 CH2ClBr (+)-223 26.50 12.39 50 - 
14 CH2Br2 (+)-223 26.55 12.32 46 - 
15 1,4-dioxane (+)-223 22.32 11.21 29 - 
16 THF (+)-223 26.71 12.38 30 - 
Table 7.10: Solvent screen for the enantioselective synthesis of 208/223 
 
7.5.7.2 Concentration, catalyst loading and temperature screen 
OH
OHMeO
+
BocN
O
OMe
O
OR1
OR1MeO
BocN
O O
OMe
208,  R1 = -CH2-   
223,  R1 =  Ac
1) cat QD-71
    ps-IO4- (2 equiv)
2) Na2S2O4 (aq)
3) Ac2O, pyridine
or, CH2ClBr, Cs2CO3
163
207  
According to general procedure C, replacing ps-BEMP with cat. QD-71, 3-
methoxycatechol 163 was reacted with 207 in CH2Cl2 on a 0.1 mmol scale under 
the conditions detailed in Table 7.11 to give 208 or 223 (following methylene acetal 
or acetate protection) in the yields and enantioselectivities shown.  In cases where 
the yield was not determined, enantiomeric excesses were determined from a 
sample of product obtained from preparative TLC of a sample of reaction mixture. 
 
Entry Mol % QD-71 
T/ºC Conc./M t(minor)/min t(major)/min % ee % Yield
1 50 -20 0.1 19.18 10.16 52 - 
2  2 -20 0.1 19.63 10.32 51 - 
3  10 -20 0.02 19.54 10.27 56 - 
4  30 -20 0.01 21.02 10.80 62 - 
5  10 0 0.1 22.77 11.41 20 49 
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6 10 -60 0.1 22.33 11.30 26 2 
7 10 -20 - -60 0.1 22.49 11.30 37 5 
Table 7.11: conditions screen of enantioselective oxidative coupling of 3-
methoxycatechol 163 and 207. 
7.5.8 Preparation of catalysts 
7.5.8.1 Attempted synthesis of a range of benzyl quinidine derivatives 
The synthesis of a range of benzyl-substituted quinidine derived organocatalysts 
was attempted following procedures reported by Deng and co-workers.80  De-
methylation was attempted following the reported procedure with BBr3,81(a) 
however this resulted in cleavage of the benzyl group in most cases.  Additional 
example were synthesised with thiolate demethylation to prevent cleavage of the 
benzyl group.  1-dodecanethiol was found to be a suitable alternative for NaSEt that 
is not malodorous.  
 
7.5.8.2 Synthesis and characterization of (9S)-9-{[4-(1H-pyrazol-1-
yl)benzyl]oxy}cinchonan-6'-ol, QD-260 
N
O
N
OH
N
N
N
HO
N
OMe N
O
N
OMe
N
N
135
260b QD-260
N
N
Br
NaH, DMF BBr3
 
To a stirred solution of quinidine (162 mg, 0.50 mmol) in DMF (5 mL) was added 
NaH (40 mg of a 60% dispersion in mineral oil, 2.00 mmol) and the reaction 
mixture stirred at room temperature for 30 min before adding 1-[4-
(bromomethyl)phenyl]-1H-pyrazole (119 mg, 0.50 mmol).  The reaction mixture 
was stirred for 4 h then quenched with saturated NaHCO3(aq) (10 mL), diluted with 
EtOAc (20 mL) and washed with water (3 x 10 mL) and brine (10 mL).  The 
organic phase was dried over Na2SO4, filtered and concentrated.  The residue was 
dissolved in CH2Cl2 (5 mL) and cooled to 0 ºC.  BBr3 (1 mL of a 1 M solution in 
CH2Cl2, 1 mmol) and the reaction mixture allowed to warm to room temperature.  
The reaction mixture was stirred at room temperature for 24 h then quenched with 
sat. NaHCO3(aq).  The organic phase was separated and the aqueous extracted with 
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CH2Cl2.  The combined organic portions were dried over Na2SO4, filtered and 
concentrated. The residue was purified by mass guided HPLC to give QD-260 (44 
mg, 19%) as a yellow solid. [α]D25 = +88.7 (c 1.10, CHCl3); 1H NMR (500 MHz, 
CDCl3) δH 6.64 (1H, d, J = 4.5 Hz, ArH), 8.22 (1H, d, J = 2.5 Hz, ArH), 7.94 (1H, 
d, J = 9.0 Hz, ArH), 7.74 – 7.72 (3H, m, ArH), 7.58 (1H, br. s, ArH), 7.48 (2H, br. 
d, J = 8.0 Hz, ArH), 7.36 (1H, dd, J = 9.0, 2.5 Hz, ArH), 7.33 (1H, br. s, ArH), 
6.53 (1H, t, J = 2.0 Hz, ArH), 5.99 (1H, ddd, J = 17.5, 10.0, 7.5 Hz, CH=CH2), 
5.32 (1H, br. s, CHOCH2Ar), 5.03 – 4.97 (2H, m, CH=CH2), 4.53 (1H, d, J = 11.5 
Hz, OCH2Ar), 4.44 (1H, d, J = 11.5 Hz, OCH2Ar), 4.31 (1H, br. s, aliphatic CH), 
3.09 (1H, br. s, aliphatic CH), 2.92 – 2.85 (2H, br. m, aliphatic CH), 2.79 – 2.73 
(1H, br. m, aliphatic CH), 2.29 (1H, dd, J = 17.0, 8.0 Hz, aliphatic CH), 2.18 (1H, 
br. m, aliphatic CH), 1.73 (1H, br. s, aliphatic CH), 1.60 – 1.50 (2H, br. m, aliphatic 
CH), 1.24 (1H, br. s, aliphatic CH); 13C NMR (75 MHz, CDCl3) δC  158.0 (4º  
ArC), 147.5 (ArCH), 145.8 (4º  ArC), 144.4 (4º  ArC), 142.3 (ArCH), 141.5 
(CH=CH2), 141.1 (4º  ArC), 137.6 (4º  ArC), 131.7 (ArCH), 130.7 (ArCH), 129.2 
(4º  ArC), 129.0 (ArCH), 123.5 (ArCH), 120.5 (ArCH), 120.3 (ArCH), 115.3 
(CH=CH2), 108.8 (ArCH), 105.2 (ArCH), 81.0 (COCH2Ar), 72.0 (OCH2Ar), 60.7 
(NCH), 50.9 (NCH2), 50.4 (NCH2), 41.1 (CH), 29.5 (CH), 27.1 (CH2), 22.2 (CH2); 
IR υmax/cm-1 3070, 2940, 1614, 1526, 1467, 1394, 1030, 830;  MP 139 – 144 ºC; 
MS (ES+) m/z (relative intensity %) 467 (M + H+, 100%);  HRMS (ES+): calcd. 
for C29H31O2N4 (M + H+) 467.2442, found 467.2439. 
7.5.8.3 Synthesis and characterization of (9S)-9-[(3-
nitrobenzyl)oxy]cinchonan-6'-ol, QD-261 
N
O
N
OH
N
HO
N
OMe N
O
N
OMe
135 261b QD-261
Br
NaH, DMF BBr3
NO2 NO2
NO2
 
According to the above procedure for the synthesis of catalyst QD-260, catalyst 
QD-261 was prepared in 9% yield on a 0.50 mmol scale. [α]D25 = +75.4 (c 0.76, 
CHCl3); 1H NMR (500 MHz, CDCl3) δH 8.63 (1H, d, J = 4.5 Hz, ArH), 8.30 (1H, 
s, ArH), 8.17 (1H, dd, J = 8.0, 1.0 Hz, ArH), 7.93 (1H, d, J = 9.0 Hz, ArH), 7.73 
(1H, d, J = 8.0 Hz, ArH), 7.59 (1H, t, J = 8.0 Hz, ArH), 7.56 (1H, br. d, J = 4.5 Hz, 
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ArH), 7.36 (1H, dd, J = 9.0, 2.5 Hz, ArH), 7.33 (1H, br. s, ArH), 6.04 (1H, ddd, J 
= 17.5, 10.0, 7.5 Hz, CH=CH2), 5.36 (1H, br. s, CHOCH2Ar), 5.05 – 5.00 (2H, m, 
CH=CH2), 4.61 (1H, d, J = 12.0 Hz, OCH2Ar), 4.58 (1H, d, J = 12.0 Hz, 
OCH2Ar), 3.37 (1H, br. s, aliphatic CH), 3.14 (1H, br. s, aliphatic CH), 2.95 – 2.86 
(2H, m, aliphatic CH), 2.82 – 2.76 (1H, m, aliphatic CH), 2.32 (1H, q, J = 8.5 Hz, 
aliphatic CH), 2.21 (1H, br. t, J = 10.0 Hz, aliphatic CH), 1.77 (1H, br. s, aliphatic 
CH), 1.63 – 1.53 (2H, m, aliphatic CH), 1.29 (1H, br. s, aliphatic CH); 13C NMR 
(75 MHz, CDCl3) δC 158.0 (4º ArC), 149.8 (4º ArC), 147.6 (ArCH), 145.4 (4º 
ArC), 144.4 (4º ArC), 141.6 (4º ArC), 141.4 (CH=CH2), 135.1 (ArCH), 131.7 
(ArCH), 130.8 (ArCH), 129.1 (4º ArC), 123.7 (ArCH), 123.6 (ArCH), 123.5 
(ArCH), 120.4 (ArCH), 115.3 (CH=CH2), 105.2 (ArCH), 81.8 (COCH2Ar), 71.4 
(OCH2Ar), 60.7 (NCH), 50.9 (NCH2), 50.5 (NCH2), 40.9 (CH), 29.4 (CH), 27.0 
(CH2), 22.4 (CH2); IR υmax/cm-1 3386, 2941, 1617, 1529, 1350, 1270, 809;  MP 
118 – 122 ºC; MS (ES+) m/z (relative intensity %) 446 (M + H, 100%);  HRMS 
(ES+): calcd. for C26H28O4N3 (M + H+) 446.2074, found 446.2071. 
7.5.8.4 Synthesis and characterization of (9S)-9-
{[3,5bis(trifluoromethyl)benzyl]oxy}cinchonan-6'-ol, QD-267 
N
O
N
OH
CF3
CF3
QD-267
 
To a stirred solution of quinidine 135 (324 mg, 1.00 mmol) in DMF (5 mL) was 
added NaH (80 mg of a 60% dispersion in mineral oil, 2.00 mmol) and the reaction 
mixture stirred at room temperature for 30 min before adding 1-(bromomethyl)-3,5-
bis(trifluoromethyl)benzene (0.18 mL, 1.00 mmol).  The reaction mixture was 
stirred for 4 h then quenched with saturated NaHCO3(aq) (10 mL), diluted with 
EtOAc (20 mL) and washed with water (3 x 10 mL) and brine (10 mL).  The 
organic phase was dried over Na2SO4, filtered and concentrated.  The residue was 
dissolved in DMF (10 mL).  To the DMF solution was added 1-dodecanethiol (1.2 
mL, 5 mmol) followed by portion wise addition of NaH (200 mg of a 60% 
dispersion in mineral oil, 5 mmol). CAUTION: significant foaming of the reaction 
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mixture occurred upon addition of NaH.  The reaction mixture was heated to 110 ºC 
overnight, cooled to room temperature and quenched with saturated. NH4Cl (30 
mL).  The mixture was diluted with EtOAc (50 mL) and washed with water (3 x 20 
mL) and brine (20 mL).  The organic phase was dried over Na2SO4, filtered and 
concentrated.  The residue was purified by column chromatography on silica gel to 
give QD-267 (300 mg, 56%) as an off-white solid. [α]D25 = +76.3 (c 0.82, CHCl3); 
1H NMR (500 MHz, CD3OD) δH 8.62 (1H, d, J = 4.5 Hz, ArH), 7.98 (2H, br. s, 
ArH), 7.93 (1H, d, J = 9.0 Hz, ArH), 7.89 (1H, br. s, ArH), 7.55 (1H, br. d, J = 4.0 
Hz, ArH), 7.37 – 7.35 (2H, br. m, ArH), 6.01 (1H, ddd,  J = 17.5, 10.5, 7.5 Hz, 
CH=CH2), 5.46 (1H, br. s. CHOCH2Ar), 5.05 – 5.01 (2H, m, CH=CH2), 4.69 – 
4.64 (2H, br. m, OCH2Ar), 3.41 (1H, br. s, aliphatic CH), 3.21 (1H, br. s, aliphatic 
CH), 3.02 – 2.96 (2H, m, aliphatic CH), 2.88 – 2.82 (1H, m, aliphatic CH), 2.37 
(1H, q, J = 8.0 Hz, aliphatic CH), 2.24 (1H, br. t, J = 10.0 Hz, aliphatic CH), 1.80 
(1H, br. s, aliphatic CH), 1.65 – 1.55 (2H, m, aliphatic CH), 1.29 (1H, br. s, 
aliphatic CH);  13C NMR (125 MHz, CD3OD) δC 158.1 (4º ArC), 147.6 (ArCH), 
144.7 (4º ArC), 144.4 (4º ArC), 142.5 (4º ArC), 140.8 (CH=CH2), 132.82 (q, J = 
33.5 Hz, CF3) 131.8 (ArCH), 129.2 (ArCH), 129.0 (4º ArC), 123.7 (ArCH), 123.5 
(ArCH), 122.5 (m, ArCCF3), 120.1 (ArCH), 115.6 (CH=CH2), 105.1 (ArCH), 81.6 
(COCH2Ar), 71.2 (OCH2Ar), 60.7 (NCH), 50.9 (NCH2), 50.5 (NCH2), 40.5 (CH), 
29.2 (CH), 26.6 (CH2), 22.1 (CH2); IR υmax/cm-1 3077, 2941, 2877, 1620, 1469, 
1280, 1177, 1134; MP 97 – 101  ºC MS (ES+) m/z (relative intensity %); 537 (M + 
H+, 100%); HRMS (ES+): calcd. for C28H27F6O2N2 (M + H+) 537.1971, found 
537.1957. 
7.5.8.5 Synthesis and characterization of (9S)-9-{[2-
(trifluoromethyl)benzyl]oxy}cinchonan-6'-ol, QD-265 
N
O
N
OH
CF3
QD-265
 
According to the above procedure for the preparation of catalyst QD-267, quinidine 
135 (3.24 g, 10.0 mmol) was benzylated with 1-(bromomethyl)-2-
(trifluoromethyl)benzene (1.52 mL, 10.0 mmol) and demethylated with 1-
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dodecanethiol (12.0 mL, 50.0 mmol) to give cat. QD-265 (3.81 g, 82%) as a pale 
yellow solid. [α]D25 = +104.4 (c 1.78, CHCl3); 1H NMR (500 MHz,CD3OD) δH 
8.63 (1H, d, J = 4.5 Hz, ArH) 7.95 (1H, d, J = 9.5 Hz, ArH), 7.81 (1H, br. d, J = 
7.5 Hz, ArH), 7.68 – 7.63 (2H, m, ArH), 7.56 (1H, br. d, J = 4.0 Hz, ArH), 7.48 
(1H, t, J = 7.5 Hz, ArH), 7.38 – 7.36 (2H, m, ArH), 5.95 (1H, ddd, J = 17.5, 10.0, 
7.5 Hz, CH=CH2), 5.43 (1H, br. s, CHOCH2Ar), 4.99 – 4.96 (2H, m, CH=CH2), 
4.64 (1H, d, J = 12.0 Hz, OCH2Ar), 4.60 (1H, d, J = 12.0 Hz, OCH2Ar), 3.39 (1H, 
br. s, aliphatic CH), 3.14 (1H, br. s. aliphatic CH), 2.95 – 2.90 (2H, m, aliphatic 
CH), 2.82 – 2.76 (1H, m, aliphatic CH), 2.31 (1H, q, J = 8.0 Hz, aliphatic CH), 
2.19 (1H, br. m, aliphatic CH), 1.74 (1H, br. s, aliphatic CH), 1.61 – 1.50 (2H, m, 
aliphatic CH), 1.25 (1H, br. s, aliphatic CH); 13C NMR (125 MHz, CD3OD) δC 
158.0 (4º ArC), 147.5 (ArCH), 145.0 (4º ArC), 144.4 (4º ArC), 141.0 (CH=CH2), 
137.3 (4º ArC), 133.5 (ArCH), 131.8 (ArCH), 131.78 (ArCH), 129.4 (4º ArC), 
129.0 (ArCH), 128.9 (q, J = 30.5Hz, CF3), 126.9 (q, J = 5.5 Hz, ArCCF3) 126.9 
(ArCH), 123.6 (ArCH), 120.1 (ArCH), 115.4 (CH=CH2), 105.1 (ArCH), 81.7 
(CHOCH2Ar), 68.8 (CHOCH2Ar), 60.8 (NCH), 50.8 (NCH2), 50.3 (NCH2), 40.7 
(CH), 29.3 (CH), 26.8 (CH2), 22.1 (CH2); IR υmax/cm-1 3074, 2941, 2877, 1670, 
1619, 1469, 1316, 1167, 1119; MP 98 – 101 ºC MS (ES+) m/z (relative intensity 
%); 469 (M + H+, 100%); HRMS (ES+): calcd. for C27H28F3O2N2 (M + H+) 
469.2097, found 469.2088. 
7.5.8.6 Synthesis and characterization of (9R)-9-{[2-
(trifluoromethyl)benzyl]oxy}cinchonan-6'-ol Q-265 
N
O
N
HO
CF3
Q-265  
According to the above procedure for the synthesis of catalyst Q-265, quinine 136 
(1.62 g, 5.00 mmol) was benzylated with 1-(bromomethyl)-2-
(trifluoromethyl)benzene (0.76 mL, 5.00 mmol) and demethylated with 1-
dodecanethiol (6.0 mL, 25.0 mmol) to give cat. Q-265 (1.61 g, 69%) as a cream 
coloured solid, [α]D25 = -18.5 (c 1.00, CHCl3); 1H NMR (500 MHz, CD3OD) δH 
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8.61 (1H, d, J = 4.5 Hz, ArH), 7.95 (1H, d, J = 9.0 Hz, ArH), 7.78 (1H, br. s, ArH), 
7.67 – 7.63 (2H, m, ArH), 7.56 (1H, d, J = 4.0 Hz, ArH), 7.48 – 7.36 (1H, br. s, 
ArH), 7.47 (1H, t, J = 7.5 Hz, ArH), 7.37 (1H, d, J = 9.0 Hz, ArH), 5.74 (1H, br. 
m, CH=CH2), 5.35 (1H, br. s, CHOCH2Ar), 4.97 – 4.88 (2H, m, CH=CH2), 4.65 
(1H, d, J = 12.0 Hz, OCH2Ar), 4.58 (1H, d, J = 12.0 Hz, OCH2Ar), 3.45 (1H, br. s, 
aliphatic CH), 3.17 (1H, br. s, aliphatic CH), 3.07 (1H, br. t, J = 10.0 Hz, aliphatic 
CH), 2.71 – 2.60 (2H, br. m, aliphatic CH), 2.33 (1H, br. s, aliphatic CH), 1.90 (1H, 
br. s, aliphatic CH), 1.79 – 1.75 (2H, br. m, aliphatic CH), 1.64 (1H, br. s, aliphatic 
CH), 1.59 – 1.54 (1H, br. m, aliphatic CH); 13C NMR (75 MHz, CD3OD) δC  158.0 
(4º ArC), 147.5 (ArCH), 145.3 (4º ArC), 144.5 (4º ArC), 142.5 (CH=CH2), 137.5 
(4º ArC), 133.5 (ArCH), 131.8 (ArCH), 131.3 (ArCH), 129.3 (4º ArC), 129.0 
(ArCH), 128.7 (q, J = 30.5 Hz, CF3), 126.9 (q, J = 5.5 Hz, ArCCF3), 126.9 
(ArCH), 123.5 (ArCH), 120.0 (ArCH), 115.2 (CH=CH2), 105.0 (ArCH), 81.0 
(CHOCH2Ar), 68.7 (OCH2Ar), 61.1 (NCH), 57.5 (NCH2), 44.1 (NCH2), 40.8 
(CH), 29.1 (CH), 28.2 (CH2), 22.4 (CH2); IR υmax/cm-1 3424, 2943, 1637, 1620, 
1315, 1167, 1118;  MP 207 – 212 ºC; MS (ES+) m/z (relative intensity %) 469 (M 
+ H+, 100%);  HRMS (ES+): calcd. for C27H28F3O2N2 (M + H+) 469.2097, found 
469.2094. 
7.5.8.7 Attempted synthesis of halogenated benzyl derivatives 
N
HO
N
OMe Br
NaH, DMF
N
O
N
OMe
Br
Br
135 268
 
To a solution of quinidine 135 (300 mg, 0.93 mmol) in anh DMF (5 mL) was added 
NaH (93 mg of a 60% wt dispersion in mineral oil, 2.33 mmol).  The reaction 
mixture was stirred at room temperature for 30 min before adding 2-bromobenzyl 
bromide (255 mg, 1.02 mmol).  The reaction mixture was stirred at room 
temperature for 18 h then quenched with brine (30 mL) and extracted with EtOAc 
(3 x 10 mL).  The combined organic extracts were washed with brine (2 x 10 mL), 
dried over Na2SO4, filtered and concentrated.  The residue was purified by column 
chromatography on silica gel, eluting with CH2Cl2 containing 5 – 10% MeOH to 
give 268 (358 mg, 73%).  [α]D25 = +98.4 (c 1.75, CHCl3); 1H NMR (500 MHz, 
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CDCl3) δH 8.69 (1H, d, J = 4.5 Hz, ArH), 7.98 (1H, d, J = 9.0 Hz, ArH), 7.66 (1H, 
d, J = 4.5 Hz, ArH), 7.57 – 7.54 (2H, m, ArH), 7.45 – 7.43 (2H, m, ArH), 7.36 (1H, 
t, J = 7.5 Hz, ArH), 7.22 (1H, dt, J = 7.5, 1.5 Hz, ArH), 5.98 (1H, ddd, J = 17.5, 
10.5, 7.5 Hz, CH=CH2), 5.49 (1H, br. s, CHOCH2Ar), 5.02 – 4.97 (2H, m, 
CH=CH2), 4.58 (1H, d, J = 12.0 Hz, OCH2Ar), 4.54 (1H, d, J = 12.0 Hz, 
OCH2Ar), 3.96 (3H, s, OCH3), 3.47 – 3.44 (1H, br. m, NCH2), 3.14 (1H, br. m, 
CH), 2.96 – 2.96 – 2.88 (2H, m, NCH2), 2.83 – 2.77 (1H, m, NCH2), 2.34 – 2.30 
(1H, m, CH), 2.25 (1H, br. t, J = 11.0 Hz, CH2), 1.75 (1H, br. s, CH), 1.61 – 1.51 
(2H, m, CH2), 1.26 (1H, br. m, CH); 13C NMR (125 MHz, CDCl3) δC  159.9 (4º 
ArC), 148.1 (ArCH), 146.0 (4º ArC), 145.1 (4º ArC), 141.2 (CH=CH2), 138.2 (4º 
ArC), 133.9 (ArCH), 131.7 (ArCH), 131.6 (ArCH), 130.9 (ArCH), 128.7 (4º ArC), 
128.7 (ArCH), 124.5 (4º ArC), 123.7 (ArCH), 120.5 (ArCH), 115.3 (CH=CH2), 
102.4 (ArCH), 81.5 (CHOCH2Ar), 72.1 (OCH2Ar), 61.0 (CH), 56.4 (OCH3), 50.8 
(CH2), 50.3 (CH2), 40.7 (CH), 29.3 (CH), 26.8 (CH2), 22.2 (CH2); IR υmax/cm-1 
2937, 2873, 1620, 1591, 1508, 1472, 1433, 1241, 1229, 1028, 830, 753;  MP 38 – 
39 ºC; MS (ES+) m/z (relative intensity %) 493 (M + H+, 50%), 495 (M + H+, 
50%);  HRMS (ES+): calcd. for C27H30O2N2Br (M + H+) 493.1485, found 
493.1480. 
Attempted de-methylation of 268 with 1-dodecanethiol as described above did not 
give the desired benzylated catalyst.  Therefore an alternative route via TIPS-
protected quinidine derivative 270 was attempted. 
7.5.8.8 Synthesis and characterisation of (9S)-6'-[(2-
bromobenzyl)oxy]cinchonan-9-ol, QD-271 and (9S)-6',9-bis[(2-
bromobenzyl)oxy]cinchonan, QD-272 
Br
NaH, DMF N
O
N
OBr
Br
N
HO
N
OTIPS
1)
2) TBAF
Br
N
HO
N
O
Br
+
QD-271, 30% QD-272, 15%
270
 
Following the above procedure for the benzylation of quinidine, 270 (100 mg, 0.21 
mmol) was reacted with 2-bromobenzy bromide (21 mg, 0.54 mmol) and the crude 
reaction mixture dissolved in THF (10 mL) and treated with TBAF (55 mg, 0.21 
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mmol).  The reaction mixture was concentrated by rotary evaporation and the 
residue purified by column chromatography on silica gel, eluting with CH2Cl2 
containing 1 – 10% MeOH.  The desired organocatalyst was not isolated from the 
reaction mixture; instead benzylated derivatives QD-271 (21 mg, 15%) as a pale 
yellow solid and QD-272 (30 mg, 30%) also as a pale yellow solid were obtained. 
QD-271: [α]D25 = +109.8 (c 0.47, CHCl3); 1H NMR (500 MHz, CDCl3) δH 8.69 
(1H, d, J = 4.5 Hz, ArH), 8.00 (1H, d, J = 9.0 Hz, ArH), 7.70 (1H, d, J = 4.5 Hz, 
ArH), 7.66 (1H, d, J = 7.5 Hz, ArH), 7.61 (1H, d, J = 7.5 Hz, ArH), 7.57 (1H, d, J 
= 2.5 Hz, ArH), 7.52 (1H, dd, J = 9.0, 2.5 Hz, ArH), 7.39 (1H, t, J = 7.5 Hz, ArH), 
7.27 (1H, dt, J = 7.5, 1.5 Hz, ArH), 6.12 (1H, ddd, J = 17.5, 10.5, 7.5 Hz, 
CH=CH2), 5.70 (1H, br. d, J = 3.5 Hz, CHOH), 5.36 (1H, d, J = 12.5 Hz, 
OCH2Ar), 5.33 (1H, d, J = 12.5 Hz, OCH2Ar), 5.16 – 5.10 (2H, m, CH=CH2), 3.63 
– 3.59 (1H, br. m, NCH2), 3.22 – 3.19 (1H, br. m, CH), 3.02 – 2.84 (3H, m, NCH2), 
2.40 (1H, q, J = 8.5 Hz, CH), 2.23 (1H, br. m, CH2), 1.80 (1H, br. s, CH), 1.68 – 
1.57 (2H, m, CH2), 1.22 – 1.16 (1H, m, CH2); 13C NMR (125 MHz, CDCl3) δC  
158.4 (4º ArC), 149.8 (4º ArC), 148.5 (ArCH), 145.0 (4º ArC), 140.8 (CH=CH2), 
137.2 (4º ArC), 134.0 (ArCH), 131.7 (ArCH), 131.1 (ArCH), 131.0 (ArCH), 128.9 
(ArCH), 128.0 (4º ArC), 124.3 (4º ArC), 123.5 (ArCH), 120.4 (ArCH), 115.8 
(CH=CH2), 104.2 (ArCH), 71.8 (CHOH), 71.3 (OCH2Ar), 61.2 (CH), 50.7 
(NCH2), 50.1 (NCH2), 40.6 (CH), 29.4 (CH), 26.4 (CH2), 21.5 (CH2); IR υmax/cm-1 
3211, 2937, 2872, 1620, 1591, 1509, 1457, 1440, 1240, 1224, 1025; MP 144 – 149 
ºC; MS (ES+) m/z (relative intensity %) 479 (M + H+, 50%), 481 (M + H+, 50%);  
HRMS (ES+): calcd. for C26H28O2N2Br (M + H+) 479.1329, found 479.1329. 
QD-272: [α]D25 = +61.7 (c 0.44, CHCl3); 1H NMR (500 MHz, CDCl3) δH 8.72 (1H, 
d, J = 4.5 Hz, ArH), 8.03 (1H, d, J = 9.0 Hz, ArH), 7.66 – 7.62 (3H, br. m, ArH), 
7.57 – 7.53 (3H, m, ArH), 7.50 (1H, br. d, J = 7.5 Hz, ArH), 7.37 – 7.33 (2H, m, 
ArH), 7.26 – 7.20 (2H, m, ArH), 5.92 (1H, ddd, J = 17.5, 10.5, 7.0 Hz, CH=CH2), 
5.62 (1H, br. s, CHOCH2Ar), 5.36 (1H, d, J = 12.5 Hz, OCH2Ar), 5.32 (1H, d, J = 
12.5 Hz, OCH2Ar), 5.03 – 4.99 (2H, m, CH=CH2), 4.58 (1H, d, J = 11.5 Hz, 
OCH2Ar), 4.51 (1H, d, J = 11.5 Hz, OCH2Ar), 3.52 (1H, br. s, NCH2), 3.31 (1H, 
br. s, CH), 3.05 (1H, br. m, NCH2), 2.91 (2H, br. s, NCH2), 2.44 (1H, br. m, CH), 
2.23 (1H, br. m, CH2), 1.82 (1H, br. s, CH), 1.70 – 1.59 (2H, m, CH2), 1.40 (1H, br. 
m, CH2); 13C NMR (125 MHz, CDCl3) δC  158.5 (4º ArC), 148.5 (ArCH), 145.4 
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(4º ArC), 144.8 (4º ArC), 139.9 (CH=CH2), 137.8 (4º ArC), 137.1 (4º ArC), 134.0 
(ArCH), 133.9 (ArCH), 133.1 (4º ArC), 132.0 (ArCH), 131.9 (ArCH), 131.1 
(ArCH), 131.0 (ArCH), 130.9 (ArCH), 128.8 (ArCH), 128.5 (4º ArC), 124.8 (4º 
ArC), 124.2 (ArCH), 124.0 (ArCH), 121.4 (ArCH), 116.2 (CH=CH2), 104.3 
(ArCH), 80.5 (CHOCH2Ar), 72.3 (OCH2Ar), 71.4 (OCH2Ar), 61.3 (NCH), 50.6 
(NCH2), 49.8 (NCH2), 39.7 (CH), 28.9 (CH), 25.7 (CH2), 22.4 (CH2); IR υmax/cm-1 
2936, 2870, 1619, 1590, 1508, 1440, 1226, 1026;  MP 58 – 62 ºC; MS (ES+) m/z 
(relative intensity %) 647 (M + H+, 50%) 649 (M + H+, 100%), 651 (M + H+, 50%);  
HRMS (ES+): calcd. for C33H33O2N2Br2 (M + H+) 649.0886, found 649.0882. 
7.5.9 Screen of novel benzyl-functionalised organocatalysts 
OH
OHMeO
+
BocN
O
OMe
O
OR
ORMeO
BocN
O O
OMe
1) cat
     ps-IO4- (2 equiv)
2) Na2S2O4(aq)
3) Ac2O, pyridine
or CH2ClBr, Cs2CO3
208, R = -CH2-
223, R = Ac
163
207
 
According to general procedure C (section 7.3.6), replacing ps-BEMP with cat. 
QD-260, QD-261, QD-265, QD-267 and QD265 (10 mol %), 3-methoxycatechol 
163 was reacted with 207 (1 equiv) on a 0.1 mmol scale to give 208 or 223 
(following methylene acetal or acetate protection) in the yields and 
enantioselectivities shown. 
Entry Catalyst (loading) Product Conc./M t(minor)/min t(major)/min 
% 
ee 
% 
Yield 
1 QD-260(10 mol %) (+)-223 0.1 22.32 11.66 43 41 
2 QD-261(10 mol %) (+)-223 0.1 22.20 11.65 50 25 
3 QD-267 (10 mol %) (+)-223 0.1 22.52 11.32 43 38 
4 Cat QD-265 (10 mol %) (+)-223 0.1 22.01 11.24 64 56 
5 QD-271 (10 mol %) (-)-223 0.1 11.905 24.42 44 32 
6 QD-272 (10 mol %) (+)-223 0.1 24.52 11.78 5 24 
7 QD-265 (20 mol %) (+)-223 0.0125 21.71 11.27 73 54 
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8 QD-265 (30 mol %) (+)-223 0.025 21.79 11.27 72 55 
7 QD-265 (20 mol %) (+)-208 0.025 11.95 18.30 70 57 
8 Q-265 (20 mol %) (-)-208 0.025 11.12 16.97 70 55 
 
7.5.10 Asymmetric Synthesis 
7.5.10.1 Synthesis of (+)-1-tert-butyl 3-methyl 2-hydroxy-3-(7-methoxy-1,3-
benzodioxol-5-yl)pyrrolidine-1,3-dicarboxylate (+)-209 
N
MeO O
O
O
OMeO
O
O
N
MeO O
O
O
OMeO
O
HO
Super-hydride®
THF, -78 ºC
(+)-208
(+)-209
 
According to the procedure for racemate synthesis (section 7.4.3.3), (+)-208 (2.06 g, 
5.25 mmol) was reacted with Super-hydride® (6.3 mL of a 1 M solution in THF, 
6.30 mmol) to give (+)-209 (1.87 g, 90%) as a colourless solid, the 4 stereoisomers 
could not be completely separated by chiral HPLC analysis, [α]D24 = + 22.6 (c 0.95, 
CHCl3); MP 40 – 44 ºC. Other data identical to racemic compound. 
7.5.10.2 Synthesis of (-)-1-tert-butyl 3-methyl 3-(7-methoxy-1,3-benzodioxol-5-
yl)-2-(2-oxopropyl)pyrrolidine-1,3-dicarboxylate, (-)-210 
N
MeO O
O
O
OMeO
O
HO
N
MeO O
O
O
OMeO
O
AcO
N
MeO O
O
O
OMeO
O
O
OTMS
(+)-209 216
Ac2O, pyridine
(-)-210
BF3.Et2O
 
According to the procedure for racemate synthesis (section 7.4.3.5), (+)-209 (1.87 
g, 4.73 mmol) was treated with acetic anhydride (2 mL) in pyridine (10 mL) and the 
crude acetylated product reacted with (isopropenyloxy)trimethylsilane (7.9 mL, 
47.3 mmol) to give (-)-210 (1.89 g, 92%) as a colourless oil in 3:1 dr and 69% ee 
determined by HPLC analysis [Chiralpak AD, hexane/iso-propanol 95:5, 1.0 
mL.min-1, λ = 215 nm, minor diastereomer: t (major) = 16.12 min, t (minor) = 19.90 
 189
min], major diastereomer: t (minor) = 24.41 min, t (major) = 32.41 min] by 
comparison to a racemic sample. [α]D24 = - 15.4 (c 0.46, CHCl3).  Other data 
identical to racemic compound. 
7.5.10.3 Synthesis and characterisation of (-)-tert-butyl-6-methoxy-3a-(7-
methoxy-1,3-benzodioxol-5-yl)-4-oxo-2,3,3a,4,7,7a-hexahydro-1H-indole-1-
carboxylate, (-)-212 
N
MeO O
O
O
OMeO
O
O
MeO O
O
NO
O
O
O
MeO O
O
NO
O
O
OMe(-)-210 211
KOt-Bu, THF TiCl4, MeOH
(-)-212  
According to the procedure for racemate synthesis (section 7.4.3.6), (-)-210 (1.83 g, 
4.20 mmol) was treated with KOtBu (8.83 mL of a 1 M solution in THF, 8.83 
mmol) and the crude diketone treated with TiCl4 (0.19 mL of a 1M solution in 
CH2Cl2, 0.19 mmol) in MeOH (20 mL) to give (-)-212 (950 mg, 54%) as a 
colourless solid in 24% ee determined by HPLC analysis [Chiralpak AD, 
hexane/iso-propanol 95:5, 1.0 mL.min-1, λ = 215 nm, t (major) = 27.73 min, t 
(minor) = 31.62 min], by comparison to a racemic sample. [α]D24 = - 18.9 (c 1.82, 
CHCl3); MP 48 - 52 ºC.  Other data identical to racemic compound. 
7.5.10.4 Studies into racemisation of (-)-tert-butyl-6-methoxy-3a-(7-methoxy-
1,3-benzodioxol-5-yl)-4-oxo-2,3,3a,4,7,7a-hexahydro-1H-indole-1-carboxylate, 
(-)-212 
Any change in enantiomeric excess of enol ether (-)-212 during the reaction was 
investigated by removing aliquots from the Dieckmann cyclisation at varying time 
intervals: 
N
MeO O
O
O
OMeO
O
O
MeO O
O
NO
O
O
O
MeO O
O
NO
O
O
OMe(-)-210 211
KOt-Bu, THF TiCl4, MeOH
(-)-212  
To a solution of keto-ester (-)-210 (200 mg, 0.46 mmol) in anh THF (9 mL) at 40 
ºC was added KOtBu (0.97 mL of a 1 M solution in THF, 0.97 mmol).  A 2.5 mL 
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aliquot was removed from the reaction mixture after 1, 5, 10 and 20 min and 
quenched immediately with 1 M HCl (5 mL).  Each mixture was extracted with 
ethyl acetate (2 x 5 mL) and the crude organic residues treated with TiCl4 in MeOH 
according to the procedure for racemate production to give, following column 
chromatography on silica gel, (-)-212 in the yields and enantioselectivities shown in 
Table 7.12. 
Entry Time/min t(major)/min t(minor)/min % Yield % ee 
1 1 - - - - 
2 5 26.06 29.73 27 26 
3 10 27.48 31.32 21 27 
4 20 28.05 31.96 17 25 
Table 7.12: Measurement of enantiomeric excess of (-)-212 with time, insufficient product could be 
obtained from the aliquot removed after 1 min, this mainly contained starting material. 
Racemisation of the starting material was investigated by quenching the reaction 
after 1 min and measuring the enantiomeric excess of the recovered starting 
material: 
To a solution of keto-ester (-)-210 (44 mg, 0.1 mmol) in anh THF (2 mL) at 40 º C 
was added KOtBu (0.21 mL of a 1 M solution in THF, 0.21 mmol).  The reaction 
mixture was stirred for 1 min then quenched at 40 ºC with 1 M HCl (5 mL).  The 
reaction mixture was extracted with ethyl acetate (2 x 5 mL) and the combined 
organic portions dried over Na2SO4, filtered and concentrated.  The residue was 
purified by column chromatography on silica gel to recover the starting material (-)-
210 (20 mg, 45%), in 1.7:1 dr and 26/21% ee for the major/minor diastereomers 
respectively [Chiralpak AD, hexane/iso-propanol 95:5, 1.0 mL.min-1, λ = 215 nm, 
minor diastereomer: t (major) = 17.32 min, t (minor) = 20.14 min], major 
diastereomer: t (minor) = 26.12 min, t (major) = 35.33 min] by comparison to a 
racemic sample. 
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Crystal data 
C21H25NO6     F(000) = 824 
Mr = 387.43     Dx = 1.339 Mg m−3 
Monoclinic, P21/c    Melting point: not measured K 
Hall symbol: -P 2ybc    Mo Kα radiation, λ = 0.71073 Å 
a = 5.8975 (1) Å    Cell parameters from 4452 reflections 
b = 12.5457 (2) Å    θ = 5–27° 
c = 25.9990 (4) Å    μ = 0.10 mm−1 
β = 92.6152 (6)°    T = 150 K 
V = 1921.62 (5) Å3    Plate, colourless 
Z = 4      0.26 × 0.24 × 0.08 mm 
 
Data collection 
Area diffractometer    3384 reflections with I > 2.0σ(I) 
graphite     Rint = 0.042 
ω scans     θmax = 27.5°, θmin = 5.1° 
Absorption correction: multi-scan 
DENZO/SCALEPACK  
(Otwinowski & Minor, 1997)  h = −7→7 
Tmin = 0.93, Tmax = 0.99   k = −16→13 
22970 measured reflections   l = −33→33 
4365 independent reflections 
 
Refinement 
Refinement on F2  Primary atom site location: structure-invariant 
direct methods 
Least-squares matrix: full  Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2σ(F2)] = 0.041   H-atom parameters constrained 
wR(F2) = 0.098 Method = Modified Sheldrick w = 1/[σ2(F2) + 
(0.04P)2 + 0.82P],where P = (max(Fo2,0) + 
2Fc2)/3 
S = 0.94     (Δ/σ)max = 0.0004 
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4365 reflections    Δρmax = 0.38 e Å−3 
253 parameters    Δρmin = −0.36 e Å−3 
0 restraints 
 
Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) 
 x y z Uiso*/Ueq 
O1 0.36310(16) 0.86815(8) 0.15997(3) 0.0311 
C2 0.4543(2) 0.80516(11) 0.18988(5) 0.0236 
O3 0.63940(15) 0.74621(8) 0.18095(3) 0.0279 
C4 0.7273(2) 0.73901(12) 0.12867(5) 0.0287 
C5 0.8180(2) 0.84590(12) 0.11226(5) 0.0328 
C6 0.5425(3) 0.69700(15) 0.09113(6) 0.0447 
C7 0.9187(3) 0.65893(13) 0.13643(6) 0.0370 
N8 0.37855(17) 0.78318(9) 0.23738(4) 0.0212 
C9 0.5180(2) 0.73002(10) 0.27849(4) 0.0196 
C10 0.3902(2) 0.75558(10) 0.32814(5) 0.0209 
C11 0.5583(2) 0.75893(10) 0.37498(5) 0.0215 
C12 0.6879(2) 0.85078(11) 0.38594(5) 0.0252 
C13 0.8449(2) 0.84439(11) 0.42668(5) 0.0253 
O14 0.98970(17) 0.92367(8) 0.44517(4) 0.0344 
C15 1.1494(3) 0.86916(12) 0.47936(6) 0.0334 
O16 1.04468(16) 0.77139(8) 0.49443(4) 0.0313 
C17 0.8788(2) 0.75416(11) 0.45588(5) 0.0244 
C18 0.7564(2) 0.66210(11) 0.44564(5) 0.0239 
C19 0.5941(2) 0.66698(11) 0.40453(5) 0.0231 
O20 0.80395(17) 0.57536(8) 0.47553(3) 0.0303 
C21 0.7135(3) 0.47529(11) 0.45736(5) 0.0300 
C22 0.2030(2) 0.67564(11) 0.33590(5) 0.0232 
C23 0.1632(2) 0.58830(11) 0.30772(5) 0.0246 
C24 0.3176(2) 0.55526(11) 0.26771(5) 0.0249 
C25 0.5433(2) 0.61064(10) 0.26961(5) 0.0226 
O26 0.26723(18) 0.48511(8) 0.23656(4) 0.0385 
C27 0.2739(2) 0.86254(10) 0.31446(5) 0.0239 
C28 0.1981(2) 0.84924(11) 0.25817(5) 0.0240 
H51 0.8809 0.8384 0.0786 0.0489* 
H53 0.9394 0.8687 0.1362 0.0485* 
H52 0.6959 0.9000 0.1111 0.0484* 
H61 0.6110 0.6835 0.0583 0.0657* 
H63 0.4157 0.7481 0.0863 0.0660* 
H62 0.4851 0.6294 0.1038 0.0663* 
H71 0.9930 0.6485 0.1034 0.0553* 
 201
H73 1.0345 0.6840 0.1629 0.0545* 
H72 0.8595 0.5906 0.1471 0.0559* 
H91 0.6688 0.7631 0.2811 0.0208* 
H121 0.6706 0.9142 0.3662 0.0304* 
H151 1.1815 0.9141 0.5104 0.0391* 
H152 1.2917 0.8524 0.4609 0.0391* 
H191 0.5077 0.6048 0.3959 0.0267* 
H211 0.7777 0.4217 0.4808 0.0435* 
H212 0.5465 0.4757 0.4585 0.0433* 
H213 0.7588 0.4618 0.4224 0.0438* 
H221 0.1002 0.6929 0.3627 0.0286* 
H231 0.0332 0.5443 0.3132 0.0291* 
H252 0.6336 0.5815 0.2993 0.0269* 
H251 0.6224 0.5970 0.2382 0.0282* 
H271 0.3830 0.9203 0.3171 0.0292* 
H272 0.1476 0.8779 0.3363 0.0300* 
H281 0.1873 0.9168 0.2395 0.0283* 
H282 0.0507 0.8111 0.2542 0.0281* 
 
Atomic displacement parameters (Å2) 
 U11 U22 U33 U12 U13 U23 
O1 0.0286(5) 0.0406(6) 0.0241(5) 0.0045(4) -0.0007(4) 0.0101(4) 
C2 0.0201(6) 0.0282(7) 0.0224(6) -0.0016(5) -0.0013(5) 0.0024(5) 
O3 0.0265(5) 0.0367(6) 0.0208(5) 0.0050(4) 0.0058(4) 0.0039(4) 
C4 0.0279(7) 0.0376(8) 0.0213(6) -0.0046(6) 0.0071(5) -0.0032(6) 
C5 0.0300(7) 0.0424(9) 0.0264(7) -0.0052(7) 0.0037(6) 0.0042(6) 
C6 0.0394(9) 0.0608(11) 0.0342(8) -0.0152(8) 0.0042(7) -0.0149(8) 
C7 0.0365(8) 0.0361(9) 0.0395(8) -0.0002(7) 0.0149(7) -0.0038(7) 
N8 0.0183(5) 0.0250(6) 0.0202(5) 0.0030(4) 0.0007(4) 0.0033(4) 
C9 0.0174(6) 0.0230(7) 0.0185(6) 0.0006(5) 0.0003(5) 0.0020(5) 
C10 0.0212(6) 0.0224(7) 0.0193(6) 0.0010(5) 0.0021(5) 0.0001(5) 
C11 0.0221(6) 0.0233(7) 0.0194(6) 0.0014(5) 0.0037(5) -0.0011(5) 
C12 0.0296(7) 0.0238(7) 0.0223(6) 0.0008(6) 0.0017(5) 0.0007(5) 
C13 0.0288(7) 0.0235(7) 0.0236(7) -0.0044(6) 0.0023(5) -0.0044(5) 
O14 0.0408(6) 0.0276(5) 0.0337(5) -0.0087(5) -0.0100(4) -0.0004(4) 
C15 0.0353(8) 0.0320(8) 0.0321(8) -0.0061(7) -0.0061(6) -0.0011(6) 
O16 0.0355(6) 0.0327(6) 0.0248(5) -0.0071(4) -0.0085(4) 0.0004(4) 
C17 0.0253(7) 0.0297(7) 0.0180(6) -0.0005(6) -0.0014(5) -0.0031(5) 
C18 0.0275(7) 0.0257(7) 0.0187(6) 0.0009(6) 0.0014(5) 0.0014(5) 
C19 0.0252(7) 0.0231(7) 0.0208(6) -0.0018(5) 0.0001(5) -0.0009(5) 
O20 0.0385(6) 0.0252(5) 0.0262(5) -0.0035(4) -0.0101(4) 0.0040(4) 
C21 0.0361(8) 0.0235(7) 0.0296(7) 0.0000(6) -0.0059(6) 0.0009(6) 
C22 0.0201(6) 0.0285(7) 0.0209(6) 0.0029(5) 0.0015(5) 0.0053(5) 
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C23 0.0195(6) 0.0265(7) 0.0277(7) -0.0021(5) -0.0007(5) 0.0049(6) 
C24 0.0270(7) 0.0210(7) 0.0264(7) 0.0021(5) -0.0031(5) 0.0009(5) 
C25 0.0220(6) 0.0241(7) 0.0217(6) 0.0035(5) 0.0009(5) 0.0011(5) 
O26 0.0383(6) 0.0336(6) 0.0437(6) -0.0048(5) 0.0020(5) -0.0134(5) 
C27 0.0231(6) 0.0226(7) 0.0261(7) 0.0038(5) 0.0031(5) 0.0016(5) 
C28 0.0200(6) 0.0251(7) 0.0269(7) 0.0046(5) 0.0020(5) 0.0036(5) 
 
 Geometric parameters (Å, °) 
O1—C2 1.2167(16) H71—C7—H73 108.8 
C2—O3 1.3477(16) C4—C7—H72 110.3 
C2—N8 1.3603(16) H71—C7—H72 108.1 
O3—C4 1.4794(15) H73—C7—H72 109 
C4—C5 1.512(2) C2—N8—C9 123.59(10) 
C4—C6 1.524(2) C2—N8—C28 119.48(10) 
C4—C7 1.518(2) C9—N8—C28 112.12(9) 
C5—H51 0.971 N8—C9—C10 103.43(9) 
C5—H53 0.97 N8—C9—C25 112.89(10) 
C5—H52 0.989 C10—C9—C25 112.47(10) 
C6—H61 0.976 N8—C9—H91 109.3 
C6—H63 0.989 C10—C9—H91 109.1 
C6—H62 0.976 C25—C9—H91 109.4 
C7—H71 0.99 C9—C10—C11 110.11(10) 
C7—H73 0.998 C9—C10—C22 110.97(10) 
C7—H72 0.971 C11—C10—C22 111.18(10) 
N8—C9 1.4777(15) C9—C10—C27 102.42(10) 
N8—C28 1.4713(16) C11—C10—C27 115.07(10) 
C9—C10 1.5575(16) C22—C10—C27 106.75(10) 
C9—C25 1.5238(18) C10—C11—C12 120.60(11) 
C9—H91 0.981 C10—C11—C19 119.32(11) 
C10—C11 1.5351(17) C12—C11—C19 119.90(12) 
C10—C22 1.5121(18) C11—C12—C13 116.68(12) 
C10—C27 1.5413(18) C11—C12—H121 122.3 
C11—C12 1.4048(18) C13—C12—H121 121.1 
C11—C19 1.3969(18) C12—C13—O14 127.48(12) 
C12—C13 1.3770(18) C12—C13—C17 123.32(12) 
C12—H121 0.949 O14—C13—C17 109.21(11) 
C13—O14 1.3828(16) C13—O14—C15 104.44(10) 
C13—C17 1.3726(19) O14—C15—O16 107.28(11) 
O14—C15 1.4382(17) O14—C15—H151 109 
C15—O16 1.4359(17) O16—C15—H151 109.3 
C15—H151 0.995 O14—C15—H152 110 
C15—H152 1.007 O16—C15—H152 109.2 
O16—C17 1.3852(15) H151—C15—H152 111.8 
C17—C18 1.3814(18) C15—O16—C17 103.55(10) 
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C18—C19 1.4030(18) O16—C17—C13 110.59(12) 
C18—O20 1.3590(16) O16—C17—C18 127.99(12) 
C19—H191 0.953 C13—C17—C18 121.42(12) 
O20—C21 1.4356(16) C17—C18—C19 116.27(12) 
C21—H211 0.974 C17—C18—O20 117.83(11) 
C21—H212 0.986 C19—C18—O20 125.90(12) 
C21—H213 0.974 C18—C19—C11 122.40(12) 
C22—C23 1.3330(19) C18—C19—H191 118.8 
C22—H221 0.969 C11—C19—H191 118.8 
C23—C24 1.4730(19) C18—O20—C21 116.63(10) 
C23—H231 0.96 O20—C21—H211 105.7 
C24—C25 1.4998(18) O20—C21—H212 110 
C24—O26 1.2235(16) H211—C21—H212 110.2 
C25—H252 0.988 O20—C21—H213 110.2 
C25—H251 0.973 H211—C21—H213 110.5 
C27—C28 1.5198(18) H212—C21—H213 110.2 
C27—H271 0.969 C10—C22—C23 125.68(12) 
C27—H272 0.976 C10—C22—H221 115.6 
C28—H281 0.977 C23—C22—H221 118.6 
C28—H282 0.993 C22—C23—C24 121.36(12) 
O1—C2—O3 125.74(12) C22—C23—H231 120.8 
O1—C2—N8 123.94(12) C24—C23—H231 117.9 
O3—C2—N8 110.32(11) C23—C24—C25 115.00(11) 
C2—O3—C4 120.83(10) C23—C24—O26 122.04(13) 
O3—C4—C5 110.39(11) C25—C24—O26 122.91(12) 
O3—C4—C6 109.83(11) C9—C25—C24 111.57(11) 
C5—C4—C6 112.20(13) C9—C25—H252 107.3 
O3—C4—C7 102.01(11) C24—C25—H252 107.5 
C5—C4—C7 110.72(12) C9—C25—H251 110.7 
C6—C4—C7 111.23(13) C24—C25—H251 110.5 
C4—C5—H51 108.8 H252—C25—H251 109.2 
C4—C5—H53 109.9 C10—C27—C28 103.59(10) 
H51—C5—H53 107.9 C10—C27—H271 110.3 
C4—C5—H52 110.5 C28—C27—H271 108.4 
H51—C5—H52 110.3 C10—C27—H272 112.4 
H53—C5—H52 109.4 C28—C27—H272 112.5 
C4—C6—H61 107.9 H271—C27—H272 109.5 
C4—C6—H63 111.8 C27—C28—N8 103.27(10) 
H61—C6—H63 110 C27—C28—H281 113.2 
C4—C6—H62 109.4 N8—C28—H281 109.7 
H61—C6—H62 108 C27—C28—H282 111.8 
H63—C6—H62 109.6 N8—C28—H282 109.5 
C4—C7—H71 109.2 H281—C28—H282 109.2 
C4—C7—H73 111.4   
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Hydrogen-bond geometry (Å, °) 
D—H···A D—H H···A D···A D—H···A 
C5—H53···O1 0.97 2.55 3.4038(19) 147 
C15—H151···O14 0.99 2.57 3.3802(19) 139 
C21—H213···O1 0.97 2.52 3.3451(19) 143 
 
Symmetry codes: (i) x+1, y, z; (ii) −x+2, −y+2, −z+1; (iii) −x+1, y−1/2, −z+1/2. 
 
 
